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Mycotoxins are secondary metabolites produced by fungi of different species (mainly Aspergillus,
Fusarium, and Penicillium) with toxic effects for humans and animals that can contaminate food and
feed. Notifications on the Rapid Alert System for Food and Feed (RASFF) concerning mycotoxins
are becoming frequent, being among the “top 10” hazards reported on food products, mainly cereals
and nuts [1]. The European Union (EU), among others, has established maximum permitted or
recommended levels for several mycotoxins, including aflatoxins (AF) B1, B2, G1, G2 and M1,
ochratoxin A (OTA), patulin (PAT), deoxynivalenol (DON), zearalenone (ZEN), fumonisins (FB1 and
FB2), HT-2 and T-2 toxins, or citrinin (CIT) in different food commodities [2]. However, there are
other mycotoxins not included in regulations, the so-called “emerging mycotoxins”, whose toxicity
is still not clear, that could also pose a risk to humans and animals. This group includes Alternaria
toxins, sterigmatocystin (STC), phomopsins, and Fusarium toxins as enniatins (ENN) or beauvericin
(BEA), among others [3]. Moreover, the so-called “modified or masked mycotoxins” (produced as a
consequence of a detoxification strategy of the host plant of the fungus or during food processing) could
be equally or even more toxic than the original mycotoxin, and should also be taken into account [4].
All these facts make it necessary to develop analytical methods for the accurate determination
of mycotoxins in different food matrices and feeds. In this sense, liquid chromatography tandem
mass spectrometry (LC–MS/MS) is a powerful tool for the unique identification and quantification of
analytes. Moreover, the use of high-resolution mass spectrometry (HRMS) allows the identification of
novel mycotoxins and targeted/untargeted approaches for their study.
This Special Issue is dedicated to recent applications of LC–MS/MS in mycotoxin studies, including
the development and validation of new analytical methods for their identification and quantification
in different food matrices and feed, occurrence studies and biomonitoring of mycotoxins, and their
metabolites in biological fluids.
Although most of the papers propose methods for the simultaneous determination of several
mycotoxins, Bertuzzi et al. focus their work on the improvement of determination of moniliformin
(MON) by adding lanthanide ions to the mobile phase during chromatographic separation [5]. MON is
weakly retained in reversed-phase chromatography, making the separation difficult. The addition of
La3+, Tb3+ or Eu3+ to the mobile phase is investigated, improving peak shape and MON separation,
probably due to the formation of coordination complexes lanthanide–MON. After extraction and
purification, the method is applied to the determination of MON in maize and wheat samples.
The potential of LC–MS/MS for multi-mycotoxin determination in different food matrices is shown
in different contributions of this Special Issue. For instance, Guo et al. propose a modified QuEChERS
(Quick, Easy, Cheap, Efficient, Rugged, and Safe) procedure for the determination of 6 Alternaria toxins
in 56 grape samples [6]. A total of 40 samples (incidence of 71.4%) were contaminated with Alternaria
toxins, tentoxin being the most frequently found mycotoxin (37.5%). Cannabidiol food supplements
(a scarcely studied matrix) are analyzed by Narváez et al., who develop an LC–HRMS method for
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the quantification of 16 mycotoxins produced by major C. sativa fungi [7]. They report that up to six
different Fusarium mycotoxins were found in seven of the ten analyzed samples, the most prevalent
being ZEN (60%) and ENN B1 (30%). Co-occurrence was observed in four samples, including one with
ENN B1, ENN A, and ENN A1. Moreover, 46 pesticides were detected after a retrospective analysis.
Considering that cereals are one of the most susceptible matrices for contamination by mycotoxins,
the brewing industry is an interesting field to be considered in these studies. In this context, Piacentini
et al. characterize the Fusarium isolates from brewing barley, and the phylogenetic study shows that
the majority of the strains clustered with F. graminearum, F. poae, and F. avenaceum [8]. Moreover,
DON and ZEN were detected in 90.6% and 87.5% of the samples, respectively, and 86% of the samples
contaminated with ZEN were above the limits set by the EU and Brazilian regulations. The same
research group studied the stability of DON and ZEN during all steps of the malting and brewing
processes [9]. The results show that during the malting process, DON levels decreased significantly
in the steeping, germination, and malting steps (62%, 51.5%, and 68%, respectively). Considering
ZEN, when the levels were compared between barley and the last step of the process, a significant
decrease was observed. Another paper by Nafusa et al. reports the variation of fungal metabolites in
81 sorghum malts used to prepare Namibian traditional fermented beverages (omalodu and otombo
malts) [10]. It must be highlighted that 102 metabolites were quantified in both malts (96% in omalodu
malts and 93% in otombo malts). An average of 48 metabolites (including emerging mycotoxins,
AF precursors, and ergot alkaloids) was quantified in otombo malts while an average of 67 metabolites
was quantified in omalodu malts. Co-occurrence of EU-regulated mycotoxins, such as PAT, AFs (B1,
B2, and G2), and fumonisins (FB1, FB2, and FB3) was detected in both malts with a prevalence range of
2–84%. All these studies accentuate the need to control mycotoxins in cereals intended for brewing,
their resistance to food processing treatments, and their fate in the beverages.
Considering the high toxicity of mycotoxins, occurrence studies and exposure assessment in
different regions of the world (especially those without a food safety regulation system) are relevant
aspects, LC–MS/MS being the technique of choice for multi-mycotoxin analysis. In the framework
of the first multi-center Sub-Saharan Africa Total Diet Study (SSA-TDS), 194 composite samples of
cereals, tubers, legumes, vegetables, nuts and seeds, dairy, oils, beverages and miscellaneous were
tested for mycotoxins [11]. The results show that populations from North Cameroon and Benin may
suffer chronic and simultaneous exposure to AFB1, FB1, STC, OTA, and CIT, which are prevalent in
their diet. In the same line, Ijeoma-Ekwomadu et al. investigate the variation of different Fusarium
metabolites (including regulated, modified, and emerging mycotoxins) in 123 maize samples from
various regions of South Africa [12]. The relationship between the maize producing regions, the maize
type, as well as the mycotoxins, was established. The results reveal that all maize types exhibited a
mixture of free, modified and emerging mycotoxins contamination across the regions with an average
of 5 mycotoxins, and up to 24 out of 42 investigated Fusarium mycotoxins, including 1 to 3 modified
forms at the same time, fumonisins (FB1, FB2, FB3, FB4, and FA1) being the most prevalent mycotoxins.
Significant differences in the contamination pattern were observed between the agricultural regions and
maize types. Finally, the presence of 15 mycotoxins in 120 cereal samples (including barley, maize, rice,
and wheat) from Algeria is evaluated by Mahdjoubi et al. [13]. Analytical results show that 78 cereal
samples (65%) were contaminated with at least one toxin, while 50% were contaminated with three to
nine mycotoxins, T-2 toxin, CIT, BEA, and DON being the most frequently found. Moreover, the exposure
assessment shows that the high levels of fumonisins (FB1 and FB2) in maize, and DON, ZEN, HT-2 and
T-2 toxins in wheat, could represent a health risk for the average adult consumer in Algeria.
Contamination of mycotoxins in feed samples is also a matter of concern, as this is the first link in
the food chain, with negative effects not only on the health of animals but also on humans consuming
animal-derived products. Arroyo-Manzanares et al. carry out a survey, including 228 pig feed samples
from different Spanish farms and suppliers, exploring the occurrence of 19 mycotoxins [14]. Although
97% of samples were in accordance with EU regulations, the study shows the high occurrence of
emerging mycotoxins (100% samples were contaminated with ENN B and more than 90% were
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contaminated with BEA), as well as the high co-occurrence of different mycotoxins in the same sample
(40% samples were contaminated with more than five mycotoxins). Moreover, Facorro et al. develop a
methodology for the simultaneous determination of 26 mycotoxins in 97 mixed feed rations collected in
20 dairy cows farms [15]. LC–HRMS based on data-independent acquisition was employed. All unified
samples analyzed showed co-occurrence of two or more mycotoxins, recurrently ZEN, FB1, and
β-zearalenol, with an occurrence frequency ranging from 60% to 90%. Additional screening based on a
retrospective approach enabled the identification of non-targeted mycotoxins, most of them originated
from Fusarium fungi. The results of these studies show that, in order to ensure feed safety, emerging
and modified mycotoxins, as well as the co-occurrence of different mycotoxins, should be considered
as a potential risk.
In addition to foodstuff and feed, the determination of mycotoxins in biological fluids is also one of
the topics addressed in this Special Issue. Debevere et al. develop and fully-validate a UHPLC–MS/MS
method for the quantitative determination in the rumen fluid of some of the most relevant mycotoxins
found in maize silage [16]. Extraction recovery and matrix effects were determined in the rumen fluid
with and without maize silage. Differences in extraction recovery and matrix effect between rumen
fluid alone and rumen fluid with maize silage highlight the importance of using matrix-matched
calibration curves for the quantification of mycotoxins in this complex sample. This method can be
applied to investigate the degradation of the reported mycotoxins by rumen microbiota. Related to
this topic, another aspect that is attracting great interest is biomonitoring of biological fluids as an
alternative approach to assessing health risk. However, metabolic pathways have not been investigated
thoroughly for all mycotoxins, and, consequently, most of the existing analytical LC–MS methods
used for the assessment of human exposure focus only on the detection of parent compounds. In this
context, Slobodchikova et al. perform human in vitro microsomal incubations of 17 mycotoxins
in order to characterize all resulting metabolites using LC–HRMS [17]. The results allowed them
to build a comprehensive LC–MS library. Moreover, the method can also screen 188 additional
metabolites, including 100 metabolites reported for the first time. This contribution represents one
of the most comprehensive LC–HRMS methods for mycotoxin biomonitoring or metabolism/fate
studies. In other work covering this topic, Lauwers et al. propose the combination of LC–MS/MS
to determine regulated and emerging mycotoxins in biological matrices of pigs and broiler chickens,
with LC–HRMS to determine mycotoxin metabolites for which analytical standards are not always
commercially available [18]. After in-house validation, the methods were applied to plasma, urine,
feces, and/or excreta samples obtained during in vivo toxicokinetic studies with DON and ZEN in
pigs, and with DON, AF B1 and OTA in broiler chickens, and during a pilot field screening study to
monitor exposure to mycotoxins.
Most of the papers reported so far use solid–liquid or liquid–liquid extractions, or QuEChERS-based
extractions as sample treatments. However, novel extraction methods are also proposed in this Special
Issue, as in the paper of Arroyo-Manzanares et al. that explores the potential of dispersive magnetic
solid-phase extraction (DMSPE) for the determination of emerging mycotoxins (ENN A, ENN A1,
ENN B, ENN B1, and BEA) [19]. After its characterization, a magnetic multiwalled carbon nanotube
(Fe3O4@MWCNT) composite was selected for the extraction and preconcentration of these mycotoxins
in human urine samples. Analysis of the extracts was performed by LC–HRMS. Matrix-matched
calibration curves were necessary, obtaining limits of quantification between 0.04 and 0.1 μg/L, relative
standard deviation lower than 12%, and recoveries between 89.3% and 98.9%.
Method validation is a very important aspect in the development of an analytical methodology.
The proposed methods must assure compliance with the requirements and recommendations of
mycotoxins determination in order to ensure high-quality results. Most of the published papers
have carried out in-house validation. On the other hand, Bessaire et al. present the results of an
intercollaborative study (including 23 entities) organized to evaluate the performance characteristics
of an LC–MS/MS procedure for the determination of 12 mycotoxins in food, based on QuEChERS
and immunoaffinity column cleanup [20]. Each participant analyzed 28 incurred and/or spiked blind
3
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samples composed of spices, nuts, milk powder, dried fruits, cereals, and baby food using the protocol
given. The results show that the method is applicable regardless of the food, the regulated mycotoxin,
and the concentration level (even at low regulated levels for foods intended for infants and young
children), therefore being an excellent candidate for future standardization.
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Abstract: An innovative chromatographic analysis was developed for the determination of
moniliformin (MON). Because of its ionic nature, MON is weakly retained in reversed-phase
chromatography and the separation may be tricky. Nevertheless, this technique is normally used
either with the formation of ion pairs or employing specific RP columns for polar compounds, or
combining anion exchange and hydrophobic interactions. Hydrophilic interaction chromatography
(HILIC) was also used, but a non-negligible peak tailing was observed. Besides its ionic nature, MON
is a di-ketone and di-ketones, mainly β-di-ketones, can easily form complexes with lanthanide ions.
Then, in this work the addition of lanthanide ions to the mobile phase was investigated, aiming at
improving peak shape and MON separation. La3+, Tb3+ or Eu3+ aqueous solutions were used as
mobile phase and MON was chromatographed using a LC-NH2 column. The probable formation of
coordination complexes lanthanide-MON in the HPLC mobile phase allowed to obtain a symmetrical
peak shape and a satisfactory chromatographic separation by both mass spectrometry (MS/MS) and
UV detection. Finally, a suitable extraction and purification method for MON determination in cereal
samples was developed.
Keywords: moniliformin; lanthanide complexes; LC-MS/MS; LC-UV
Key Contribution: Simple and innovative LC-MS/MS and LC-UV methods for the determination of
MON were developed.
1. Introduction
Moniliformin (MON) is a Fusarium mycotoxin often occurring in cereals; it is mainly produced by
F. avenaceum, proliferatum, subglutinans, tricinctum and verticilloides [1]. MON is a small, highly polar,
acidic molecule and because of the low pKa value (<1.7) of the free acid, MON occurs as a water-soluble
sodium or potassium salt [2]. MON is toxic to experimental animals, causing myocardial degeneration,
muscular weakness and respiratory distress [3,4]; the European Food Safety Authority (EFSA) Panel
on Contaminants in the Food Chain (CONTAM) indicated haematotoxicity and cardiotoxicity as major
adverse health effects of MON [5]. At present, no specific maximum levels for MON in food and feed
have been set by EU legislation. MON was detected worldwide in several cereal crops at different
concentration levels with values up to 2606 μg kg−1 in maize and 326 μg kg−1 in wheat produced,
respectively, in Italy and in the Netherlands being reported [1,6–11]. However, EFSA recommended the
collection of more occurrence data on MON in foods and feeds to enable a comprehensive risk assessment
for humans, and for farm and companion animals [5]. The same report recommended the development
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of validated analytical methods for MON determination. Because of its ionic nature, MON is weakly
retained by reversed-phase (RP) chromatography. Nevertheless, this technique is normally used either
with the formation of ion pairs [12] or employing specific RP columns for polar compounds, or combining
anion exchange and hydrophobic interactions [9,13,14]. Hydrophilic interaction chromatography was
also used, but a non-negligible peak tailing was observed [8]. In this work, a new approach was
evaluated; besides its ionic nature, MON is a di-ketone (1-hydroxycyclobut-1-ene-3,4-dione. As seen
in Figure 1, di-ketones, mainly β-di-ketones, can easily form complexes with lanthanide ions (as
Lanthanum La3+, Terbium Tb3+ or Europium Eu3+), linking the metallic ion through the oxygen
atoms [15]. Generally, three di-ketones are linked to one lanthanide ion (Figure 2).
Figure 1. Chemical structure of moniliformin (X = H, Na or K).
 
Figure 2. Structure of a [Ln-(β-di-ketone)3] complex (Ln: lanthanide ion).
Then, in this work the addition of lanthanide ions to the mobile phase was investigated, aiming
at improving peak shape and MON separation. MON determination was carried out using both UV
and mass spectrometry (MS/MS) detection. UV detection was used for its major flexibility during
the development of the method and MS/MS detection for its major accuracy and lower detection
limits. Finally, a suitable extraction and purification method for MON determination in cereal samples
was developed.
2. Results and Discussion
2.1. Development of the Chromatographic Method
It is known that MON is weakly retained in RP chromatography, recently, specific columns for polar
compounds were used for its determination. Initially, four columns were tested using an HPLC-UV
instrument: an RP-8 (Lichrospher, 5 μm particle size, 125 × 4 mm i.d., Merck, Darmstadt, Germany),
a X-Select HSS T3 (RP-18 with low ligand density, 2.5 μm particle size, 100 × 2.1 mm i.d., Waters
Corporation, Milford, MA, USA), a XBridge BEH Amide column (2.5 μm particle size, 100 × 2.1 mm i.d.,
Waters Corporation, Milford, MA, USA) and a Supelcosil LC-NH2 column (250 × 3 mm, 5 μm, Supelco,
Bellefonte, PA, USA); a mixture acetonitrile:water 20 + 80 v/v at a flow rate of 1.0 mL min-1 was used
as mobile phase. A MON standard at 1000 μg L−1 was injected; MON was weakly retained by RP-8,
X-Select HSS T3 and BEH Amide columns (retention time lower than 2.0 min); on the other hand, MON
was strongly retained by the LC-NH2 column (no peak was observed until 30 min). Successively, the
mobile phase was substituted with acetonitrile: 10 mm LaCl3·7H2O 20 + 80 v/v; no relevant difference
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of the retention time was observed for RP-8, X-Select HSS T3 and BEH Amide column, while MON







Figure 3. Chromatographic separation of moniliformin (MON) standard (1000 μg l−1) on a LC-NH2
column using water (a) or 10 mM La3+ aqueous solution (b) in the mobile phase.
Five calibration standards were injected (20, 100, 250, 500 and 1000 μg L−1), showing a satisfactory
calibration curve (R2 = 0.998). Successively, increasing concentrations from 1 to 50 mM of LaCl3·7H2O
in the mobile phase were tested and a decrease of the retention time was observed (Figure 4).
Figure 4. Variation of retention time depending on concentration of LaCl3 (mM) in the mobile phase.
Finally, a satisfactory chromatographic separation was obtained applying a linear gradient
acetonitrile:2.5 mM LaCl3·7H2O (Figure 5); a low LaCl3·7H2O concentration was preferred in order to
delay MON elution and avoid co-elution with other substances.
9







Figure 5. Chromatograms of: (a) MON standard (1000 μg L−1); (b) maize spiked extract (250 μg L−1).
Chromatographic separation was carried out using linear gradient acetonitrile: 2.5 mM LaCl3·7H2O
solution; detection at 260 nm (UV).
Similar results were obtained using Tb3+ or Eu3+; MON was detected at a retention time of 7.0 min
using acetonitrile:2.5 mM TbCl3·6H2O 60 + 40 v/v (Figure 6). Because of its easy availability and lower







Figure 6. Chromatographic separation of MON standard (1000 μg L−1) on LC-NH2 column using:
(a) 2.5 mM Tb3+ aqueous solution:acetonitrile 4 + 6 v/v; (b) 2.5 mM Tb3+ aqueous solution:acetonitrile
6 + 4 v/v; (c) 2.5 mM Tb3+ aqueous solution:acetonitrile 8 + 2 v/v, as mobile phase.
The chromatograms indicate a coordination of MON with lanthanide metals during the separation,
resulting in a stronger affinity of MON for the mobile phase and a consequent faster elution from the
LC-NH2 column. Furthermore, increasing the concentration of La3+, a higher MON affinity for the
mobile phase is favoured and therefore shorter retention times are shown. It is known that lanthanide
ions can form coordination complexes with di-ketones [15], as well as with other organic compounds.
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Recently, a coordination between cyclopiazonic acid, a neurotoxin and lanthanide metals was reported
by Maragos [16].
Generally, the luminescence of some lanthanides, such as Terbium and Europium, can be enhanced
by interaction with selected molecules. For example, Terbium was used in post-column HPLC separation
to increase the luminescence of ochratoxin A [17]. The luminescence is greatly influenced by the
solvent and in particular by the presence of water, as well as by the lanthanide concentration and the
chelate/lanthanide ratio [16]. Using a mobile phase 2.5 mM Tb3+ aqueous solution:acetonitrile 4 + 6 v/v,
we replaced the UV with a fluorimetric detector (λex = 260 nm; λem = 550 nm) in order to evaluate
a possible fluorescence. However, the results showed a negative peak at the retention time of MON
detected by the fluorimeter, showing a decrease of fluorescence of the baseline (Figure 7). During
the chromatographic separation, water and lanthanide concentrations are very much higher than








Figure 7. Chromatograms of MON standard (1000 μg L−1) detected by UV at 260 nm (a) and fluorimeter
detector at λex = 260 nm; λ em = 550 nm (b).
The process of MON separation adding lanthanide ions in the mobile phase can be speculated
considering the theory of ligand exchange chromatography (LEC), a chromatographic process in which
complex-forming compounds are separated through the formation and breaking of labile coordinate
bonds to a central metal atom, coupled with partition between a mobile and a stationary phase [20].
Based on LEC theory, the coordination of lanthanide ions with water in the mobile phase, can be partially
replaced with the coordination to MON, resulting in the formation of mixed coordination complexes
(Figure 8). These coordination complexes are kinetically weak, their formation and dissociation is fast
and can be described by the following reversible reaction:
MON + [Ln(H2O)n]↔ [Ln(MON)(H2O)n−1] + H2O Ln—lanthanide
This process could explain the higher MON affinity for the mobile phase and the faster elution,
when lanthanide concentration is increased. In absence of lanthanide ions in the mobile phase, MON
is strongly retained by the stationary phase of the LC-NH2 column.
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Figure 8. Possible structure of the coordination complex during chromatographic separation in presence
of La3+ in the mobile phase.
Finally, the chromatographic analysis was carried out using a mass spectrometric detector (MS/MS,
triple quadrupole, Thermo Fisher Scientific, San Jose, CA, USA) in order to obtain high accuracy and
lower detection limits; a very low LaCl3·7H2O concentration was used (1.25 mM) to avoid troubles
during the ionisation. MON was chromatographed on a 75 × 3 mm, 3 μm LC-NH2 column (Supelco)
and detected at 4.4 min, improving the limit of detection (Figure 9).
Figure 9. Chromatograms of: (a) MON standard (100 μg L−1); (b) naturally contaminated maize sample
(1637 μg kg−1). Chromatographic separation was carried out using a linear gradient methanol: 25 mM
ammonium acetate containing 1.25 mM LaCl3·7H2O; detection by MS/MS (MRM transition m/z 97 >41).
2.2. Development of an Extraction and Purification Method for Cereal Samples
Generally, MON was extracted using a mixture acetonitrile:water 84:16 (as for tricothecenes).
Considering that MON is highly water-soluble, Barthel et al. [10] and Herrera et al. [9] recently
increased the percentage of water in the extraction mixture, using acetonitrile:water 50 + 50 v/v or pure
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water, obtaining higher extraction yields. Since in our tests the extract using water 100% was turbid,
probably for the presence of other large polar molecules, the mixture acetonitrile:water 50 + 50 v/v
was preferred. As regards the purification step, several authors used either a SAX-like SPE [9] or a
MycoSep® MON 240 column [8,13]. However, Herrera et al. [10] did not obtain satisfactory recoveries
using these columns and consequently no clean-up step was carried out in their method. In this
work, we previously tested MycoSep® MON 240 (Romer Labs, Getzersdorf, Austria), MAX, WAX and
HLB OASIS columns (Waters Corporation, Milford, MA, USA) and the Quechers procedure; in all
tests, unsatisfactory purification or low recoveries were obtained. Moreover, we confirmed that the
evaporation under N2 flow decreased the recovery, as reported by Herrera et al. [10]. Finally, a LC-NH2
column (Supelco) was tested, in order to retain MON and elute it using a lanthanide ion solution,
as for the HPLC separation. This clean-up step was only introduced for HPLC-UV determination,
for LC-MS/MS analysis, the presence of high concentration of La3+ (12.5 mM) in the purified extract
worsened MON detection.
2.3. Performances of the Method
The result of the considered parameters are shown in Table 1. Despite the omission of clean-up
step for LC-MS/MS analysis, the matrix effect, calculated at the concentration of 100 μg L−1 (800 μg kg−1
for a cereal sample), was low, close to 4% and 6% for wheat and maize samples, respectively.
Table 1. Validation parameters of MON analysis using UV and LC-MS/MS detector (three replicates).
HPLC-UV LC-MS/MS
Matrix effect
(at 800 μg kg−1) * /
5% (wheat)
8% (maize)
Calibration range * 160–8000 μg kg−1 20–2000 μg kg−1
LOD * 80 μg kg−1 10 μg kg−1
LOQ * 200 μg kg−1 25 μg kg−1
Average recovery
Wheat 88.2% ± 5.5% 97.1% ± 4.3%
Maize 84.8% ± 5.4% 96.4% ± 5.1%
LOD: limit of detection; LOQ: limit of quantification. * Data referred to cereal sample.
A satisfactory linearity was calculated for both LC-MS/MS (R2 = 0.997) and HPLC-UV (R2 = 0.998).
The limit of detection (LOD), for a cereal sample, was 10 and 80 μg kg−1 using LC-MS/MS and
HPLC-UV, respectively. The decision limit (CCα) and the detection capability (CCβ) were 10 and
18 μg kg−1 for LC-MS/MS, 80 and 136 μg kg−1 for LC-UV.
Skipping the clean-up step (LC-MS/MS analysis), the global average recoveries were 97.1% ± 4.3%
and 96.4% ± 5.1% for wheat and maize, respectively. Using purification step (UV analysis), the average
recoveries were: 86.4% ± 6.4% and 89.8% ± 4.5% for wheat (at 100 and 500 μg kg−1, respectively),
83.6% ± 5.9% and 86.1% ± 5.1% for maize (at 250 and 1000 μg kg−1, respectively).
Finally, the standard deviation obtained by repeatability tests was less than 9.2%.
2.4. MON Occurrence in Cereal Samples
MON occurred in 100% and 50% of maize and wheat samples, respectively. The levels of
contamination, corrected for the recovery percentage, ranged between 38 and 3629 μg kg−1 (the last
value was obtained after dilution of the sample extract) for maize (in 4 samples MON exceeded
1000 μg kg−1), <10 and 481 μg kg−1 for wheat samples (Figure 10).
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Figure 10. Frequency of occurrence (%) of MON in wheat (n = 10) and maize (n = 10) collected in
northern Italy.
3. Materials and Methods
3.1. Reagents and Standards
Chemicals and solvents used for extraction and clean-up were ACS grade or equivalent (Carlo Erba,
Milan, Italy); deionised water was purified through a Milli-Q treatment system (Millipore, Bedford, MA,
USA). For HPLC and LC-MS/MS analysis, water, methanol and acetonitrile were HPLC grade (Merck,
Darmstadt, Germany). MON (as sodium salt), Lanthanum (III) chloride heptahydrate (LaCl3·7H2O),
Terbium (III) chloride hexahydrate (TbCl3·6H2O) and Europium (III) chloride hexahydrate (EuCl3·6H2O)
were obtained from Sigma-Aldrich (St. Louis, MO, USA). A MON stock standard solution was prepared
in acetonitrile at a concentration of 100 mg L−1; working solutions were obtained by dilution using
water:methanol 15 + 85 v/v. All the solutions were stored at −20 ◦C when not in use.
3.2. LC-MS/MS Analysis for Moniliformin Determination
MON was extracted from cereal samples (10 g each) with 40 mL of a mixture acetonitrile: water
50 + 50 v/v using a rotary-shaking stirrer for 60 min. After filtration on a folded filter paper, the
extract was diluted (1 + 1) with methanol:water 85 + 15 v/v and injected into the LC-MS/MS system
(20 μL). The HPLC-MS/MS system consisted of a LC 1.4 Surveyor pump (Thermo Fisher Scientific,
San Jose, CA, USA), a PAL 1.3.1 sampling system (CTC Analytics AG, Zwingen, Switzerland) and
a Quantum Discovery Max triple quadrupole mass spectrometer; the system was controlled by
an Excalibur 1.4 software (Thermo-Fisher). MON was chromatographed on a Supelcosil LC-NH2
column (75 × 3 mm, 3 μm, Supelco, Bellefonte, PA, USA) and separated using a gradient elution with
25 mM ammonium acetate containing 1.25 mM LaCl3·7H2O, and methanol as mobile phase A and B,
respectively. The gradient program was linear gradient from 15% to 35% of solvent A in 3 min, then
isocratic for 1 min; column conditioning lasted 7 min. The flow rate was 0.3 mL min-1. The ionisation
was carried out with an ESI interface (Thermo-Fisher) in negative mode as follows: spray capillary
voltage was 3.5 kV, sheath and auxiliary gas 40 and 15 psi, respectively; skimmer 9 V, temperature
of the heated capillary 350 ◦C. The mass spectrometric analysis was performed in selected reaction
monitoring (SRM). For fragmentation of the [M–H]- ion (97 m/z), the argon collision pressure was set
to 1.2 mTorr and the collision energy to 21 V. The detected and quantified fragment ion was 41 m/z.
Quantitative determination was performed by an LC-Quan 2.0 software (Thermo-Fisher, Waltham,
MA, USA).
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3.3. HPLC-UV Analysis for Moniliformin Determination
After extraction as for LC-MS/MS analysis, a purification step was introduced before HPLC-UV
analysis; a 2 mL aliquot of the extract was purified through a LC-NH2 column (500 mg, 3 mL, Supelco,
Bellefonte, PA, USA), previously conditioned with 2 mL acetonitrile:water 50 + 50 v/v. The column
was washed with acetonitrile (2 mL), deionized water (2 mL) and 1 mL of a 12.5 mM LaCl3·7H2O
aqueous solution; then, MON was eluted in a graduated glass vial with additional 2 mL of the 12.5 mM
LaCl3·7H2O aqueous solution. The purified extract was diluted (1 + 1) using acetonitrile and injected
into a HPLC-UV system (30 μL). The HPLC system consisted of a Jasco PU 1580 pump (Jasco Corp.,
Tokyo, Japan) equipped with an AS 2055 sampling system and a UV 1575 detector set at 219 and
260 nm. The system was governed by a Borwin 1.5 software (Jasco). MON was chromatographed
on a Supelcosil LC-NH2 column (250 × 3 mm, 5 μm, Supelco) and separated using a gradient elution
with 2.5 mM LaCl3·7H2O (or TbCl3·6H2O) and acetonitrile as mobile phase A and B, respectively.
The gradient program was 15% solvent A for 1 min, linear gradient to 35% solvent A in 3 min, then
isocratic for 5 min; column conditioning lasted 7 min. The flow rate was 0.7 mL min−1; the column
was thermostated at 25 ◦C.
3.4. Method Validation
For method validation, different parameters were considered. As regards LC-MS/MS, the matrix
effect was examined; this effect is due to the presence of compounds that can co-elute, affecting the
ionisation of the analyte. It was defined as the difference between the mass spectrometric response for
the analyte in standard solution and the response for the same analyte at the same concentration in
matrix extract. A comparison between the mass spectrometric response of MON in standard solution
and in matrix extract at 100 μg l−1 was conducted; the matrix extract was evaluated by spiking an
uncontaminated wheat or maize extract (950 μL) with MON standard (50 μL). Linearity of both
HPLC-UV and LC-MS/MS measurement was established through five calibration standards in solvent,
at concentrations between 2.5 and 250 μg L−1 for LC-MS/MS (20 and 2000 μg kg−1 for a cereal sample)
and between 20 and 1000 μg L−1 (160 and 8000 μg kg−1 for a cereal sample) for HPLC-UV. The limit of
detection (LOD) was defined as the level corresponding to a signal-to-noise ratio (S/N) of three, while
the limit of quantification (LOQ) as the lowest level for which the repeatability of the analysis was
below 10%. The decision limit (CCα) and the detection capability (CCβ) was calculated as reported
by Commission Decision 2002/657/EC [21]. The accuracy of the proposed method was evaluated by
determination of the recovery. Recovery experiments were performed by spiking wheat or maize
flour in triplicate at two levels, 100 and 500 μg kg−1 for wheat and 250 and 1000 μg kg−1 for maize.
The matrices were also analysed without spiking, as reagent blank. The spiked samples were allowed
to stand for two hours at ambient temperature under a fume hood to allow any residual solvent to
evaporate. Finally, the method repeatability was evaluated. Four samples (2 wheat and 2 maize flours)
were extracted and analysed three times in different days.
3.5. Real Sample Collection and Analysis
A total of ten samples of maize and ten of wheat (2 durum wheat) were collected in northern Italy;
samples were dried at 65 ◦C, milled using a cyclone hammer mill (1 mm sieve, Pulverisette, Fritsch
GmbH, Idar-Oberstein, Germany) and homogenised. Then, an aliquot (1 kg) of the sample was taken
and stored at −20 ◦C until the time of analysis. Quantification was carried out by LC-MS/MS, to detect
lower contamination values.
4. Conclusions
Simple and suitable LC-MS/MS and LC-UV methods for MON determination were developed,
fulfilling the wishes of the EFSA report. The simple addition of lanthanide ions to the mobile phase
allowed an easy determination of MON using either mass spectrometric or UV detection. Data on
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MON occurrence in food and feed can be easily obtained using this method with a satisfactory accuracy.
Further studies are needed to confirm the formation of mixed coordination complexes during the
chromatographic separation. Finally, this chromatographic technique could be applied to the analysis
of other mycotoxins, and also to the development of chiral separations.
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Abstract: A simple and reliable analytical method for the simultaneous determination of
alternariol (AOH), altenuene (ALT), tentoxin (TEN), altenusin (ALS), tenuazonic acid (TeA), and
alternariol monomethyl ether (AME) in grapes was developed by ultra-high-performance liquid
chromatography–tandem mass spectrometry (UHPLC-MS/MS). A modified QuEChERS (quick, easy,
cheap, effective, rugged, and safe) procedure with the extraction by acetonitrile and purification by
sodium chloride (0.5 g) and anhydrous magnesium sulfate (0.5 g) was established to recover the six
Alternaria toxins. After validation by determining the linearity (R2 > 0.99), recovery (77.8–101.6%),
sensitivity (limit of detection in the range of 0.03–0.21 μg kg−1, and limit of quantification in the
range of 0.09–0.48 μg kg−1), and precision (relative standard deviation (RSD) ≤ 12.9%), the analytical
method was successfully applied to reveal the contamination state of Alternaria toxins in grapes.
Among 56 grape samples, 40 (incidence of 71.4%) were contaminated with Alternaria toxins. TEN
was the most frequently found mycotoxin (37.5%), with a concentration range of 0.10–1.64 μg kg−1,
followed by TeA (28.6%) and AOH (26.8%). ALT (10.7%), AME (3.6%), and ALS (5.4%) were also
detected in some samples. To the best of our knowledge, this is the first report about the Alternaria
toxins contamination in grapes in China.
Keywords: Alternaria toxins; grape; modified QuEChERS; UHPLC-MS/MS
Key Contribution: An accurate and reliable UHPLC-MS/MS method was developed for
simultaneous determination of six Alternaria toxins in grapes for the first time.
1. Introduction
Alternaria toxins, secondary metabolites produced by Alternaria spp, e.g., A. alternata, A. tenuissima,
and A. infectoria—are frequently found in cereals, fruits, and vegetables [1,2]. The most important
members include alternariol (AOH), alternariol monomethyl ether (AME), altenuene (ALT), altenusin
(ALS), tentoxin (TEN), and tenuazonic acid (TeA) [3]. Acute and chronic ingestion of Alternaria
toxins can be associated with carcinogenesis [4], teratogenesis [5,6], and cytotoxicity [7], as well as
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reproductive and developmental toxicities [8,9], and therefore pose high potential risks to human
health. The European Food Safety Authority (EFSA) has established the threshold of toxicological
concern (TTC) values as 2.5 ng kg−1 body weight per day for AOH and AME, and 1500 ng kg−1 for
TeA [10]. Considering its widespread occurrence and intense toxicity, TeA, the most prevalent Alternaria
toxin, has been registered as a toxic chemical by the Occupational Safety and Health Act (OSHA), and a
maximal limit of 500 μg kg−1 was proposed by German federal state Bavaria in sorghum/millet-based
infant food [11].
As a worldwide grown fruit, global grape production is over 3 million tons annually, of which
71% are used for wine-making, 27% for fresh consumption, and 2% for raisin producing [12]. Grapes
and its derived products are susceptible to the infection of Alternaria spp during maturation, as well as
post-harvest and during processing, when they are improperly stored. AOH and AME have been found
in red and white wine with concentrations in the range of 0.03–19.4 ng mL−1 and 0.01–0.23 ng mL−1,
respectively, and also in red and white grape juice samples with concentrations of 0.03–0.46 ng mL−1
and 0.01–39.5 ng mL−1, respectively [13]. TeA, AOH, and AME have also been found in raisins
with the concentrations in the range of 6.9–594.4 μg kg−1, 0.3–13.5 μg kg−1 and 3.5–15.6 μg kg−1,
respectively [14]. However, until now, the literature has been sparse on the presence of Alternaria toxins
contaminating grapes, and it is ambiguous whether the risks come from the production process or from
the original fruits. Hence, it is important to develop a reliable and accurate method for simultaneous
determination of multiple Alternaria toxins, and to investigate their real contamination levels in grapes.
A variety of analytical methods, i.e., thin-layer chromatography (TLC) [15], gas chromatography
[GC] [16], and high-performance liquid chromatography (HPLC) with different detectors [17,18],
have been developed for determination of Alternaria toxins. The most frequently used technique for
toxin separation is HPLC, as it combines high resolution with increasingly sophisticated automation.
The availability of different ionization sources, i.e., electrospray (ESI) and atmospheric pressure
chemical ionization (APCI), has drastically improved the possibilities of employing HPLC-tandem
mass spectrometry (HPLC-MS/MS) in Alternaria toxin analysis, resulting in enhanced performance,
providing additional selectivity, and generating information with a high degree of structural specificity.
Hitherto, most of the previous reports only focused on TeA, AOH, and AME [13,17,19], and
other important Alternaria toxins (e.g., TEN, ALS, and ALT) were not investigated. Recently, an
UHPLC-MS/MS method was established for the detection of various Alternaria toxins in wine,
vegetable juices, and fruit juices [20]. The low recovery of ALS and tedious sample pretreatment
procedures made this method unsuitable for analysis of the targeted Alternaria toxins in grapes.
The major objective of this study is to develop a rapid and reliable ultra-high performance
liquid chromatography tandem mass spectrometry (UHPLC-MS/MS) method for simultaneous
determination of AOH, AME, ALT, ALS, TEN, and TeA based on a simple sample preparation of
modified QuEChERS (quick, easy, cheap, effective, rugged and safe) approach, and to explore the
actual contamination situations of Alternaria toxins in grapes for the first time in the world.
2. Results and Discussion
2.1. Optimization of the Ultra-High-Performance Liquid Chromatography–Tandem Mass
Spectrometry Conditions
MS/MS parameters were optimized by flow injection analysis of an individual Alternaria toxin
standard at a concentration of 50–200 ng mL−1. The precursor ions and cone voltage were optimized by
MS scan acquisition, both in positive and negative ionization modes. Then, MS/MS scan acquisitions
were applied to find the optimum product ions and collision energies (CE), cone voltages, and dwell
time (Figure S1). As shown in Table 1, the majority of Alternaria toxins displayed better specificity and
selectivity in ESI+, except for ALS, which showed stronger signals and lower background interference
in ESI−.
To obtain good chromatographic separation with symmetry and a sharp peak shape for targeted
analytes, the compositions of the mobile phase and the chromatographic columns were optimized.
20
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Different additives—e.g., formic acid, ammonium formate, and ammonium acetate—were primarily
evaluated. The highest ionization efficiency and sensitivity were obtained for all Alternaria toxins
when methanol (A) and water containing 5 mmol L−1 aqueous ammonium acetate methanol (B) were
used as the mobile phase. Subsequently, various chromatographic columns, i.e., the Waters ACOUITY
UPLC BEH C18 column (100 mm × 2.1 mm, 1.7 μm), Agilent Proshell EC18 column (50 mm × 2.1 mm,
2.7 μm), and Waters ACQUITY UPLC® HSS T3 (50 mm × 2.1 mm, 2.7 μm), which represented different
stationary phases, were compared. Considering the efficient separation and response values, shown in
Figure 1, the Proshell EC18 column (50 mm × 2.1 mm, 2.7 μm) was finally selected.
 
Figure 1. Multiple reaction monitoring (MRM) chromatograms of the six Alternaria toxins in the mixed
standard solution. The concentration is 50 ng mL−1.
21
Toxins 2019, 11, 87














185.1 * 0.025 64 28
213.1 0.025 64 24
AME 273.0 [M+H]+
128.1 * 0.030 54 26
258.0 0.030 54 25
ALT 293.0 [M+H]+
257.1 * 0.025 4 14
275.1 0.025 4 8
TEN 415.2 [M+H]+
199.2 * 0.029 32 12
312.2 0.029 32 18
TeA 198.1 [M+H]+
125.0 * 0.025 42 16
153.1 0.025 42 12
ALS 288.8 [M−H]− 235.1 * 0.029 −8 −20245.1 0.029 −8 −16
* Primary product ion.
2.2. Optimization of the Sample Pretreatment Method
Establishment of an efficient sample pretreatment method is always the bottleneck for the
development of an accurate and sensitive analytical method, due to the diversity of the physical
and chemical properties of various Alternaria toxins, along with the complex sample matrices. In this
study, five different frequently used extraction solvents, including methanol, methanol/water (80/20,
v/v), acetonitrile, acetonitrile/water (84/16, v/v), and acetonitrile/acetic acid (99/1, v/v) were
evaluated by using the blank grape samples spiked with 50 μg kg−1 of the targeted Alternaria toxins.
As shown in Figure 2A, when methanol or methanol/water (80/20, v/v) were used, unsatisfactory
recoveries (48.0–76.0%) were obtained for AOH, TeA, and AME. In addition, the extraction was
emulsified with high contents of pigments and sugar. When acetonitrile was used as the extraction
solvent, the recoveries were significantly increased (92.7–102.2%), especially for AOH and AME,
against the recoveries of 70.4% and 66.2% for acetonitrile/water (84/16, v/v), and 69.8% and 70.9%
for acetonitrile/acetic acid (99/1, v/v). As a consequence, acetonitrile was selected as the optimal
extraction solvent.
For sample clean-up, a modified QuEChERS method was developed to enrich the targeted
analytes, and to remove the co-extractives as completely as possible. Different materials, including
graphitized carbon black (GCB) (0.5 g), primary secondary amine (PSA) (0.5 g), C18 (0.5 g), MgSO4
(0.5 g), and NaCl (0.5 g) were tested for their purification efficiency. Unsatisfactory recoveries of
18.2–77.5% and 3.4–51.2% were obtained (Figure 2B) by using GCB and PSA, respectively, which had
been used frequently to remove chlorophylls from fruits and vegetables in the previous studies [21].
The poor purification effects in the current work might be because of the π–π interactions through the
sp2 hybrid orbitals of GCB and the planar aromatic compounds (i.e., AOH, AME, and ALT), as well as
the ionic affinity between the amines in PSA and the carboxyl group in ALS [22–24]. With regard to
C18, this material showed poor recoveries in the range of 15.0–61.5%. Finally, the salting-out step with
anhydrous MgSO4 and NaCl was employed with the highest recoveries. in the range of 77.9–98.5%
(Figure 2B), and lowest matrix effects, in the range of 82.8–102.3% (Figure 3).
Different membrane filters for filtering the re-dissolved solutions before injection into
UHPLC-MS/MS, including nylon, poly tetra fluoroethylene (PTFE), mixed cellulose membrane (MCM),
and polyvinylidene difluoride (PVDF), were compared. As shown in Figure S2, all membrane filters
could be used for filtering ALT, TEN, ALS, and TeA. However, when nylon, MCM, and PVDF were
applied, the recoveries were unsatisfactory for AOH and AME (3.6–19.0%). Satisfactory recoveries
in the range of 86.1–100.5% for all Alternaria toxins were achieved when a PTFE membrane filter
was selected.
22
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Figure 2. Comparison of the extraction efficiencies of different solvents (A) and purification efficiencies
of different materials (B), using spiked grape samples. The concentration is 50 μg kg−1 (n = 6).
23
Toxins 2019, 11, 87
Figure 3. Matrix effects of the six Alternaria toxins in green grapes (A) and red grapes (B), purified by
different materials (n = 6).
2.3. Method Validation
The linearity of the six analytes in neat solvent and in matrix is shown in Table 2. Good linear
relationships with correlation coefficients R2 > 0.99 were obtained. The limit of detection (LOD) and
limit of quantification (LOQ) values were in the range of 0.03–0.21 μg kg−1 and 0.09–0.48 μg kg−1,
respectively. The recoveries and precisions for the six Alternaria toxins at the three fortified levels are
listed in Table 3. The mean recovery values ranged from 78.4% to 101.6% for green grapes, and 77.8%
to 100.1% for red grapes. Intra- and inter-day precision was in the range of 2.5–12.2% and 3.7–12.9% for
green grapes, and 1.9–11.4% and 2.9–10.8% for red grapes. Overall, the validation data indicated that
the accuracy, repeatability, and sensitivity of the proposed method were acceptable and in agreement
with the requirements of European Commission Decision 2002/657/EC (EC 2002). The current method
could be used for the accurate detection of six Alternaria toxins in grapes.
24
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2.4. Method Application
The validated method was applied to detect six Alternaria toxins in 56 grape samples randomly
collected from the different markets and vineyards in Shanghai. MRM chromatograms of a typically
contaminated grape sample are shown in Figure 4. The occurrences and concentration levels of the six
Alternaria toxins are summarized in Table 4.
 
Figure 4. MRM chromatograms of a typical contaminated grape sample (No.3).
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Among the 56 samples, 40 (incidence of 71.4%) were contaminated Alternaria toxins. TEN
was the most frequently found mycotoxin (incidence of 37.5%), with concentrations in the
range of 0.10–1.64 μg kg−1, followed by TeA (28.6%) and AOH (26.8%), with concentrations of
0.25–46.97 μg kg−1 and 0.09–7.15 μg kg−1, respectively. ALT (10.7%), AME (3.6%), and ALS (5.4%)
were also detected in some samples. The contamination situations of Alternaria toxins revealed in
the current work were in great agreement with the microbial status reported in the previous studies,
in which, the toxigenic fungi, especially Alternaria spp., that could produce ALT, AOH, AME and TeA,
were recovered from grapes [25,26]. It is not surprising to find so many Alternaria toxins in grapes,
since large amounts of these toxins have been detected in grape juice and red/white wine with the
incidences of almost 100% [13,17,19,20,27]. Compared to the contaminations in grape derivatives, the
obviously lower incidences of AOH, TeA, and TEN in the original fruit were possibly because the
production of Alternaria toxins occurred during the processing and storage processes. It is noteworthy
that the grapes are frequently contaminated with multiple Alternaria toxins, and there is a need to
improve prevention and control strategies during pre- and post-harvest procedures.
3. Conclusions
An accurate and reliable UHPLC-MS/MS method based on a modified QuEChERS technique
was developed for the simultaneous determination of six Alternaria toxins in grapes for the first time.
The method was proven to be simple, efficient, and accurate after validation by the determination
of linearity, accuracy, and precision, and is feasible in practical grape samples. The survey results
strongly suggested that the grape is a favorable matrix for Alternaria spp producing Alternaria toxins,
and emphasizes the necessity of the current established method, which could be used for continuous
monitoring of Alternaria toxins and reducing the health risk to consumers in China.
4. Materials and Methods
4.1. Chemicals and Reagents
The analytical standards (stock solutions) of AOH (100.0 μg mL−1), AME (100.3 μg mL−1), TEN
(100.4 μg mL−1), and TeA (101.1 μg mL−1), dissolved in acetonitrile, were purchased from Romer labs
(Union, MO, USA). Solid portions of ALT (99.4%) and ALS (98.0%) standards were purchased from
AdipoGen (Liestal, Basel, Switzerland). The chemical structures of the six Alternaria toxins are shown
in Figure S3.
Acetonitrile and methanol (HPLC grade) from Merck (Darmstadt, Germany) were used.
Anhydrous magnesium sulfate (MgSO4, analytical grade), sodium chloride (NaCl, analytical grade),
and ammonium acetate (HPLC grade) were supplied by ANPEL (Shanghai, China). Water used
throughout the whole experiment was prepared by a Milli-Q system (Millipore, Billerica, MA, USA).
4.2. Preparation of Standard Solution
Solid portions of the ALT and ALS standards were dissolved in acetonitrile to prepare
100.0 μg mL−1 of stock solutions. A mixed standard solution of AOH, AME, ALT, ALS, TEN, and TeA
with a concentration of 1 μg mL−1 was prepared in acetonitrile by diluting and mixing appropriate
amounts of stock solutions of Alternaria toxins, and stored at −20 ◦C until use.
4.3. Samples Collection
A total of 56 grape samples, including 9 varieties (Kyoho, Summer Black, Shenhua, Hupei No.1,
Shenfeng, Muscat Hamburg, Shenyu, Zuijinxiang, and Gold Finger) were randomly collected from
different markets and vineyards in Shanghai. Approximately 0.5 kg of each sample was collected
and mashed by a food processer (Midea, Guangdong, China). All samples were stored in a freezer at
−20 ◦C until analysis.
28
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4.4. Sample Preparation
The homogenized grape samples (2.0 g) were weighted into a 50 mL centrifuge tube and 10 mL of
acetonitrile was added. The mixture was shaken at 200 rpm for 30 min. Subsequently, 0.5 g anhydrous
magnesium sulfate and 0.5 g sodium chloride were added to the slurry and vigorously shaken for
30 s immediately. After centrifugation at 4500 rpm for 10 min, 5 mL of the supernatant was collected
and evaporated under a soft stream of nitrogen gas at 40 ◦C. The residue was re-dissolved with 1 mL
acetonitrile/water containing 5 mmol L−1 ammonium acetate (20/80 v/v), and filtered through a
0.22 μm PTFE membrane filter to be ready for analysis.
4.5. UHPLC–MS/MS Analysis
UHPLC analysis was performed on a Waters ACQUITY Ultra High-Performance LC system
(Waters, Milford, MA, USA). Chromatographic separation was achieved on a Proshell EC18 column
(50 mm × 2.1 mm, 2.7 μm). The mobile phase was consisted of methanol (A) and water containing
5 mmol L−1 ammonium acetate (B). A linear gradient elution program was set as follows: initial 10% A;
1 min, 10% A; 5 min, 90% A; 6 min, 90% A; 6.5 min, 10% A; 8 min, 10% A. The flow rate was 0.4 mL
min−1. The injection volume was 3 μL, and the column temperature was 35 ◦C.
For MS/MS detection, a Waters T-QS mass spectrometer system (Waters, Milford, MA, USA) was
used both in positive electrospray ionization mode (ESI+) and in negative electrospray ionization mode
(ESI−) with the following parameters: interface voltages of capillary, 2.5 kV(ESI+) and 1.5 kV(ESI−);
desolvation temperature, 500 ◦C; and source temperature, 150 ◦C. The gas flow rates were 7.0 bar for
nebulizing gas and 1000 L h−1 for desolvation gas, respectively. Multiple reaction monitoring (MRM)
mode was used for the quantification and confirmation of the Alternaria toxins with the parameters
shown in Table 1.
4.6. Method Validation
The proposed method was validated by determination of the linearity, sensitivity, recovery,
precision, and matrix effect according to the recommendations of European Commission Decision
2002/657/EC [28]. Different concentrations (0.1, 0.2, 0.3, 0.5, 1, 5, 10, 50, 100, and 200 ng mL−1) of
Alternaria toxins were freshly prepared by diluting the working solution step by step with acetonitrile
and a blank matrix, respectively. The calibration curves were constructed by plotting the responses
versus analyte concentrations. The sensitivity was evaluated by determining the limit of detection
(LOD) and limit of quantification (LOQ), which were designed as the concentrations of the toxins
that produced signal-to-noise ratios (S/N) of 3 and 10 in matrix, respectively. The recoveries were
tested using non-contaminated grape samples spiked with low, intermediate, and high concentration
levels (10, 50, and 100 μg kg−1) of Alternaria toxins. The intra- and inter-day precisions were evaluated
through the relative standard deviations (RSDs), using the non-contaminated samples spiked with
different concentrations (10, 50, and 100 μg kg−1) of Alternaria toxins in the same day and in five
successive days, respectively. All experiments were performed in sextuplicate.
Signal suppression and enhancement (SSE) was used to evaluate the matrix effect, which was
calculated according to Equation (1) [21]:
SSE (%) = 100 × slope matrix / slope solvent (1)
where slope matrix is the slope of matrix-matched calibration curve, and slope solvent is the slope of
standard calibration curve.
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Supplementary Materials: The following are available online at http://www.mdpi.com/2072-6651/11/2/87/s1,
Figure S1: MS/MS spectra for AOH with the collision energy of 28 eV (A), for AME with the collision energy of
26 eV (B), for ALT with the collision energy of 14 eV (C), for ALS with the collision energy of −20 eV (D), for TEN
with the collision energy of 12 eV (E) and for TeA with the collision energy of 16 eV (F). The concentration for all
Alternaria toxins was 200 ng mL−1. Figure S2: Recoveries of the six Alternaria toxins in a standard solution filtered
by different membrane filters. The concentration is 50 μg kg−1 (n = 6). Figure S3: Chemical structures of the six
Alternaria toxins.
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Abstract: Cannabidiol (CBD) food supplements made of Cannabis sativa L. extracts have quickly
become popular products due to their health-promoting effects. However, potential contaminants,
such as mycotoxins and pesticides, can be coextracted during the manufacturing process and
placed into the final product. Accordingly, a novel methodology using ultra-high-performance
liquid chromatography coupled with quadrupole Orbitrap high-resolution mass spectrometry
(UHPLC-Q-Orbitrap HRMS) was developed to quantify 16 mycotoxins produced by major C. sativa
fungi, followed by a post-target screening of 283 pesticides based on a comprehensive spectral library.
The validated procedure was applied to ten CBD-based products. Up to six different Fusarium
mycotoxins were found in seven samples, the most prevalent being zearalenone (60%) and enniatin
B1 (30%), both found at a maximum level of 11.6 ng/g. Co-occurrence was observed in four samples,
including one with enniatin B1, enniatin A and enniatin A1. On the other hand, 46 different pesticides
were detected after retrospective analysis. Ethoxyquin (50%), piperonyl butoxide (40%), simazine
(30%) and cyanazine (30%) were the major residues found. These results highlight the necessity of
monitoring contaminants in food supplements in order to ensure a safe consumption, even more
considering the increase trend in their use. Furthermore, the developed procedure is proposed as
a powerful analytical tool to evaluate the potential mycotoxin profile of these particular products.
Keywords: mycotoxins; pesticides; Q-Exactive Orbitrap; CBD capsule; nutraceutical
Key Contribution: The first multi-class analysis of CBD-based supplements regarding mycotoxins
and pesticide residues using high-resolution mass spectrometry techniques.
1. Introduction
Nutrition is known to be an essential component of the health state, so having an unbalanced diet
can lead to several disorders and diseases [1]. Due to current lifestyles, new and fast ways to maintain
proper dietary habits are required. Nutraceuticals have emerged as an alternative to increase the input
of nutrients, contributing to an improvement in health. These products are bioactive compounds
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naturally occurring in food or produced de novo in human metabolism, biologicals or botanicals,
each intended to impart a physiological or medicinal effect after ingestion [2]. They can be delivered
either in foods and beverages or in other non-conventional forms, such as capsules, tablets, powders
or liquid extracts. In terms of marketing, nutraceuticals include a large number of different products
packaged for specific groups by age, gender, physical conditions and activity level. The global market
was valued at US$109 billion in 2015 and is projected to reach US$180 billion by 2020 [3].
Inside the variety of products classified as nutraceuticals, food supplements based on botanical
ingredients represent the second largest segment, behind vitamins and minerals. Most recently,
cannabidiol (CBD) dietary supplements made of Cannabis sativa L. extracts have quickly become
popular products. CBD is a phytocannabinoid present in the resin secreted from trichomes in female C.
sativa plants, and is mainly found in inflorescences. The bioactivity of this compound has been related to
an enhancement of its antioxidant and neurological activity, among others, by the promotion of several
metabolic pathways [4–6]. However, the European Union (EU) does not consider CBD supplements as
a novel food [7] and lets member states set their own rules over its marketing, leading to a convoluted
situation in terms of regulation. Despite several ambiguities in its legislation, the European market for
CBD-based supplements was valued at US$318 million in 2018 and with a strong growth projection [8].
Due to the complex nature of C. sativa and other botanicals, potential contaminants can be
coextracted during the different stages of the manufacturing process and placed into the final
product. Among all the potential non-desirable compounds in herbal-based supplements, mycotoxins
and pesticides are the most commonly reported [9,10]. Mycotoxins are secondary metabolites
mainly produced by the fungi genera Fusarium, Aspergillus, Penicillium, Claviceps and Alternaria.
These compounds can be present in food and feed commodities and display immunosuppressive,
nephrotoxic or carcinogenic effects, among others [11]. According to their carcinogenic potential,
some mycotoxins, like aflatoxins, have been included in the classification list of human carcinogens
provided by the International Agency for Research on Cancer (IARC) [12]. These mycotoxins are
produced by the genera Aspergillus, which has been categorized as a major fungus occurring in C. sativa
inflorescences alongside other mycotoxin producing fungi, like Fusarium spp., so different mycotoxins
could be also expected [13,14]. On the other hand, pesticides include a broad range of compounds
routinely applied to protect crops from different pests. However, residues coming from these products
can accumulate in plants intended for human consumption, leading to several health issues related
to neurotoxicity, carcinogenicity and pulmonotoxicity, as well as developmental and reproductive
disorders [15–18].
In terms of regulation, maximum residue limits (MRL) for different types of contaminants have
been set by the EU. Regulation (EC) No. 396/2005 [19] establishes limits for pesticides, whereas
Regulation (EC) No. 1881/2006 [20] covers mycotoxins, attaching maximum limits in food and
feeds. Nevertheless, nutraceutical products are not considered by the legislation yet but, due to
a potential carryover during the manufacturing process, contamination could be expected not only
in raw material, but also in other by-products. Moreover, several studies have reported the sole
presence of pesticides [21,22], mycotoxins [23,24] and both types of contaminants [25–27] in diverse
food supplements, remarking the necessity to evaluate the contamination profile of these products
considering their rising consumption and popularity.
To overcome this point, the development of analytical procedures is needed. Concerning the
extraction of contaminants, QuEChERS (quick, easy, cheap, effective, rugged and safe) [21,23,24] and
“dilute and shoot” procedures have been recently applied to food supplements delivered as gelatin
capsules, traditional capsules, tablets, powder extracts or liquid presentations [25–27]. Analytical
methods used in the detection and quantification of contamination include ELISA detection [28],
gas chromatography (GC) coupled with mass spectrometry (MS) [22] and ultra-high-performance
liquid chromatography (UHPLC) coupled with tandem mass spectrometry (MS/MS) [23,24] and
high-resolution Orbitrap mass spectrometry (Q-Orbitrap HRMS) [25–27]. Due to its high resolving
power, sensitivity and accurate mass measurement, high-resolution mass spectrometry stands as
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a suitable alternative for evaluating a large number of contaminants present in complex matrices at
low concentrations. Therefore, the aim of the present study was to provide an analysis of pesticide
residues and mycotoxins produced by major C. sativa fungi occurring in CBD-based food supplements,
using ultra-high-performance liquid chromatography coupled with high-resolution Orbitrap mass
spectrometry. To achieve this, a novel methodology was developed in order to identify and quantify
16 mycotoxins after evaluating different extraction procedures, followed by a post-target screening
of 283 pesticides based on a comprehensive spectral library. To the best of the authors’ knowledge,
this is the first multi-class analysis of CBD-based supplements through the use of high-resolution mass
spectrometry techniques.
2. Results
2.1. Optimization of Extraction Procedure
The molecular complexity of this matrix demands an effective extraction in order to detect and
quantify several mycotoxins in a reliable way. A QuEChERS methodology previously developed on
this typology of sample [24] was selected as the starting point, whereas different volumes of extraction
solvent and the type of sorbent for clean-up was tested.
2.1.1. Evaluation of the Volume of Extraction Solvent
The extraction procedure was first evaluated in triplicate by spiking the sample at 10 ng/g using
the following volumes of extraction solvent per gram of sample: 2.5, 5, 7.5 and 10 mL.
The extraction performed with 2.5 mL showed recovery values below the minimum limit (70%) for
the vast majority of the studied analytes as a consequence of solvent saturation (Figure 1a). Satisfactory
recoveries (70–120%) were obtained after performing the extraction with 5 mL of solvent for the
majority of compounds, with the exception of β-ZEL (155%) and ZAN (150%), which were significantly
more efficient than the other volumes tested (p < 0.05). On the other hand, the extractions performed
with 7.5 and 10 mL showed a gradual decrease in recoveries due to the larger dilution of the analytes.
Therefore, 5 mL of AcN was selected as the optimal volume of extraction solvent for this type of
CBD capsule.
2.1.2. Evaluation of the Type of Sorbent for Clean-Up
The molecular composition of the soft gel capsules mainly consists on fatty acids and proteins.
Because of the complex nature of this matrix, an efficient clean-up is required in order to avoid
interference with the analytes. To achieve this, clean-up with different sorbents (100 mg), including
C18, as previously suggested [24], GCB, Z-Sep+ and PSA was performed.
PSA exhibited a good performance for the vast majority of analytes (Figure 1b) but was unable to
recover other important mycotoxins, such as AFB1 and AFG1. The moderate affinity of PSA with polar
compounds may explain low recoveries for aflatoxins, being consistent with other works based on
oily matrices [29,30]. Similarly, extraction with C18 was efficient for most compounds and only some
low-polarity mycotoxins showed recoveries out of the range set, like ZAN (150%) and β-ZEL (155%).
Clean-up using GCB showed poor results, allowing us to detect only NEO (85%), HT-2 (89%) and T-2
(89%). This sorbent is able to retain planar molecules and mycotoxin adsorption has been previously
reported [31], which might be the reason for the low recoveries obtained here. Finally, extraction
performed with Z-Sep+ showed satisfactory recoveries (70–120%) for all the mycotoxins studied.
On the other hand, the influence of the matrix was minimal (80%≤ signal suppression/enhancement
(SSE) ≤ 120%) for all targeted analytes when using Z-Sep+ and PSA. Clean-up based on Z-Sep+ has
been successfully applied to the extraction of analytes from lipid matrices [32,33]. Furthermore, Z-Sep+
is also able to form irreversible links with carboxylic groups present in proteins [34], standing as the
most suitable sorbent for the here-analyzed matrix. Similarly, the use of PSA has been suggested to
remove coextracted fatty acids and other ionic lipids [35].
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Figure 1. Percentage of mycotoxins extracted with a recovery value (R) below 70% (white), between 70%
and 120% (black) and above 120% (grey), corresponding to extractions performed with: (a) different
volumes of solvent at a spiking level of 10 ng/g; (b) different sorbents for clean-up at a spiking level of
10 ng/g.
On the contrary, a strong matrix effect was evidenced for half the analytes when using C18
and GCB. Signal suppression was detected after using C18, obtaining SSE ranging from 40% to 69%,
whereas signal enhancement occurred after GCB clean-up, with SSE increasing from 128% to 167%.
Since both sorbents have a preferential affinity for non-polar compounds, matrix interferents were not
fully removed but coextracted. The presence of these coextracted species can change the ionization
efficiency, leading to improper SSE and preventing a reliable quantification. Although no significant
differences were observed between the use of Z-Sep+ and PSA (p > 0.05), Z-Sep+ was chosen because
of its better performance minimizing matrix interference.
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2.2. Analytical Method Validation
The optimized method was validated for the simultaneous extraction of 16 mycotoxins in
CBD-based products. Results are shown in Table 1. Good linearity was observed for all analytes
in the range assessed (0.20–100 ng/g), with regression coefficients (r2) above 0.990 and a deviation
≤20% for each level of the calibration curve. Comparison between calibration curves built in a blank
matrix and in neat solvent showed a minimal interference in the matrix (±20%) for the studied analytes.
Hence, external calibration curves were used for quantification purposes. Limits of quality (LOQs)
obtained for all studied analytes were between 0.20 and 6.25 ng/g. Regarding trueness, recovery values
corresponding to a fortification level of 20 ng/g ranged between 63 and 103% and between 63 and
113% for the lowest fortification level (10 ng/g). Referring to the additional spiking level (2 ng/g)
for aflatoxins, recoveries ranged between 63% and 86%. Precision study revealed both RSDr and
RSDR values below 20% for all the mycotoxins analyzed. These results confirmed that the optimized
procedure is suitable for a reliable quantification of the mycotoxins analyzed, fulfilling the criteria
set by Commission Decision 2002/657/EC [36]. Table 2 reviews the available literature regarding
mycotoxins in herbal-based supplements. As shown, the here-obtained LOQs were lower than the
ones reported in previous studies using UHPLC-Q-Orbitrap HRMS. As established by Regulation
(EC) No. 1881/2006 [20], maximum limits for aflatoxins in many food matrices must not reach levels
which are below those LOQs (5 ng/g), whereas LOQs obtained in this study were between 5 and
25 times lower. Other analytical methods based on low resolution mass spectrometry [37] required
longer and more complicated extraction procedures than the QuEChERS developed here. Even ELISA
detection has been used for quantification of mycotoxins in medicinal herbs [28], but a very specific
extraction had to be performed for different groups of analytes using several multi-functional columns.
The QuEChERS procedure developed in this study, in combination with UHPLC-Q-Orbitrap mass
spectrometry, was extremely simple and reliable, allowing for the quantification of all mycotoxins with
high sensitivity.
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2.3. Application to Commercial CBD-Based Products
The validated UHPLC-Q-Orbitrap HRMS procedure was applied to ten commercially available
samples in order to evaluate the occurrence of mycotoxins. Results are shown in Table 3. A considerable
occurrence of mycotoxins was observed, since contamination with at least one analyte was found in
70% of the samples. Up to six different mycotoxins (T-2, ZAN, ZEN, ENNB1, ENNA, ENNA1) were
quantified at a range from below LOQ to 11.6 ng/g, all produced by Fusarium genera, reported as a major
C. sativa pathogen fungus [14]. Previous studies regarding mycotoxins in different herbal-based extracts
have revealed the occurrence of similar mycotoxins independently of the matrix and the dosage form
(Table 2). Despite the fact that the percentage of positive samples varied among the different studies
(19–99%), when the sensitivity of the analytical method increased, reaching lower LOQs, the number of
positive samples dramatically increased. This indicated that mycotoxin contamination in herbal-based
products at low levels is frequent.
In the here-analyzed samples, ZEN appeared to be the most common mycotoxin, with an incidence
of 60% and concentration levels ranging from 4.2 to 11.6 ng/g (mean level = 6.9 ng/g). A high incidence
of ZEN has also been previously reported in supplements made of different herbals from Czech and US
retail markets (84%, n = 69) at a wide range of concentrations (5–824 ng/g, mean value = 75.7 ng/g) [24].
Moreover, ZEN was previously found in 96% of medicinal herbals from Spain (n = 84) as well, but in
a tighter range (1–44.1 ng/g, mean value = 8.9 ng/g) [28].
Referring to T-2, results reported contamination in one sample at 2.0 ng/g, in contrast with the
prevalent presence of T-2 in 78% (n = 69) of the same Czech and US samples, at concentrations rising
from 69 to 1,870 ng/g (mean value = 162 ng/g) [24]. High levels of T-2 were also observed in milk thistle
samples from Spain (363–453.9, mean value = 408.9 ng/g) in only two out of seven samples [38]. In the
other hand, T-2 was quantified in 98% (n = 84) of the Spanish medicinal herbals, but in much lower
concentrations (0.6–256 ng/g, mean value = 22.645 ng/g) [28].
Similarly, ZAN was quantified in one sample at 1.9 ng/g. This mycotoxin has been scarcely
targeted in dietary supplement studies, but has been previously quantified at similar concentrations as
those here-reported in two samples of Chinese medicinal herbals (n = 33) [39].
Results also showed ENN contamination. ENNB1, ENNA and ENNA1 were found in the same
sample at 11.6, 4.2 and 5.8 ng/g, respectively, whereas ENNB1 was detected in two other samples
below the LOQ (1.56 ng/g). These emerging Fusarium mycotoxins have been previously found
in herbal products (84–91%, n = 69) widely ranging from 5 ng/g up to 10,900 ng/g (mean value
= 354 ng/g) [24]. Similarly, ENNB1 was the most common toxin out of these emerging Fusarium
mycotoxins, being consistent with the results here obtained.
All the mycotoxins found in the present study correspond to low- to non-polar compounds,
which should be prevalently expected due to the nature of the matrix.
Co-occurrence of at least two mycotoxins was also observed in four out of ten samples. Results
showed the presence of ZEN in combination with ENNs B1, A and A1, ZAN or T-2, which are common
associations found by previous studies in herbal-based supplements [24,28]. It must be highlighted
that synergic or additive effects have been observed as a consequence of these combinations in in vitro
assays [40]. Based on what has been discussed and considering the uprising trend of C. sativa-based
products, alongside the use of environment-friendly raw materials cultivated without pesticides, quality
controls regarding mycotoxins should be set for these products in order to ensure safe consumption.
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Table 3. Occurrence of studied mycotoxins in the analyzed samples.
Sample
Mycotoxin (ng/g)
T-2 ZAN ZEN ENN B1 ENN A ENN A1







2.4. Identification of Non-Target Compounds through Retrospective Analysis in Studied Samples
The post-target screening approach allowed us to detect pesticide residues in the analyzed samples
using a spectral library. Results are shown in Figure 2. Up to 46 different pesticides were tentatively
identified based on the pesticides mass spectral library. Ethoxyquin was putatively found in five
samples, being the most prevalent pesticide. The main function of ethoxyquin is to avoid fungal
contamination during the postharvest stage of the plant through its scald-preventive properties [42].
Surprisingly, the use of this pesticide is forbidden by the European Commission (EC) Decision
2011/143/EU. Piperonyl butoxide was found in four samples. This compound is not a pesticide by
itself but can inhibit the resistance mechanisms of insects, being widely used in combination with
other different pesticides [42]. The tentative presence of cyanazine and simazine, both found in three
different samples, must also be noted. The use of these pesticides was prohibited by EC Regulation
No. 1107/2009 [43] and Commission Decision 2004/247/EC [44], respectively. Therefore, the occurrence
of forbidden pesticides found in the here-analyzed samples highlights the necessity of monitoring
potential contaminants in C. sativa-derived products acquired from online shops.
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Figure 2. Occurrence of non-target pesticides in analyzed samples after post-run retrospective screening.
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3. Conclusions
A sample preparation procedure based on a QuEChERS followed by UHPLC coupled with
high-resolution Q-Orbitrap mass spectrometry was optimized in order to determine and quantify
16 mycotoxins in C. sativa-based supplements. The proposed methodology was validated following
the EU criteria, ensuring a proper specificity, selectivity, linearity, trueness and precision with a fast
chromatography run performance (8 min). The validated procedure was applied to ten CBD-based
supplements that are commercially available online, allowing us to quantify up to six different Fusarium
mycotoxins in 70% of samples. ZEN was the most prevalent mycotoxin (60%) found at a maximum
level of 11.6 ng/g (mean value = 6.9 ng/g). Co-occurrence was observed in four out of ten samples,
including one sample with ENNB1, ENNA and ENNA1. Additionally, a retrospective analysis of
pesticide residues was performed. Up to 46 different pesticides were tentatively detected, including
some forbidden in C. sativa cultivation. Considering the uprising trend of CBD-based products, quality
controls regarding contaminants should be set for these products in order to ensure a safe consumption.
Furthermore, the developed procedure is proposed as a powerful analytical tool to evaluate the
potential mycotoxin profile of these particular products.
4. Materials and Methods
4.1. Chemicals and Reagents
Acetonitrile (AcN), methanol (MeOH), and water for LC mobile phase (HPLC grade) were
acquired from Merck (Darmstadt, Germany). Formic acid and ammonium formate were obtained
from Fluka (Milan, Italy). Sodium chloride (NaCl), magnesium sulfate (MgSO4), octadecyl carbon
chain-bonded silica (C18), graphitized carbon black (GCB), primary-secondary amine (PSA) and
zirconium oxide (Z-Sep+) were obtained from Sigma Aldrich (Milan, Italy).
Mycotoxin standards and metabolites, namely aflatoxins (AFB1, AFB2, AFG1, and AFG2),
HT-2 toxin (HT-2), T-2 toxin (T-2), neosolaniol (NEO), zearalenone (ZEN), α-zearalenol (α-ZEL),
β-zearalenol (β-ZEL), zearalanone (ZAN), beauvericin (BEA) and enniatins (ENNA, ENNA1, ENNB,
and ENNB1) were purchased from Sigma Aldrich (Milan, Italy). Individual stock solutions of all
analytes were prepared by diluting 1 mg of each mycotoxin in 1 mL of methanol. The working standard
solution including all the mycotoxins was made by adequate diluting in MeOH:H2O (70:30 v/v) 0.1%
formic acid to reach the required concentrations for performing the spike experiments: 20, 10 and
2 μg/mL. All solutions were kept in safe conditions at −20 ◦C.
4.2. Sampling
For the analysis of real samples, ten different CBD gelatin capsules were obtained from online
shops based in different European countries. The capsules are made of gel mass, which contains
gelatin, water, glycerin and other minor additives whereas the fill formulation consists of olive
oil mixed with hemp oil containing CBD at certain concentrations. The weight of each capsule
depended on the manufacturer; there were 0.25, 0.5 and 1 g capsules. Only soft gel capsules were
studied since it was the prevalent presentation available for CBD supplements. On the other hand,
one sample of CBD supplements delivered as soft gel capsules was acquired from a local store (Naples,
Italy). After confirming the absence of contaminants, they were used for preparing fortified samples
for recovery assays and matrix-matched standards for calibration purposes. All the samples were
conserved in dark and cool conditions, as recommended by the manufacturer, until further analysis.
4.3. Sample Preparation
The sample preparation procedure developed by Veprikova et al. [24] was selected as
a starting point and then slightly modified, as follows: 1 g of sample was weighed into a 50 mL
polytetrafluorethylene (PTFE) tube and mixed with 5 mL of 1% aqueous formic acid. The mixture
was placed in an SKO-D XL orbital shaker (Argo Lab, Italy) for 30 min at 294 × g. Then, 5 mL of
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AcN were added and the mixture was shaken for an additional 30 min at 294 × g. After that, 0.5 g of
sodium chloride and 2 g of magnesium sulfate were added and the tube was shaken for 1 min by hand,
followed by centrifugation at 4907 × g for 15 min in an SL 16R centrifuge (Thermo Fisher Scientific
LED GmbH, Germany). A 2 mL aliquot of the upper acetonitrile layer was taken for dispersive solid
phase extraction (d-SPE) cleanup in a 15 mL PTFE tube containing 100 mg of Z-Sep+ sorbent and
300 mg of magnesium sulfate. The tube was vortexed for 1 min and then centrifuged at 4907 × g for
15 min. An aliquot of the supernatant (1 mL) was collected and filtered through a 0.2 μm PTFE filter
(Phenomenex, Italy) into a vial prior to UHPLC-Q-Orbitrap HRMS analysis.
4.4. UHPLC-Q-Orbitrap HRMS Analysis
The qualitative and quantitative profiles of the mycotoxins were obtained using
an ultra-high-pressure liquid chromatograph (UHPLC, Thermo Fisher Scientific, Waltham, MA,
USA) equipped with a degassing system, a Dionex Ultimate 3000, a Quaternary UHPLC pump
working at 1250 bar, an auto sampler device and a thermostated (T = 30 ◦C) Luna Omega 1.6 μm
(50 × 2.1 μm) column.
The eluent consisted of two different phases: A (H2O containing 0.1% formic acid and 5 mM
ammonium formate) and B (MeOH containing 0.1% formic acid and 5 mM ammonium formate).
The gradient elution for LC-Orbitrap HRMS analyses was applied as follows: an initial 0% of phase B
was held for 1 min, which linearly went up to 95% B over 1 min and held for 0.5 min. Next, the gradient
decreased to 75% B over 2.5 min and then decreased again to 60% B over 1 min. Finally, the gradient
turned to 0% B over 0.5 min and then the column was equilibrated for 1.5 min at 0% B. The total run
time was 8 min, at a flow rate of 0.4 mL/min. A total of 5 μL of the sample was injected. Detection
was performed using a Q-Exactive mass spectrometer. The mass spectrometer was operated in both
positive and negative ion mode using fast polarity switching by setting two scan events (full ion MS
and all ion fragmentation (AIF)). Full scan data were acquired at a resolving power of 35,000 FWHM at
m/z 200.
The ion source parameters were: spray voltage 4 kV (-4 kV in ESI−mode); capillary temperature
290 ◦C; S-lens RF level 50; sheath gas pressure (N2 > 95%) 35, auxiliary gas (N2 > 95%) 10, and auxiliary
gas heater temperature 305 ◦C. The value for automatic gain control (AGC) target was set at 1 × 106,
a scan range of m/z 100 to 1000 was selected and the injection time was set to 200 ms. The scan rate
was set at 2 scans/s. For the scan event of AIF, the parameters in the positive and negative ion mode
were: mass resolving power = 17,500 FWHM; maximum injection time = 200 ms; scan time = 0.10
s; ACG target = 1 × 105; scan range = 100–1000 m/z, isolation window to 5.0 m/z, and retention time
window to 30 s. The Orbitrap-MS parameters were optimized in a previous work [45]. The exact
mass for the studied compounds, including elemental composition, retention time (RT), theoretical
masses and accurate mass errors for the detected ions are shown in Table 4. A mass error below 5
ppm, referring to the molecular ions, was set for identification. Retrospective screening was carried
out on spectral data collected using a pesticide spectral library (Pesticide Spectral Library Version
1.1 for LibraryView™ Software, AB SCIEX, Framingham, USA). For accurate mass measurement,
identification and confirmation were performed at a mass tolerance of 5 ppm for the molecular ion and
for both fragments at the intensity threshold of 1000. Data analysis and processing were performed
using the Xcalibur software, v. 3.1.66.10.
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NEO 4.25 C19H26O8 [M+NH4]+ 400.1966 400.1963 −0.67
AFG2 4.50 C17H14O7 [M+H]+ 331.0812 331.0808 −1.36
AFG1 4.52 C17H12O7 [M+H]+ 329.0656 329.0655 −0.27
AFB2 4.58 C17H14O6 [M+H]+ 315.0863 315.0862 −0.51
AFB1 4.62 C17H12O6 [M+H]+ 313.0707 313.0705 −0.42
HT-2 4.74 C22H32O8 [M+NH4]+ 442.2435 442.2432 −0.7
α-ZEL 4.83 C18H24O5 [M-H]- 319.1551 319.1550 −0.31
T-2 4.85 C24H34O9 [M+NH4]+ 484.2541 484.2543 0.39
β-ZEL 4.97 C18H24O5 [M-H]- 319.1551 319.1550 −0.31
ZAN 4.98 C18H24O5 [M-H]- 319.1551 319.1549 −0.6
ZEN 5.01 C18H22O5 [M+H]+ 317.1395 317.1393 −0.54
ENN B 5.56 C33H57N3O9 [M+NH4]+ 657.4433 657.4435 0.26
ENN B1 5.68 C34H59N3O9 [M+NH4]+ 671.4599 671.4594 −0.76
BEA 5.73 C45H57N3O9 [M+NH4]+ 801.4433 801.4432 −0.16
ENN A1 5.82 C35H61N3O9 [M+NH4]+ 685.4746 685.4745 −0.18
ENN A 5.99 C36H63N3O9 [M+NH4]+ 699.4903 699.4899 −0.56
4.5. Validation Parameters
An in-house validation study was conducted following the EU Commission Decision
2002/657/EC [36]. The parameters evaluated were selectivity, specificity, linearity, trueness, repeatability
(intra-day precision), within-reproducibility (inter-day precision), limit of quantification (LOQ) and
limit of detection (LOD). The selectivity and specificity of the method were evaluated by analyzing
both standard solutions and samples, comparing the retention time of the peaks corresponding to the
analytes of interest alongside the determination of its precursor and product ion, with a mass error
below 5 ppm. For linearity, standard solutions built in neat solvent and matrix-matched calibration
were analyzed by spiking blank samples at eight concentration levels from 0.2 to 100 ng/g. The slopes
of each linear calibration function were compared in order to detect a signal suppression/enhancement
(SSE) effect due to the matrix interference. This effect was quantified following the equation: SSE
(%) = matrix-matched calibration slope/solvent calibration slope x 100. An SSE value of 100% was
interpreted as no matrix interference in the concentration range evaluated. An SSE value above 100%
revealed signal enhancement whereas a value below 100% indicated signal suppression. For trueness,
recovery studies were evaluated by spiking three blank samples at three different levels. Additionally,
a lower spike level was used only for aflatoxins. Intra-day precision (RSDr) was expressed as the
relative standard deviation after three determinations in a single day (n = 3). Inter-day precision was
calculated by repeating the measurements in triplicate on three non-consecutive days (n = 9) and
expressed as relative standard deviation (RSDR). The LOD was defined as the minimum concentration
where the molecular ion can be identified by the instrument (mass error value below 5 ppm) and the
LOQ as the minimum concentration where a linear response (mass error value below 5 ppm) can be
observed with an accuracy and precision of ≤ 20%.
4.6. Statistical Analysis
Validation experiments were performed in triplicate and the results expressed as the average
values alongside relative standard deviation (RSD, %). The Saphiro–Wilk test was applied to evaluate
normality and multivariant analysis was performed using a non-parametric Kruskal–Wallis test,
considering p values < 0.05 as significant. Analysis of data was carried out using IBM SPSS version 25
statistical software package (SPSS, Chicago, IL, USA).
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Abstract: Fusarium species threaten yield and quality of cereals worldwide due to their ability
to produce mycotoxins and cause plant diseases. Trichothecenes and zearalenone are the most
economically significant mycotoxins and are of particular concern in barley, maize and wheat.
For this reason, the aim of this study was to characterize the Fusarium isolates from brewing barley
and to assess deoxynivalenol and zearalenone contamination in grains. Characterization of the
Fusarium strains was carried out by the phylogeny based on two loci (EF-1α and RPB2). Mycotoxin
detection and quantification were performed by LC-MS. The results show that Fusarium was the
predominant genus. Phylogenetic study demonstrated that the majority of the strains clustered
within the Fusarium sambucinum species complex followed by the Fusarium tricinctum species complex.
The results revealed high incidence of deoxynivalenol (DON) and zearalenone (ZEA) contamination
(90.6% and 87.5%, respectively). It was observed that 86% of the samples contaminated with ZEA
were above the limits set by the EU and Brazilian regulations. These results may highlight the
importance of controlling Fusarium toxins in barley, mainly because of its use in the brewing industry
and the resistance of various mycotoxins to food processing treatments.
Keywords: cereals; mycotoxigenic fungi; phylogeny; deoxynivalenol; zearalenone
Key Contribution: High contamination of deoxynivalenol and zearalenone was found in barley
analyzed. Most of the samples contaminated were above to the limits set by the regulations.
1. Introduction
The Fusarium genus includes plant pathogens which are of great concern to agricultural production
and food/feed safety worldwide [1], threatening yield and quality of cereals and producing mycotoxins,
secondary metabolites that are toxic to humans and other animals [2]. Fusarium genus is capable of
producing several mycotoxins, including fumonisins, trichothecenes and zearalenone. These are the
most economically significant Fusarium mycotoxins and are of particular concern in barley, maize and
wheat [3].
Trichothecenes have been classified into four groups: types A–D, according to their chemical
structure [4], the most important in cereals are types A and B [1]. The B-trichothecenes include
the mycotoxins deoxynivalenol (DON), its acetylated derivatives, 3-acetyldeoxynivalenol (3ADON)
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and 15-acetyldeoxynivalenol (15ADON) and nivalenol (NIV). DON is the most frequent type-B
trichothecene and can be found worldwide. Furthermore, DON inhibits protein synthesis and it has
been associated with intoxication of animals through consumption of contaminated feed [5].
Zearalenone (ZEA) is a mycotoxin with estrogenic effects produced by several Fusarium species
and is usually found in cereal grains. Swine are especially sensitive to the estrogenic effects of ZEA.
This toxin has been shown to bind to the estrogenic receptors and to inhibit ovulation. It is, therefore, often
involved in hormonal disorders of farm animals and it is also related to hypoestrogenic syndromes
in humans [6]. ZEA has been classified into group 3 (non-classifiable due to its carcinogenicity to
humans) by IARC (International Agency for Research on Cancer) [7].
During recent years, mycotoxins have attracted international attention not only for their perceived
impact on human health but also because of the economic losses accruing from contaminated foods.
Considering barley matrix, several international studies have reported on Fusarium and its mycotoxins
contamination due to the beer gaining increased popularity [8]. The main problem is the characteristics
that these compounds have. Some mycotoxins such as trichothecenes, zearalenone and fumonisins
are considered stable during the brewing process [9] and can persist to the final product, the beer.
Furthermore, Fusarium infection causes a negative impact on barley germination rates which results in
malting quality and yield reduction. Additionally, this produces gushing and changes in color and
flavor of the beer [10].
Barley is considered to have good characteristics for fungi contamination under favorable
conditions. In addition, environmental factors associated with barley varieties and agronomic practices
influence the Fusarium infection and the mycotoxin production. The climate conditions during critical
phases of barley plant growth could lead to noticeable difference between the mycotoxin diversity.
Tropical conditions, such as those found in Brazil contribute to fungi dissemination and consequently
mycotoxin production in barley. For example, 2015 demonstrated a high rainfall average and high
levels of humidity, which prompted worse contamination levels found until now [11]. It is necessary
to mention that only two Fusarium mycotoxins were analyzed. Other fungi mycotoxins should be
evaluated along with their masked toxins.
All of the barley harvested in Brazil is destined for the brewing industry and the production
continues to increase. Southern Brazil has the largest number of barley-producing regions, therefore,
the quality of the grains needs to be monitored and studies about the fungi profile should be taken into
account. The knowledge of the current contamination of barley in the region, as well as the constant
monitoring, is necessary in order to evaluate if agronomic practices are being duly effective to control
the contamination in grain production. The irrigation management, resistant cultivars, harvesting
strategies, chemical and biological control and disease forecasting could minimize the loss of grain
quality and avoid the disease caused by mycotoxigenic fungi [12].
The current occurrence of mycotoxins in barley could lead to the necessity of developing new
strategies or improving those currently in place for more effective management of mycotoxins in the
future. This fact is even more relevant when taking into account that the Brazilian regulation for DON
in barley will be updated by 2019 [13] and therefore, the information on the occurrence of this toxin is
still discussed in the country often.
The regulations have set maximum levels for mycotoxin contamination in grains, in order to avoid
further accumulation of mycotoxins in processed food and to control mycotoxin of major concern
in unprocessed cereals, such as brewing barley, with 1.250 μg/kg being the maximum permitted
for DON and 100 μg/kg for ZEA. From January 2019, DON limits for brewing barley will be set at
1000 μg/kg [13]. Similarly, the limits for DON and ZEA fixed by the European Commission [14] are
equal to 1.250 μg/kg and 100 μg/kg for unprocessed cereals.
For the reasons stated above, the aim of the present research was to characterize the Fusarium
isolates and to assess DON and ZEA contamination in brewing barley grains. These findings provide
new insights into the diversity of Fusarium species isolated from Brazilian barley and add information
to the mycotoxin profile in a source (raw material) destined for the food industry.
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2. Results
2.1. Water Activity and Identification of Isolated Fungi
Water activity levels ranged from 0.579 to 0.667 (mean: 0.622 ± 0.02) for all of the 64 brewing
barley samples analyzed. Filamentous fungi were isolated from 96.8% of the samples, highlighting that
Fusarium was the predominant genus (46%), followed by Alternaria (28.8%), Phoma (15%), Epicocum
(6.2%), Penicillium (2%), Aspergillus (1.1%) and Rhyzopus (0.9%). Species belonging to Fusarium genus
were initially identified through the sequencing of the EF-1α locus. Sequences were submitted to Blast
(basic local alignment) tool on NCBI database (https://blast.ncbi.nlm.nih.gov/Blast.cgi?PAGE_TYPE=
BlastSearch).
The identification analysis was carried out with 48 Fusarium strains and sequencing analysis
determined 56.26% of the Fusarium species isolated in this study, were within the Fusarium sambucinum
species complex (FSAMSC), 31.25% within the Fusarium tricinctum species complex (FTSC), 8.33%
within the Fusarium fujikuroi species complex (FFSC) and 2% within both, Fusarium incarnatum-equiseti
(FIESC) and Fusarium oxysporum species complexes (FOSC) (Table 1).
Table 1. Frequency of the members of each Fusarium species complex isolated from brewing
barley grains.









FIESC 2 F. incarnatum-equiseti 1.6
FOSC 2 F. oxysporum 1.6
* FSAMSC: F. sambucinum species complex, FTSC: F. tricinctum species complex, FFSC: F. fujikuroi species complex,
FIESC: F. incarnatum-equiseti species complex, FOSC: F. oxyxporum species complex.
2.2. Phylogenetic Study
The phylogenetic study was conducted for the species complexes that have the potential to
produce trichothecenes and for the closely related species complex F. tricinctum. The concatenated loci
EF-1α and RPB2 were used to infer the phylogeny of the species isolated from barley. The data set
consisted of 65 taxa, 1292 nucleotides with 452 parsimony-informative characters (PICs) (Figure 1).
The analysis resulted in a one most parsimonious tree (CI = 0.69 RI = 0.94). The majority of the
isolates clustered within F. graminearum, F. poae and F. avenaceum species complexes with both posterior
probability and bootstrap supports (Figure 1).
The method validation and recovery experiments are summarized in Table 2 and Table S2.
The reported LODs were set at 5 and 10 μg/kg for DON and ZEA, respectively and LOQs 25 μg/kg
for both toxins. The coefficients of correlation (R2) of the calibration curve were 0.997 and 0.999 for
DON and ZEA, respectively. Spiking was performed in triplicates at three levels in the barley matrix.
In addition, the spiking experiments for the F. graminearum strains grown in culture media were carried
out at two levels.
The method is suitable for the determination of mycotoxins in barley as the given LOQ’s are
lower than the maximum limit set by the Brazilian and EU regulations for the content of DON and
ZEA. The parameter linearity, reproducibility, repeatability and recovery obtained were also shown to
be adequate.
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Figure 1. LC-MS/MS method performance.
2.3. Mycotoxins Analysis
The analysis carried out in the present research revealed the occurrence of the two mycotoxins
most commonly found in barley. Grain samples that presented levels above the LOQ were considered
positive. Mean calculations were performed using Microsoft® Excel 2007 only including positive
samples. Deoxynivalenol showed the highest incidence (90.6%) with levels ranging from 45.95 to
1155.21 μg/kg. ZEA also had a high occurrence (87.5%) with values ranging from 82.41 to 423.71 μg/kg.
Regarding the Brazilian regulation for DON, only one sample was above the established maximum
levels (1000 μg/kg). Nevertheless, for ZEA, 55 samples (86%) were above the regulation (100 μg/kg)
(Table 2).
Additionally, the mycotoxin production from toxigenic potential F. graminearum strains was
observed. The frequency of the DON strain producers was 80% (12 strains) and only 20% (3 strains)
for ZEA. The levels ranged from 123.03 to 592.61 μg/kg and 33.64 to 140.58 μg/kg, respectively.
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3. Discussion
This study has shown that the majority of the Fusarium species isolated from brewing barley
grains belonged to the FSAMSC, whereas the main trichothecene producing species are clustered.
Mycotoxins analysis demonstrated that most of the samples were contaminated with DON (90.6%)
and ZEA (87.5%), highlighting the importance of this investigation.
Fusarium species are found in cereal grains, such as barley, wheat, maize and rice worldwide,
where mycotoxins can be found in high concentrations [15–18]. This fact, may be worsened by
weather conditions, such as high humidity and temperatures that tend to increase Fusarium infection
in plants [19,20]. Humidity is an important environmental factor and it influences the water activity of
the grains. This intrinsic factor is important for fungal growth and has considerable association with
mycotoxin production [21].
Generally, Fusarium development as well as DON and ZEA production can be seen with higher
levels of water activity (0.90) [22]. Nevertheless, the current research showed a low variation of
the water activity that was observed among the 64 brewing barley samples, with mean value of
0.622 ± 0.02. In this case, both the germination of fungal spores and the growth of storage fungi
are inhibited. However, the grain analyses were carried out after the cleaning and drying stages,
explaining the levels found. For safe storage of grain, the grain moisture content must be compatible
with the period of time the grain will be stored in order to avoid the fungi growth and therefore,
the water activity should be less. To associate Fusarium mycotoxins found in this study it is necessary
to assume that the DON and ZEA production could be correlated to the fungi presence and high
water activity in the growing plant stages. This fact could be explained in our recent study with rice
grains, where the levels of ZEA found are associated with the presence of Fusarium during pre-harvest,
in grains freshly harvested with high levels of moisture content and water activity. After the food
processing steps were completed in the industry, there was not any Fusarium growth in the grains,
however, the ZEA levels remained in the parboiled rice (water activity: 0.64 ± 0.02), resisting the
degradation [23].
The phylogenetic study showed that the majority of the strains clustered with F. graminearum,
F. poae and F. avenaceum. Fusarium poae can produce high levels of nivalenol; therefore, further
analyses should be done to investigate the degree of nivalenol contamination in Brazilian barley.
Previous studies carried out by [24] in Russia and [25] in Italy have shown a high incidence of
F. avenaceum in barley as well as other Fusarium species. [26] observed a high incidence of F. avenaceum,
F. graminearum and F. culmorum in in Finnish barley grains between the years of 2005–14, with high
levels of trichothecene contamination. The presence of F. avenaceum in barley may indicate the presence
of enniatins, moniliformin and beauvericin in the samples. In Brazil, another study in barley has
demonstrated that the majority of the isolates belonged to the F. graminearum lineage; however,
mycotoxin analysis was not performed in that study [27]. To our knowledge, this is the first report of
phylogenetic identification of the Fusarium species in Brazilian barley and the first correlation with
DON and ZEA contamination.
With respect to DON contamination, the current study showed similarities with those found
in a survey carried out in Spain with a mean level of 119.9 μg/kg [28]. In addition, the highest
results were obtained by [25] reporting incidence and a maximum contamination level of 108.7 μg/kg.
Also, [29] in Italy, a study reported lower incidence and concentrations of DON with a maximum
level of 35.5 μg/kg; and [30] in Tunisia evaluated its presence with a maximum level of 6.1 μg/kg.
In the current study, only one sample presented a high level of DON (1155.21 μg/kg) and was above
the established maximum level set by the Brazilian regulation. The samples showed mean values of
147.65 μg/kg and median values of 98.68 μg/kg that also demonstrated low levels.
In contrast, the ZEA contamination found in the present study were of significance, considering
the maximum levels established by the Brazilian and international regulation, where 86% of the
samples were above [13,31]. The samples showed mean values of 123.24 μg/kg and median values of
119.26 μg/kg. In a study performed by [32] in the Czech Republic, a few samples were contaminated
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with ZEA with values ranging from 181.2 to 204.4 μg/kg, which is quite similar to the results of our
study. Furthermore, high levels (max 985.9 μg/kg) of ZEA were found in another survey carried out
in the Czech Republic with samples from the 2011 crop [33].
Two other studies were conducted in Brazil by the current author and can be compared to this
study. The first one was from the 2014 crop and low levels of DON were found ranging from 200 μg/kg
to 15.000 μg/kg [34]. The other one was from the 2015 crop and higher levels were found for both
toxins, DON and ZEA. The last study was considered an issue for the industry due to the levels
exceeding the regulation levels established. The mean levels ranged from 1700 to 7500 μg/kg and
from 300 to 630 μg/kg for DON and ZEA, respectively.
It is necessary to mention that not only the large-scale brewing industry is increasing but that the
craft breweries in Brazil are expanding. These small brewing groups always look for the best sources
and have the characteristic of “German beer purity law,” meaning that just barley is used for beer
production. For these reasons, barley needs to be of higher quality. On the other hand, the large-scale
industry in Brazil uses other grains such as corn, rice and sorghum for beer production which are
considered low quality grains [35]. Some studies were carried out and they showed contamination
with fumonisin B1 [36] that is commonly found in corn and its derivatives [37].
In the last years the stability of these metabolites has been studied. Deoxynivalenol showed
to be a mycotoxin that persists through the process and demonstrated stability in some industry
processes, such as cleaning, milling, brewing and extrusion [9]. Zearalenone has had some studies
published about it which showed lower stability. However, its levels are high when they are found.
A research conducted by [38] showed a considerable reduction of ZEA levels in the presence of
Saccharomyces cerevisiae yeast. The main point is even if there is a significant reduction of these
metabolites, sometimes they still offer a risk, especially when in beer, which is considered one of the
most consumed beverages in the world.
Another aspect that should be taken into account is the masked toxins. ZEN-14-sulfate and
DON-3-glucoside are most commonly observed in grains. They could be present in the matrix, however
masked toxins are either bound to carbohydrates or proteins and, therefore, are not extractable with
existing protocols aimed at the extraction of the toxin, or they are not detectable using established
chromatography routines; hence their name “masked” mycotoxins [39]. Further studies are being
planned to gain more knowledge on these metabolites in barley and also in beer.
The Fusarium mycotoxins found in barley grains and the toxigenic potential analysis of the
F. graminearum strains isolated in this study reinforce the importance of these genera in this relevant
commodity. Furthermore, the identification of F. poae, F. avenaceum and the genus Alternaria in barley
samples highlights the importance of further research on other mycotoxins in barley and its by-products.
Alternaria species were recovered from 28% of the barley samples. This may have important
implications on other mycotoxins that may be found in high concentrations, such as tenuazonic
acid. Further studies should be conducted in order to evaluate the co-occurrence of the mycotoxins
produced by this genus [25,40].
In this study, the toxigenic potential of the F. graminearum strains isolated in the brewing barley was
evaluated and both toxins detected in the samples were produced by them. In total, 80% and 20% of the
strains produced DON (mean: 297.02 μg/kg and median: 268.74 μg/kg) and ZEA (mean: 79.7 μg/kg
and median: 64.86 μg/kg), respectively. The toxins levels found were lower when compared to that of
a study performed by Wu et al. (2017), in which the strains exhibited a production of 1405.05 μg/kg
for DON and 4118.31 μg/kg for ZEA. The parameter temperature is crucial for DON production and
some studies showed a variation of the optimal value, that varies between 20 and 28 ◦C [19,20,41].
On the other hand, temperature negatively affected ZEA production. The optimized condition for ZEA
production was cultivation at 15 ◦C [41]. The toxin combination can be related to several mycotoxigenic
fungi that contaminate barley in the field. However, the mycotoxin occurrence in Brazilian barley
suggests high prevalence of toxigenic F. graminearum and related species, which could explain the
DON and ZEA levels in almost 85% of the samples.
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4. Conclusions
The DON and ZEA contamination in brewing barley grains were detected in 90.6% and 87.5%
of the samples. The phylogenetic study showed that the majority of the strains clustered with
F. graminearum, F. poae and F. avenaceum. Toxigenic species of F. graminareum isolates presented a
higher percentage in the samples (31.25%) and can explain the DON and ZEA contamination found
in the barley samples. Taking into account the Brazilian regulation of ZEA levels in barley, 86% of
the samples were significantly higher than the current maximum limit, while for DON, only one
sample was above the established maximum levels. The Brazilian regulation for mycotoxins will
be updated by 2019 and therefore, the new maximum limits are still under discussion, based on
the analysis of the largest amount of data available of the occurrence of mycotoxins in the grains
produced in Brazil. This monitoring data of the toxigenic Fusarium and its mycotoxins could lead to
greater knowledge of the current situation of the barley contamination in the industry, which can assist
Brazilian regulation and the programing of management strategies in order to avoid the toxic effects
on human and animal health.
Fungal infection and the presence of mycotoxins in cereals is natural and the prevention of
these occurrences is difficult even if good agricultural practices are maintained. The data provided
in this study was important for the knowledge on Fusarium diversity and toxin contamination.
Furthermore, the results highlight the importance of monitoring DON and ZEA contamination in barley
grains during pre, post-harvest and in processed food, such as beer, mainly for the development of
management strategies. Consequently, serious economic losses and health problems could potentially
be avoided.
5. Materials and Methods
5.1. Barley Samples
A total of 64 brewing barley (BRS Brau variety) samples were obtained from the 2016 harvest, from
the States of Paraná and Rio Grande do Sul, the largest barley-producing regions in Brazil. Samples
were collected from bulk batches, after dirt removal and drying (up to 60 ◦C) in the storage units.
Sampling was performed using a grain auger from different points of the bulk batches, with a minimum
final weight of 5 kg. Each sample was homogenized, reduced into portions of 1.0 kg to be representative
of the overall sample and further was milled for each analysis. Samples were packed in polyethylene
bags and stored at 4 ◦C and different amounts were used for mycobiota and mycotoxin analyses.
5.2. Water Activity
To perform water activity (aw) analysis, 2 g of each barley sample were submitted to Aqua-Lab
4TE equipment Aqua-Lab 4TE, Decagon Devices (Sao Jose dos Campos, SP, Brazil). Samples were
analyzed in triplicate according to the Association of Official Analytical Chemists—[42].
5.3. Mycobiota and Identification of Fungi
The dilution technique was used for fungal isolation, as described by [43]. To summarize briefly,
twenty-five grams of each sample were added to 225 mL of 0.1% peptone dissolved in water in sterile
conditions. The mixture was stirred on a rotary shaker for 2 min., dilutions of 10−1, 10−2, 10−3 and
10−4 were obtained, 0.1 mL aliquots of each dilution were spread on the PDA medium [9,10] containing
chloramphenicol (100 mg/L) (in duplicate). These were incubated for 5 days, at 25 ◦C in the dark.
The results were expressed into colony forming units per gram (CFU/g) in the dilution 10−1, as the
colonies were easily distinguished in this dilution factor. The isolates were identified morphologically
according to Pitt and Hocking, (2009).
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5.4. Identification of the Fusarium Species
The strains were grown in yeast extract sucrose (YES) agar [44] for 3 days at 25 ◦C. The DNA
was extracted using DNeasy Plant Mini Kit (Qiagen, Hilden, Germany) according to the
manufacturer’s instructions.
The partial sequences of elongation factor (EF-1α) and the second fragment of RPB2 (7CF/11AR)
were selected in order to identify the Fusarium isolates. The amplification of the EF-1α and RPB2
loci were performed according to [45,46]. Amplicons were purified with ExoSAP-IT (Affymetrix,
Santa Clara, CA, USA) and sent to the Centre of Human Genome Studies, University of Sao Paulo,
Brazil for sequencing in ABI PRISM 3130 DNA Analyzer (Applied Biosystems, Foster City, CA, USA).
Sequences were aligned using the multiple alignment software ClustalX v. 1.83 plug-in in the
software Geneious v. 5.3.6 (Biomatters, Auckland, New Zealand). The alignments were edited using
the sequence alignment-editing program Geneious v. 1.83 and each polymorphism was re-examined
by checking the chromatograms. The sequences generated in this study were deposited in the GenBank
(Table 1 and Table S1).
5.5. Phylogenetic Analysis
Phylogenetic analysis was performed based on the EF-1α and RPB2 combined datasets using the
PAUP 4.0b10 (Sinauer Associates, Sunderland, MA, USA) [47]. Phylogenies were obtained by using
Unweighted Parsimony analysis and heuristic search option with 1000 random addition sequences
and tree bisection reconnection branch swapping in PAUP 4.0b10 [48]. Gaps were treated as missing
data. The Consistency Index (CI) and the Retention Index (RI) were calculated to indicate the amount
of homoplasy present. Clade stability was assessed via bootstrap analysis in PAUP 4.0b10, using
1000 heuristic search replications with random sequence addition. The data sets were rooted with
Fusarium sp. as it is considered a suitable out-group [49]. The reference sequences for the Fusarium
species used in this study were obtained from NCBI (Table S1).
5.6. Mycotoxin Analysis
5.6.1. Chemicals and Reagents
Both standards (DON and ZEA) were purchased from Sigma Aldrich Chemicals (St. Louis, MO,
USA). Stock solution standards were prepared in methanol at concentrations of 1 mg/mL for DON and
ZEA. From the individual stock standard solutions, a standard mixture was prepared at the following
concentrations: 0.025, 0.0375, 0.0625, 0.125, 0.375, 0.500 μg/mL. The standard mixture was prepared
in methanol and stored at −18 ◦C. Methanol and acetonitrile (LC-MS/MS grade) were supplied by
J.T Baker (Sao Paulo, SP, Brazil). Acetic acid was obtained from Biotec (Pinhais, PR, Brazil). High-purity
Milli-Q water (18.2 MΩ/cm) was obtained from the Millipore Synergy system (Billerica, MA, USA).
5.6.2. DON and ZEA Extraction
Mycotoxin extraction was carried out according to [50], with some minor modifications. Briefly,
2 g of brewing barley were ground and homogenized in 8 mL of acetonitrile:water (80:20 v/v) and
shaken for 60 min. The mixture was then centrifuged for 10 min at 3500 rpm. The supernatant was
transferred to an amber vessel and dried using a heating block and a nitrogen stream. The dried
extract was resuspended in 500 μL of a mobile phase consisted of 70% of water:methanol:acetic acid
(94:5:1, v/v/v) and 30% of water:methanol:acetic acid (2:97:1, v/v/v). Finally, 5 μL was injected in the
LC-MS/MS system for analysis.
5.7. Production of DON and ZEA by the Strains
The isolates of F. graminearum were grown onto PDA (three agar plugs, 6 mm in diameter) and
tested for DON and ZEA production. The culture media was incubated at 24 ◦C and 15 ◦C with a
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moisture content of 90% and 80% for 20 days for DON and ZEA, respectively [51,52]. The mycelium
was transferred into an Erlenmeyer flask containing 30 mL of chloroform and shaken for 60 min for
mycotoxin extraction, followed by filtration through anhydrous sodium sulfate (Na2SO4). The extract
was dried and re-suspended with 500 μL of mobile phase. Finally, the extract was filtered with a
syringe filter (nylon membrane 0.22 μM). The sample was quantified by liquid chromatography/mass
spectrometry (LC-MS/MS) for DON/ZEA.
5.8. Chromatography Conditions
Detection and quantification were carried out using an LC-MS system from Thermo Scientific®
(Bremen, Germany) composed of an ACCELA 600 quaternary pump, an ACCELAAS auto-sampler
and a triple quadrupole mass spectrometer TSQ Quantum Max.
The chromatographic conditions were performed according to [53]. In short, the following
instrumental settings were applied: the triple quadrupole mass spectrometer TSQ Quantum Max was
operated at positive polarity and the ionization conditions were 208 ◦C for capillary temperature,
338 ◦C for vaporizer temperature, 4500 V for spray voltage and 60 arbitrary units for sheath gas
pressure. For selectivity, the mass spectrometer was operated at MRM mode monitoring, three
transitions per analyte, using a collision gas pressure of 1.7 mTorr and collision energy (CE) ranging
from 11 to 40 eV.
The mass spectrometric conditions were optimized by re-tuning different analytes by direct
infusion of each analyte individually. The tube lens potential, collision energies and product ions were
optimized and carefully chosen. The most abundant mass-to-charge ratio (m/z) was selected for each
compound of interest. The mycotoxins exhibited precursor ions and product ions with reasonably
high signal intensities in positive ESI mode (ESI+) and protonated molecules [M + H] were found.
Table S2 shows the retention times (tR), MRM transitions as well as the tube lens potential and collision
energies optimized for each compound.
Separation was performed on a C8 Luna column, with a particle size of 3 μm, 150 × 2.0 mm,
length and diameter, respectively, Phenomenex (Torrance, CA, USA). In the mobile phase, solvent A
(water:methanol:acetic acid, 94:5:1, v/v/v) and solvent B (water:methanol:acetic acid, 2:97:1, v/v/v)
were used. The gradient program was applied at a flow rate of 0.2 mL/min under the following
conditions: 0–1 min 55% B; 1–3 min 55–100% B; 3.01–7 min 100% B and 7.01–12 min 55% B. The total
analytical run time was 7.5 min for the 2 toxins (Table 3).







(m/z) * CE (V) TubeLens








* Q, Quantification transition C, Confirmation transition.
Method Validation
The methods for extraction of mycotoxins in brewing barley and in culture media with Fusarium
growth were validated according to the Commission Regulation [54] guideline. To determine the limit
of detection (LOD), limit of quantification (LOQ), recovery, repeatability and selectivity/specificity,
samples with non-detectable levels of mycotoxins were submitted to spiking experiments.
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Considering linearity, a six-point calibration curve was constructed with the following
concentrations of the mycotoxin standard mixture (DON and ZEN): 0.025, 0.0375, 0.0625, 0.125,
0.375, 0.500 μg/mL. The LOD and LOQ methods were determined by fortifying blank samples with
different concentration levels and the experiments were repeated on three different days. The LOD
was defined as the minimum concentration of an analyte in the spiked sample with a signal noise ratio
equal to 3 and LOQ with a signal noise ratio equal to 10.
5.9. Data Analysis
Results regarding DON and ZEA in brewing barley samples and F. graminearum strains were
reported as the mean ± standard deviation and median, using Microsoft office Excel 2007.
Supplementary Materials: The following are available online at http://www.mdpi.com/2072-6651/11/1/31/s1,
Table S1: Fusarium species references used in this study for phylogenetic analysis, Table S2: Characteristics of the
method performance for extraction of deoxynivalenol and zearalenone in barley grains and culture media.
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Abstract: Mycotoxins are widely studied by many research groups in all aspects, but the stability of
these compounds needs further research for clarification. The objective of this study is to evaluate
deoxynivalenol and zearalenone stability during all steps of the malting and brewing processes.
The levels of these compounds decreased significantly during the production process (barley to beer).
During the malting process, the DON levels decreased significantly in the steeping, germination,
and malting steps (62%, 51.5%, and 68%, respectively). Considering ZEN, when the levels were
compared between barley and the last step of the process, a significant decrease was observed. Most
of the mycotoxins produced were transferred to the rootlets and spent grains, which is advantageous
considering the final product. Furthermore, the mycotoxin dietary intake estimation was included
in this study. The results proved that if the concentrations of target mycotoxins in raw material are
under the limits established by the regulations, the levels decrease during the malting and brewing
processes and make the beer secure for consumers. The quality of the five commodities involved in
the beer process plays a decisive role in the creation of a safe final product.
Keywords: mycotoxins; stability; malting; brewing; beer
Key Contribution: Deoxynivalenol and Zearalenone shown to decrease in levels over the entire
process with significant difference. This study showed that if the raw material is under the limits
established by the regulations, the levels can decrease during the process and make the beer safe
for consumers.
1. Introduction
Fusarium contamination in cereals has increased in recent years, mainly in barley, wheat, corn,
and oats [1–5]. This can be related to changes in climate condition, but is also due to problems
during cultivation and harvest. Along with fungi contamination, temperature, and changes in forecast,
the production of secondary metabolites occurs.
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Mycotoxins are being widely studied by many research groups in all aspects, such as the occurrence
of these compounds in food, effects on animals and also on humans, prevention, and mitigation [2,6,7].
The stability of mycotoxins is also studied, but all aspects need further research for clarification and
perhaps help in the control of contamination.
In this context, the beer industry has several concerns about fungi and mycotoxin contamination
due to the loss of raw material, economic impact, and, one of the most significant issues, loss of quality.
Two Fusarium toxins that are considered hazardous to the entire industry are deoxynivalenol
(DON) and zearalenone (ZEN). These toxins are very common and can be found throughout the entire
malting and brewing processes [8].
DON, also named vomitoxin, is a trichothecene B-type that elicits a complex spectrum of toxic
effects. Chronic exposure to low doses of DON can lead to anorexia, impaired weight gain, and
immunotoxicity. Acute exposure to high doses can cause diarrhea, vomiting, leukocytosis, circulatory
shock, and, ultimately, death [9].
Trichothecenes are products of the sesquiterpenoid metabolism of some genera in the order
Hypocreales [10] and, among them, deoxynivalenol (DON) is notorious for its worldwide occurrence.
This mycotoxin is mainly produced by phylogenetic species within the Fusarium graminearum species
complex, which includes the F. graminearum sensu stricto [11]. This species is encountered on barley,
maize, and wheat causing Fusarium head blight, a disease that leads to yield losses in small grain cereals.
ZEN is another mycotoxin that should be taken into account due to the high contamination found
in recent monitoring studies in grains [2,3,12]. It is treated as a non-steroidal estrogenic compound
because its structure is similar to the hormone estrogen and it competes with 17β-estradiol for binding
of the estrogen receptor, resulting in infertility and reproductive problems [13].
Regulations have been established worldwide to fix the maximum levels allowed of mycotoxins
in grains. In Europe, the levels for DON and ZEN in barley are set at 1250 μg/kg and 100 μg/kg,
respectively [14]. In Brazil, the regulations are being updated and in 2019 the DON levels for barley will
be set at 1000 μg/kg for barley and 750 μg/kg for malt. Considering ZEN, the levels will be maintained
at 100 μg/kg [15].
Some studies have shown a high contamination of these two mycotoxins in beer, but no studies
have been developed to control or decrease the levels. The beer industry requires more information
about the stability of these compounds during the entire process.
For the reasons stated above, the objective of the current study is to evaluate the stability of
DON and ZEN during all steps of the malting and brewing processes, considering that barley grains
constantly pass through different conditions, which can increase or decrease the levels of these




The methods for extraction of mycotoxin grains and liquid matrices during the malting and
brewing process were validated according to the Commission Regulation [16] guidelines. To determine
the recovery, repeatability, and selectivity/specificity, solid and liquid samples with non-detectable
levels of mycotoxins were submitted to spiking experiments.
The blank solid malt control sample was used (produced from the barley variety Kangoo) with
no targeted mycotoxins detected. The spiking levels were chosen considering the contamination
levels of examined samples. The blank liquid sample used was wort (from the above-mentioned malt,
according to Section 4.3). The spiking levels of the liquid matrix were chosen considering the predicted
contamination levels of examined samples of produced wort and beer. The standards were applied
to the matrix in methanol:water (1:1 v:v). Average recovery was calculated using triplicate analyses
conducted for each level. The experiments were repeated on three different days.
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The limit of detection (LOD) was defined as the minimum concentration of an analyte in the
spiked sample with a signal–noise ratio equal to 3 and limit of quantification (LOQ) with a signal–noise
ratio equal to 10. Considering linearity, a seven-point calibration dependence was constructed with
the following concentrations of the mycotoxin standard mixture (DON and ZEN): 5, 10, 20, 50, 100,
200, and 1000 ng/mL. The coefficients of determination (r2) for DON and ZEN were 0.9994 and 0.9992,
respectively. The parameters achieved are shown in the Table 1.























2.0 6.750 89.2 0.9
100 97.9 0.8
* grain: μg/kg; liquid: μg/L; a DON: deoxynivalenol; b ZEN: zearalenone; c RSD: relative standard deviation; d LOD:
limit of detection; e LOQ: limit of quantification.
2.2. DON and ZEN Stability during the Malting and Brewing Processes
The stability of the mycotoxins was evaluated in the steps considered as the most important
(N = 13) of the malting and brewing processes (Figure 1). First of all, as aforementioned, the barley
used for the analysis was naturally contaminated and the levels among ten samples had an average of
3835 μg/kg and 1069 μg/kg for DON and ZEN, respectively (Table 2).
 
Figure 1. Map of malting and brewing process sampling (blocks in gray) carried out in the study.
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Table 2. Average, minimum, and maximum values for all of the steps of the malting and
brewing processes.
Process Steps DON (μg/kg) ZEN (μg/kg)
Average Maximum Minimum Average Maximum Minimum
Malting
Barley 3835 5204 2687 1070 3596 175
Water 1st day 599 851 470 12 21 3
Steeping 1st day 1319 2906 438 222 1045 53
Steeping 3rd day 1442 2103 754 799 2602 15
Germination 1st day 1308 2641 617 618 2385 57
Germination 3rd day 1858 2957 822 1172 2854 140
Malt 1211 1780 728 392 1386 95
Rootlets 1797 2181 1431 1122 1735 206
Brewing
Wort 1105 1505 808 25 64 9
Spent grains 1068 1742 590 1429 3188 200
After boiling 1132 1483 840 <LOQ <LOQ <LOQ
After
fermentation/beer 1089 1414 863 <LOQ <LOQ <LOQ
Yeast 166 241 89 <LOQ <LOQ <LOQ
Considering DON in the malting process, water was analyzed first and an average of 599 μg/kg
was found. In this experiment, the mass balance of mycotoxins DON and ZEN was always related
to 1 kg of the original barley and the reported values in malt, wort, beer after boiling, and beer after
fermentation were recalculated according to the weight balance, where barley is 100%.
Detected levels in byproducts (yeasts, spent grains, and rootlets) were reported in μg/kg and were
not included in the mass balance.
Comparing DON levels found in barley with levels found on the first and third day of steeping
and the third day of germination and malt, DON had a decrease of 66%, 62%, 51.5%, and 68%,
respectively, and were significantly different (*** p < 0.001) (Figure 2). On the other hand, DON
decreased significantly (38%) between the third day of germination and malt (* p < 0.05).
The ZEN levels during the malting process decreased significantly (79%) when barley was
compared to the first day of steeping (* p < 0.05). Nevertheless, an increase could be seen between the
first day of steeping and the third day of germination (173%), with a significant difference (** p < 0.01).
Further analyses were completed in brewing. Considering the entire process (barley to beer),
DON showed a significant (*** p < 0.001) decrease of 71.6%. In the same context, when ZEN levels
were compared, a significant decrease was also observed (** p < 0.01).
It is necessary to highlight that all of the results for the liquid matrix were recalculated to 1 kg.
Figure 2. Cont.
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Figure 2. Steps of the malting and brewing processes showing (A) DON and (B) ZEN levels expressed
as mean ± SD and different significance between the steps, according to ANOVA followed by Tukey
test (* p < 0.05; ** p < 0.01; *** p < 0.001).
2.3. Mycotoxin Dietary Intake Estimation from Beer Consumption
Using an average adult body weight of 60 kg and the mean mycotoxin data from this study, an
estimation of dietary exposure to DON from the last step of the process while following the levels
established by the regulation was carried out (Table 3).
Table 3. Mycotoxin dietary intake estimation from beer consumption.
DON
Level Study Level Regulation
Mean (μg/L) 272.17 88.75
Daily average exposure (μg/kg/bw) 0.77 0.25
Tolerable daily intake (μg/kg/bw) 1 1
% of tolerable daily intake 77 25
It is important to mention that the level of the mycotoxin in the last step was 1089 μg, recalculated
to 1 kg. Based on the literature [17], 1 kg of barley is able to produce 4 L of beer. 272 μg/L of DON in
beer is equivalent to 1088 μg/kg DON in barley. This corresponds to a 71.6% reduction of DON content
in the final product, whereas the average DON concentration in the original barley was 3835 μg/kg.
Applying the same model to barley contaminated with 1250 μg/kg DON (the maximum allowable
limit), the resulting DON concentration in beer will be 89 μg/L.
3. Discussion
As the literature shows, mycotoxins are highly stable compounds (resistant to high temperatures
and extreme pH levels) [18]. Although the malting and brewing processes have maximum operation
temperatures below the ones able to destroy the mycotoxins, they may influence mycotoxin
concentration due to physical, chemical, and biochemical changes that take place [17,19]
In the current study, mycotoxin levels were determined in seven steps of the malting process. First,
barley and water were analyzed and the results showed levels for DON in both matrices (barley average
3835 μg/kg, water average 599 μg/kg). The amount of DON found in the water can be explained by the
soluble characteristic of this mycotoxin; for this reason, it was eluted from the matrix [20]. On the other
hand, low levels for ZEN in water were found.
Furthermore, when DON levels of barley were compared to the first and third day of steeping,
a decrease in the levels was observed. These results could also be related to the loss of mycotoxins in
the water.
The next step involved in malting is germination. In this study, the samples were taken from
the first and third day of this process. The levels of DON decreased significantly between barley and
the third day of germination. A possible reason for this reduction (DON glycosylation) is due to the
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increase in glucose content, which might activate the barley enzyme responsible for the respective
reaction, transforming DON into DON-3-glucoside. Some studies have shown that 50% of DON
is converted after a few days of germination [21]. To our knowledge, there is no study carried out
considering ZEN glycosylation during germination in barley. However, the results of the current study
could suggest this reaction (between barley and the first day of germination), transforming ZEN in
α- and β-zearalenol and other masked toxins, even though the decrease in the levels is considered
without significant difference [22].
Additionally, during germination, fungal biomass and mycotoxin production may grow, most
likely as a result of cross-contamination from the residual steeping water or because of a latent barley
grain infection, which may be activated with the increase in humidity during this process [23]. This
can be seen in the current study when ZEN levels from the first day of steeping and the third day of
germination are compared.
The final procedure in malting is kilning, where the germination is interrupted and the green malt
is prepared for storage and transportation. This step is characterized by several temperature scales
(55–100 ◦C) and it is considered crucial to malt flavor and color formation [19]. In the current study,
DON levels were shown to decrease significantly between the third day of germination and malt. This
could be related to the high temperatures, but also due to the separation of the rootlets from the grain.
Malt and rootlets were analyzed for both toxins and it is necessary to highlight the eminent
amount of both toxins found in rootlets. For the beer industry, it was considered a good result, as most
of the mycotoxins are released in this part of the grain. On the other hand, it should be a concern for
agriculture, as this matrix is frequently used to feed animals [24–26].
After barley is malted, the grains are milled, and water is added to start the brewing process.
In the mashing phase, the water is heated to about 62–71 ◦C and enzymes, such as α- and β-amylases,
are activated to allow the conversion of starches into fermentable sugars [17]. Concerning the influence
on mycotoxin levels at this step, there is a possible release of DON conjugated to protein structures
and, as a result, there is an increase in total DON concentration [27]. This fact could be seen in the
current study for both mycotoxins, not only for DON. Being more specific, DON and ZEN had an
average malt level of 1211 μg/kg and 391 μg/kg, respectively. In mashing, if the results of wort and
spent grains are added, the value is almost twice as high for DON and almost four times as high
for ZEN (DON: 2173 μg/kg; ZEN: 1460 μg/kg). Also, the milling process could interfere in the levels
due to the mycotoxin homogeneous spread into the entire malt batch and its later solubilization into
mashing water [8].
Boiling is the next stage and it is characterized by the enzyme inactivation, hops addition,
isomerization of hop alfa acids, evaporation of water and volatile compounds (dimethyl sulphides,
undesirable in beer), protein precipitation, sterilization, Maillard reactions, and flavour modulation [17].
Regarding the impact of wort boiling on mycotoxin content, the temperature in this process, (above
100 ◦C) and the average time of boiling (1 h) could cause a decrease in mycotoxin concentration [8,28].
This experience can be seen in the results of the present study, even in low concentrations.
On the other hand, a few authors have shown that DON and ZEN are very stable compounds and
the melting points in food processing are around 153 ◦C and 165 ◦C, respectively [18,29]. Another thing
that should be mentioned in this stage is the addition of adjuncts, such as corn, wheat, and sorghum,
which might represent an additional source of mycotoxins [1,30].
After the boiling process, the wort is cooled to 21 ◦C and the fermentation of wort is initiated by
the yeast (Saccharomyces genus). In general, the fermentation temperature ranges from 2 ◦C to 30 ◦C,
over 7–9 days [31,32]. DON was shown to be very stable in this process and the results did not show
significant differences (after boiling: 1132 μg/kg; after fermentation: 1089 μg/kg = 3.8% of apparent
reduction). In research performed by [33], similar results were found, where there was a reduction of
only 11.6% of DON.
The adsorption of mycotoxins by yeasts have been studied and this phenomenon occurs due to
the binding of the toxins to ß-glucans from yeast to the cell wall [34]. In the current study, the yeasts
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were also analyzed after fermentation and DON was shown to be adsorbed. For ZEN, any amount of
this mycotoxin found after boiling made this determination impossible in the present experiments.
Nevertheless, in a study conducted by [33], ZEN was shown to have a very high ratio of adsorption
(75.1%) on the beer fermentation residues.
Finally, considering the results of tolerable daily intake, the consumption of 62 L/year per capita [35]
(0.17 L/day of beer) resulted in an exposure of 0.77 μg/kg/bw/day from the beer in this study and
0.25 μg/kg/body weight (bw)/day from beer using the levels established by the regulation for a 60 kg
adult. Both these estimated daily intake (DI) results are still lower than the provisional maximum
tolerable daily intake (PMTDI) of 1 μg/kg bw/day for DON stipulated by the Joint Expert Committee
on Food Additives (JECFA) [36].
4. Material and Methods
4.1. Samples
A total of 10 barley samples (Hordeum vulgare L.) with a weight of 500 g each were used from a
2015 harvest and were supplied by the Brazilian agricultural research corporation (Embrapa). It is
important to mention that the samples studied had natural mycotoxins levels acquired in the field
without artificial interference.
The samples used in the current study were sown in May 2015 and harvested in December 2015.
During this period, above-average rainfall with a mean precipitation of 95 mm was recorded [37].
Furthermore, the humidity was also considered significant, with an average value of 80% [38]. Another
parameter included was the high temperature (average of 29 ◦C). These barley samples contained a
concentration average of 3835 μg/kg for DON and 1070 μg/kg for ZEN, according to our previous
study [2]; the environmental conditions presumably affected the mycotoxin production, thereby
justifying the levels found.
The samples were used in the entire processes of malting and brewing (microscale) and aliquots
were taken in the selected steps for mycotoxin analysis.
4.2. Chemicals and Reagents
Deoxynivalenol and zearalenone standards were purchased from Sigma Aldrich (Vienna, Austria).
The stock solutions standards were prepared in methanol:water (1:1) at a concentration of 1 μg/mL.
All reagents used in the following analyses were analytical and LC/MS-MS grade. For quality
assurance in the mycotoxin analyses, wheat flour certified reference materials (CRM) (Trilogy,
Washington) were used. The concentrations for DON and ZEN were 700 ± 100 μg/kg and
454.2 ± 37.6 μg/kg, respectively.
4.3. Malting and Brewing Process
All of the malting and brewing trials were carried out in the Research Institute of Malting
and Brewing, Brno, Czech Republic. The procedures used for malting were according to
the [39] methodology and amendments were approved by the barley and malt European Brewery
Convention [32].
The first step of malting was steeping, carried out as follows: On the 1st day of steeping, water
was added to the grains for 5 h, followed by 19 h of air rest. On the 2nd day, grains were submitted
to 4 h in the water, followed by 20 h of air rest. Finally, on the 3rd day of steeping, the grains were
in the water for 20 min and then submitted to air rest for 23 h and 40 min. The germination step
was performed over 3 days (72 h), with a subsequent kilning step. The grains in the steeping and
germination processes were always maintained at a controlled temperature (14 ◦C) and the moisture
content of the grains was measured in each step, being controlled to 45%. The total kilning time was
22 h, with a pre-kilning temperature of 55 ◦C for 12 h and a kilning temperature of 80 ◦C for 4 h.
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Furthermore, the methodology used for wort production was according to [39] and the [32], with
slight modifications. Fifty grams of milled malt was weighed into the mashing beaker and 200 mL of
water (45 ◦C) was added. The beaker was placed into a programmed mashing bath with automatic
stirrers. The temperature was maintained for 30 min under constant stirring (100 rpm). Following
this period, the temperature of the mashing bath was increased 1 ◦C per minute for 25 min. Once
the temperature reached 70 ◦C, 100 mL of water at 70 ◦C was added and maintained at 70 ◦C for 1 h.
The beaker was then removed and cooled to room temperature. The contents of the beaker were
adjusted to 450 g with water, stirred, and the contents filtered through filter paper. Wort and spent
grains were used for further analyses.
The methods carried out for the final steps of the brewing process, such as boiling and fermentation,
were developed by the Research Institute of Brewing and Malting and also according to available
literature [31,32], in an attempt to simulate the real brewing process. In short, each sample with 200 mL
of the wort was boiled with 8 g of traditional hops for one hour. It is necessary to mention that the hops
were added at two different times, in the beginning (4 g) and after 30 min of boiling (4 g). The boiled
wort was cooled to 21 ◦C for the yeast (W 34/70Starobrno Lager Yeast, Saccharomyces pastorianus)
addition. The fermentation process was carried out over the course of 3 days at a controlled temperature
(18 ◦C).
The sampling for mycotoxin analysis was performed in 8 steps of the malting process and 5 steps
in the brewing process, as shown in Figure 1.
4.4. Extraction and Mycotoxin Cleanup
To accomplish the procedure for extraction and cleanup of DON and ZEN analysis, immunoaffinity
columns (DZT MS-Prep—R. Biopharm, Glasgow, Scotland) for both mycotoxins were used. This step
was performed according to the DZT MS-Prep protocol with some modifications. In short, for grains,
10 g of milled barley, malt, rootlets, and spent grains were mixed with methanol 70% for 50 min,
followed by 15 min of centrifugation at 4500 rpm. Then, 2 mL of the extract were added to 48 mL of PBS
buffer (pH 7.4, adjusted with 2M NaOH) [40] and shacked manually. Twenty mL of the diluted extract
were passed through the column at one drop per second. In addition, to wash the column, 20 mL of
distilled water was added. The elution was performed with 2 mL of 100% methanol. For injection,
the extract was dried and then dissolved with 1 mL of 50% methanol in water. For the yeast extract,
the procedure described above was applied to 2 g per sample.
The DZT MS-Prep columns were also used for mycotoxin extraction from a liquid matrix.
In summary, 2 mL of wort or beer was added to 18 mL of PBS buffer and then loaded to the column.
For washing, 20 mL distilled water was used, followed by elution with 2 mL of 100% methanol. Finally,
the extract was dried and dissolved in 1 mLof 50% methanol for injection.
4.5. LC/MS-MS Method for Analysis
To accomplish the identification and quantification of mycotoxins (DON and ZEN), LC/MS-MS
system consisting of Finnigan Surveyor HPLC coupled to the ion trap LCQ Advantage mass
spectrometer (Thermo-Fisher, USA) with atmospheric pressure chemical ionization (APCI) was used.
The chromatographic conditions were adopted according to the procedure developed by [41].
Chromatographic separation was performed with Synergi Hydro RP 80A column (3.0 × 150 mm,
4.0 μm particle size) equipped with a Security Guard™ cartridge C18 (4.0 × 3.0 mm, 4.0 μm) at 30 ◦C
using gradient elution. The mobile phase was comprised of solvent A (water containing 10 mM
ammonium acetate) and solvent B (methanol). The gradient program was applied at a flow rate of
0.5 mL/min under the following conditions: 0.1 min 90% A; 2 min 50% A; 10 min 20% A; 15 min 20% A;
16 min 90%; 25 min 90% A. The total analytical run time was 25 min for the two toxins.
The APCI interface was operated at negative polarity and the following ionization conditions
were used: Capillary temperature, 160 ◦C; source heater temperature of 450 ◦C; nitrogen sheath gas
flow of 35 L/min; nitrogen auxiliary gas flow of 10 L/min; source voltage of 6.0 kV; collision gas was
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helium. For selectivity, the mass spectrometer was operated in MRM mode and two transitions per
analyte were monitored (Table 4).



















* C: Confirmation transition; Q: Quantification transition.
The mass spectrometry conditions were optimized by re-tuning different analytes via direct
infusion of each analyte individually. The cone voltages, collision energies, and product ions were
optimized and carefully chosen.
4.6. Estimation of the Average Tolerable Daily Intake (TDI) and Maximum Tolerable Daily Intake
The mycotoxin dietary intake estimation was calculated using the mean level of DON found in the
end of the process (after fermentation/beer) which was divided by four, considering that 1 kg of barley
is able to produce 4 L of beer [17]. The mean level obtained was multiplied by the daily consumption
of beer according to [42] and divided by 60 kg (body weight). The TDI calculation was based on the
tolerable intake 1 μg/kg body weight/day for DON [36].
4.7. Statistical Analysis
Results regarding DON and ZEN during the malting and brewing processes were reported as
mean, maximum, and minimum using Microsoft Office Excel 2007. Also, analysis of variance (repeated
measures ANOVA) using the Tukey test was conducted on the obtained data. The results are presented
as mean ± standard deviation and values of p < 0.05 were considered statistically significant.
5. Conclusions
The malting and brewing processes may impact the stability of DON and ZEN. Both mycotoxins
were shown to decrease in levels over the entire process (barley to beer), with significant difference.
It is necessary to highlight that rootlets and spent grains were shown to discard most of the mycotoxins
produced in the previous processes. However, it should be a concern for the agriculture, due to this
matrix being destined for animal feeding.
The quality of the five commodities involved (barley, hops, water, yeast, and adjuncts) in the beer
process plays a decisive role in the creation of a safe final product. Finally, according to mycotoxin
dietary intake estimation, this study showed that if the raw material is under the limits established by
the regulations, the levels can decrease during the process and make the beer safe for consumers.
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Abstract: Sorghum malts, which are important ingredients in traditional fermented beverages, are
commonly infected by mycotoxigenic fungi and mycotoxins may transfer into the beverages, risking
consumers’ health. Liquid chromatography–tandem mass spectrometry was used to determine
variation of fungal metabolites in 81 sorghum malts processed for brewing of Namibian beverages,
otombo (n = 45) and omalodu (n = 36). Co-occurrence of European Union (EU)-regulated mycotoxins,
such as patulin, aflatoxins (B1, B2, and G2), and fumonisins (B1, B2, and B3) was detected in both malts
with a prevalence range of 2–84%. Aflatoxin B1 was quantified in omalodu (44%) and otombo malts
(14%), with 20% of omalodu malts and 40% of otombo malts having levels above the EU allowable limit.
Fumonisin B1 was quantified in both omalodu (84%) and otombo (42%) malts. Emerging mycotoxins,
aflatoxin precursors, and ergot alkaloids were quantified in both malts. Notably, 102 metabolites
were quantified in both malts, with 96% in omalodu malts and 93% in otombo malts. An average of
48 metabolites were quantified in otombo malts while an average of 67 metabolites were quantified in
omalodu malts. The study accentuates the need to monitor mycotoxins in sorghum malts intended for
brewing and to determine their fate in the beverages.
Keywords: traditional sorghum malts; mycotoxins; aflatoxins; Aspergillus; LC/MS/MS
Key Contribution: This paper reports the first results on LC/MS/MS based fungal metabolite
quantification in sorghum malt varieties used to prepare traditional fermented beverages, otombo
and omalodu, in Namibia. The quantification of EU-regulated mycotoxins, emerging mycotoxins,
aflatoxin precursors, and ergot alkaloids in both malt varieties necessitates adequate malt processing
under hygienic conditions to reduce fungal contamination and possible transfer into popularly
consumed beverages.
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1. Introduction
Sorghum is a genus of cereals in the family Poaceae of approximately 30 species. One species,
Sorghum bicolor, is native to Africa and is the world’s fifth most important cultivated cereal crop [1], with
many significant uses, such as being a staple food in some sub-Saharan countries, the main ingredient
in the production of beverages, and animal feed [2]. In Namibia, sorghum is mainly cultivated by
rural subsistence farmers of the northern regions and is mainly used for the brewing of traditional
beverages [3]. Specifically, unground malted sorghum grains are used as the main ingredients in the
brewing of the traditional alcoholic drink locally known as otombo, while malted sorghum flour is used
for the brewing of the non-alcoholic beverages omalodu and oshikundu [3]. Otombo, which is mainly
brewed nationwide for income generation, is sold at shebeens in rural areas and at open markets
in urban areas, and, due to its alcoholic content, is generally consumed by elders. Omalodu is also
a popular ceremonial traditional beverage in Namibian Oshiwambo and Rukwangali communities.
In both communities, omalodu is primarily consumed at sociocultural ceremonies.
Sorghum malts used in this study vary depending on the malting process and the milling stages.
According to [4], malting is defined as the germination of grains to promote the development of
hydrolytic enzymes which were inactive in the raw grain. Generally, the malting process involves
three main processes: Steeping, germination, and drying [5]. In Namibia, particularly among the
Oshiwambo and Rukwangali communities, the malting process is carried out at the household level
and is similar, with minor differences due to cultural specifications and weather conditions. Basically,
the process of sorghum malting involves steeping the cleaned grains in water for 24 to 48 h, draining,
and germination in sealed plastics, jute sacks, or metal trays for 1 to 2 weeks. Some Oshiwambo
community members may add sandy soil to facilitate the germination process. The germinated grains
are then air dried at ambient temperature, then the dry malted grains, including the root fragments,
are used for otombo brewing. Milling of the dry malts used for omalodu brewing is usually carried
out in a hut or an open area by pounding with strong wooden sticks in a wooden traditional mill.
The pounding is continued until all grains are pulverized with intermittent sifting using a circular
basket made from palm leaves. The initial round of sifted coarse sorghum flour with grains and root
fragments is reserved for omalodu brewing. Omalodu malts are mainly prepared for brewing at the
household level and for family use, while some may also be transported and sold at open markets in
urban areas. Otombo malts are prepared for brewing at shebeens and for selling at open markets.
Due to the warm, moist, and likely unhygienic conditions during the traditional malting and
milling processes, the growth of mycotoxigenic fungi is stimulated [6]. In addition, mycotoxigenic fungi
can infiltrate deep into sorghum matrices and produce mycotoxins during the pre-harvest, storage,
transportation, processing, and marketing stages [7]. Mycotoxins are fungal secondary metabolites
representing natural contaminants in raw materials, foods, and feeds [8]. The most dangerous
mycotoxins are aflatoxins, ochratoxins, fumonisins, patulin, and ergot alkaloids, produced by fungi
belonging to Aspergillus, Penicillium, Claviceps, and Fusarium genera [9]. The toxins are known to
have carcinogenic, mutagenic, teratogenic, cytotoxic, neurotoxic, nephrotoxic, estrogenic, dermotoxic,
and immunotoxic effects in humans [10,11]. Many parts of the world are regulating mycotoxins by
creating maximum allowable limits in different foods and feed. According to a global food prevalence
mycotoxin survey by [12], 72% of the food samples, including cereals, contained detectable amounts
of mycotoxins addressed by regulatory limits in the European Union (EU). However, other fungal
metabolites, such as beauvericin (BEA), moniliformin (MON), sterigmatocystin (STE), emodin (EMO),
alternariol (AOH), tenuazonic acid (TeA), and 3-Nitropropionic acid, (3-NPA), are now frequently
quantified in a variety of foods and feed in different parts of the world [13]. There are also indications
that the incidence of these so-called emerging mycotoxins, which are neither routinely determined nor
legislatively regulated, is rapidly increasing [14–16].
The quality of raw materials used to prepare traditional beverages influences the final product
safety. Many reports on the occurrence and quantities of fungal metabolites in sorghum malts and
related products from countries neighboring Namibia have been documented in South Africa [17],
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Zimbabwe [18], and Botswana [19]. A previous study in Namibia, which determined the diversity of
fungal metabolites in sorghum malt samples used for oshikundu beverage production and their transfer
rates into the beverage, reported that, although EU-legislated mycotoxins were not quantifiable in the
beverage, transfer rates into the beverage were above 50% for most of the other fungal metabolites [20].
Due to the diversity of malting and processing methods for different beverages, the types and quantities
of fungal metabolites in the specific malts may vary. Consequently, consumers’ exposure to the
metabolites will also vary. There is, therefore, a need to investigate the quality of raw materials used
to prepare other traditional Namibian beverages, such as otombo and omalodu, which are consumed
daily and by many people. This study, therefore, aimed at determining the occurrence and variation of
fungal metabolites in sorghum malts intended for the brewing of omalodu and otombo beverages.
2. Results and Discussion
2.1. Occurrence of Fungal Metabolites in Sorghum Malts for Omalodu and Otombo Brewing
Only metabolite concentration levels that were above the limits of quantification (LOQ) were
quantified for both malts. Hence, a total of 102 fungal and bacterial metabolites, including seven
regulated mycotoxins, were quantified in sorghum malts for both omalodu and otombo beverages
(Tables 1–3). Only 4% of the 102 metabolites were of non-fungal origin. The occurrence of fungal
metabolites, including mycotoxins in sorghum malts intended for the beverage oshikundu, quantified
using the same analytical technique and method, was previously reported in Namibia [20], with a total
of 98 metabolites quantified. Other reports on the occurrence and quantities of fungal metabolites
in sorghum malts and grains from Southern Africa have been documented in South Africa [17],
Malawi [21], Zimbabwe [18], and Botswana [19].
The total number of metabolites was higher in omalodu malts (n = 101) than in otombo malts (n =
96). An average of 48 metabolites was quantified in otombo malts, while an average of 67 metabolites
was quantified in omalodu malts, respectively. Although some metabolites were quantified with low
prevalence rates and quantities, the risks of exposure to these complex mixtures of metabolites by
consumption of brews should be studied in more detail in order to minimize the possible synergistic
and/or additive effects during brewing.
The metabolites detected were representatives of the following mycotoxigenic fungal genera:
Aspergillus 34%, (Tables 1 and 2) Penicillium 16%, (Table 1), Fusarium 15%, (Tables 1 and 2), Alternaria
7% (Tables 1 and 2), and Claviceps 6% (Table 1), while 22% were non-fungal metabolites or produced by
unspecified and uncommon fungal genera (Table 3). According to [22], these genera are known to be
associated with sorghum malts and grains in Nigeria, Botswana [19], and Ethiopia [23] and also known
as the main mycotoxigenic fungal genera [24,25]. Only 2% of the metabolites were 100% prevalent in
otombo malts, whereas 15% of the metabolites were 100% prevalent in omalodu malts. Of the quantified
fungal metabolites, 64%, 69%, 65%, and 85% of the Aspergillus, Fusarium, Penicillium, and Alternaria
metabolites had higher average concentrations in omalodu malts than in otombo malts, respectively.
2.2. Variation of Regulated Mycotoxins and Aflatoxins Precursors
Seven mycotoxins addressed by regulatory limits in the EU (i.e., aflatoxin B1, B2, and G1,
fumonisins B1, B2, and B3, and patulin) were quantified in both malts (Table 1). Due to the absence
of such limits in Namibia, the limits fixed by the EU [26] were used as the basis for discussion in the
present study. The same mycotoxins have been recently reported in sorghum malts from Namibia
using the same analytic method by [20], with the exception of patulin found in the present study and
fumonisin B4 quantified only in the previous study. Overall, 98% and 76% of the omalodu and otombo
samples were contaminated with at least one of the EU regulated toxins, respectively. Comparing
the two groups of malt samples, 71% of the of the EU-regulated mycotoxins had higher incidences in
omalodu malts than in otombo malts, while 47% of these mycotoxins had higher average concentrations
in otombo malts than in omalodu malts.
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AFB1 was quantified in omalodu (prevalence = 44%, average = 2.87 ± 2.93 μg/kg) and otombo malts
(prevalence = 14%, average = 15.1 ± 22.9 μg/kg) with 20% of omalodu malts and 40% of otombo malts
having levels above the EU regulatory limit of 5 μg/kg. An independent-samples t-test conducted
to compare average AFB1 levels in omalodu and otombo malts showed that the difference was not
statistically significant (p > 0.05). Differences in averages of AFB2, AFG1, FB1, FB2, and FB3 levels
between omalodu and otombo malts were also not statistically significant (p > 0.05). These results suggest
that the different malt preparation methods may not have a significant effect on levels of aflatoxins.
In the previous study [20], AFB1 was quantified with higher prevalence rate (50%) and level (average:
4.5 ± 5.5 μg/kg) in the sorghum malt flour samples compared with omalodu malts (44% prevalence;
average: 2.87 ± 2.93 μg/kg).
Other reports regarding aflatoxin occurrence in sorghum malt grain samples intended for beverage
production in Africa analyzed using other techniques were conducted: In Malawi [21], total aflatoxin
contents were identified via immunoaffinity column and were reportedly higher (408 ± 68 μg/kg)
in sorghum malts prepared for beer brewing than in the current study (5.47 ± 13.8 μg/kg).
In Burkina Faso [27], aflatoxin B1 and ochratoxin A were purified with immunoaffinity columns
and analyzed using high-performance liquid chromatography (HPLC), revealing a higher AFB1
level (97.6 ± 88.2 μg/kg) for malt samples than the present study (8.49 ± 16.9 μg/kg). In South
Africa [17], mycotoxins were identified using a multi-mycotoxin thin-layer chromatography method
and quantified via HPLC to screen sorghum malt grains intended for traditional beers (Utshwala). The
former study revealed the presence of zearalenone and absence of AFB1 in sorghum malt grains,
while the current study revealed contrasting results. FB1 is one of the common toxicologically
important mycotoxins and was quantified in omalodu malts with 84% prevalence (average concentration:
61.4 ± 70 μg/kg) and in otombo malts with a prevalence of 42% (average concentration:
29.1 ± 25.7 μg/kg) (Table 1).
FB1 was quantified with a higher prevalence rate (75%) in sorghum flour malts from Namibia
prepared for oshikundu beverage [20] compared to the current study. In Botswana, FB1 was detected
at a lower prevalence rate of 6% in sorghum malt samples, with concentrations ranging from 47 to
1316 μg/kg [19]. All sorghum malt samples had FB1 concentrations below the EU regulatory level of
2000 μg/kg.
Patulin, which is normally found in fruits and vegetables, particularly apple and its
products [28–30], was quantified in a single sample of omalodu (average = 57.7 μg/kg) and only
two samples of otombo malts (average = 183.1 ± 143.2 μg/kg). However, the average concentrations
for omalodu and otombo malts were higher than those fixed by the EU at 50 μg/kg for patulin in apple
juice. Patulin is of concern because it is produced by many fungal genera and is suspected of being
clastogenic, mutagenic, teratogenic, genotoxic, and cytotoxic [31]. The co-occurrence of different
regulated toxins suggests synergistic toxic effects that raise concerns on the health hazards associated
with these malts.
Several metabolites from the biosynthetic pathway of aflatoxins, namely averufanin, averufin,
STE, and versicolorin C (Table 1), were quantified in the sorghum malts. The same aflatoxin precursors
were reported by [20] in sorghum malts prepared for oshikundu, with the exception of versicolorin C,
found only in the present study. Averufanin was quantified in 27% of the omalodu malts and not
in the otombo malts, while averufin was quantified in 84% of the otombo malts but not in omalodu
malts. A high incidence rate of 91% (average = 95.49 μg/kg) was recorded for STE from omalodu
malts. STE is classified as a possible human carcinogen by the International Agency of Research in
Cancer [32]. In addition, in vitro genotoxic and cytotoxic studies of STE revealed that it is genotoxic
to liver hepatocellular cells [33] and cytotoxic to immortalized ovarian hamster cells [34] and liver
hepatocellular cells [35].
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2.3. Emerging Mycotoxins and Ergot Alkaloids Quantified in Sorghum Malts
As shown in Table 1, some emerging mycotoxins, especially 3-NPA, EMO, AOH, AME, TeA, MON,
STE, and BEA, occurred with prevalence ranges of 84–100% in omalodu malts and 17–100% in otombo
malts. A magnetic resonance imaging study by [36] reported that 3-NPA is a potent mitochondrial toxin
and neurotoxin. 3-NPA was observed in all sorghum flour malt samples, similar to previously reported
results in Namibia [20]. The average concentration of 3-NPA was lower (2530 ± 2860 μg/kg) in malts for
oshikundu [20] than that observed in malts for otombo (3290 ± 5000 μg/kg). MON was not quantified
in sorghum flour malts in the previous study [20], but it was observed in all samples of omalodu malts
and quantified with a concentration of 348 ± 511 μg/kg and with concentration of 75.6 ± 135.9 μg/kg
in otombo malts. In vivo toxicity investigations suggest that MON can induce cardiotoxicity [37] and
cause immunosuppression, muscular weakness, and intestinal problems in poultry [38]. EMO is both
a fungal and plant metabolite and it was quantified with average concentrations of 23.7 ± 17.7 μg/kg
and 19.6 ± 31.9 μg/kg in omalodu and otombo malts, respectively. Several studies demonstrated that
EMO has anticancer [39,40], antiviral [41,42], and antibacterial activity [43]. BEA was quantified at
concentrations of 5.08 ± 7.01 μg/kg and 1.60 ± 1.72 μg/kg in omalodu and otombo malts, respectively.
BEA has shown cytotoxic effects on human cell lines [44]. Among the Alternaria toxins, TeA was
quantified with high amounts in both omalodu (1925.6 ± 3406.4 μg/kg) and otombo (999 ± 2170 μg/kg)
malts, compared to lower amounts of AOH (14 ± 30 μg/kg) and (9.99 ± 18.09 μg/kg) in omalodu and
otombo malts, respectively. Some in vivo studies of TeA revealed that it is toxic to animals, such as mice
and rats [45], beagle dogs, monkeys [46], and chickens [47]. According to an in vitro study [48], AOH
and AME are mutagenic to hamster lung fibroblast cells lines.
Six clavine ergot alkaloids, synthesized mainly by fungal species of Claviceps genera were
quantified in both malt samples. Elymoclavine was observed in 3% and 38% of otombo and omalodu
malt samples, respectively. Other alkaloids were observed with high prevalence (50–100%) in both
malt samples (Table 1). Ergot alkaloids are typically important because chronic poisoning by these
toxins through consumption of contaminated grain products causes ergotism. Sorghum crops are
also vulnerable to ergot disease during cultivation. In Africa, the pathogen is recognized as a distinct
species, Claviceps africana [49]. Damages caused by C. africana have been recognized as a major cause
for decreased quality and nutritive value of sorghum grains [50].
2.4. Other Fungal Metabolites Quantified in Sorghum Malts
The prevalence and concentrations of other fungal metabolites quantified in both malt samples
are indicated in Table 2. Metabolites produced solely by Aspergillus genus were mostly quantified
at a prevalence of 49%; 19 of these metabolites were quantified in 80% to 100% of omalodu
samples analyzed, as opposed to three metabolites of the same prevalence rate quantified in
otombo malts. Secondary metabolites of Aspergillus are representatives from the following groups:
Gliotoxins, fumitremorgins, fumagillins and fumiquinazolines, helvolic acids, tryptoquivalines, and
pseurotins. Although there are no regulations in force for these metabolites, some of them have
their in vitro toxicities reported. An example is gliotoxin, an epipolythiodioxopiperazine produced
by Aspergillus fumigatus and quantified in both omalodu (78%) and otombo (44%) malts. Its disulfide
bridge may cause immunosuppressive properties and apoptosis in macrophages and monocytes [51].
Bis (methylthio) gliotoxin is an inactive derivative of gliotoxin, proposed as a stable biomarker for
invasive aspergillosis [52]. Another toxic metabolite from Aspergillus flavus quantified in both omalodu
(69%) and otombo (39%) malts is cyclopiazonic acid, an indole tetramic. Cyclopiazonic acid causes
degenerative changes and necrosis in the liver, spleen, pancreas, kidney, salivary glands, myocardium,
and skeletal muscles, based on toxic effects observed in male and female rats [53]. Higher prevalence
rates of Aspergillus metabolites are an indication of the higher contamination by storage mycotoxigenic
fungi such as Aspergillus fumigatus, Aspergillus clavatus and Aspergillus niger. The latter findings are
expected because both malts are traditionally processed under likely unhygienic conditions. The poor
storage conditions for prolonged times at homes and markets makes the malts susceptible to fungal
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contamination. Other metabolites synthesized by Fusarium, Penicillium, and Alternaria species were
quantified as well.
2.5. Other Metabolites Quantified in Sorghum Malts
Twenty-two metabolites synthesized by non-fungal organisms and uncommon fungal species
were quantified in both omalodu and otombo malts (Table 3). Dihydroxymellein and tryptophol were
absent in omalodu malts, while abscisic acid was absent in otombo malts. Four diketopiperazines
synthesized by fusion of 2 different amino acids, namely Cyclo (L-Pro-L-Tyr), or maculosin, cyclo
(L-Pro-L-Val), brevianamide F, or cyclo (L-Trp-L-Pro), Fellutanine A or cyclo (L-Trp-L-Trp), were
quantified in both omalodu and otombo malts. Cyclo (L-Pro-L-Tyr) is formed by the fusion of tyrosine
and proline and has been reported as a secondary metabolite of various fungi [54] and bacteria [55].
Additionally, it is identified as a host-specific phytotoxin produced by Alternaria alternata [54]. It was
quantified at a prevalence of 100% in omalodu malts and at 94% in otombo and at concentration
ranges of 48.2–48,200 μg/kg in omalodu and 32.5–165 μg/kg in otombo malts, respectively. Cyclo
(L-Pro-L-Val) is formed by the fusion of valine and proline and synthesized by marine Penicillium
species [56]. It was quantified at higher average concentrations (456 ± 158 μg/kg) in omalodu
malts than in otombo malts (121 ± 86.4 μg/kg) and had a maximum prevalence of 100% in both
malts. Brevianamide F is the simplest member and the biosynthetic precursor of prenylated
tryptophan-proline 2.5-diketopiperazines that are produced mainly by Aspergillus fumigatus and
other Aspergillus species [57]. In addition, Brevianamide F is produced by many Penicillium species and
intermediaries of many fungal species. The brevianamide F average concentration of these malts was
highest in omalodu malts (144 ± 92.6 μg/kg) the lowest in otombo malts (90.1 ± 56.1 μg/kg). Fellutanine
A is bio-active, naturally occurring, 2.5 diketopiperazine alkaloid synthesized by Penicillium fellutanum
and Penicillium simplicissimum, [58]. It is also understood to be a non-annulated analogue of “cis” cyclic
dipeptide, cyclo (L-Trp-L-Trp). The concentration range of this metabolite in the samples is indicated
in Table 3. Tryptophol is an aromatic alcohol that induces sleep in humans and is produced by the
trypanosomal parasite in wine as a secondary product of alcoholic fermentation [59]. Tryptophol is
also formed from tryptophan during fermentation as well. Otombo malts had the highest concentration
of 110 ± 80.5 μg/kg, but it was not quantified in omalodu malts.
2.6. Method Performance Characteristics
The values reported in Table 4 are for the LC/MS/MS method validation characteristics, such as
limits of detection (LOD) and LOQ, apparent recoveries (i.e., spiked samples vs. solvent standards),
and relative standard deviations (RSD). LOD were observed from 0.02 to 124 ng/g while LOQ were
observed from 0.03 to 421 ng/g. Deviations from the target range of 50–120% of apparent recoveries,
set by the Commission Regulation (EC) No 401/2006, are mainly caused by matrix effects, whereas the
recovery of the extraction step has been determined to be in this target range for the majority of all
investigated compounds in other matrices (manuscript in preparation). In addition, the determination
of the apparent recoveries was hampered by the fact that 15% of the metabolites (e.g., 3-nitropropionic
acid, kojic acid) none of the samples were true blanks. This resulted in apparent recoveries significantly
larger than 120%, despite a correction for the concentration in the blank samples being performed. The
same holds true for large values for the respective RSD not complying with the <20% criterion that are
set for replicate analysis, whereas in this study, three different individual samples were spiked, which
potentially resulted in higher values for the repeatability and the combined method uncertainty [60].
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3. Conclusions
The present study reports data on the variation of fungal metabolites in two different sorghum
malts as raw materials for the brewing of two indigenous and popular traditional Namibian beverages,
otombo and omalodu. Both malts were substantially contaminated with fungal metabolites produced
by major mycotoxigenic fungal genera. The study found little contamination variation between the
two malts. Regulated mycotoxins, emerging mycotoxins, aflatoxin precursors, and ergot alkaloids
were quantified in both malts. Generally, the study findings were that omalodu malts were mostly
contaminated with fungal metabolites and health risk mycotoxin groups than otombo malts. Based
on the high incidence of mycotoxins and other metabolites in both malt samples, adequate milling
and processing conditions (low moisture) must be ensured to reduce the prevalence of these toxins.
The present study on two sorghum malts provides three major findings: First is the co-occurrence of
seven EU-regulated mycotoxins in both malts, particularly toxic AFB1, which was quantified in 20% of
omalodu malts and 40% of otombo malts at levels above the EU allowable limit of 5 μg/kg. Second is the
high occurrence of several fungal metabolites in both malts and the existing knowledge gap on the
effects of such intricate metabolite mixtures in humans. The third is the high incidence of emerging
mycotoxins such as 3-NPA, MON, STE, and TeA and pending risk assessment studies for these toxins
in humans. Since traditional malting and processing are likely carried out by mycotoxin-unaware
traditional processors, it is also advised to educate the public on the health risks of mycotoxins and
possible methods to alleviate fungal contamination and on hygienic conditions during malting and
storage. Data from the present study serves as a foundation for more detailed mycotoxin-related
studies, such as further investigation on the fate of mycotoxins during the brewing processes of these
beverages, considering the possible formation of masked/bound mycotoxins which may not have
been quantifiable in the present study. Investigations of the occurrence of fungal metabolites in other
indigenous food commodities from Namibia are necessary, as well as the determination of exposure to
mycotoxins and their health effects in the Namibian population.
4. Materials and Methods
4.1. Sorghum Malts Collection
A total of 81 sorghum malt samples, purchased in November 2017 at open-markets in Oshana
region, Namibia, were collected for this study. The sorghum malt samples were purchased based
on availability at the open markets, hence, 45 sorghum flour malt samples intended for omalodu
brewing and 36 un-milled sorghum malts grain samples intended for otombo brewing. Approximately,
500 g of the samples were collected following the sampling procedure described by [61]. Samples
were placed in paper bags, transported to the Centre for Analytical Chemistry, Department of
Agrobiotechnology, (IFA-Tulln), University of Natural Resources and Life Sciences, Austria, and
stored at −20 ◦C until analysis.
4.2. Metabolites Extraction and Analysis by LC/MS/MS
Sorghum malt samples were extracted for the presence of targeted multi-metabolites, including
regulated, conjugated, and emerging mycotoxins. The extraction was done according to the methods
described by [26]. Briefly, 5 g of each milled sample and 20 mL of acetonitrile/water/acetic acid
(79:20:1, v/v/v) was agitated in a 50 mL polypropylene tube for 90 min at 180 rpm using a rotary
shaker (GFL 3017, Burgwedel, Germany). The mixture was then settled and supernatants/extracts
were stored at −20 ◦C until further analysis.
The occurrences of fungal metabolites were detected and quantified using the procedure described
by [62]. Briefly, 500 μL of each extract was diluted with an equal volume of acetonitrile/water/acetic
acid (79:20:1, v/v/v) and 5 μL was directly injected into the LC/MS/MS system consisting of an
Agilent (Waldbronn, Germany) 1290 HPLC and an AB Sciex 5500 QTrap MS/MS with an electrospray
ionization (ESI) triple quadrupole. Chromatographic separation was performed on a Phenomenex
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Gemini C18 column (150 × 4.6 mm, 5 μm) equipped with a C18 (4 × 3 mm) i.d. security guard
cartridge, eluted with a gradient of methanol/water containing ammonium acetate and acetic acid.
Data acquisition was achieved in the time-scheduled multiple reactions monitoring (MRM) mode
both in positive and negative polarities in two separate chromatographic runs per sample. The
expected retention time of the MRM detection window of each metabolite was set at about 27 s and
about 48 s for both positive and negative modes, respectively. Data were analyzed using MultiQuant™
3.0.3 software (AB Sciex, Foster City, CA, USA). Quantification of metabolites was performed using
external calibration based on serial dilution of a multi-metabolites stock solution. Results were
corrected for apparent recoveries based on relative responses of the two matrices by spiking three
different approximately blank samples at three concentration levels. Limits of detection and limits of
quantification were determined following the Eurachem guide described by [63]. The accuracy of the
method is verified on a routine basis by participation in interlaboratory testing schemes including a
broad variation of matrices of grains, nuts, dried fruits, spices, baby food, and animal feed. Satisfactory
z-scores between −2 and 2 have been obtained for >94% of the >1000 results submitted so far and for
11 of the 12 results submitted for sorghum, respectively.
Confirmation of positive metabolite identification was attained by the acquisition of two MRMs
per metabolite (apart from moniliformin and 3-nitropropionic acid, which displayed only one fragment
ion). This generated 4.0 identification points according to Ref. [63]. In addition, the LC retention time
and the intensity ratio of the two MRM transitions agreed with the related values of a true standard
within 0.03 min and 30% relatively and singly.
4.3. Data Analysis
Data evaluation, averages, and range calculations were performed in Microsoft® Excel 2010.
An independent-samples t-test was done using the Statistical Package for the Social Sciences (SPSS)
software, version 21.0 (SPSS, Inc., Chicago, IL, USA).
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Abstract: In the framework of the first multi-centre Sub-Saharan Africa Total Diet Study (SSA-TDS),
2328 commonly consumed foods were purchased, prepared as consumed and pooled into
194 composite samples of cereals, tubers, legumes, vegetables, nuts and seeds, dairy, oils, beverages
and miscellaneous. Those core foods were tested for mycotoxins and other fungal, bacterial and
plant secondary metabolites by liquid chromatography, coupled with tandem mass spectrometry.
The highest aflatoxin concentrations were quantified in peanuts, peanut oil and maize. The mean
concentration of the sum of aflatoxins AFB1, AFB2, AFG1 and AFG2 (AFtot) in peanut samples
(56.4 μg/kg) exceeded EU (4 μg/kg) and Codex (15 μg/kg) standards. The AFtot concentration (max:
246.0 μg/kg) was associated with seasonal and geographic patterns and comprised, on average,
80% AFB1, the most potent aflatoxin. Although ochratoxin A concentrations rarely exceeded existing
Codex standards, it was detected in unregulated foods. One palm oil composite sample contained
98 different metabolites, including 35.4 μg/kg of ochratoxin A. In total, 164 different metabolites
were detected, with unspecific metabolites like asperglaucide, cyclo(L-pro-L-val), cyclo (L-pro-L-tyr),
flavoglaucin, emodin and tryptophol occurring in more than 50% of composite samples. Aflatoxin B1
(AFB1), fumonisin B1 (FB1), sterigmatocystin (STC), ochratoxin A (OTA), citrinin (CIT) and many
other secondary fungal metabolites are frequent co-contaminants in staple foods, such as maize and
sorghum. Populations from North Cameroon and from Benin may, therefore, suffer chronic and
simultaneous exposure to AFB1, FB1, STC, OTA and CIT, which are prevalent in their diet.
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1. Introduction
Mycotoxins are secondary metabolites produced by filamentous fungi in food commodities
due to inadequate pre- or post-harvest conditions and practices. These fungal toxins are, therefore,
naturally-occurring chemical hazards. Since they are structurally stable, mycotoxins are likely to
persist in foods, even if toxin-producing moulds are eliminated during the food preparation process.
Consumption of mycotoxin-contaminated food may result in acute or chronic affections, including
non-communicable diseases. A particularly severe record of acute toxicity was reported after a
major outbreak struck Kenya in 2004, resulting in 317 aflatoxicosis cases including 125 deaths [1].
This episode was the consequence of high exposure to aflatoxins due to the consumption of
extensively-contaminated maize [2]. Long-term exposure to aflatoxin B1 or its precursors has been
associated with genotoxicity and hepatocellular carcinoma [3,4]. Fumonisin B1 was associated with
oesophageal cancer incidence in South Africa and some areas of China [5,6]. Growth impairment,
the main indicator for child chronic malnutrition, is also associated with mycotoxin exposure [7–10].
Of the world’s 161 million stunted children in 2013, about half live in Asia and over one-third live
in Africa [11]. Although often overlooked as a possible cause of retarded growth, mycotoxins may
contribute a significant public health burden in less developed countries [12].
An additive or synergistic effect of fumonisin and aflatoxin co-exposure in the development of
preneoplastic lesions or hepatocellular carcinoma was suggested in laboratory animals [13–15].
Mycotoxins form the group of food chemicals which triggered the most cases of border rejection
(489) recorded in the EU Rapid Alert System on Food and Feed [16]. According to the European
Commission Regulation 1881/2006 [17], the maximum level for aflatoxins for peanuts and cereals
intended for direct human consumption was set to 2 μg/kg of aflatoxin B1 (AFB1) and 4 μg/kg of the
sum of AFB1, AFB2, AFG1 and AFG2. The maximum limit from the international standard [18] is
15 μg/kg of AFB1 or AFtot, which only applies to a variety of nuts (including peanuts) intended for
further processing (and 10 μg/kg for ready to eat dried figs, almonds, hazelnuts and pistachios).
In order to assess if the chronic intake of substances is likely to harm consumer health, it is
pertinent to assess food safety risks by combining available toxicological studies, as well as food
contamination and food consumption data.
One way of assessing the dietary exposure of populations to food chemicals, such as mycotoxins
is the Total Diet Study (TDS) approach [19–24]. Two specific aspects characterize a TDS—(1) the
representativeness of the sampling, and (2) the preparation of the samples “as consumed”—so
that it represents a pertinent public health risk assessment tool as far as food safety and nutrition
are concerned.
The World Health Organization (WHO) and the Food and Agriculture Organization of the
United Nations (FAO) endorse the TDS methodology, which is both cost-effective and more accurately
characterizes human exposure to food chemicals than mere occurrence studies [23].
Following a first experience in Sub-Saharan Africa [25,26], a regional TDS was implemented by
FAO in Benin, Cameroon, Mali and Nigeria (2014 and 2018) by four national food safety authorities,
in close collaboration with WHO and Centre Pasteur of Cameroon [27]. The purpose of this project is
to assess the typical contamination levels of eight African population groups. The dietary exposure
of those population groups will then be compared with existing health-based guidance values or
end points.
The study methodology was described elsewhere [28].
In this paper, we are presenting the occurrence of mycotoxins and selected fungal, bacterial and
plant toxins quantified in composite samples of foods prepared as consumed. The 194 composites
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result from the pooling of 12 subsamples, representative of the food consumption habits of three study
centres located in coastal areas (Duala, the Littoral of Benin and Lagos) and five study centres in
non-coastal areas (Bamako, the Borgou region of Benin, Kano, North Cameroon and Sikasso).
2. Results
Since we are dealing with pooled samples (12 sub-samples per composite) of foods prepared
as consumed in this study, we will not always be able to conclude with regard to the conformity of
food commodities to selected standards [17,18], which, in most cases, apply to raw food commodities.
This comparison is nonetheless useful, particularly when the mean concentration (quantified in a
composite sample) exceeds or is close to the maximum legal limit of the substances of interest, because
this means that at least one subsample out of 12 may have exceeded this limit.
Additionally, since these data will be used for a dietary exposure assessment, they are presented
with (1) lower bound (i.e., LB: concentration of non-detected analytes set to zero and to the LOD for
detected but non-quantified analytes) and (2) upper bound (i.e., UB: concentration of non-detected
analytes set to LOD for non-detected analytes and to the limit of quantification (LOQ) for detected
but non-quantified analytes) scenarios. This means that the uncertainty due to censored data will be
taken into consideration. When LB–UB is not specified, it is meant that the difference between LB
and UB concentrations in not perceptible or less than 0.1 μg/kg. Maximum concentration values are
systematically UB concentrations.
Mycotoxins of public health and economic interest (including aflatoxins, fumonisins, ochratoxin A,
zearalenone, deoxynivalenol and citrinin) represented 9% of the detected metabolites.
2.1. Aflatoxins
2.1.1. Aflatoxins in Maize
Composite samples were prepared with maize from each study centre (8) purchased during the
rainy season (October 2017) and again during the dry season or harmattan (February 2018).
The AFtot concentration in maize was significantly higher (p < 0.05) during the wet season
(detected: 7/8; mean LB–UB: 22.2–22.5 μg/kg; max: 76.6 μg/kg) than during the dry season (detected:
4/8; mean LB–UB: 0.4–0.8 μg/kg; max: 2.7 μg/kg). Overall, we detected that AFtot > LOD in 11 of
16 composites (69%) with a mean LB–UB concentration of 11.3–11.7 μg/kg (Table 1) in ready-to-eat
maize samples, which exceeds the EU standard for both processed (4 μg/kg) and unprocessed maize
to be subjected to sorting or physical treatment before human consumption or use as an ingredient
(10 μg/kg). However, the fact that all maize composites collected during the dry season contained
AFtot concentrations that were below 4 μg/kg and, therefore, complied with EU standard needs to
be emphasized.
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There is currently no Codex standard applicable to aflatoxins in maize. AFB1, the most potent
aflatoxin, represented 87.6% of the sum of AFB1, AFB2, AFG1 and AFG2 detected in maize samples
(Table 2).
2.1.2. Aflatoxins in Peanut
As displayed in Table 1, the highest AFtot concentration in this study was quantified in one peanut
composite sample from Bamako (Mali): 246.0 μg/kg (mean LB–UB: 56.4–56.7 μg/kg). Aflatoxins
were detected in 80% of peanut composites (rainy season: 100%, dry season: 60% detection exceeding
LOD = 0.1 μg/kg). The mean AFtot concentration in peanuts was 93.7–93.9 μg/kg (rainy season) and
19.1–19.4 μg/kg (dry season). A high variance of AFtot levels in peanut was observed (CV > 100%).
It was noted that while 50% of samples contained AFtot concentrations below the EU standard (4 μg/kg)
and 50% were above the Codex standard (15 μg/kg), the mean AFtot concentrations exceeded both EU
and Codex standards, regardless of the season. The proportion of AFB1 in peanut was 75.8% of the
sum of AFB1, AFB2, AFG1 and AFG2 (Table 2).
Table 2. Proportions of aflatoxin B1, B2, G1 and G2 by core food and by weight.
CORE FOOD AFB1 (%) AFB2 (%) AFG1 (%) AFG2 (%) Sum (%)
Maize 87.6 6.8 5.6 0.0 100
Peanut 75.8 14.3 9.4 0.5 100
Peanut oil 86.6 13.1 0.3 0.0 100
Other core foods 87.0 4.0 9.1 0.0 100
Total 80.1 12.1 7.5 0.3 100
2.1.3. Aflatoxins in Peanut Oil
Two composite samples of peanut oil were tested (Table 1) and both contained significant amounts
of total aflatoxins: 15.8 μg/kg (Kano) and 105.1 μg/kg (Cotonou). There is currently no standard
for aflatoxins in oil, and these concentrations exceed Codex standards available for processed and
unprocessed peanuts. The proportion of AFB1 in peanut oil was 86.6% of the sum of AFB1, AFB2,
AFG1 and AFG2 (Table 2).
2.1.4. Aflatoxins in Other Foods
Aflatoxins were detected in 60% of sorghum and 19% of bean composites. In Table 1, we reported
that one bean sample contained 15.8 μg/kg AFtot. One smoked fish composite contained 4.9 μg/kg
AFtot. The observed mean concentration of all tested core foods was below 1 μg/kg in Duala and
Lagos (detection rate of 10%) but those recorded in North Cameroon exceeded 10 μg/kg (detection
rate of 47%).
2.2. Fumonisins
FUMtot (sum of fumonisins FB1, FB2, FB3 and FB4) were most concentrated in maize samples in
all eight centres (Table 3). Although fumonisins were detected in 94% of ready-to-eat maize composites,
all FUMtot concentrations (mean LB–UB: 285.2–288.2 μg/kg; max: 855.9 μg/kg) remained below the
Codex standard of 2 mg/kg applying to fumonisins in maize. Although there is no Codex standard for
fumonisins in other foods than maize, other core food samples contained FUMtot of up to 159.4 μg/kg.
Apart from maize, composites containing fumonisins are sorghum (including a traditional fermented
drink from North Cameroon processed from sorghum called bili-bili) and millet and tubers having
undergone a drying process prior to being prepared as consumed (cassava and yam), as reported in
Table 3. In food composites from Mali (Bamako and Sikasso), the mean FUMtot concentration was
three to ten-fold lower than in samples collected in the other study centres, with UB and LB scenario
respectively. FUMtot in our samples comprised 67.2% FB1, 18.9% FB2, 8.0% FB3 and 6.0% FB4. This is
close to the proportions determined in maize samples (Table 4).
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Table 4. Proportions of fumonisins B1, B2, B3 and B4 by core food and by weight.
CORE FOOD FB1 (%) FB2 (%) FB3 (%) FB4 (%) Sum (%)
Maize 65.9 19.3 8.4 6.4 100
Sorghum 76.7 15.8 4.6 2.8 100
Cassava dry 75.4 14.1 6.2 4.2 100
Other core foods 88.2 11.8 0.0 0.0 100
Total 67.2 18.9 8.0 6.0 100
The co-occurrence of FB1 and AFB1 was observed in 11 of 16 maize composites (69%) and four of
10 sorghum composites (40%), as well as one of eight millet composites (13%) and in one of 12 cassava
dry samples (8%).
2.3. Sterigmatocystin (STC)
STC, which is a known aflatoxin precursor [29] was mostly prevalent in cooking oils (Table 5).
STC was quantified in 50% of peanut composites (mean: 0.6 μg/kg; max: 2.9 μg/kg) and in all
peanut oil samples (mean: 8.5 μg/kg; max: 8.7 μg/kg), which also contained aflatoxins (Table 1).
Interestingly, STC was quantified in 100% of “other vegetable oil” samples (cottonseed oil in most
cases), whereas aflatoxins were not detected in those composites (tested with the same limit of detection,
LD = 0.1 μg/kg).
Contrarily, STC detection rate in maize was only 13%, whereas aflatoxins were detected in 69% of
composite samples.
There is currently no Codex or EU standard for STC in any food commodity.
The co-occurrence of STC, AFB1 and FB1 was observed in four composites samples, all collected
during the rainy season:
1. Maize (North Cameroon): 56.6 μg/kg AFB1; 458.5 μg/kg FB1; 1.0 μg/kg STC
2. Maize (Benin Littoral): 71.8 μg/kg AFB1; 179.0 μg/kg FB1; 0.075 (LB = limit of
detection)–0.25 μg/kg (UB = limit of quantification) of STC, which was detected below the
limit of quantification.
3. Sorghum (Borgou): 1.7 μg/kg AFB1; 33.5 μg/kg FB1; 0.5 μg/kg STC
4. Sorghum (Sikasso): 0.8 μg/kg AFB1; 12.5 μg/kg FB1; 2.4 μg/kg STC
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2.4. Ochratoxin A (OTA)
OTA was detected in 10% of tested composite samples (Table 6). Six percent (6%) of all tested
samples exceeded 1 μg/kg OTA, including maize (13%), wheat (pasta 50%) and peanut oil (50%).
Only three samples contained OTA concentrations exceeding Codex standards applying to unprocessed
wheat, barley or rye (5 μg/kg): sorghum (Sikasso: 5.6 μg/kg), rice (Borgou: 6.3 μg/kg) and palm oil
(Benin Littoral: 35.4 μg/kg).
There is currently no standard regulating OTA in edible oils, rice and sorghum.
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2.5. Citrinin (CIT)
CIT was detected in 19% of all samples (Table 7), including maize (63%), sorghum (70%) and rice
(38%). The only available citrinin standard (EU) applies to food supplements based on rice fermented
by red yeast (2000 μg/kg). Ten percent (10%) of tested samples had CIT concentrations of 5 μg/kg
or more and four maize composite samples exceeded 100 μg/kg (25% of maize samples and 2% of
all samples).
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2.6. Foods Contaminated by Other Regulated Mycotoxins
2.6.1. Zearalenone (ZEN)
ZEN was detected in 6% of samples and never exceeded EU standards of 100 μg/kg for maize
intended for direct human consumption. However, the three composite samples containing the highest
ZEN concentrations were collected in the same study centre (Duala): maize (wet season: 7.6 μg/kg;
dry season: 97.0 μg/kg) and cassava having undergone a drying process prior to being prepared as
consumed (dry season: 7.6 μg/kg).
There is currently no Codex standard for ZEN in foods.
2.6.2. Deoxynivalenol (DON)
DON was also detected in 6% of composite samples, including in (1) bread samples (detection
rate: 100%) with a mean concentration of 68.8 μg/kg (min: 31.9 μg/kg; max: 134.6 μg/kg), (2) in 100%
of pasta prepared as consumed (mean LB–UB: 9.8–14.3 μg/kg). This is inferior to Codex standards
applying to DON cereal-based foods for children (200 μg/kg) and for wheat, maize and barley flour,
meal, semolina and flakes (1000 μg/kg).
2.6.3. Ergot Alkaloids
Twelve ergot alkaloids were detected in foods processed from wheat (5 of 6 bread samples),
with a mean concentration 62.4 of μg/kg, ranging from non-detected to 165.7 μg/kg, for the sum
of ergocornine (1.4%), ergocorninine (0.9%), ergocristine (21.0%), ergocristinine (6.8%), ergocryptine
(7.6%), ergocryptinine (2.2%), ergometrine (14.4%), ergometrinine (0.5%), ergosin (21.0%), ergosinine
(1.4%), ergotamin (21.7%) and ergotaminine (1.0%). There is no Codex standard for ergot alkaloids,
and, to the best of our knowledge, the only available standard (EU) is 0.5 g/kg for the sum of ergot
alkaloids in unprocessed cereals, except for maize and rice.
2.7. Non-Detected Mycotoxins of Health and Economic Significance
T2 and HT2 toxins, patulin and diacetoxyscirpenol were never detected in this present study.
2.8. Remarks on a Selection of Other Secondary Fungal, Bacterial and Plant Metabolites
2.8.1. Aspergillus fumigatus Metabolites in Palm Oil
The presence of 11 Aspergillus fumigatus metabolites was observed in palm oil composites only.
Bisdethiomethylgliotoxin was detected in three of four samples, with a mean (LB–UB) concentration
of 117.7–118.0 μg/kg. Tryptoquivaline was detected in three of four samples (mean: 81.6–81.8 μg/kg).
Gliotoxin was detected in three of four samples (mean: 36.6–36.2 μg/kg). Helvolvic acid was detected
in two of four samples (mean 27.2–29.3 μg/kg). Fumigaclavin was detected in three of four samples
(mean: 16.6–16.9 μg/kg). Fumagillin was detected in one of four samples (mean: 10.9–13.4 μg/kg).
Methylsulochrin was detected in four of four samples (mean: 8.54 μg/kg). Pyripyropene A was
detected in one of four samples (mean: 5.7–5.8 μg/kg). Fumitremorgin was detected in three of four
samples (mean: 3.6–3.7 μg/kg). Pseurotin A was detected in two of four samples (mean: 2.1–2.8 μg/kg).
Pyripyropene D was detected in one of four samples (mean 0.3–0.5 μg/kg). Little is known about
these substances, which are not likely to represent a threat to consumer at these concentrations. Their
presence, however, reveals that Aspergillus fumigatus, a human pathogen, may thrive in the palm oil
production chain at some point between the palm tree and final production. Therefore, it represents a
risk to value chain operators, if not to consumers [30].
2.8.2. Cereulide in Smoked Fish
The bacterial metabolite cereulide was only detected five times (2.6%) in 194 samples, but was
quantified in three of six or 50% of smoked fish samples. Mean (LB–UB) cereulide concentration
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in smoked fish was 0.8–0.9 μg/kg, and the maximum concentration was 2.5 μg/kg. The two other
composites containing cereulide concentrations above the detection limit of 0.19 μg/kg were beef
(2.0 μg/kg) and palm oil (0.7 μg/kg).
2.8.3. Cyanogenic Glucosides in Cassava
Following TDS methodology, all samples were prepared as consumed, but a distinction was made
between cassava samples having undergone size reduction, fermentation and drying processes (e.g.,
cossets or gari using dehydration as preservation and toxins reduction means) before preparation,
including rehydration (cassava dry) [31], and other cassava samples (cassava fresh).
Exposure to cyanogenic glucosides, such as linamarin and lotaustralin, may cause serious motor
neuron diseases, called konzo [32–35].
A seasonal pattern was observed, with higher concentrations of both linamarin and lotaustralin
in fresh cassava during the dry season (p < 0.05), which was already reported by previous studies on
the matter [36].
While linamarin concentrations ranged from below LD (2.3 μg/kg) to 317 mg/kg wet weight
(mean: 134 mg/kg) in cassava fresh samples, it was quantified between 0.15 mg/kg and 18 mg/kg
(mean: 2.8 mg/kg) in cassava dry composite samples (1:47 ratio).
Similarly, lotaustralin ranged from 0.04 mg/kg to 0.66 mg/kg (mean: 0.16 mg/kg) in cassava dry
and from below LD (1.3 μg/kg) to 18 mg/kg (mean: 6.1 mg/kg) in cassava fresh (1:26 ratio).
Overall, linamarin and lotaustralin were less concentrated in dry cassava samples (p > 0.05) than
in fresh cassava. The wide range of cyanogenic glucoside concentrations in dry cassava composites
(max/min ratio of 120:1 in the case of linamarin and 510:1 for lotaustralin) may be explained by
different processing practices, such as the use of the wetting method in cassava flour [37,38], although
we were not able to verify these aspects from information requested during the collection of samples.
Four composite samples of cassava fresh were collected in each country during the wet season
and again during the dry season or harmattan. Surprisingly, neither linamarin, nor lotaustralin were
detected above LD (2.3 and 1.3 μg/kg wet weight, respectively) in samples collected in Nigeria, whereas
concentrations varied from 93 to 101 mg/kg (wet season) and from 198 to 317 mg/kg (dry season) in
Benin, Cameroon and Mali. We have not figured out the reason of this Nigeria-specific pattern, which
may include different cassava varieties or cultivars [39] as well as different cooking methods [40–42].
2.8.4. Low Contaminated Core Foods
We observed relatively low or no occurrence of mycotoxins and other toxins in foods prepared
from fresh yam without dehydration processes, in rice and in traditional, soft and fermented drinks,
as well as in sugar, onion, garlic, and eggs.
2.9. Secondary Metabolites Profile
Figure 1 shows 62 of the most frequently occurring metabolites out of 164 analytes, on the basis of
detection in our samples.
More than a third (36%) of detected metabolites are unspecific to any fungi genera and might also
be of plant origin.
Among most prevalent metabolites, six were detected in more than 50% of samples:
• asperglaucide (141 samples or 73% of 194 samples);
• cyclo(L-pro-L-val) (138 samples or 71%);
• cyclo(L-pro-L-tyr) (123 samples or 63%);
• flavoglaucin (105 samples or 54%);
• emodin (103 samples or 53%); and
• tryptophol (99 samples or 51%).
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Figure 1. Most frequently detected secondary metabolites in Sub-Saharan Africa Total Diet Study
(SSA-TDS) composite samples.
Crude red palm oil composite samples from Cotonou (Benin), Lagos and Kano (Nigeria) showed
a higher number of metabolite concentrations above LOD than any other sample (n: 3; mean: 88;
min–max: 83–98 metabolites), as noted in Table 8.






(51–98) 3 Palm oil
(21–50) 46 Maize, dried tubers, sorghum, peanuts, bread, various oils
(11–20) 62 Beans, dried cassava, rice, millet, smoked fish, onion and garlic, fermented drinks
(6–10) 45 Onion and garlic, meat, tubers, dairy products, rice, traditional soft drinks
(1–5) 36 Fresh tubers, sugar, onion and garlic, rice, eggs
0 2 Onion and garlic
(0–98) 194 TOTAL
All analytical data including quality control checks are enclosed in Table S1.
3. Discussion
First of all, the fact that 164 metabolites were detected in typical African foods does not mean
that all of them represent a threat to human health. As of now, in the case of many analytes, the lack
of knowledge on their toxicity and their combined (and potentially synergistic) effect with other
substances limits our interpretation.
It does, however, represent a contribution to knowledge which may be used when new
toxicological data with regards to some of these metabolites will be available. Therefore, the
uniqueness of the multi-analyte LC–MS/MS approach used in this study, which enabled the occurrence
characterization of a wide range of toxins and other fungal, plant and bacterial secondary metabolites,
needs to be emphasized.
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In the rest of this discussion, we found it relevant to focus on mycotoxins of public health and
international trade significance.
The prevalence of mycotoxins in maize and peanut samples, though, has often been highlighted
in previous surveys [43].
Worldwide, several total diet studies from various countries have included mycotoxins, including
France [44–46], Canada [47], Lebanon [48], Vietnam [49], and China [50].
In Africa, studies of urinary biomarkers [51–53], surveys of food commodities [54,55], and the
analysis foods prepared as consumed [56], have contributed to the rise in attention of the public health
community to the threat that mycotoxins represent.
Unsurprisingly, the high concentration of the sum of AFB1, AFB2, AFG1 and AFG2 in African
foods as consumed is probably the most significant public health and trade outcome of this
multi-mycotoxin analysis compared with other regions of the world [57]. The fact that peanut oil
may contain high AFtot concentrations has only recently been described [58]. Peanut oil, peanut
and maize are, therefore, likely to contribute significantly to AFB1 exposure, which will be used to
characterize the risk of hepatocellular carcinoma.
The presence of fumonisins in staple foods such as maize, with concentrations below the Codex
standard of 2 mg/kg, does not guarantee safety for our study populations. The Joint Expert Committee
on Food Additives and Contaminants (JECFA) noted in the 83rd session [14], that the current
worldwide exposure estimate was established with occurrence data belonging to countries of the
WHO European region, and there was no available information on fumonisin levels in maize from
the African, Eastern Mediterranean and South-East Asia regions. The JECFA also noted [14] that the
interaction between AFB1, a compound with known genotoxic properties, and fumonisins, which
have the potential to induce regenerative cell proliferation, is a concern. The completion of the dietary
exposure assessment to the sum of FB1, FB2, FB3 and FB4 with the data presented in this paper will
also result in conclusions with regards to the adequacy of protective levels of current Codex tolerances
in the context of Africa (manuscript in preparation).
Surprisingly, the presence of a high concentration of AF precursor sterigmatocystin, not only in
peanut oil but also in cottonseed oil and palm oil, was noted. In contrast, AF was never detected in
cottonseed oil but detected in only one of four palm oil samples (0.5 μg/kg AFB1 in a red palm oil
composite from sub-samples collected in the Littoral of Benin). This may be due to the production of
STC by non-aflatoxigenic Aspergilli, such as Aspergillus nidulans [59], as well as other fungi genera [60].
The fact that we quantified STC in millet and sorghum composite samples is consistent with recent
findings in sorghum [55]. Sorghum and millet, therefore, also qualify as potential STC dietary exposure
contributors, noting that typical Sub-Saharan-Sahelian diets largely rely on these cereals [28].
The fact that citrinin was most concentrated in maize means that maize is likely to be a major
contributor to CIT dietary exposures in centres where (1) maize CIT concentrations were high and
(2) maize is consumed in large amounts.
We would like to bring forward the absence of Codex standards for mycotoxins in edible
oils and, in light of occurrence data submitted in this paper, the need for surveillance of mycotoxin
contamination levels in edible oils. The presence of (1) OTA in one palm oil with 97 other secondary
metabolites, (2) high AFtot concentrations in peanut oil, and (3) the presence of STC in cotton seed oil
supports the need for an elaboration in the Codex code of practice for the production of safe edible oil.
Results of the risk characterization (manuscript in preparation) using this occurrence data and
adequate food consumption data will clarify to what extent edible oils, as well as other core foods,
contribute to the total dietary exposure to mycotoxins in Africa.
Mycotoxin exposure risk mitigation measures include growth prevention of toxin-producing
fungi via biocontrol [61] in the field, good post-harvest practices [62] and mycotoxin degradation [63].
As human co-exposure to natural toxins through typical African foods is currently inevitable,
national food safety authorities need to ensure that risk assessments are carried out properly to
safeguard human health and to maintain international trade.
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As demonstrated by the current study, AFB1, FB1, STC and many other secondary fungal
metabolites are frequent co-contaminants in many foods (such as maize and sorghum) that
threaten human health. Populations in North Cameroon and from Benin (where multiple toxins,
including ABF1, FB1 and STC, have been detected within the TDS) may suffer repeated simultaneous
exposure to natural toxins. In a recent study [15], the combined effects of various toxins at realistic
concentrations were further investigated and revealed additive, antagonistic or synergistic effects.
The results have confirmed that combinations of toxins may pose a considerable risk to human health.
Clearly, further research is needed to understand the mechanics of toxicological interactions in order to
effectively protect public health. Moreover, more TDSs in other locations of Benin, Cameroon, Mali and
Nigeria, as well as in other countries belonging to Sub-Saharan Africa need to be carried out to better
document actual dietary exposure levels to natural toxins in this region.
4. Conclusions
At this stage of the SSA-TDS project, the first ever multi-centric total diet study carried out in
Africa, we have detected 164 secondary metabolites. However, our main results with regards to the
occurrence of regulated mycotoxins in eight study centres are as follows:
• Mean AFtot concentrations exceed EU and Codex tolerances applying to peanuts. Similar AFtot
levels were quantified in peanut oil (although no Codex or EU standards are currently available for
edible oils), as well as in maize samples (aflatoxins in maize are not currently regulated by Codex).
• The TDS approach allowed for the capture of seasonal variations of the AFtot contamination
pattern in maize, which contains higher concentrations in samples collected during the
rainy season.
• The geographic component of the AFtot contamination pattern was suggested by variations in the
mean AFtot concentrations among study centres, which was also observed between two study
centres from the same country (Duala versus North Cameroon).
Due to the systematic approach applied to this study, we consider these data fit for the completion
of chronic dietary exposure assessment of mycotoxins, for which a health-based guidance value
is available (e.g., Tolerable Daily Intake (TDI) or end point for genotoxic carcinogenic substances
using the margin of exposure approach). We will then be able to take into consideration food
consumption data, at the household level, for eight population groups. We expect maize, peanut
and peanut oil to contribute to most of the dietary exposure to AFB1. Likewise, we expect maize
to contribute highly to FUMtot and CIT dietary exposure. However, other core foods, in which
lower mycotoxin concentrations were estimated, especially highly-consumed staple foods, may also
significantly contribute to households’ total dietary exposure.
Although Codex maximum limits were not exceeded in the case of FUMtot and OTA, a household
dietary exposure assessment will enable risk characterization of the investigated population groups.
From this exercise, we will be able to conclude whether currently available Codex mycotoxin standards
are sufficiently protective to African consumers.
The dietary exposure assessment of our study populations (manuscript in preparation) will
provide guidance to risk managers from Benin, Cameroon, Mali and Nigeria for the identification
of national priorities to the consumer protection agenda. We can nonetheless readily address our
recommendations to risk managers based on AFtot occurrence data referencing Codex standards only.
It will indeed be beneficial for health and trade if national food safety authorities, with the support
of their technical and financial partners, draft and implement a road-map and mobilize adequate
resources taking the following into consideration:
• Food commodity value chain structures and organization;
• Prevention of field contamination by toxin-producing fungi; and
• Post-harvest practices with emphasis on hygiene, drying and storage conditions.
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This will reduce the occurrence and concentrations of mycotoxins in African foods.
To date, these observations about STC occurrence in maize and in oils are new findings which
were not reported or highlighted by the last JECFA evaluation of mycotoxins (2016) due to a lack of
data at the time of the assessment.
Mitigation measures from Codex Alimentarius may include the updating of current codes of
practices and standards and the elaboration of new ones to contribute to the reduction of natural toxins
occurrence. This is in an effort to effectively safeguard African consumers’ health and food quality.
5. Experimental
5.1. Sample Selection and Preparation of Foods as Consumed
Food consumption data were derived from household budget surveys generated by National
Statistics Authorities, from Benin, Cameroon, Mali and Nigeria and gathering a total of 72,979 households.
Core foods of each study centre were selected based on the relative importance of their mean
consumption [28], so as to cover at least 90% of the mean total diet in grams per adult male equivalent
per day (g/AME/d).
Each core food was sampled through available representation criteria [64] (such as market share
or the origins of the food) using 12 subsamples of equal size, prepared as consumed and pooled into
composites, which underwent laboratory tests. The subsamples were prepared individually according to
recipe books [65–68]. These references are considered as representative of the diet of the study populations
and were, therefore, selected by the representatives of national competent authorities. These recipe books
allow the identification of the processes used in the preparation of the foods, especially cooking time and
temperature. The actual recipes were, however, not prepared as each composite sample only contained
one core food or ingredient. The inedible parts were removed at the preparation stage, as a typical
consumer would do. Distilled water instead off tap water was used to prepare food as consumed to avoid
contamination. The quantity of water added during the cooking process of each of the 12 subsamples was
measured by weighing the food at each stage of the preparation process.
Two seasons were captured [69] for five main food groups, which cover staple foods and most of
the mean total diet by weight (i.e., cereals, tubers, legumes, vegetables and fruits):
• The rainy season in October 2017; and
• The dry season, or harmattan, in February 2018.
Other food groups were collected during the rainy season only (i.e., nuts and seeds, dairy, oils,
beverages and miscellaneous).
Among 335 composite samples, 194 consisted of foods which may be stored in conditions allowing
for the growth of moulds and, consequently, are likely to comprise mycotoxins. Those 194 composite
samples were selected for mycotoxin analysis. Samples were frozen and shipped by air in coolers with
dry ice, within a timeframe never exceeding 24 hours, from the kitchen laboratory (Benin, Cameroon,
Mali and Nigeria) to the testing laboratory (Austria).
5.2. Reagents and Chemicals
LC gradient grade methanol and acetonitrile, as well as MS grade ammonium acetate and glacial
acetic acid (p.a.), were purchased from Sigma Aldrich (Vienna, Austria). A Purelab Ultra system
(ELGA LabWater, Celle, Germany) was used for further purification of reverse osmosis water.
Standards of fungal and bacterial metabolites were obtained either as gifts from various research
groups or from the following commercial sources: Romer Labs®Inc. (Tulln, Austria), Sigma-Aldrich
(Vienna, Austria), BioAustralis (Smithfiled, Australia), AnalytiCon Discovery (Potsdam, Germany),
Fermentek (Jerusalem, Israel), Iris Biotech GmbH (Marktredwitz, Germany), Enzo Life Sciences Europe
(Lausanne, Switzerland) and LGC Promochem GmbH (Wesel, Germany). Stock solutions of each
analyte were prepared by dissolving the solid substance in acetonitrile, acetonitrile/water 1:1 (v/v),
110
Toxins 2019, 11, 54
methanol, methanol/water 1:1 (v/v) or water. Thirty-four combined working solutions were prepared
by mixing the stock solutions of the corresponding analytes for easier handling and were stored at
−20 ◦C. The final working solution was freshly prepared prior to spiking experiments through mixing
of the combined working solutions.
5.3. Laboratory Sample Preparation
Twenty millilitres (20 mL) of extraction solvent (acetonitrile/water/acetic acid 79:20:1, v/v/v)
were added to 5 g of sample. The samples were extracted for 90 minutes using a GFL 3017 rotary
shaker (GFL, Burgwedel, Germany) and subsequently centrifuged for two minutes at 3000 rpm (radius
15 cm) on a GS-6 centrifuge (Beckman Coulter Inc., Fullerton, CA, USA). The extracts were diluted
(1:1) with dilution solvent (acetonitrile/water/acetic acid 20:79:1, v/v/v). After appropriate mixing,
5 μL of the diluted extract was injected into the LC-MS/MS system without further pre-treatment.
5.4. LC-MS/MS Parameters
Metabolite analysis was carried out using a 1290 Series HPLC System (Agilent, Waldbronn,
Germany) coupled to a QTrap 5500 LC-MS/MS System (Applied Biosystems SCIEX, Foster City,
CA, USA) equipped with Turbo Ion Spray electrospray ionization source, as described earlier [70].
Chromatographic separation was performed at 25 ◦C on a Gemini® C18-column (150 × 4.6 mm i.d.,
5 μm particle size) equipped with a C18 4 × 3 mm i.d. security guard cartridge (Phenomenex, Torrance,
CA, USA). Confirmation of positive metabolite identification was carried out by two instances of
scheduled multiple reaction monitoring (MRMs) which yielded 4.0 identification points according to
the European Commission decision 2002/657 [71].
In order to further decrease the limits of detection (LODs) for aflatoxin B1 and ochratoxin A, larger
aliquots of 20 μL of the diluted extracts (previously fortified with the related 13C-labelled internal
standards) were re-analysed using the QTrap 6500 LC-MS/MS system while keeping all other method
parameters constant.
5.5. Quantification and Quality Control
Quantification was performed using external calibration based on serial dilution of a multi-analyte
stock solution. Results were corrected using apparent recoveries that were determined for each of the
investigated matrices by spiking experiments. The accuracy of the method is verified on a continuous
basis by participation in a proficiency testing scheme organized by BIPEA (Gennevilliers, France) with
a current success rate (i.e., a z-score between −2 and 2) of >94% of the >900 results submitted.
Supplementary Materials: The following are available online at http://www.mdpi.com/2072-6651/11/1/54/s1.
Table S1: Raw Analytical Data.
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Abstract: The presence of mycotoxins in cereal grain is a very important food safety issue with the
occurrence of masked mycotoxins extensively investigated in recent years. This study investigated
the variation of different Fusarium metabolites (including the related regulated, masked, and emerging
mycotoxin) in maize from various agriculture regions of South Africa. The relationship between the
maize producing regions, the maize type, as well as the mycotoxins was established. A total of 123
maize samples was analyzed by a LC-MS/MS multi-mycotoxin method. The results revealed that all
maize types exhibited a mixture of free, masked, and emerging mycotoxins contamination across the
regions with an average of 5 and up to 24 out of 42 investigated Fusarium mycotoxins, including 1 to
3 masked forms at the same time. Data obtained show that fumonisin B1, B2, B3, B4, and A1 were the
most prevalent mycotoxins and had maximum contamination levels of 8908, 3383, 990, 1014, and
51.5 μg/kg, respectively. Deoxynivalenol occurred in 50% of the samples with a mean concentration of
152 μg/kg (max 1380 μg/kg). Thirty-three percent of the samples were contaminated with zearalenone
at a mean concentration of 13.6 μg/kg (max 146 μg/kg). Of the masked mycotoxins, DON-3-glucoside
occurred at a high incidence level of 53%. Among emerging toxins, moniliformin, fusarinolic acid,
and beauvericin showed high occurrences at 98%, 98%, and 83%, and had maximum contamination
levels of 1130, 3422, and 142 μg/kg, respectively. Significant differences in the contamination pattern
were observed between the agricultural regions and maize types.
Keywords: Fusarium; maize; masked mycotoxins; LC-MS/MS; agricultural regions; South Africa
Key Contribution: The most important finding of this study was the environmental influence as well
as the maize type on the occurrence of Fusarium and their free, masked, and emerging mycotoxins.
However, significant differences in contamination pattern were observed between the agricultural
regions and maize types.
1. Introduction
Mycotoxins can adversely affect human and animal health condition, productivity, economics,
and trade [1–3]. The United Nations’ Food and Agricultural Organization (FAO) made an estimate
that there was significant contamination of about twenty-five percent of the world’s food crops with
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mycotoxins leading to annual loss in the range of one million tons [4]. Recently, studies suggest
that the percentage of contaminated cereals is much higher at 72% [5]. The difference may be due
in part, to what levels are considered as contamination, in addition to advances in detection and
monitoring [6]. Recently, it has come to be clearer that in mycotoxin-contaminated products, various
structurally-related compounds produced during plant metabolism or during after food processing
can co-occur with the parent toxins [7]. These mycotoxin derivatives had a very different chemical
behavior including polarity and solubility, compared to the precursor and thus, can easily escape
routine analyses [8]. Since they are undetectable by conventional analytical techniques because of their
altered structures, there is thus generally an underestimation of the mycotoxin load. Also, despite
their chemical alteration, coupled with the fact that they are generally not regulated by legislation,
they may be considered as being masked [6]. Furthermore, it has to be highlighted that masked
mycotoxins can be “unmasked” again in the digestive tract of animals and humans, releasing the parent
compound with its toxicological effects again. A similar situation exists with emerging mycotoxins:
toxicological data are scarce which makes it difficult to set up regulations and maximum tolerated
limits to protect humans and animals from potential health risks. On the other hand, “emerging
mycotoxins” generally represents a group of chemically altered mycotoxins which have no regulations
up till date. Studies employing LC–MS/MS for structure elucidation provide insights about these newly
discovered metabolites [9]. Common emerging Fusarium mycotoxins are eniantins (ENNs), beauvericin
(BEA), moniliformin (MON), fusaproliferin (FP), fusidic acid (FA), culmorin (CUL), and butenolide
(BUT). Jestoi [10] published an extensive review regarding this diverse set of chemical compounds.
Conjugated or masked mycotoxins first came to the attention of public health officials, when
animals fed with apparently low mycotoxin contaminated feed, showed high severity of mycotoxicosis.
The unanticipated high toxicity was ascribed to the presence of undetected, conjugated forms of
mycotoxins [8].
Historically, Gareis et al., [11] for the first time, used the term ‘masked mycotoxins’ and it refers
to the products that are formed when plants metabolize mycotoxins, as part of their natural defense
system. These secondary metabolites are not detectable by conventional techniques because their
structure has been altered in the plant, nor are they regulated. The metabolites are so-called masked
as they become toxic again as soon as they cleave off their sugar molecule in the intestine of the
humans and animals. The term conventional applies to the analytical detection methods that have
previously or initially been developed for specific mycotoxins only. Then in 2013, researchers revisited
the masked mycotoxin topic again and Berthiller et al. [8] made a clear definition of what masked
mycotoxins are. The term “masked mycotoxins” is now widely accepted. However, in 2014, Michael
Rychlik and his research group came up with a comprehensive definition to include all modified forms
of mycotoxins as well as masked mycotoxins as “modified mycotoxins” [12]. Actually, the latter is
the umbrella term of all mycotoxins that are modified by some sort of process (for example, food
processing). Masked mycotoxins are sort of, part of this definition, but only entail the molecules that
are formed by the plants.
The likelihood of mobilization of mycotoxins that interact with metabolically active plants in
the field is the issue. As Fusarium infection usually occurs in the field (in contrast to Aspergillus and
Penicillium infections), the Fusarium mycotoxins (deoxynivalenol, zearalenone, fumonisins, nivalenol,
fusarenon- X, T-2 toxin, HT-2 toxin) are the most prominent target for conjugation [8]. Although,
transformation of other mycotoxins e.g., ochratoxin A, patulin, and destruxins, by plants has also
been described. Specifically, deoxynivalenol-3-glucoside (D3G), zearalenone-14-glucoside (Z14G), and
zearalenone-14-sulphate (Z14S) are the most commonly found masked mycotoxins occurring in food
commodities [8]. Currently, only glucoside and sulfate conjugates of DON, ZON, T-2, and HT-2 have
been proven to occur in naturally infected cereals such as maize, wheat, and barley [13]. However,
many researchers have carried out studies on the occurrence of free and masked Fusarium mycotoxins
in cereal-based food and feed commodities (Table 1).
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Table 1. Occurrence data of glucoside and sulfate conjugates (masked mycotoxins) and their respective






Maize 83 59–1071 [14]
Maize - <LOQ-15,700 [15]
Maize - 56 [16]
Maize 37% <50–196 [17]
Maize 90 0–135 [18]
Maize - 14 [19]
Maize - 10.2 [20]
Maize 92.5 247.8 [21]
Maize silage(feed) 79.4 20-11 [22]
Barley 5.9 <LOQ-17 [23]
Barley 67 2–31 [24]
Beans 90 185.2 [21]
Wheat 46.7 <LOQ-234 [23]
Wheat 83.3 12–109 [14]
Wheat 47.5 1–100 [24]
Peanut 57 70 [25]
Oat 41.9 <LOQ-675 [26]
Oat 66.7 13–85 [14]
Oat 100 5–15 [24]
Cocoa seeds 23.5 24.2–83.6 [27]
Bread 83.3 19–53 [14]
Breakfast cereals - 4 [28]
Corn flakes 83.3 34–90 [14]
Malt 56 102–2213 [29]
Traditional brewed beer 45 2.6–426 [30]
ZON-14G
Maize 17 274 [14]
Maize - <LOQ-9750 (total) [14]
Barley 17.6 <LOQ-9.6 [23]
Wheat 6.7 <LOQ-0.6 [23]
Wheat 0 - [14]
Oats 3.2 <LOQ [23]
Oats 0 - [14]
Bread 33.3 20–20 [14]
Corn flakes 0 - [14]
ZON-16G
Barley 23.5 <LOQ [23]
Wheat 6.7 <LOQ-2.8 [23]
Oat 58.1 <LOQ-7.9 [23]
ZON-14S
Maize 17 51 [14]
Maize - <LOQ-9750 (total) [15]
Maize silage(feed) 42.3 2–4318 [22]
Barley 8.8 <LOQ-26.1 [23]
Wheat 33.3 11 [14]
Wheat 40.0 <LOQ-22.5 [23]
Oats 16.7 12 [14]
Oats 29.0 <LOQ-220 [23]
Bread 16.7 24 [14]
Corn flakes 0 - [14]
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Maize 100 255–5245 [14]
Maize 100 90–680 [31]
Maize 100 32–2246 [32]
Maize 90 74–1382 [33]
Maize 22 9.6–745.1 [34]
Maize 100 1,469 [20]
Maize 100 0.3–4374 [32]
Maize - 380 [16]
Maize silage (feed) 71.8 1.5–13,488 [22]
Barley 82.4 LOQ-1180 [23]
Barley 100 <60 [32]
Barley 83 54–1602 [24]
Whole wheat - 8000 [28]
Wheat 83 11–1265 [13]
Wheat 97.6 LOQ-5510 [23]
Wheat 66.7 16–150 [14]
Wheat 100 540–5080 [31]
Wheat 100 46–2683 [32]
Wheat 46.5 25–2975 [24]
Wheat 46.1 LOQ-297 [35]
Wheat 75 LOQ-10,130 [36]
Wheat - 40–490 [37]
Wheat 68 up to 302 [38]
Rice 23.8 107.9 [39]
Durum wheat 100 1750 [36]
Rye 100 <50 [32]
Oat 100 2690 [23]
Oat 16.7 46 [14]
Oat 81.8 62–2216 [32]
Oat 100 67–149 [24]
Bread 66.7 20–102 [14]
Corn flakes 16.7 207 [14]
Breakfast cereals 28.6 28.6 [40]
Snacks 61.8 61.8 [40]
Flours 72.3 72.3 [40]
Wheat flour 97.2 1.3–825.9 [41]
Wheat flour 100 78.9–325.8 [35]
Swine feed 93.8 50–931 [33]
Poultry feed 93.3 157–1231 [33]
Feed 99 124–2352 [42]
Lager beer 100 1.6–6.4 [43]
Beer 90 LOQ-35.9 [44]
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Maize 100 36–1003 [14]
Maize 67 <LOQ-70 [31]
Maize 100 <35 [32]
Maize 80 14–121 [33]
Maize - <LOQ-1100 [15]
Maize silage(feed) 63.0 1.0–3159 [22]
Barley 73.5 <LOQ-1300 [23]
Barley 0 - [32]
Barley 29 43–277 [24]
Wheat 83.3 <LOQ-922 [23]
Wheat 16.7 18 [14]
Wheat 100 59–200 [31]
Wheat 83.3 43–737 [32]
Wheat 27.3 40-356 [24]
Wheat 27 16-138 [45]
Wheat 31 <LOQ [35]
Wheat 75 100-1230 [36]
Durum wheat 94 LOQ-850 [46]
Rye 0 - [32]
Oat 87.1 <LOQ-6600 [23]
Oat 100 28–97 [14]
Oat 45.5 162–287 [32]
Oat 0 - [24]
Bread 83.3 26–29 [14]
Corn flakes 50.0 24–28 [14]
Breakfast cereals 85.7 19–66 [40]
Snacks 82.4 11–94 [40]
Flours 68.2 5–72 [40]
Wheat flour 33.4 0.2–15.7 [41]
Swine feed 93.8 6–80 [33]
Poultry feed 93.3 30–107 [33]
Beer 95 LOQ-27.5 [44]
NIV
Barley 73.5 <LOQ-302 [23]
Wheat 43.3 <LOQ-74.0 [23]
Oat 71.0 <LOQ-4940 [23]
Rice - 97 [47]
Wheat flour 100 LOQ-140.6 [35]
NIV-3G
Barley 61.8 <LOQ- 65.3 [23]
Wheat 43.3 <LOQ-33.6 [23]
Oat 16.1 <LOQ-58.3 [23]
HT-2
Barley 35.3 <LOQ-39.5 [23]
Barley 100 23–233 [48]
Barley 100 3–213 [49]
Wheat 100 19–96 [48]
Wheat 63.3 <LOQ-39.5 [23]
Wheat 77.8 26–85 [50]
Oat 100 11–187 [48]
Oat 74.2 <LOQ-1830 [23]
Oat 88.9 21–851 [50]
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Barley 52.9 <LOQ-38.5 [23]
Barley 94.4 0.6–162.8 [49]
Wheat 53.3 <LOQ-15.9 [23]
Oat 16.1 <LOQ-300 [23]
T-2
Barley 100 41–160 [48]
Barley 100 1–154 [49]
Wheat 100 17–76 [48]
Wheat 55.6 11–23 [50]
Oat 100 31–165 [48]
Oat 88.9 10–377 [50]
Maize 36 7.5–29 [17]
T-2G Barley 50 0.1–14.5 [50]
Though toxicological data are scarce since masked mycotoxins represent an emerging condition,
studies highlight the potential threat to consumer safety from these substances. However, the possible
hydrolysis of masked mycotoxins back to their parent toxin during food/feed processing or during
mammalian digestion raises concerns. To ensure the safety of agricultural products (food safety), there
is a need for the identification and determination of mycotoxins and their masked forms in order
to assess possible effects on consumers. Furthermore, since there are very few investigations on the
impact of climatic differences on mycotoxins variation in the different agriculture regions of South
Africa, a comprehensive study was imperative.
2. Results and Discussion
2.1. General Mycotoxin Occurrence Data
Mycotoxins produced by Fusarium species are found on grains cultivated on every continent. The
susceptibility of maize to Fusarium fungi and mycotoxins contamination is well documented [51–53].
All the maize samples analyzed in this study were contaminated with an average of 5 to 24 out of 42
Fusarium mycotoxins, including 0 to 3 masked forms at the same time. The summary data in Table 2
highlights the relevance of fumonisin B1, B2, B3, B4, and A1 in the samples with 98%, 91%, 80%, 82%,
and 54% of 123 samples contaminated with maximum contamination levels of 8908, 3383, 990, 1014,
and 51.5 μg/kg respectively. Fumonisin B1 was the most common mycotoxin in the maize samples.
Fumonisins commonly occur in maize while in the field, predominantly when they are cultivated in
warmer regions [54].
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Table 2. Summary statistics of occurrence of investigated 42 Fusarium free mycotoxins, masked and
emerging mycotoxin metabolites in 123 maize samples on LC-MS/MS.
Concentration (μg/kg)
Number of Positive
Samples Across ARs a
N b
(123)
P c % LOQ d LOD e
Rec f
(%)






Fumonisin B1 12.6 8908 596 58 63 121 98 8 2.4 75.0
Fumonisin B2 7.9 3383 221 55 57 112 91 7 2.1 79.0
Fumonisin B3 <LOQ 990 85.6 44 54 98 80 7 2.1 75.0
Fumonisin B4 <LOQ 1014 81.6 45 56 101 82 7 2.1 75.0
Fumonisin A1 <LOQ 51.5 6.1 28 38 66 54 2.1 0.6 75.0
Fumonisin Total 20.5 14,347 990 n/a n/a n/a n/a n/a n/a n/a
Zearalenone <LOQ 146 13.6 19 22 41 33 0.6 0.2 54.0
HT-2 toxin 40.2 40.2 40.2 0 1 1 0.8 6.4 1.9 96.8
T-2 toxin 148.0 148 148 0 1 1 0.8 2.4 0.8 102.0
Deoxynivalenol 8.2 1380 152 35 26 61 50 - 1.2 85.0
Nivalenol 7.7 35.7 14.2 4 10 14 11 3.8 1.1 80.0
Masked Fusarium Mycotoxins
DON-3Glucoside 2.43 112 15.0 31 34 65 53 - 0.8 92.0
ZON-sulphate 11 146 14.0 9 13 22 18 n.a - 75.0
Hydrolysed FB1 0.7 28.0 3.9 12 19 31 25 0.7 0.2 100.0
HT-2 Glucoside 31.2 31.2 31.2 0 1 1 0.8 5.7 1.7 71.9
Emerging Mycotoxins and Other Less Well-Known Fusarium Metabolites
Monoacetoxyscirpenol 20.9 20.9 20.9 0 1 1 0.8 5.2 1.6 89.0
Diacetoxyscirpenol 4.4 5.0 4.7 0 2 2 1.7 0.5 0.2 81.8
Neosolaniol 4.5 4.5 4.5 0 1 1 0.8 4.6 1.4 83.3
Culmorin 13.3 465 90.0 7 11 18 15 5.5 1.6 76.0
15Hydroxyculmorin <LOQ 2022 181 24 25 49 40 20.8 6.2 55.7
5Hydroxyculmorin <LOQ 578 167 12 6 18 15 50 15 102.0
Moniliformin <LOQ 1130 219 57 63 120 98 5 1.5 100.0
Beauvericin <LOQ 142 7.2 56 51 107 87 0.03 0.01 100.0
Enniatin B 0.1 4.9 2.5 0 2 2 1.7 0.04 0.01 81.0
Enniatin B1 0.13 3.0 1.6 0 2 2 1.7 0.11 0.03 100.0
Enniatin B2 <LOQ <LOQ <LOQ 0 1 1 0.8 0.57 0.2 91.2
Aurofusarin <LOQ 5470 296 46 43 89 72 3.7 1.1 79.8
Bikaverin <LOQ 651 72.0 38 44 82 67 55 16 79.6
Butenolid <LOQ 214 48.9 22 13 35 28 10.8 3.2 61.0
Epiequisetin <LOQ 18.9 5.0 7 12 19 15 2 0.6 70.3
Equisetin <LOQ 129 19.4 14 16 30 24 2.3 0.7 79.9
Apicidin 2.9 15.4 9.1 1 1 2 1.6 0.65 0.2 108.0
Deoxyfusapyron <LOQ 53.0 11.1 7 16 23 19 2.7 0.8 103.0
Fusapyron <LOQ 18.0 11.1 14 24 38 31 2.4 0.7 106.0
Fusaric acid 57.9 195 85.2 14 10 24 20 30 10 91.4
Fusarinolic acid <LOQ 3422 506 57 63 120 98 30 10 89.5
7Hydroxypestalotin <LOQ 16.5 7.5 8 17 25 20 2.9 0.9 100.0
Acuminatum B <LOQ 219 33.0 4 8 12 9.8 30 10 105.0
Acuminatum C 26.5 204 98.8 4 3 7 5.7 30 10 62.4
Chlamydospordiol 2.1 5.1 7.3 1 1 2 1.7 0.3 0.1 96.5
Chlamydosporol 27.0 26.9 26.9 0 1 1 0.8 1.1 0.3 94.0
Chrysogin <LOQ 7.7 4.4 6 42 48 30 1.9 0.6 99.2
Siccanol 34.6 252 64.3 43 48 91 74 - - 86.9
a Contamination across agricultural regions (ARs), eastern region (ER), western region (WR). b Total number of
contaminated samples (N). c Percentage of total number of samples contaminated (P). d LOQ: limit of quantification,
<LOQ: less than LOQ. e LOD: limit of detection [s/n = 3:1] expressed as μg/kg sample. f Recovery: calculated from
spiking experiment of maize samples. n/a: Not applicable.
Contamination of maize by fumonisins was considered an important risk factor in human
oesophageal cancer in the former Transkei region of South Africa and Santa Catarina State, Brazil [55,56].
Fumonisin B1 has also been implicated in the development of neural tube defects in babies of mothers
consuming fumonisin-contaminated maize, especially in certain regions of South Africa, China, and
Italy [57,58].
Deoxynivalenol occurred in 50% of the samples with a mean concentration of 152 μg/kg (max
1380 μg/kg). Deoxynivalenol DON causes different unspecific symptoms, for example vomiting and
diarrhea, also causes loss of weight and feed refusal in livestock, and hence is known as vomitoxin [59].
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The presence of DON in maize has often been associated with samples originating from temperate
regions such as northern Europe and North America [60]. However, reports emerging from tropical
countries, specifically from South Africa, continue to reveal the occurrence of DON in maize and maize
products [61]. It has also been reported at a lower concentration than in this study on maize from
Burkina Faso at a mean of 31.4 μg/kg, Mozambique at a range of 116–124 μg/ kg [62] and in Nigerian
maize at a range of 11–479 μg/kg [63] and at a mean of 225 μg/kg [64].
Furthermore, according to Ediage et al. [65], DON was detected in the urine of toddlers (1.5−5 years)
from Cameroon, which also affirms its presence in food commodities originating from sub-Saharan
Africa. However, although half of the analyzed samples contained DON, the maximum level at
1380 μg/kg did not exceed the maximum allowable levels for DON in unprocessed maize as was set by
South African Regulation in 2016 at 2000 μg/kg.
Forty-one samples were contaminated with zearalenone at a mean concentration of 13.6 μg/kg. The
occurrence of ZON in agricultural commodities has not been thoroughly investigated in sub-Saharan
Africa. It was first reported on South African maize and subsequently recovered from maize and other
commodities elsewhere on the continent [66]. The maize samples analyzed in this study showed a 33%
occurrence rate for ZON, with none of the samples exceeding the maximum level of 350 μg/kg for
unprocessed maize products according to European commission [67]. Similarly, it was also reported
by Boutigny et al. [68] at 33% occurrence in naturally infected field-grown maize samples. Meyer
et al. [69] also reported that less than 10% of the South African commercial maize samples were
contaminated with ZON. The detected maximum concentration from the samples was 145.6 μg/kg
(Table 2). Compared to other reports on the occurrence of ZON in maize samples from other parts of
Africa, the levels detected in this study were lower than levels earlier reported by Adejumo et al. [34]
in maize samples from Nigeria. Zearalenone was also reported in maize samples from Cameroon
with a mean concentration of 68 μg/kg and a maximum concentration of 309 μg/kg [70]. However, the
relatively low level of ZON observed in this study somewhat supports the notion that ZON is perhaps
a persistent yet minor contaminant of foods/feeds in South Africa [66,69,71] but its significance is in its
oestrogenic potential to mammals.
Occurrence of HT-2 and T-2 in the samples was at a very low level at 0.8% (1 sample) at maximum
concentration of 40.2 and 148.0 μg/kg, respectively. The EU permissible levels of mycotoxins by
the European Commission have recommended the limit of 15–1000 μg/kg for the sum of HT-2 and
T-2 toxins in various matrices [72]. The detected maximum concentration of HT-2 and T-2 from the
samples did not exceed the recommended limit. Meanwhile, HT-2 toxin and T-2 are two related
compounds that may be synthesized by several Fusarium species. Their presence in cereal grain has
been well documented, with several reports originating from the cold climate of northern Europe [73,74].
Nevertheless, few reports from Africa indicated; 1–8% incidence rates for HT-2 in Nigerian cereals [64]
and 25% rate in Tanzanian maize for HT-2, with range of 15–25 ppb [75]. Also, South African Grain
Laboratory (SAGL) reported detection of HT-2 and T-2 only in one maize sample, with the levels 72
and 232 μg/kg, respectively [76].
Nivalenol occurred only in 11% of the samples at a contamination range of 7.7–35.7 μg/kg.
Occurrence of NIV in maize has previously been reported in Nigerian samples, although at a higher
incidence rate (54%) [63] and higher contamination range of 163–271 μg/kg [64]. Nivalenol is known to
be immunosuppressive and also as a protein inhibitor.
Of the masked mycotoxins, DON-3-glucoside occurred at highest incidence rate of 53% than the
other masked forms detected in this study. Among emerging toxins, moniliformin, fusarinolic acid, and
beauvericin showed high occurrence being found in 98%, 98%, and 83% of samples, respectively. High
incidences of these toxins in maize which serve as a staple food in South Africa is an important cause
for concern. From available literature, little or no appreciable study has been done on the occurrence of
these mycotoxins in food and food products in South Africa and neglecting them increases the risk
of exposure to humans and animals. The occurrences of these emerging mycotoxins produced by
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Fusarium specie, have been reported in food crops which represents an important problem in some
parts of the world [77,78].
Furthermore, the high incidence of these emerging toxins should not be taken for granted,
since moniliformin is known to be cytotoxic to many mammalian systems [10]. Beauvericin is also
known to be genotoxic to human lymphocytes [79]. Other detected metabolites included emerging
mycotoxins and other less well-known Fusarium metabolites such as enniatins (B, B1, and B2),
monoacetoxyscirpenol, diacetoxyscirpenol, equisetin, epi-equisetin, aurofusarin, apicidin, neosolaniol,
culmorin, 5- & 15-hydroxyculmorin, bikerverin, butenolide, chlamydospordiol, chlamydosporol,
chrysogin, fusaric acid, fusapyron, deoxyfusapyron, 7-hydroxypestalotin, acuminatum (B and C)
fusarinolic acid, and fusarin C. The co-occurrence of these emerging mycotoxins with other major
mycotoxins and many other Fusarium metabolites of unknown toxicity is a source of concern.
Beauvericin, like enniatins, is a cyclodepsipeptide that has antibiotic, insecticidal, and cytotoxic
properties presumably related to their ionophoric properties [80].
2.2. Distribution of Fusarium (Free and Masked) Mycotoxins across the Agriculture Regions of South Africa
Mycotoxins are among the food-borne risks that are dependent upon climatic conditions. Indeed,
the ability of fungi to produce mycotoxins is largely influenced by temperature, relative humidity,
insect attack, and stress conditions of the plants [81]. The main effect due to agriculture regions (AR) on
the distribution of Fusarium free and masked mycotoxins in the maize samples is presented in Table 2.
All the 42 Fusarium toxins and metabolites investigated in the maize samples across the agricultural
regions were detected and quantified except for the emerging toxin, enniantin B2, which was only
detected in 2% of the samples from the western region but was not quantified because the values were
below the limit of quantification (<LOQ). Of the major mycotoxins, HT-2 was not detected at all in
the eastern region but was quantified only in 2% of the maize from the western region at 40.2 μg/kg
concentration. Detection of HT-2 in the warm western region and not the cold eastern region as would
be expected is contrary as it was reported that HT-2 was previously considered a problem in colder
European climates [13]. Of the fumonisin Bs, FB1 occurred at the most frequency rate than FB2, FB3,
and FB4. Fumonisin B1 was the most contaminant mycotoxin, occurring at a mean concentration of 752
± 1469 μg/kg from the warm western region and of 440 ± 514 μg/kg in the cold eastern region with only
3% (2 samples) not contaminated. A similar trend was also observed when the sum of the fumonisins
was considered, for instance, the highest fumonisin (FB1 + FB2 + FB3) concentrations were detected
in warm western region and this is consistent with Munkvold [82] and De La Campa et al. [83] who
reported optimum temperatures of 30 and 32 ◦C for fumonisin production. This observation could be
correlated to the high mycotoxins production potentials of Fusarium fungi in warmer climates [84]. In
general, fumonisin B1 was detected in 98% of all the samples analyzed, irrespective of the maize type
and AR, ranging from 12.6 to 8908 μg/kg with the mean concentration of 596 μg/kg (Table 2).
Fumonisin B2 was the second most contaminant mycotoxin, across the ARs and generally,
fumonisin A1 was quantified in 32% of all the maize samples analyzed and in 22% of the samples, it
was detected but below the limit of quantification (<LOQ).
Deoxynivalenol was more prevalent in the eastern region than in the western region, having
60% and 40% of the samples all detected and quantified respectively (Table 2). This was in line with
what was reported by Chilaka et al. [64] who observed the highest incidence rate of DON in maize
samples from the DS zone in Nigeria, (an agricultural region) characterized by a lower temperature
and higher average annual. Zearalenone, nivalenol, HT-2, and T-2 were also among the major Fusarium
mycotoxins, detected and quantified in the two regions. Nivalenol, HT-2, and T-2 were detected
in higher concentration in the WR while ZON occurred at lower concentration in the same region,
occurring higher in the ER. This observation could be because ZON is known to be produced in
somewhat cool environments compared to other mycotoxins [9,22]. The highly toxic mycotoxin, T-2
toxin, has until recently not been recorded in South Africa. T-2 toxin is most commonly produced by
F. sporotrichioides, a fungus well-adapted to survive in colder countries [85]. Some T-2-producing
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Fusarium species have occasionally been isolated from wheat with Fusarium head blight (FHB) and
maize with Fusarium ear rot (FER) symptoms in South Africa [86]. The presence of T-2 toxin in local
maize grain, was reported by the SAGL, [76] and it has been shown to have a relationship with F.
verticillioides and F. graminearum [87,88].
Masked mycotoxins detected in the samples include DON-3-glucoside, zearalenone-sulphate,
hydrolysed fumonisin B1, and HT-2-glucoside. Deoxynivalenol-3-glucoside (DON-3-G) and
HT-2-glucoside had the highest and least occurrence respectively across the two regions. Although
there were no significant differences in their distribution across the agriculture regions, but to our
knowledge, there seem to be no available data on the occurrence of some of these masked mycotoxins
in South Africa. Hence, this is the first report of zearalenone-sulfate and HT-2-glucoside in South
African maize. Although toxicological data are still limited, the occurrence of masked mycotoxins is
expected to add substantially to the overall mycotoxins load and toxicity. This invariably will increase
the toxic health effects by these masked mycotoxins, which may be either direct or indirect through
hydrolysis, or released from the matrix during digestion into the free mycotoxins [89].
Moreover, monoacetoxyscirpenol, diacetoxyscirpenol, neosolaniol, enniatins (B and B1) were not
detected in maize samples from the eastern regions but had low incidences of 2%, 3%, 2%, 3%, and
3% respectively in the western region. This could be explained by the agroclimatic differences in the
agriculture regions that favored the accumulation of these emerging mycotoxins in the warmer and
drier climate of the western maize regions.
2.3. Agricultural Region and Maize Type on Fusarium Mycotoxin Distribution and Accumulation on Maize
Mycotoxin occurrence and distribution is influenced by different factors such as crop species,
climatic, and environmental conditions of a given region. The interaction between agricultural region
and maize type on the concentration of Fusarium mycotoxins on maize samples is presented in Table 3.
From the statistical analyses, the concentration of the major mycotoxins; fumonisin Bs (B1, B2, B3,
B4) and fumonisin A1 in white maize samples collected from the western region (WR) was significantly
higher (p < 0.05) than that of yellow maize from the same region, as well as on white and yellow maize
from the eastern region (ER). The mean values were 1023 ± 1698, 377 ± 645, 146 ± 197, 140 ± 207, and
10.7 ± 12 μg/kg respectively. The fact that the white maize samples of the western region (WR) had
significantly higher mean levels of fumonisin can be explained partly by high mycotoxins production
potentials of Fusarium fungi in warmer climates as reported by [84]. Then, Munkvold [82] and De
La Campa et al. [83] also reported optimum temperatures of 30 and 32 ◦C for fumonisin production,
which is what is obtained in the western region. Furthermore, differences in plant genotype cannot be
ruled out as it has been reported that white maize is a better substrate for fumonisin production than
yellow maize [90].
Deoxynivalenol concentration in yellow maize samples from the western region was significantly
higher (p < 0.05) than that of the white maize samples from the same region and on the white and
yellow maize samples from the eastern region, with the mean value being 367 ± 503 μg/kg (Table 3).
Occurrence of DON at significantly higher concentration in the western region could be explained
by high mycotoxins production potentials of Fusarium fungi in warmer climates as reported by [84].
The higher DON concentration in yellow maize than the white maize could be due to variation in
localization of pigments in yellow maize kernel, which might have a prominent role in the actual
degree of resistance to Fusarium infection/mycotoxin accumulation [91].
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(Mean ± SD) LSD (<0.05)
Concentration (μg/kg)
Fumonisin B1 607 ± 579 273 ± 362 1023 ± 1698 482 ± 634 407.26
Fumonisin B2 200 ± 189 102 ± 121 377 ± 645 203 ± 248 156.06
Fumonisin B3 80.9 ± 60 43.5 ± 35 146 ± 197 7.2 ± 59 4.87
Fumonisin B4 71.6 ± 53 39.7 ± 32 140 ± 207 75.1 ± 74 52.61
Fumonisin A1 4.2 ± 2 3.7 ± 1 10.7 ± 12 5.8 ± 3 4.37
Zearalenone 21.0 ± 47 9.8 ± 13 4.4 ± 9 19.2 ± 27 17.64
Deoxynivalenol 121 ± 186 51.0 ± 35 71.0 ± 71 367 ± 503 136.80
Nivalenol 10.2 ± 0 15.3 ± 4 15.8 ± 9 15.5 ± 6 6.79
T-2 <LOD 0 148 ± 0 0 -
HT-2 0 0 31.2 ± 0 0 -
Masked Fusarium
Mycotoxins
DON-3-glucoside 18.6 ± 25 6.7 ± 4 8.7 ± 11 25.9 ± 36 13.73
Zearalenone-Sulphate 2.78 ± 48 1.14 ± 97 7.36 ± 54 9.5 ± 71 22.30
Hydrolysed Fumonisin B1 3.8 ± 3 1.8 ± 1 6.5 ± 7 3.6 ± 4 3.13





Monoacetoxyscirpenol 0 0 20.9 ± 0 0 -
Diacetoxyscirpenol 0 0 4.7 ± 1 0 -
Neosolaniol 0 0 4.8 ± 0 0 -
Culmorin 62.4 ± 25 159 ± 177 22.7 ± 7 116 ± 102 101.47
15Hydroxyculmorin 179 ± 148 79.2 ± 55 55.5 ± 21 410 ± 597 190.36
5Hydroxyculmorin 111 ± 16 58.7 ± 349 167 ± 0 331 ± 0 233.20
Moniliformin 184 ± 178 165 ± 144 195 ± 227 331 ± 327 96.21
Beauvericine 2.3 ± 5 4.4 ± 8 7.8 ± 27 14.2 ± 26 9.24
Enniatin B 0 0 5.0 ± 0 0.1 ± 0 -
Enniatin B1 0 0 2.98 0.13 -
Enniatin B2 0 0 <LOQ <LOQ -
Aurofusarin 130 ± 188 283 ± 577 127 ± 127 643 ± 1490 351.51
Bikaverin 56.1 ± 0 156 ± 0 0 76.3 ± 16 75.81
Butenolid 31.2 ± 14 27.6 ± 11 19.3 ± 9 118 ± 97 42.67
Epiquisetin 1.5 ± 0 11.8 ± 7 4.4 ± 2 2.2 ± 0 4.13
Equisetin 4.2 ± 2 50.7 ± 56 17.8 ± 10 4.7 ± 1 28.94
Apicidin 15.4 ± 0 0 2.9 ± 0 0 -
Deoxyfusapyron 3.3 ± 0 5.0 ± 2 30.1 ± 23 6.1 ± 3 21.74
Fusapyron 3.3 ± 0 5.0 ± 8 30.1 ± 4 6.1 ± 5 21.74
Fusaric Acid 0 109 ± 46 133 ± 26 99.4 ± 22 22.70
Fusarinolic Acid 530 ± 387 493 ± 281 557 ± 590 446 ± 293 161.10
Hydrolysed Fumonisin B1 3.8 ± 3 1.8 ± 1 6.5 ± 7 3.6 ± 4 3.13
7Hydroxypestalotin 8.5 ± 4 5.8 ± 1 6.8 ± 3 9.2 ± 4 2.76
Acuminatum B 0 0 27 ± 6 103 ± 82 94.90
Acuminatum C 58.4 ± 25 164 ± 41 129 ± 0 44.8 ± 18 45.80
Chlamydospordiol 2.1 ± 0 - 5.1 ± 0 - -
Chlamydosporal - - 26.9 ± 0 - -
Chrysogin 5.6 ± 6 3.8 ± 2 3.6 ± 2 4.5 ± 2 2.01
Siccanol 62.0 ± 51.2 42.3 ± 26.2 61.7 ± 59.3 91.0 ± 55.3 24.9
AR—agriculture region, ER—eastern region, WR—western region, Qty—percentage quantified, <LOD—percentage
below limit of detection, <LOQ—percentage below limit of quantification, YM—yellow maize, WM—white maize,
LSD—least significant difference, SD—standard deviation.
Zearalenone and nivalenol concentrations showed no significant difference (p > 0.05) amongst
white and yellow maize samples collected from the western region, as well as white and yellow
maize from the eastern region. In addition, white maize from the eastern region has the highest mean
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concentration of 21.0 ± 47 μg/kg. This is in line with the finding of Ediage et al. [92], who noted no
significant difference in zearalenone accumulation in maize samples from Cameroon, irrespective of
geographical location.
The concentration of the masked mycotoxins DON-3-glucoside in yellow maize samples from the
western region was significantly higher (p < 0.05) than that of the white maize samples from the same
region and with the yellow maize samples from the eastern region. A similar trend was also observed
with the parent toxin deoxynivalenol in this study. This can also have the same explanation as is the
case with DON accumulation.
DON-3-glucoside concentration in white maize samples from the eastern region had no statistically
significant difference (p > 0.05) with the yellow maize samples from the same region and with white
maize samples from the western region. In addition, yellow maize from the western region had the
highest concentration with mean value of 25.9 ± 36 μg/kg.
Zearalenone sulfate concentrations had no significant differences (p > 0.05) amongst white and
yellow maize samples collected from the western region, white and yellow maize from the eastern
region. A similar trend was also observed with the parent mycotoxin, zearalenone, in this study.
The concentration of hydrolyzed fumonisin B1 in white maize samples collected from the western
region was significantly higher (p < 0.05) than that of yellow maize from the eastern region. The same
trend was observed with other fumonisin parent mycotoxins. Also, hydrolyzed fumonisin B1 in white
maize samples collected from the western region had no significant difference (p > 0.05) with that of the
yellow maize samples from the same region and also with the white maize samples from the eastern
region. HT-2-glucoside occurred only on white maize from the western region at mean contamination
level of 31.2 ± 0 μg/kg.
Of the emerging toxins, the concentration of 15-Hydroxyculmorin, moniliformin, aurofusarin,
and butenolid on yellow maize from the western region was significantly higher (p < 0.05) than
that of the white maize samples from the same region, as well as white and yellow maize from the
eastern region. The mean values were 410 ± 597, 331 ± 327, 643 ± 1490, 118 ± 97 μg/kg respectively.
Bikaverin, epiquisetin and equisetin concentrations in yellow maize samples from the eastern region
was significantly higher (p < 0.05) than that of the white maize samples from the same region and with
white and yellow maize samples from the western region. The concentrations of deoxyfusapyron and
fusaric acid in white maize samples collected from the western region (WR) is significantly higher
(p < 0.05) than that of yellow maize from the same region, white and yellow maize from the eastern
region. Fusarinolic acid and chrysogin concentrations had no significant difference (p > 0.05) amongst
white and yellow maize samples collected from the western region, white and yellow maize from
the eastern region. Then, beauvericin and acuminatum B concentrations in yellow maize samples
collected from the western region is significantly higher (p < 0.05) than that of yellow and white maize
from the eastern region and had no significant difference (p > 0.05) with white maize samples from the
western region.
3. Conclusions and Recommendations
The analysis showed that maize types were contaminated with a mixture of both free, masked,
and emerging mycotoxins across the maize producing regions of South Africa. All the maize samples
analyzed had an average of 5 up to 24 out of 42 mycotoxins, including 1 to 3 masked forms at the same
time. This study has also shown that there is higher risk of Fusarium mycotoxins exposure, especially
fumonisin Bs, with consumption of maize grown in the western than with the eastern agriculture
regions of South Africa. White maize samples from the western region (WR) had significantly higher
mean levels of fumonisins. It also showed that there is no significant difference in the occurrence of
the masked toxins across the agriculture regions. Although toxicological data are still limited, the
occurrence or presence of masked mycotoxins will add substantially to the overall mycotoxin load and
toxicity. However, studies highlight the potential threat to consumer safety from these substances.
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4. Materials and Methods
4.1. Chemicals and Standards
The reagents and chemicals used were of analytical grade (LC gradient grade and MS grade),
and were obtained from Merck and Co, Sigma or Microsep, Pretoria, South Africa, except others
from Sigma-Aldrich (Vienna, Austria), Merck (Darmstadt, Germany) and VWR (Leuven, Belgium).
Mycotoxin standards were obtained from various research groups or purchased from various
commercial sources (Romer Labs®Inc. (Tulln, Austria), AnalytiCon Discovery (Potsdam, Germany),
Bio Australis (Smithfield, Australia). Water was purified successfully by reverse osmosis using Purite™
water purification technology Suez, UK from LASEC, South Africa.
4.2. Sampling Site Description
The agriculture regions are the eastern region (ER), which is situated in the higher rainfall and
cooler areas and the western region (WR), which is located in the drier and warmer areas. The ER
consists of Gauteng province and the eastern Free State where the mean maximum temperatures
ranged from 24 to 27 ◦C while the WR consists of the northwest province and western Free State,
where the average temperature ranged from 29 to 32 ◦C. The geography and climatic conditions of the
regions have previously been documented [68].
4.3. Sampling and Sample Preparation
A total of 123 maize samples harvested during the 2015/2016 season were collected from randomly
selected silo sites in the northwest, Gauteng, and Free state province in the two agriculture regions.
From the silos located at the western region (WR), 65 composite samples were collected, comprising of
44 white maize and 21 yellow maize. From the eastern region (ER) silo locations, 58 composite samples
were collected, comprising of 30 white maize and 28 yellow maize. For each maize sample, at least 10
incremental samples of 100 g each were taken and combined, making approximately 1 kg according
to EC 401/2006, in sterile zip lock polythene bags, well labelled and transported to the laboratory.
The samples were thoroughly mixed and milled using a sterile high-speed laboratory blender (IKA
M20, Merck, Sarstedt, Nümbrecht, Germany) and packaged in sealed sterile plastic bags to avoid
contamination. A cleaning and decontamination routine of the equipment was performed using 70%
methanol, after each milling practice. Samples were stored prior to analysis at 4 ◦C in the freezer. The
milled sample material was vigorously homogenized with a spatula before weighing.
4.4. Fusarium Mycotoxins Analysis
4.4.1. Sample Preparation and Cleanup for LC-MS/MS Multi-mycotoxin Analyses
This was done according to Sulyok et al. [93], sample preparation was rather simple and eludes
any clean-up. Briefly, 5 g representative amount of ground maize kernels was weighed into a 50 mL
polypropylene tube (Sarstedt, Nümbrecht, Germany) and extracted for 90 min at 180 rpm on a GFL 3017
rotary shaker (GFL, Burgwedel, Germany) with 20 mL of extraction solvent, (acetonitrile/water/acetic
acid 79:20:1, v/v/v). Subsequently, the extracts were centrifuged for 2 min at 3000 rpm (radius
15 cm) on a GS-6 centrifuge (Beckman Coulter Inc., Fullerton, CA, USA). The raw extracts were
transferred into glass vials using Pasteur pipettes, and 350 μL aliquots were diluted in the same
volume (1/1) with dilution solvent, (acetonitrile/water/acetic acid 20:79:1, v/v/v) to adjust the solvent
strength. After appropriate mixing, 50 μL of the diluted extract was analyzed by LC-MS/MS without
further pre-treatment.
4.4.2. LC-MS/MS Multi-mycotoxin Measurement Parameters
Analyses for the Fusarium toxins was performed by liquid chromatography–tandem mass
spectrometry (LC-MS/MS) multi-mycotoxin method, at the Centre for Analytical Chemistry, Department
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of Agro biotechnology (IFA-Tulln), University of Natural Resources and Life Sciences, Vienna, Austria.
The analysis was performed according to the methods described by Sulyok et al. [93] and Malachová
et al. [94] with slight modifications.
Briefly, a QTrap 4000 LC-MS/MS System (Applied Biosystems, Foster City, CA) was equipped
with a turbo ion spray electrospray ionization (ESI) source and an 1100 Series HPLC System (Agilent,
Waldbronn, Germany). Chromatographic separation of the analytes was performed at 25 ◦C on a
Gemini® C18 column, 150 × 4.6 mm i.d., 5 μm particle size, equipped with a C18 4× 3 mm i.d. security
guard cartridge (Phenomenex, Torrance, CA, US), using (eluent A) methanol/water/acetic acid 10:89:1
(v/v/v) or (eluent B), methanol/water/acetic acid 97:2:1. Both eluents contained 5 mM ammonium
acetate. After an initial time of 2 min at 100% A, the proportion of B was increased linearly to 100%
within 12 min, followed by a hold-time of 3 min at 100% B and 4 min column re-equilibration at 100%
A. The injection volume of 50 μL and flow rate of 1 mL min−1 was used.
The ESI-MS/MS source temperature operated at 550 ◦C, in the multiple reaction monitoring (MRM)
mode, both in positive and negative polarities in two separate chromatographic runs per sample by
scanning two fragmentation reactions per analyte. Further MS parameters were as follows: curtain
gas 10 psi (69 kPa of max. 99.5% nitrogen); ion source gas 1 (sheath gas) 50 psi (345 kPa of nitrogen);
ion source gas 2 (drying gas) 50 psi (345 kPa of nitrogen); ion spray voltage −4000 V and +4000 V
respectively, collision-activated dissociation gas (nitrogen) high.
4.4.3. Method Validation
LC-MS/MS multi-mycotoxins method was validated in terms of linearity, apparent recovery
(AP), limit of detection (LOD), limit of quantification (LOQ), (Table 1), using blank matrices of maize,
(401/2006/EC, 2006). Apparent recoveries of the analytes were calculated by spiking five different
samples that were not contaminated with mycotoxins with a multi-analyte standard. The spiked
samples (0.25 g) each were left overnight in the dark at room temperature for evaporation of the
solvent to establish equilibrium between the analytes and the sample was then extracted with 1 mL
of extraction solvent as described above. The corresponding peak areas of the spiked samples were
used for estimation of the apparent recovery by comparison with a standard of the same concentration
prepared by dilution in pure solvent:
RA% = 100× Peak area spiked samples
Peak area liquid standards
Limits of detection (LOD) and limit of quantification (LOQ) were calculated from the signal to
noise ratios (S/N) of the respective multiple reaction monitoring (MRM) chromatograms deriving from
analysis of the spiked samples: LOD = 3 × S/N and LOD = 10 × S/N, respectively.
4.4.4. Data Analysis
The data collected were subjected to analyses of variance (ANOVA), as outlined for factorial
arrangement in a completely randomized design (CRD) using GenStat Release 10.3DE [95] statistical
software. The means were compared using Fisher’s least significant difference (F-LSD) at 5% probability
level. The data were not log-transformed, only the geometric means were taken. Microsoft Office Excel
software version 2016 was used to determine the frequencies, range, and percentages.
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Abstract: A survey on 120 cereal samples (barley, maize, rice and wheat) from Algerian markets has
been carried out to evaluate the presence of 15 mycotoxins (ochratoxin A, deoxynivalenol, fumonisin
B1 and B2, T-2 and HT-2 toxins, zearalenone, fusarenon X, citrinin, sterigmatocystin, enniatins A,
A1, B and B1, and beauvericin). With this purpose, a QuEChERS-based extraction and ultra-high
performance liquid chromatography coupled to tandem mass spectrometry (UHPLC-MS/MS) were
used. Analytical results showed that 78 cereal samples (65%) were contaminated with at least one
toxin, while 50% were contaminated with three to nine mycotoxins. T-2 toxin, citrinin, beauvericin
and deoxynivalenol were the most commonly found mycotoxins (frequency of 50%, 41.6%, 40.8%
and 33.3%, respectively). Fumonisins (B1 + B2), enniatins B and B1, deoxynivalenol and zearalenone
registered high concentrations (289–48878 μg/kg, 1.2–5288 μg/kg, 15–4569 μg/kg, 48–2055 μg/kg and
10.4–579 μg/kg, respectively). Furthermore, concentrations higher than those allowed by the European
Union (EU) were observed in 21, 8 and 1 samples for fumonisins, zearalenone and deoxinivalenol,
respectively. As a conclusion, the high levels of fumonisins (B1 + B2) in maize and deoxynivalenol,
zearalenone and HT-2 + T-2 toxins in wheat, represent a health risk for the average adult consumer in
Algeria. These results pointed out the necessity of a consistent control and the definition of maximum
allowed levels for mycotoxins in Algerian foodstuffs.
Keywords: Mycotoxins; cereals; UHPLC-MS/MS; exposure assessment; Algeria
Key Contribution: The study describes the incidence of 15 mycotoxins in 120 Algerian cereal
samples (barley, maize, rice and wheat grains) by UHPLC-MS/MS. The results have pointed out the
high co-occurrence of mycotoxins, as well as the high concentration (above the maximum allowed
concentration) of some mycotoxins legislated in the EU in those cereals, posing a risk for consumers.
These results highlight the necessity of establishing maximum levels for mycotoxins in Algeria.
1. Introduction
Mycotoxins are secondary metabolites of low molecular weight produced by a variety of fungi
(mainly Aspergillus, Fusarium and Penicillium spp.). They present diverse chemical structures, having
different biological effects on animals and humans, such as teratogenicity, carcinogenicity, mutagenicity,
immunotoxicity or neurotoxicity [1,2]. These toxic compounds are often naturally occurring in the
food chain and, therefore, result in human exposure either by direct consumption of contaminated
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crops, plants, seeds and fruits, or indirectly through ingestion of food derived from exposed animals
(meat, eggs or milk) [3–5].
More than 400 mycotoxins have been reported so far, being aflatoxins (AFs), trichothecenes,
fumonisins, zearalenone (ZEN) and ochratoxin A (OTA) the most representatives. However, other
mycotoxins are becoming a global issue of high concern due to their extensive incidence in food and
feed, including emerging Fusarium toxins, such as beauvericin (BEA) and enniatins (ENNs) [6–8].
Humans and animals are more frequently exposed to multiple mycotoxins than to a single
one [9–11], producing an increasing concern about the health hazard. The combined effects of
mycotoxins have been reported in several studies [12–15]. However, the actual health risk assessment
is limited to their single effects, since there is not enough information available about the nature of the
observed effects or the relative potencies of each mycotoxin in the mixture [16].
Due to the toxic effects of these compounds, the EU [17,18] and many countries have set maximum
levels or recommendations in foodstuffs intended to human consumption (see Table 1). Moreover,
for the most well-documented toxins, tolerable daily intakes (TDI) or provisional maximum tolerable
daily intakes (PMTDI) have been established by the Food and Agriculture Organization (FAO)/World
Health Organization (WHO) Joint Expert Committee on Food Additives (JECFA) [19,20].
Table 1. Maximum tolerable levels set for some mycotoxins in cereals.
Mycotoxin Commodity Maximum Level (μg/kg)
European Union [17,18]
Aflatoxin B1 Cereals and cereal products 2
Aflatoxins a
Cereals and cereal products 4
Maize 10
Ochratoxin A Unprocessed cereals 5
Zearalenone
Unprocessed maize 350
Unprocessed cereals other than maize 100
Fumonisins B1 + B2 Unprocessed maize 4000
Deoxynivalenol Unprocessed cereals other than durum wheat, oats, maize 1250
Unprocessed durum wheat, oats and maize 1750
T-2 + HT-2
Unprocessed barley and maize 200
Unprocessed oats 1000
Unprocessed wheat, rye and other cereals 100
United States of Americ [21,22]
Aflatoxin B1 All food crops 15
Fumonisins B1 + B2 + B3 Unprocessed maize 4000
Canada [23]
Deoxynivalenol Unprocessed wheat 2000
Japan [24,25]
Aflatoxin B1 All food crops 10




Rice (brown rice) 10
Unprocessed wheat barley, other cereals 5
Deoxynivalenol Maize, barley, wheat, other cereals 1000
Ochratoxin A Unprocessed cereals 5
Zearalenone Unprocessed wheat and maize 60
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Table 1. Cont.
Mycotoxin Commodity Maximum Level (μg/kg)
Morocco [27]
Aflatoxin B1 Cereals and cereal products 2
Aflatoxins a Cereals and cereal products 4
Ochratoxin A Unprocessed cereals 5
Deoxynivalenol Unprocessed durum wheat, oats and maize 1750
Zearalenone Unprocessed maize 200
a AFs: Sum of AFB1 + AFB2 + AFG1 + AFG2; b Provisional maximum level.
Studies show that mycotoxins are ubiquitous contaminants [28,29]. It is estimated that they are
present in approximately 25% of cereals consumed worldwide and a recent study suggests that this
percentage could be even higher [30]. In general, mycotoxin contamination is higher when climatic
conditions are favourable. Algeria is a North African country whose climate is characterised by high
temperatures and high relative humidity in some areas that seems to stimulate the toxigenic moulds
growth and toxinogenesis, in which cereals and cereal-based products represent a staple food for
the population [31]. Moreover, no applicable norms concerning mycotoxin contamination of cereal
(local or imported) have been set in Algeria. Indeed, a large amount of cereal commercialized in
Algeria is imported and little is known about toxin contamination. Therefore, in order to the health
risks associated with mycotoxin exposure different preventive approaches have been used. These
include enforcement of legislation, good agricultural practices and the monitoring of mycotoxin
contamination. But for this, it is essential to establish evidence and data on the presence of mycotoxins
and exposure levels. Accurate exposure data on mycotoxins is an important input in risk assessment
and management efforts as well as in the establishment of appropriated legislation for the monitoring
and control of mycotoxin exposure in food [32].
In order to quantify the concentration of these hazards in different commodities, reliable and
accurate analytical methods that allow their unambiguous identification and accurate quantification at
low concentration are needed. In this sense, liquid chromatography (LC) or ultra-high performance
LC (UHPLC) coupled to tandem mass spectrometry (MS/MS) have become the techniques of choice for
the determination of multiple mycotoxins in food and feed [33–35]. In addition, alternative sample
treatment methods, such as QuEChERS (acronym of Quick, Easy, Cheap, Effective, Rugged and
Safe), are being increasingly applied to the analysis of mycotoxins, due to their feasibility, flexibility,
versatility, low cost and rapidity [36].
Within this context, the main objective of this work is the validation of an analytical method based
on a simple QuEChERS-based extraction and UHPLC–MS/MS for the determination of 15 mycotoxins,
namely: OTA, deoxynivalenol (DON), fumonisin B1 (FB1) and B2 (FB2), T-2 and HT-2 toxins, ZEN,
fusarenon X (F-X), citrinin (CIT), sterigmatocystin (STE), enniatin A (ENNA), A1 (ENNA1), B (ENNB)
and B1 (ENNB1) and BEA. Secondly, the analysis of cereals samples (barley, maize, rice and wheat)
collected from different Algerian markets will help to estimate the potential contribution to the dietary
exposure of Algerian consumers.
2. Results
2.1. Method Validation
The selected analytical method was validated for each cereal in terms of linearity, matrix effect,
recovery, precision, limits of detection (LODs) and limits of quantification (LOQs). The results are
summarised in the supplementary material (Table S1).
Method linearity was assessed by spiking blank samples at five concentration levels (processed in
duplicate). All calibration curves showed a good linearity, with coefficients (R2) higher than 0.98 in all
the cases. LODs and LOQs were determined as the concentration of analyte giving a signal to noise
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ratio (S/N) equal to 3 and 10, respectively. In all cases, LOQs were lower than maximum permitted or
recommended concentrations established by the EU for those mycotoxins in cereals (FBs, DON, OTA,
ZEN, T-2 and HT-2 toxin) [17,18].
Matrix effect was evaluated at the following concentration levels: OTA and STE: 25 μg/kg; CIT:
100 μg/kg; FB1, FB2, T-2, HT-2 and ZEN: 250 μg/kg; ENNB, ENNB1, ENNA, ENNA1 and BEA:
400 μg/kg; DON: 1000 μg/kg and F-X: 2500 μg/kg. Matrix effect was calculated as follow:
ME = 100 × (signal of spiked extract − signal of standard solution)/signal of standard solution
A strong ion suppression was observed for all the selected compounds in the four matrices under
study, ranging from −77.8% to −18.2 % for barley, −76.5% to −15.6% for maize, −80.4% to −18.2%
for rice and −76.9% to −14.3% for wheat (see supplementary material, Figure S1). As a consequence,
calibration curves in matrix were used.
The efficiency of the extraction process was evaluated by recovery studies, spiking blank samples
at the same levels used in the matrix effect study. Each sample was processed in triplicate and injected
three times. The ratio of peak areas of the samples spiked before extraction and the extracts spiked
after extraction was used to calculate the recovery. The average recovery values were: 87.5% for barley,
84.8 % for maize, 88.5 % for rice and 86.2 % for wheat.
Intra-day (repeatability) and inter-day precision (intermediate precision) were evaluated and
expressed as relative standard deviation (%RSD). Spiked blank samples (processed and injected three
times) at the same concentration levels mentioned above for the matrix effect and recovery studies were
used. For the intra-day precision study, samples were analysed on the same day, while the inter-day
precision was estimated through samples analysed on three consecutive days. The relative standard
deviation (%RSD) for intra-day and inter-day precision were lower than 14% and 23%, respectively, for
all the mycotoxins and matrix combination (see supplementary material Table S2). These values were
all in a permitted range by European Commission [37].
2.2. Mycotoxins Occurrence Data
A total of 120 samples comprising barley (n = 30), maize (n = 30), rice (n = 30) and wheat (n = 30)
were evaluated for the occurrence of mycotoxins (OTA, DON, FB1, FB2, T-2, HT-2, ZEN, F-X, CIT, STE,
ENNA, ENNA1, ENNB, ENNB1 and BEA). Table 2 presents the occurrence, concentration range and
mean concentration of each mycotoxin in positive cereal samples that is, considering only mycotoxins
with a concentration above the LOQ.
Moreover, 78 out of 120 samples (65%) evidenced at least one mycotoxin above the LOQ, and
13 out of 15 mycotoxins included in the study were found in some of the analysed samples, being the
exceptions OTA and STE (not detected). Overall, T-2, CIT, BEA and DON were the most commonly
found mycotoxins with a global incidence of 50%, 40.8%, 38.3% and 33.3%, respectively. However, the
maximum concentration value was found for FB1 in maize (42,143 μg/kg).
The results obtained for each mycotoxin (or group of mycotoxins) are commented below.
2.2.1. Occurrence of Trichothecenes
Regarding the distribution of the studied trichothecenes (HT-2, T-2, DON and F-X), T-2 was the most
frequently found, being present in 100% samples of maize and wheat at concentrations ranging from 16.6
to 47.2 μg/kg, being the mean concentrations (considering only positive samples) 24.9 μg/kg in maize and
21.8 μg/kg in wheat. HT-2 was present only in 7 wheat samples (23%) at concentrations from 8.4 to 36.7
μg/kg (mean value 18.1 μg/kg). None of the samples exceeded the maximum recommended concentration
for these toxins in non-processed cereals (ranging from 100–1000 μg/kg for the sum of T-2 +HT-2) [17].
DON was found in 27 wheat samples (90%) and 13 maize samples (43.3%), with mean concentrations
of positives samples of 588 μg/kg and 632 μg/kg, respectively. The highest concentration found for DON
was 2055 μg/kg, corresponding to one maize sample that exceeded the maximum permitted concentration
for DON established by the EU in maize (1750 μg/kg) [18]. As an example, a chromatogram of a wheat
sample contaminated with DON is shown in supplementary material (Figure S2A).
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F-X was determined in 3 samples of barley (10%), 24 of maize (80%) and 3 of wheat (10%).
The maximum content of F-X was found in a maize sample (477 μg/kg).
In addition, the incidence of T-2 toxin in positive samples was higher than the incidence of DON
in the same samples. Similar to our finding, Bouafifssa et al. [38] reported higher levels of T-2 and HT-2
compared to DON in Moroccan pasta, with contamination levels from 4 to 419 μg/kg and 4 to 50 μg/kg
for T-2 and HT-2, respectively. The higher incidence of DON in maize and wheat compared to other
cereals was also reported by Pleadin et al. [39] in 181 cereal samples from Croatia, where DON was
found in 71%, 65%, 53% and 21% samples of maize, wheat, barley and oat, with mean concentrations
of 1565, 223, 342 and 145 μg/kg, respectively. However, lower incidence and concentrations of DON,
HT-2, T-2 and F-X were found in cereal samples from Italy, where mean levels in positive samples were
20.1, 4.8, 0.3 and 36.7 μg/kg, for DON, HT-2, T-2 and F-X respectively [40].
2.2.2. Occurrence of Zearalenone
ZEN was found in 7 samples of maize (23.3%), 6 of rice (20%) and 19 of wheat (63.3%), being
the mean concentrations of positive samples 109 μg/kg in maize, 9.9 μg/kg in rice and 102 μg/kg in
wheat. One sample of maize (579 μg/kg) and 7 samples of wheat (with concentrations up to 295 μg/kg)
exceeded the maximum permitted levels established in the EU for ZEN (350 μg/kg for maize and
100 μg/kg for other unprocessed cereals) [18].
The incidence of ZEN in our study was similar to those reported in other studies [41,42], but the
contamination levels were lower than other values from literature. For instance, ZEN was found at
concentrations up to 1399 μg/kg in cereals from Nigeria [43] and up to 15,700 μg/kg in maize samples
from Belgium, where mean level of ZEN in the analysed samples was 2180 μg/kg [44]. However, other
studies reported lower ZEN concentrations with an average of 12 and 14 μg/kg in Italian and Moroccan
cereals, respectively [40,45].
2.2.3. Occurrence of Fumonisins
FB1 and FB2 were found only in maize samples, with high concentrations and incidence rate.
Thus, FB1 was present in 29 samples (96.6%) at concentrations from 289 up to 42,143 μg/kg, whereas FB2
was quantified in 27 samples (90%) at concentrations from 27.5 to 8603 μg/kg. The mean concentrations
for positives samples were 14,812 and 2789 μg/kg for FB1 and FB2, respectively. Considering the sum
of fumonisins (FB1 + FB2), it was in the range of 289–48,878 μg/kg. A total of 21 samples (70%) showed
concentrations of (FB1 + FB2) above the maximum allowed level established by the EU (4000 μg/kg for
unprocessed maize) [18] suggesting the high exposure of the population to these toxins.
According to the analyses, fumonisins were not detected in barley, rice and wheat samples. Such a
trend was also observed by Ghali et al. in cereals from Tunisia, reporting the highest levels for fumonisins
in maize samples at an incidence rate of 52% [46]. This confirms that the risk of fumonisin contamination
of wheat, barley and rice is rather low due to the known tendency of the Fusarium spp. producing
fumonisins (F. verticillioides and F. proliferatum) to infect maize [47]. This result is in agreement with other
previous studies: thus, a high fumonisin incidence was reported in Nigerian maize-based products with
concentrations ranging from 74 to 22064 μg/kg [43], in maize from South Africa, reporting concentrations
up to 53863 μg/kg for FB1 [48], and from Ethiopia, where 77% samples of maize contaminated with
fumonisins at concentrations between 25–4500 μg/kg, were attributed to F. verticillioides [49].
2.2.4. Occurrence of Citrinin
Remarkably, 40.8% of the total analysed samples were contaminated by CIT; it was present in
9 (30%), 25 (83.3%) and 15 (50%) samples of barley, maize and wheat, respectively, showing mean levels
of 26.2 μg/kg in barley, 32.7 μg/kg in maize and 16.8 μg/kg in wheat samples. The highest concentration
of CIT was found in a maize sample (273 μg/kg). CIT was not detected in rice samples.
These results may be explained by the susceptibility of the analysed cereals (barley, maize and
wheat) to CIT-producing fungi (Aspergillus and Penicillium spp.) and to the influence of climatic
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conditions such as substrate composition, temperature and water activity (aw) to enhance CIT
production, especially during storage, as it is well-known that mycotoxin production is modulated by
environmental factors [50].
2.2.5. Occurrence of Emerging Mycotoxins
Only maize and wheat samples were contaminated with BEA and ENNs, while these emerging
mycotoxins were not detected in rice and barley. ENNB1 was the most frequent ENN (2 samples (6.6%)
of maize and in 21 samples (70%) of wheat) with concentrations from 15.0–107 μg/kg and 19.5–4569
μg/kg for maize and wheat, respectively. ENNA1 was quantified in 3 samples (10%) of maize and 14
samples (46.7) of wheat, with mean concentrations for positive samples of 56.4 μg/kg and 107 μg/kg,
respectively. ENNA and ENNB were found in 7 (23.3%) and 18 samples (60%) of wheat, respectively.
The contamination levels varied between 8.4 and 87.6 μg/kg for ENNA and from 1.2 to 5288 μg/kg for
ENNB, with mean values for positive samples of 28.3 and 1668 μg/kg, respectively. ENNA and ENNB
were not detected in maize. A chromatogram of a wheat sample contaminated with ENNB1 is shown
in supplementary material (Figure S2B).
Concerning BEA, 25 samples (83.3%) of maize and 21 samples (70%) of wheat were positives, with
concentrations between 0.85–31.4 μg/kg and 2.8–486 μg/kg in maize and wheat samples, respectively.
Other previous works including determination of ENNs and BEA in cereals also showed the
high incidence of these mycotoxins. Thus, a high incidence of BEA (80%) was recently reported in
Serbian maize with levels ranging from 8 to 129 μg/kg [7]. Moreover, a study on the occurrence of
emerging mycotoxins in Spanish cereals showed high incidence of ENNs (73.4%), wherein ENNA1
was the most frequent emerging mycotoxins, with the highest concentrations (33.3–814 mg/kg) [51].
Furthermore, the high contamination of BEA and ENNs was also reported in cereals from Italy [40] and
up to 800 mg/kg of ENNB1 were found in a wheat-based cereal sample from Morocco [8]. In contrast
with our results, Oueslati et al. [52] did not detect BEA in maize and wheat from Tunisia.
2.2.6. Co-Occurrence of Mycotoxins in Analysed Samples
The co-occurrence of mycotoxins as well as the main combinations found in the analysed cereal
samples were evaluated (see supplementary material Table S3). Among the positive samples, 50%
(all maize (n = 30) and wheat (n = 30) samples) were found to be contaminated with more than one
mycotoxin. The most frequent co-occurrence was the combination of 5 mycotoxins for maize and
8 mycotoxins for wheat. Moreover, different combinations were observed, depending on the cereal, the
most frequent combinations being: (FB1 + FB2 + T-2 + F-X + CIT + BEA) and (FB1 + FB2 + T-2 + F-X +
BEA) in maize, and (DON + T-2 + ZEN + ENNA1 + ENNB + ENNB1) in wheat samples. The highest
number of mycotoxins occurring simultaneously was nine in 2 maize samples (DON + FB1 + FB2 +
T-2 + ZEN + F-X + CIT + BEA + ENNA1) and 1 wheat sample (DON + HT-2 + T-2 + ZEN + CIT +
BEA + ENNA1 + ENNB + ENNB1).
The co-occurrence of mycotoxins in cereals has been studied previously, especially in the
Mediterranean area [38,40,52]. In agreement with our results, in wheat grains from Morocco, 51%
samples were contaminated with 2–6 mycotoxins [53], whereas that at least one mycotoxin was present
in the 65% cereal-derived samples from Spain [54]. Recently, a study performed in Italy showed
that 81% cereal samples were contaminated with more than one mycotoxin and the most frequent
co-occurrence was with DON, F-X, ENNB and ENNA1 [40]. A summary of the results obtained in this
study and other previously reported occurrence studies are presented in Table 3.
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These results demonstrated that it is not unusual to find cereals contaminated with several
mycotoxins, and evidenced the human exposure to multiple mycotoxins [9,11–13]. Therefore, these
findings point out the necessity of more toxicity studies that consider co-exposure to multiple
mycotoxins, to detect possible synergism and additive effects and its consequent potential impact for
public health.
2.3. Exposure Estimates
The dietary exposure to the studied mycotoxins was evaluated by calculating the probable daily
intake (PDI), which combines mycotoxins analysis data obtained from the analysed samples with the
food consumption of the adult population with a body weight of 60 kg [55].
The PDI (μg/kg per body weight (bw)/day) of each mycotoxin was calculated using the following
equation [55]:
PDI = (Cm × K)/bw (1)
where Cm is the mean content of a mycotoxin in the cereal (μg/kg); K is the average consumption of
the commodity (g/day) and bw is the body weight used for adult population.
Once the PDI had been calculated, the health risk characterization of each mycotoxin (% of relevant
TDI) was estimated as the ratio of PDI to TDI (μg/kg bw/day) for each mycotoxin as follows:
%TDI = (PDI/TDI) × 100 (2)
The PMTDI or TDI and the provisional tolerable weekly intake (PTWI) set by both the FAO/WHO
JECFA and the Scientific Committee on Food (SCF), were used as reference doses [19,20]. Data on
consumption of barley (36 g/day), maize (44 g/day), rice (8 g/day) and wheat (502 g/day) by Algerian
population were mainly obtained from FAO statistical study [56]. The results obtained are summarised
in Table 4.






















FB1 0 10.86 0 0
FB2 0 2.05 0 0
SumFBs 2 0 0 12.91 645.4 0 0 0 0
HT-2 0 0 0 0.15
T-2 0 0.02 0 0.18
SumHT2-T2 0.1 0 0 0.02 18.26 0 0 0.33 333.8
DON 1 0 0 0.46 46.35 0 0 4.92 491.9
ZEN 0.25 0 0 0.08 31.97 1.3·10−3 0.53 0.85 341.4
F-X 0.11 0.21 0 1.27
CIT 0.02 0.02 0 0.14
BEA 0 2.8·10−3 0 1.30
ENNA 0 0 0 0.24
ENNA1 0 0.04 0 0.90
ENNB 0 0 0 13.96
ENNB1 0 0.04 0 3.92
From the PDI values, it can be concluded that maize and wheat samples represent an important
dietary exposure of mycotoxins for the Algerian population, with a dietary exposure range of 2.8 ×
10−3–12.91 (μg/kg bw/day) and 0.14–13.96 (μg/kg bw/day) in maize and wheat, respectively. In these
samples, the obtained values for FB1 (10.86 μg/kg bw/day) in maize and ENNB (13.96 μg/kg bw/day)
in wheat were the highest contribution for the PDI of mycotoxins for the Algerian population.
The exposure assessment was evaluated for all the mycotoxins with TDI available, namely DON,
FB1+ FB2, ZEN, T-2 + HT-2 (see Table 4). The results showed that Algerian consumers present at a
high risk of exposure to the sum of fumonisins (FB1 + FB2) through maize consumption (%TDI of
645.4), and to DON, ZEN and the sum of (HT-2 + T-2) through wheat consumption with %TDI of 491.9,
341.4 and 333.8, respectively. These values are several-hundred fold higher than the values established
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by JECFA for FB1 + FB2 (PMTDI of 2 μg/kg bw/day), DON (PMTDI of 1 μg/kg bw/day), ZEN (TDI of
0.25 μg/kg bw/day) and for the sum of HT-2 and T-2 toxins (TDI of 0.1 μg/kg bw/day).
These findings suggest that the intake of mycotoxins from analysed maize and wheat samples
represent a high health risk for the average adult consumers in Algeria and pointed towards the
necessity for a consistent control over these contaminants.
These results are globally in line with other studies from African countries; for instance, a study
performed in Tanzania reported that fumonisin exposures to adult individuals in 38% of the households
exceeded the provisional maximum tolerable daily intake (PMTDI) of 2 μg/kg bw based on the
fumonisins (FB1 + FB2) concentration of up to 11 mg/kg in the maize grains [57]. Similar results were
found for fumonisins (FB1 + FB2 + FB3) dietary exposure of 12.4 μg/kg bw/day in Nigerian infants
and 8.2 μg/kg bw/day in children by maize intake with %TDI of 622.2 and 414.8, which were 311 and
207 times higher than the tolerable daily intake of 2 μg/kg bw/day [58].
Moreover, high attention should be devoted to the health risk scenarios for consumers in the case
of co-exposures to multiple mycotoxins. However, the effect of co-occurrence of mycotoxins have
not been well understood yet. These effects could be additive, synergistic and can vary with dose,
exposure time, and toxicological end point [9].
3. Conclusions
In this study, a LC-MS/MS analytical method for determination of 15 mycotoxins in cereals has
been applied to provide data on the occurrence of these hazards in barley, maize, rice and wheat
from Algeria. Moreover, the risk associated with the exposure to mycotoxins through intake of cereal
products has been estimated.
Results on mycotoxins occurrence showed that 65% of the samples were contaminated with at
least one mycotoxin. The maximum acceptable levels established in EU where exceeded in 21 samples
(70%) for fumonisins (4000 μg/kg of FB1 + FB2 in maize), 8 samples for ZEN (100 μg/kg for maize
and 350 for other unprocessed cereals) and 1 sample for DON (1750 μg/kg for wheat and maize) [18].
Co-contamination was observed in 50% of the analysed samples (all maize and wheat samples).
Among them, some samples were contaminated with up to 9 mycotoxins. Due to these high levels
of contamination, this study concluded that the Algerians are at high risk of exposure to the sum
of fumonisins (FB1 + FB2) through the consumption of maize, and to DON, ZEN and the sum of
(HT-2 +T-2) through the consumption of wheat. Therefore, preventive approaches to curtail health
risks associated with mycotoxins exposures are needed, which requires, at first instance, government
intervention. The analytical results of this survey should encourage Algerian authorities to introduce
allowed maximum limits of mycotoxins in cereals. In our opinion, continuous monitoring of these
mycotoxins with a higher number of samples and other susceptible foodstuffs (such as cereal-based
products, nuts or dried fruits) are recommended to assess the situation, at least for such a time until
proper regulatory limits are set. On the other hand, the focus should also be directed towards reduction
and control of mycotoxins producing fungi in the food chain.
4. Materials and Methods
4.1. Reagents and Materials
Methanol (MeOH) and acetonitrile (MeCN) of LC-MS grade, and ammonium formate were
supplied by VWR International Eurolab S.L. (Barcelona, Spain). Formic acid eluent additive for LC–MS
was obtained from Sigma Aldrich (St. Louis, MO, USA). Magnesium sulphate (MgSO4), sodium
chloride (NaCl) and sodium citrate were purchased from Panreac Química (Barcelona, Spain), while
disodium hydrogen citrate sesquihydrate was supplied by Merck (Darmstadt, Germany). Ultrapure
water was obtained from a Milli-Q Plus system (Millipore Bedford, MA, USA).
Mycotoxin standard solutions (10 mg/L in MeCN) of OTA, STE, F-X, DON, CIT, ZEN, FB1, FB2,
T-2 and HT-2 were purchased from Techno Spec (Barcelona, Spain). Individual standards (powder)
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of ENNA, ENNA1, ENNB, ENNB1 and BEA were obtained from Sigma Aldrich and stock solutions
were prepared at 1000 mg/L in MeCN. Multi-mycotoxins intermediate working solutions in MeCN
(1 mg/L of OTA and STE; 2 mg/L of CIT; 10 mg/L of FB1, FB2, T-2, HT-2 and ZEN; 100 mg/L of DON,
ENNA, ENNA1, ENNB, ENNB1 and BEA and 1000 mg/L of F-X) were prepared by combining suitable
aliquots of each individual standard stock solution. These solutions were stored at −20 ◦C.
Nylon syringe filters (13 mm, 0.22 μm, from VWR) were used for filtration of extracts prior to the
injection into the chromatographic system.
4.2. Instruments and Equipment
UHPLC-MS/MS analyses were performed in an Agilent 1290 Infinity LC (Agilent Technologies,
Waldbronn, Germany) coupled to an API 3200 triple quadrupole mass spectrometer (AB Sciex,
Darmstadt, Germany) with electrospray ionization (ESI). The chromatographic separation was
performed using an Agilent Zorbax Eclipse Plus RRHD C18 column (50 × 2.1 mm, 1.8 μm). Analyst
software (Version 1.6.3, AB Sciex, Darmstadt, Germany) was used for acquisition and data analysis.
During the sample treatment, an evaporator System (System EVA-EC, from VLM GmbH, Bielefeld,
Germany), a vortex-2 Genie (Scientific Industries, Bohemia, NY, USA), a universal 320R centrifuge
(Hettich ZENtrifugen, Tuttlingen, Germany), and a kitchen blender were used.
4.3. Samples
A total of 120 cereal samples (barley, maize, rice and wheat) destined for human consumption were
randomly purchased from different local markets in three areas of the western region of Algeria—Aint
Temouchent, Oran and Tiaret—during the year 2018 (see Table 5). In order to obtain representative
samples, several sub-samples were taken from each batch, being thoroughly mixed to achieve a final
1-kg sample. Finally, the samples were grinded, homogenized and stored in a dark and dry place
until analysis.
Table 5. Sampling information.
Sample Type Selected Areas No. of Markets No. of Samples Origin
Barley
Aint Temouchent 5 10




Aint Temouchent 7 10




Aint Temouchent 10 10




Aint Temouchent 6 10
Oran 9 10 NG
Tiaret 8 10
Total = 30
OAIC: Office Algérien interprofessionnel des céréales, NG: not given.
4.4. Mycotoxins Extraction Procedure
A previous method was used for the extraction of mycotoxins in the different samples [59]. Briefly,
2 g of grounded sample were weighed in a polypropylene centrifuge tube (50 mL), 8 mL of water was
added, and the mixture was vortexed for 10 s. Subsequently, 10 mL of 5% formic acid in MeCN was
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added to the tube, shaking by vortex for 2 min. Then, 4 g of MgSO4, 1 g of NaCl, 1 g of sodium citrate
and 0.5 g of disodium hydrogen citrate sesquihydrate were added and the tube was shaken vigorously
for 1 min. After centrifugation at 4500 rpm (3722× g) for 5 min, 2 mL of the upper supernatant layer was
transferred to a 4-mL vial, evaporated to dryness under a gentle stream of nitrogen, and reconstituted
to a final volume of 1 mL with a mixture of MeOH:water (50:50, v/v). The samples were filtered before
injection and the 15 mycotoxins were determined by UHPLC-MS/MS. A graphical scheme of the
procedure is shown in Figure 1.
Figure 1. Graphical scheme of the extraction procedure.
4.5. Ultra-High Performance Liquid Chromatography Coupled to Tandem Mass Spectrometry
(UHPLC-MS/MS) Analysis
Chromatographic analyses were performed using a gradient elution with water (phase A), and
MeOH (phase B), both containing 0.3% formic acid and 5 mM ammonium formate, at a flow rate of
0.4 mL/min. The gradient elution program was as follows: 0–1 min, 5% B; 4 min, 50% B; 5 min, 80% B;
5.5 min, 90% B; 5.7 min, 5% B; 5.7–8 min, 5% B. The temperature of the column was kept at 35 ◦C and
the injection volume was 5 μL.
The electrospray ionization was carried out in in the positive mode and the acquisition was
performed under multiple reaction monitoring (MRM) conditions. The ionization source parameters
were set as follows: source temperature: 500 ◦C; curtain gas (nitrogen): 30 psi; ion spray voltage: 5000 V;
and GAS 1 and GAS 2 (both of them nitrogen): 50 psi. The applied cone voltages and collision energies
for each mycotoxin are summarized in the supplementary material (Table S4). In all cases, the most
abundant product ion was used for quantification, while the second one was used for confirmation.
Supplementary Materials: The following are available online at http://www.mdpi.com/2072-6651/12/3/194/s1,
Figure S1: Matrix effect (%) for each studied mycotoxin extracted from barley, maize, rice and wheat samples
(concentration levels: OTA and STE: 25 μg/kg; CIT: 100 μg/kg; FB1, FB2, T-2, HT-2 and ZEN: 250 μg/kg; ENNB,
ENNB1, ENA, ENA1 and BEA: 400 μg/kg, DON: 1000 μg/kg and FUS-X: 2500 μg/kg); Figure S2: UHPLC-MS/MS
MRM chromatogram of two samples of positive wheat contaminated with (A) DON (1362 μg/kg) and (B) ENNB1
(419 μg/kg); Table S1: Performance characteristics of the UHPLC-MS/MS method for each mycotoxin in barley,
maize, rice and wheat samples; Table S2: Recovery (%R), intra-day precision (%RSDr) and inter-day precision
(%RSDR) for barley, maize, rice and wheat samples (n = 9); Table S3: Co-occurrence of analysed mycotoxins in
wheat and maize samples; Table S4: Monitored ions of the target analytes and MS/MS parameters.
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Abstract: A survey including 228 pig feed samples from Spain has been developed, exploring the
occurrence of 19 mycotoxins (aflatoxins B1, B2, G1 and G2, ochratoxin A, fumonisins B1 and B2,
citrinin, zearalenone, deoxynivalenol, fusarenon X, sterigmatocystin, T-2 toxin, HT-2 toxin, enniatins
A, A1, B and B2, and beauvericin). The samples were analysed by solid-liquid extraction followed by
liquid chromatography coupled with fluorescence or mass spectrometry detection. Enniatin B was
found in 100% of the samples (up to 1200 μg/kg) and beauvericin in more than 90%. Moreover, 40% of
samples were contaminated with more than five mycotoxins. This high occurrence is insurmountable
and surpasses all previous studies, probably due to the inclusion of emerging mycotoxins, scarcely
explored. The majority of the samples (96.9%) were in accordance with EU regulations, which do not
address emerging mycotoxins or co-occurrence. These results show that in order to ensure mycotoxin
absence, emerging mycotoxins should always be considered.
Keywords: feed; pig; mycotoxins; liquid chromatography; fluorescence detection; mass spectrometry;
solid-liquid extraction; co-occurrence
Key Contribution: A total of 19 mycotoxins have been determined in 228 pig feed samples from
Spain by solid-liquid extraction followed by HPLC-FLD (aflatoxins) and LC-MS/MS. The results show
the great incidence of emerging mycotoxins as well as the co-occurrence of up to five mycotoxins in a
significant number of samples.
1. Introduction
The European Union (EU) ensures the safety of foods by setting maximum levels of different
contaminants including mycotoxins, which are toxic secondary metabolites produced by certain fungi
(as Aspergillus, Fusarium or Penicillium) that can contaminate food during harvesting, processing
or storage. Among them, there are well-known hazards such as aflatoxins (AFs), considered as
carcinogenic to humans by the International Agency for Research on Cancer [1] or ochratoxin A (OTA)
and fumonisin B1, considered as possibly carcinogenic to humans [2,3]. Currently, several mycotoxins
are included in the EU legislation and maximum contents have been established in different raw
materials and food commodities. However, despite the effort to control these food contaminants, every
year mycotoxins are found among the “top ten” hazards reported annually by the Rapid Alert System
Toxins 2019, 11, 342; doi:10.3390/toxins11060342 www.mdpi.com/journal/toxins155
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for Food and Feed (RASFF), aflatoxins being the most frequently reported [4]. Moreover, there are still
some mycotoxins without maximum content allowed in regulation, but with some evidence of adverse
effects on human health. These are the so-called “emerging mycotoxins”, including some Fusarium
toxins such as enniatins (ENNs) and beauvericin (BEA).
In addition to food, it is also important to control contamination in feeds, as they are the first link
in the food-chain, having influence not only on the health of animals but also on humans consuming
animal-derived products. To deal with feed safety, the EU has established regulatory levels for aflatoxin
B1 (AFB1) and guidelines for deoxynivalenol (DON), zearalenone (ZEA), OTA, fumonisin B1 and
B2 (FB1 and FB2), and T-2 and HT-2 toxins in different raw materials and feed, including pig diets
(Table 1) [5–7]. Moreover, the European Food Safety Authority (EFSA) has published different scientific
opinions about the risks to animal health related to the presence of different mycotoxins [8]. One of
these opinions about the risks to human and animal health, related to the presence of BEA and ENNs in
food and feed, concluded that in the absence of toxicological data for most livestock animals, research
studies on their adverse effects are required [9].
Table 1. Maximum content (AFB1) or recommended levels for mycotoxins in feed (only those concerning
swine) [5–7].
Mycotoxin Product Intended for Pig Feed Maximum/Guidance Value (μg kg−1)
AFB1
Feed materials 20
Complementary and complete feed 10
Compound feed for pigs (except piglets) 20
Compound feed for piglets 5
DON
Maize by-products 12,000
Cereals and cereal products with the exception of maize
by-products 8000
Maize by-products 12,000
Complementary and complete feedingstuffs for pigs 900
ZEA
Cereals and cereal products with the exception of maize
by-products 2000
Maize by-products 3000
Complementary and complete feedingstuffs for piglets
and gilts (young sows) 100
Complementary and complete feedingstuffs for sows
and fattening pigs 250
OTA
Cereals and cereal products 250
Complementary and complete feedingstuffs for pigs 50
FB1+FB2
Maize and maize products 60,000
Complementary and complete feedingstuffs for pigs 5000
T-2+HT-2
Oat milling products (husks) 2000
Other cereal products 500
Compound feed 250
Given their relatively high susceptibility to Fusarium toxins and the high content of cereals in their
diet, pigs should be given the highest priority. Thus, several studies have shown the toxic effect of
mycotoxins on pig health, including a modulation of the immune response, resulting in an increase
in susceptibility and severity of infectious diseases, and a reduction in vaccine efficacy, whilst also
having an indirect effect on animal productivity [10]. Especially abundant are the number of studies
about the pathological effects of Fusarium toxins on pig reproduction [11]; these include abortion,
embryonic and foetal death, increased number of oestrus repetitions, failure of induction programs
with PGF2α and increased number of stillbirths and splaylegged piglets. What is more, ZEA can
produce hyperestrogenism [12] and tail necrosis in suckling piglets [13]. The effects of DON on gut
function [14,15], and DON and ZEA on colon microbiota, have also been reported [16]. Moreover,
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diets co-contaminated with AFs and FBs negatively affected the growth of piglets, despite the absence
of pathology and despite the absence of clinical signs [17].
Different studies and reviews have reported the occurrence of mycotoxins in raw materials and feed,
showing that multi contamination is very frequent and seems to be normal and not exceptional [18–27].
However, most of these studies are focused on regulated mycotoxins and only a few studies included
emerging mycotoxins [28–30]. Nevertheless, EFSA has concluded that further data on the co-occurrence
of different mycotoxins, including BEA and ENNs with other toxins in feed, and the probable combined
effects are needed [9].
The aim of this work was to evaluate the occurrence of nineteen different mycotoxins, including
Fusarium emerging mycotoxins, in pig feed from Spain. With this purpose, 228 samples were collected
during 2017 from different farms and analysed using high performance liquid chromatography with
post-column photochemical derivatisation and fluorescence detection (HPLC-FLD) for quantification
of AFs and ultra-high performance liquid chromatography with tandem mass spectrometry
(UHPLC-MS/MS) for the rest, while solid-liquid extraction was used as sample treatment.
2. Results and Discussion
Ocurrence of Mycotoxins in Pig Feed Samples
Among the 19 mycotoxins under study, the most commonly found (considering samples with
concentrations above the LOQs) were: ENNB (100% samples), BEA (93.4%), ENNB1 (53.5%), FB1 (50.0%)
and ENNA1 (40.8%). Besides that, none of the samples presented concentrations above the LOD
for AFG2 and OTA. Figure 1 summarises the results. This high mycotoxin occurrence surpasses
all previous studies of occurrence; i.e., Streit et al. [18] found 72% positive samples for at least one
mycotoxin when analysing 17,316 samples of feed and feed raw materials from all over the world
to study contamination with AFs, OTA, ZEA, DON and fumonisins. However, other regional and
national studies of occurrence have found higher occurrences for some mycotoxins above the LOD;
i.e., Li et al. [31] detected DON and ZEA at percentages of 97 and 100% in samples of complete feeds
randomly collected from 15 pig farms in the Beijing region (China), and Ma et al. [24] found AFB1, ZEA
and DON at percentages from 96.4 to 100% also in samples of complete feeds from different provinces
of China. The maximum incidence reached in the present study is probably due to the high number of
mycotoxins analysed, including emerging mycotoxins, scarcely explored in other studies. This fact
shows that for both a correct diagnosis and in order to ensure its absence, it is not enough to analyse
only the most common mycotoxins.
Figure 1. Percentage of positive samples of each mycotoxin.
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Concerning the concentrations found, the contents of the two mycotoxins with higher incidence
ranged from 2.0 to 1222 μg kg−1 for ENNB, and from 1.7 to 747 μg kg−1 for BEA in positive samples
(100% and 93.4% respectively). However, the mycotoxin detected at the highest level was FB1 with a
concentration of 3959 μg kg−1. A summary of all the results obtained is shown in Table 2. As can be
seen from the high values of the %RSD, a great difference in the content of the different mycotoxins
was observed among the samples.
The EU has established recommended guidance values on raw materials, complementary and
complete feeding stuff with differences associated to age of animal and phase of production. Focusing
the attention on those mycotoxins with maximum permitted or recommended levels, it can be concluded
that all the samples fulfil the requirements about maximum content of AFB1, as well as the guidelines
for OTA, FB1+FB2, T-2+HT-2 toxins, and DON. However, several samples (3.1%) showed contents of
ZEA above the recommended levels: one sample of maize (7681 μg kg−1); five samples of compound
feed for piglets (ranging from 125 to 956 μg kg−1), and one for fattening pigs (290 μg kg−1). In a
recent study, it has been proven that growing pigs (six-week-old and 19 kg BW at the beginning) fed
ad libitum with feed containing 80 μg kg−1 ZEA for four weeks reduced body weight gain, daily
feed intake, feed conversion rate, and the serum levels of immunoglobulin IgG and IgM, and total
antioxidants, showing microscopic lesions in kidneys [32]. This study shows the need to reduce the
levels of tolerance for ZEA in feeds for pigs.
These results are in accordance with other survey studies carried out in Europe, where Fusarium
toxins, such as DON, ZEA, and FBs, were the most frequently found mycotoxins in feed [23].
Another aspect of concern was the high co-occurrence of mycotoxins. Thus, 69% of analysed
samples contained between 3 and 5 mycotoxins (Figure 2), the most common combinations being those
involving co-occurrence of different emerging mycotoxins: ENNB + BEA (12.7%); ENNB + ENNB1 +
BEA (8.3%) and ENNA1 + ENNB + ENNB1 + BEA (10.5%). Moreover, the co-occurrence of more than
one regulated mycotoxin (AFs, OTA, FBs, DON, ZEA, and T-2 + HT-2) was detected in 19 samples
(8.3% of all samples). The natural co-occurrence of mycotoxins in feeds is already known and several
surveys have reported this everywhere [21]; this can be explained by these diets being usually made
up of multiple cereal and other grain sources; and mycotoxin frequency and levels in feed depend on
these raw materials and, especially, on their geographic origin [21,24,31]; i.e., a study of 17,316 samples
of feed and feed raw materials from all over the world showed 38% samples co-contaminated [18].
Although several reviews of existing data and of the literature on worldwide mycotoxin contamination
of food and feed are available, the impact of the different raw materials used on feed formulation
has not been widely studied. Concerning cereals and derived cereal product samples, 127 mycotoxin
combinations were described by Smith et al., showing that 70%, 24% and 6% of the studies concerning
the effect of co-occurrence of mycotoxins were binary, ternary and quaternary or quinary mixtures,
respectively [33]. However, this level of study is not proportional to the co-occurrence found in the
present study with 13.16%, 22.37% and 46.49% for binary, ternary and quaternary or quinary mixtures,
respectively. Nevertheless, the current regulations do not consider the mycotoxin combination effects
and the maximum allowed or recommended levels are fixed for a single mycotoxin. These results
should be a matter of concern, as additive or synergistic effect (still not well-known) can increase the
toxicity of mycotoxins. Hence, guidelines should not only be individually set for each mycotoxin but
also for especially concerning combinations, particularly for those including emerging mycotoxins such
as moniliformin, BEA or ENNs [22]. This fact has also been pointed out in a recent review compiling
in vitro experimental data on mycotoxins combined toxicity [33]. Besides, more stringent mycotoxin
limits of tolerance should be established, especially when there is a risk of chronic ingestion of regular
contaminants of pig feed [32].
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Figure 2. Frequency and co-occurrence of different mycotoxins in feed samples.
In order to elucidate which factors were the most relevant, one-way ANOVA studies were carried out
for total content of mycotoxins as well as for each mycotoxin individually, considering different factors.
• PRESENTATION. ANOVA showed that no significant differences for total mycotoxin content
(flour: 467 ± 549 μg kg−1; pellet: 404 ± 360 μg kg−1; p-value: 0.4741) existed between both
presentations, however higher concentration of sterigmatocystin (STE) was found in pellet (flour:
0.193 ± 1.50 μg kg−1; pellet: 11.3 ± 53.1; p-value: 0.0053).
• SAMPLING POINT. This factor was significant for total mycotoxin content (silo: 436 ± 607 μg kg−1,
feeder: 244 ± 160 μg kg−1, sack: 677 ± 554 μg kg−1, bulk: 3091 ± 4075 μg kg−1, p-value: 0.0000).
In addition, significant differences were obtained for citrinin (CIT) (silo: 11 ± 31 μg kg−1, hopper:
22 ± 50 μg kg−1, sack: 70 ± 135 μg kg−1, bulk: 0 ± 0 μg kg−1, p-value: 0.0022), DON (silo:
14 ± 56 μg kg−1, hopper: 0 ± 0 μg kg−1, sack: 0 ± 0 μg kg−1, bulk: 93 ± 207 μg kg−1, p-value:
0.0074), FB1 (silo: 150 ± 353 μg kg−1, hopper: 12 ± 38 μg kg−1, sack: 323 ± 399 μg kg−1, bulk:
1278 ± 1462 μg kg−1, p-value: 0.0000), FB2 (silo: 0 ± 0 μg kg−1, hopper: 45 ± 123 μg kg−1, sack:
71 ± 105 μg kg−1, bulk: 339 ± 362 μg kg−1, p-value: 0.0000) and ZEA (silo: 41 ± 137 μg kg−1,
hopper: 0 ± 0 μg kg−1, sack: 32 ± 132 μg kg−1, bulk: 1297 ± 2855 μg kg−1, p-value: 0.0001).
In all the cases, higher concentrations were obtained for samples from bulk storage without
container in warehouse except for CIT, where the highest concentrations were found in sack.
The higher mycotoxin content could be explained because bulk storage without container is less
hygienic and the feed is in contact with the warehouse floor. Sampling is usually the principal
source of variation in toxin analysis, originating close to 90% of the error in some analyses [34].
Traceability is important and sampling of feed should cover from factory to feeder, including silos
and warehouses.
• TYPE OF ANIMAL. These feeds have different proportions of raw materials to provide different
nutrient levels; however, cereal grains are always the main component. ANOVA results in no
significant differences among the feeds for the total mycotoxin content and for any isolated
mycotoxin; the high proportion of cereals in all these feeds could explain the lack of differences.
However, less contamination could be expected in piglet feed than in older pig feed, which could
be explained by the lower level of maize used for piglets diet, maize being the main contributor to
mycotoxin contamination [21].
3. Conclusions
A survey of nineteen mycotoxins (including emerging mycotoxins) in pig feed samples collected
during 2017 from different farms and suppliers from Spain has been carried out. The methods
of analysis were fully validated, using HPLC-FLD for AFs and UHPLC-MS/MS for the remaining
160
Toxins 2019, 11, 342
mycotoxins as analytical techniques, while solid-liquid extraction was used as sample treatment.
All the samples fulfilled the requirement about the maximum or recommended content of AFB1,
OTA, FB1+FB2, T-2+HT-2 and DON. However, several samples showed contents of ZEA above the
recommended levels.
This survey on mycotoxin occurrence in pig feed contains one of the most complete analyses,
quantifying 19 different mycotoxins, including five emerging ones. Although compliance with EU
regulations has been generally high, the study showed the high occurrence of emerging mycotoxins
(100% contaminated samples), as well as the high co-occurrence of different mycotoxins in the
same sample.
Livestock species respond differently to mycotoxin poisoning, so that clinical signs can be difficult
to detect and a correct analysis of the food is the most appropriate way to diagnose and detect it.
Moreover, the synergistic interaction of co-occurring mycotoxins is well-known, hence regulations
for maximum levels should be set including some particular combinations, focusing on emerging
mycotoxins such as ENNs. These results highlight the necessity for a reinforcement of quality control
of feeds with continuous monitoring from feed mill to pig feeder.
4. Materials and Methods
4.1. Chemicals and Reagents
All reagents were of analytical reagent grade and solvents were HPLC grade. Acetonitrile (MeCN),
methanol (MeOH) and ammonium formate were obtained from VWR BDH Prolabo (West Chester,
PA, USA). Formic acid was supplied by Merck (Darmstadt, Germany). Sodium chloride, magnesium
sulfate, sodium citrate, disodium hydrogen citrate sesquihydrate and sodium phosphate dihydrogen
monohydrate were purchased from Panreac Química (Barcelona, Spain).
Ultrapure water used throughout the work was obtained from a Milli-Q water purification system
(18.2 MΩ cm-1, Milli-Q Plus system, Millipore, Bedford, MA, USA).
AFs (AFB1, AFB2, AFG1, AFG2) were purchased from Sigma-Aldrich (St. Louis, MO, USA); OTA,
DON, ZEA, CIT, T-2, HT-2, fusarenon-X (F-X), STE, FB1, FB2 and ENNs (ENNA, ENNB and ENNB1)
were purchased from Techno Spec (Barcelona, Spain), while BEA and ENNA1 were supplied by VWR
International Eurolab, S.L. (Barcelona, Spain). Individual stock standard solutions were prepared for
all of them in MeCN and kept in the dark at −18 ◦C.
Different intermediate solutions were prepared due to the differences in the analytical method
and sample treatment. The first solution was composed of ENNA, ENNA1, ENNB, ENNB1 and BEA
at a concentration of 10 μg mL−1. The second solution was composed of FB1 and FB2, DON, ZEA, CIT,
OTA, T-2, HT-2, F-X and STE at a concentration of 1 μg mL−1 each mycotoxin. The third solution was
composed of AFB1, AFB2, AFG1 and AFG2 at a concentration of 50 μg mL−1. Working solutions were
prepared by diluting the intermediate solutions in MeOH:water (50:50).
Syringe filters (25 mm, 0.2 μm nylon membrane, VWR, West Chester, PA, USA) were used for
filtration of samples prior to the injection into the chromatographic system.
4.2. Instrumentation and Equipment
The determination of AFs was carried out using a modular HPLC system consisting of a quaternary
low pressure gradient pump (Model PU-2089, Jasco, Tokyo, Japan); an autosampler with a 100 μL loop
(Model AS-2055, Jasco, Tokyo, Japan); a C18 Kinetex separation column (150 mm × 4.6 mm, 2.6 μm)
from Phenomenex (Torrance, CA, USA) placed in a column oven; a UV derivatization module, which
consists of a photochemical reactor specific for the analysis of aflatoxins with a 254 nm lamp (LCTech,
Dorfen, Germany) and finally, a fluorescence detector (Model FP 2020, Jasco, Tokyo, Japan) used to
acquire the signals. ChromNAV software (1.09.03 version, Jasco, Tokyo, Japan) was used for data
acquisition and processing of AFs.
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In order to determine the remaining mycotoxins an Agilent 1290 Infinity LC system (Agilent
Technologies, Waldbronn, Germany) equipped with a binary pump, an on-line degasser, autosampler
and a column oven placing a Zorbax Eclipse Plus RRHD C18 column (50 mm × 2.1 mm, 1.8 μm)
coupled to a triple quadrupole (QqQ) mass spectrometer API 3200 (AB SCIEX, Toronto, ON, Canada)
with electrospray ionization (ESI) was used. Data were processed using the Analyst Software version
1.5 with schedule multiple reaction monitoring (MRM) TM Algorithm (AB SCIEX).
For sample treatment, an evaporator system (System EVA-EC, from VLM GmbH, Bielefeld,
Germany), a vortex-2 Genie (Scientific Industries, Bohemia, NY, USA) and a universal 320R centrifuge
(HettichZentrifugen, Tuttlingen, Germany) were used.
4.3. Samples
A total of 228 samples of pig feed were collected from February to August 2017 at different farms
and manufacturing industries around Spain. Samples (approximately 500 g) were sent directly to the
laboratory by the veterinarians responsible for farms or feed mills. Analytical personnel were not
present to oversee the sampling. They included: 71 compound feed samples destined to fattening pigs,
42 to sows, 111 to piglets, 2 to gilts, and 2 samples of maize (grain given to the fattening pigs in two
farms). The information of each sample comprised: animals to which it was destined, presentation
(flour or pellet) and sampling point (silo, feeder, sack and bulk storage without container in warehouse).
Samples were milled and homogenised using a standard grinder. Finally, all samples were stored at
room temperature until analysis.
4.4. Sample Preparation
Two different extractions were carried out: one for determination of AFs by HPLC-FLD and the
other for the rest of mycotoxins by UHPLC-MS/MS.
4.4.1. Aflatoxins
A previously reported method was adapted [35]. Briefly, 2 g of homogenised sample were placed
into a 50-mL screw cap test tube with conical bottom. The sample was extracted with 10 mL of MeCN,
shaking by vortex for 3 min. The sample was centrifuged at 4500 rpm for 5 min. Afterwards, 2 mL of
the upper layer was pipetted into a vial and dried under a gentle stream of N2. Finally, the residue was
dissolved with 1 mL of MeOH:water (50:50, v/v) and the solution thus obtained was filtered through a
0.22 μm nylon membrane filter before injection into the HPLC-FLD system.
4.4.2. Multimycotoxins, Enniatins and Beauvericin
Two g of homogenised sample and 8 mL of water were placed into a 50-mL screw cap test tube
with conical bottom, shaken by vortex for 1 min. Then, 10 mL of solvent (MeCN, 5% formic acid)
were added to the tube, shaken by vortex for 3 min, following by the addition of salts (4 g MgSO4,
1 g NaCl), shaken vigorously for 2 min. After these steps, the tubes were centrifuged at 4500 rpm
for 5 min. Finally, 2 mL of the organic layer was evaporated to dryness under a gentle stream of N2.
The residue was dissolved with 1 mL of MeOH:water (50:50, v/v). Each solution was filtrated with 0.22
μm membrane filter prior to the UHPLC-MS/MS analysis.
4.5. Chromatographic Separation and Detection
In order to achieve the lowest limits of quantification, determination of the different mycotoxins
was carried out in three different analyses: AFs were determined by HPLC-FLD, multimycotoxins by
UHLC-MS/MS and emerging mycotoxins (ENNs and BEA) in a different UHPLC-MS/MS analysis.
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4.5.1. Determination of Aflatoxins by HPLC-FLD
The chromatographic separation was carried out according to Arroyo-Manzanares et al. [35]. The
chromatographic separation was achieved using a C18 Kinetex separation column (150 mm × 4.6 mm,
2.6 μm). The mobile phase consisted of three different solvents: eluent A (water), eluent B (MeOH) and
eluent C (MeCN) and a linear gradient elution was used as follows, keeping constant eluent B at 27%:
0–3 min: 0% C; 20 min: 13% C; and 21–23 min: 68% C, followed by an equilibration time of 10 min.
The injection volume was 50 μL and the flow rate was 1 mL min−1. The temperature of the column
was kept constant at 30 ◦C. Excitation and emission wavelengths of the FLD for the determination of
the aflatoxins were set at 365 nm and 460 nm, respectively. The FLD was working at gain x100.
4.5.2. Determination of Multimycotoxins by LC-MS/MS
Conditions similar to those reported in a previous paper were used [36]. The chromatographic
separation of multimycotoxins (OTA, FB1, FB2, T-2, HT-2, STE, CIT, F-X, DON, ZEA) was carried out
on a C18 Zorbax Eclipse Plus RRHD column (50 × 2.1 mm, 1.8 μm) and as mobile phase eluent A
(5 mM ammonium formate aqueous solution, 0.3% formic acid), and eluent B (MeOH with 5 mM
ammonium formate, 0.3% formic acid), under the following gradient conditions: 0 min: 5% B; 1 min:
50% B; 4 min: 80% B; 6 min: 90% B, 6.20 min: 5% B and 8 min: 5% B. The injection volume was 5 μL,
the flow rate was 0.4 mL min−1 and the temperature of the column was 35 ◦C.
MRM conditions of the mass spectrometer for the determination of multimycotoxins are shown in
Supplementary Materials (Table S1). The working conditions of the mass spectrometer were established
in positive ESI mode under the following conditions: temperature of the source 500 ◦C; voltage of
the ion spray 5 KV, collision gas (nitrogen) 5 psi; curtain gas (nitrogen) 30 psi; GAS 1 and GAS 2
(both of them nitrogen) 50 psi. In all circumstances, an ion was used as precursor and two ions were
obtained from the fragmentation process: the most abundant one for quantification (Q) and the other
for confirmation (I).
4.5.3. Determination of Enniatins and Beauvericin by LC-MS/MS
The same column (C18 Zorbax Eclipse Plus RRHD) was used for separation of the five emerging
mycotoxins. However, the mobile phase did not include ammonium formate in its composition in
order to avoid the formation of ammonium adducts. Thus, this mobile phase consisted of eluent A
(0.3% formic acid aqueous solution), and eluent B (MeOH with 0.3% formic acid). The following linear
gradient elution was used: 0 min: 70% B; 2 min: 90% B; 4 min: 90% B; 4.2 min: 70% B, and 6 min:
70% B. The flow rate was 0.4 mL min−1. The injection volume was 5 μL and the column temperature
was 35 ◦C.
MRM conditions of the mass spectrometer are shown in the Supplementary Materials (Table S1).
The working conditions of the mass spectrometer were established in positive ESI mode, working
under the conditions described for multimycotoxin determination.
4.6. Method Development
Optimisation of Sample Preparation
The extraction of AFs was performed according to a previously reported method [35], so no
further optimisation was required.
Extraction of multimycotoxins and emerging mycotoxins was optimised, trying to obtain one
single sample treatment suitable for the extraction of all mycotoxins. With this purpose, solid-liquid
extraction with and without partitioning process were tested using 2 g of sample, as follows: (a) 10 mL
MeCN with 5% formic acid; (b) 10 mL MeOH with 5% formic acid; (c) 8 mL H2O + 10 mL MeCN with
5% formic acid + 4 g MgSO4 + 1 g NaCl; (d) 8 mL H2O + 10 mL MeCN with 5% formic acid + 4 g
MgSO4 + 1 g NaCl + 1 g sodium citrate + 0.5 g disodium hydrogen citrate sesquihydrate; (e) 8 mL
30 mM NaH2PO4 buffer pH 7.1 +10 mL MeCN with 5% formic acid + 4 g MgSO4 + 1 g NaCl + 1 g
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sodium citrate + 0.5 g disodium hydrogen citrate sesquihydrate; and (f) 8 mL H2O + 10 mL MeCN
with 5% formic acid + 4 g MgSO4, 1 g NaCl). The best results in terms of recovery were obtained with
conditions described in (c).
Subsequently, the volume of extraction solvent (MeCN, 5% formic acid) was studied within 5 and
10 mL, 10 mL being chosen as optimum in view of the worst recoveries if lower extraction volumes
were utilised. Afterwards, the volume of extract to dry was studied, choosing a volume of 2 mL as a
compromise to achieve a short time of sample treatment and low limits of detection (LODs).
4.7. Method Validation
The validation of each method comprised the establishment of the calibration curves in the
presence of matrix, evaluation of LODs and limits of quantification (LOQs), selectivity, precision
(as interday and intraday precision at different concentration levels) and extraction recovery studies
at different concentration levels. In all the cases, a sample of feed previously analysed and free of
mycotoxins was chosen as the representative matrix.
4.7.1. Aflatoxins
As stated previously, this method had been previously validated for different kinds of feeds,
including pig feeding [35]. The method provided good linearity in the concentration range 1–50 μg kg−1
(R2 > 0.99), LOQs of 1 μg kg-1, precisions expressed as RSD lower than 7.9% and 9.2% for intraday and
interday studies, respectively, and recoveries higher than 85%.
4.7.2. Multimycotoxins
For the evaluation of linearity, calibration curves were obtained by spiking portions of a
representative feed sample with different concentrations of analytes, depending on the analytical
sensitivity for each mycotoxin. Samples were submitted to the sample treatment and analysed and the
area of the Q ion was selected as analytical signal. LODs and LOQs were calculated as 3 × S/N and
10 × S/N, respectively. The results are shown in Table 3.
Table 3. Calibration curves, LODs and LOQs for multimycotoxin, enniatins and beauvericin determination.
Calibration Curve Linear Range (μg kg−1) R2 LOD (μg kg−1) LOQ (μg kg−1)
DON y = 3.5279x + 100.67 86.1–1000 0.998 26 86
F-X y = 1.0892x − 8.111 135.9–2000 0.995 41 136
CIT y = 395.99x − 13280 24.3–500 0.999 7.3 24
HT-2 y = 8.555x − 29.894 33.9–2000 0.998 10 34
FB1 y = 11.103x + 347.53 22.2–500 0.999 6.7 22
T-2 y = 40.038x + 1245.4 26.8–2000 0.995 8.1 27
ZEA y = 29.141x − 758.98 99.0–500 0.998 30 99
OTA y = 82.66x + 333.23 8.1–100 0.993 2.5 8.1
STE y = 208.73x − 848.16 9.9–100 0.991 3.0 9.9
FB2 y = 13.57x + 112.34 38.5–500 0.999 12 38
ENNB y = 987.45x − 2943.8 2.00–500 0.998 0.60 2.0
ENNB1 y = 1482.5x + 9430.2 2.53–500 0.999 0.76 2.5
BEA y = 372.32x + 0.0047 1.72–500 0.998 0.52 1.7
ENNA1 y = 1092.9x + 3989.6 4.52–500 0.999 1.4 4.5
ENNA y = 1578.8x + 3790.5 2.94–500 0.999 0.88 2.9
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The matrix effect was evaluated by relative comparison of the analyte peak area of a spiked
extract of sample and a standard solution at the same concentration. Ion suppression was observed for
most of the analytes, so calibration in presence of matrix was mandatory for quantification. These
studies, as well as intra and interday precision and recovery studies, were carried out at three different
concentration levels (three samples, injected in triplicate). The results are shown in Supplementary
Materials (Tables S2 and S3).
4.7.3. Enniatins and Beauvericin
A similar procedure was followed for validation of UHPLC-MS/MS determination of emerging
mycotoxins. Calibration curves were obtained by spiking a feed sample with concentrations of analytes
up to 500 μg kg−1, submitted to the whole procedure and analysed. Table 3 summarises the results.
The matrix effect, precision and trueness were evaluated at three different concentration levels
(three samples, injected in triplicate). Once again, ion suppression was observed for all the analytes,
so calibration in presence of matrix was mandatory for quantification. The results are shown in
Supplementary Materials (Tables S2 and S3).
4.8. Data Processing
One-way ANOVA studies were carried out for total content of mycotoxins as well as for each
mycotoxin individually, considering different factors, namely: presentation (pellet or flour), sampling
point (silo, feeder, sack and bulk storage without container in warehouse), and type of animal feed
(piglet, gilts, sows and fattening pigs). When this information was not available, the sample was not
included in the study. These studies were performed to determine statistical differences with a level of
confidence of 95%.
PRESENTATION. A total of 226 samples were analysed, 183 presented as flour and 43 as pellet
(n = 43). The two samples of maize (grain) were excluded from this study.
SAMPLING POINT. In this case, a total of 137 were processed, 77 samples were collected from a
silo, 29 from a feeder, 25 from a sack and 6 were stored in bulk without container in warehouse.
TYPE OF ANIMAL. Another factor is the type of pig for which the compound feed is intended.
In this sense, different types of feed (classified according to the necessities of the animal) can be
distinguished: piglets (n = 111), fattening (n = 71), gilts (n = 2) and sows (n = 42). The two samples of
maize (grain) were excluded from this study.
Supplementary Materials: The following are available online at http://www.mdpi.com/2072-6651/11/6/342/s1,
Table S1: Monitored ions of multimycotoxins, enniatins and beauvericin, and MS/MS parameters; Table S2:
Matrix effect (%ME), recovery (%R) and recovery precision (%RSD) for multimycotoxin enniatins and beauvericin
determination (n = 9); Table S3: Precision study for multimycotoxin, enniatins and beauvericin determination at
different concentration levels (n = 9).
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Abstract: The objective of this work was the development of a methodology capable of simultaneously
determine 26 mycotoxins in mixed feed rations collected in 20 dairy farms. A sample preparation
methodology based on a combination of (d)SPE and QuEChERS extractions was used. Liquid
chromatography-high resolution mass spectrometry was employed for both identification and
quantification purposes. To this respect, a powerful workflow based on data-independent acquisition,
consisting of fragmenting all precursor ions entering the mass spectrometer in narrow m/z isolation
windows (SWATH), was implemented. SWATH data file then contains all the information that
would be acquired in a multitude of different experimental approaches in a single all-encompassing
dataset. Analytical method performance was evaluated in terms of linearity, repeatability and
matrix effect. Relative recoveries were also measured, giving values above 80% for most compounds.
Matrix-matched calibration was carried out and enabled reaching the low ng mL−1 level for many
mycotoxins. The observed matrix effect, in most cases suppressive, reached even values higher
than 60%. The repeatability was also adequate, showing a relative standard deviation lower than
10%. All unified samples analyzed showed co-occurrence of two or more mycotoxins, recurrently
zearalenone, fumonisin B1, and β-zearalenol, with an occurrence frequency ranging from 60% to 90%.
Keywords: Mycotoxins; mixed feed rations; QuEChERS; dispersive solid phase extraction; liquid
chromatography; high-resolution mass spectrometry; data independent SWATH
Key Contribution: The optimized analytical methodology, based on QuEChERS with (d)SPE clean-up
and HPLC-HRMS analysis by means of SWATH mode, allowed the identification and quantification
of 26 mycotoxins in 97 mixed ration samples collected in 20 dairy farms (NW Spain). Fumonisins
B1 and B2, zearalenone and its metabolite β-zearalenol, cyclopiazonic acid and enniatin B were
the mycotoxins most frequently found. All samples showed co-occurrence of two or more of these
mycotoxins, recurrently zearalenone and fumonisin B1. None of the samples showed concentrations
higher than the maximum values established for feed intended for dairy cows.
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1. Introduction
Mycotoxins are natural secondary metabolites produced by various filamentous fungi, mainly
belonging to Aspergillus, Penicillium, and Fusarium genera. Around 400 of these metabolites are
identified and classified, being the most predominant zearalenone, ochratoxin A, fumonisins and
trichothecenes [1]. Mycotoxins can be produced during all stages; from pre-harvest, when plants are
growing, to storage, transport or further processing [2].
Mycotoxins can cause some adverse effect on animal and human health. They can be carcinogenic
agents (aflatoxin B1 (AFB1), fumonisins B1 and B2, (FB1 and FB2)), present estrogenic activity (zearalenone
(ZEA)), or teratogenic (ochratoxin A, (OTA)) and immunotoxinogenic effects (deoxynivalenol, (DON)) [3].
In consequence, the presence and intake of mycotoxins can also strongly reduce animal productivity in
farms. The severity of the damage depends on the compound, the degree of exposure and the possible
co-occurrence of various mycotoxins. This is a frequent situation, such is the case with zearalenone and
deoxynivalenol or zearalenone/deoxynivalenol/nivalenol/fumonisin B1 [4].
Most studies concerning mycotoxins occurrence were carried out in food matrices, cereals [5–8]
feedstuff [1,9,10], plant based beverages [11], and ruminant milk [12]. Nonetheless, some researchers
also found traces of these toxins in human breast milk [13,14]. Due to mycotoxins stability to high
temperatures and persistence during food preparation procedures [15], they present a risk to the whole
food chain.
With the purpose of protecting consumers against mycotoxin intake, maximum levels of aflatoxins
(AFB1, and sum of AFB1, AFB2, AFG1, and AFG2), sum of FB1 and FB2, DON, OTA, and ZEA, were
established by the European Union for products intended for animal feeding [16,17]. In 2013, maximum
recommended levels were set for the sum of toxins T-2 and HT-2 in cereals, as well [18].
Due to the hazard mycotoxins may cause, sensitive and selective analytical techniques are needed
for their monitoring in food and feed. Besides, because of their frequent co-occurrence, the European
Food Safety Authority (EFSA) recommends multianalyte methodologies. Nevertheless, finding an
appropriate methodology, in terms of sample preparation, for a wide number of mycotoxins can be a
tough task due to the structural variety and different chemical properties of the compounds.
Many sample treatment procedures for the simultaneous determination of multiple mycotoxins
have been published. From classic approaches like solid liquid extraction (SLE) and liquid–liquid
extraction (LLE) to the most recent ones, like modified Quick, Easy, Cheap, Effective, Rugged,
and Safe (QuEChERS) extraction or matrix solid-phase dispersion (MSPD). Modified QuEChERS
procedure is the sample pre-treatment of choice in many recent publications, due to its simplicity and
cost-efficiency [8,9,19,20].
In the case of food and feed samples, clean-up steps are usually needed in order to reduce the
matrix effect, especially in the case of liquid chromatography analyses. Solid phase extraction (SPE)
and dispersive solid phase extraction (dSPE) are the most used as described in literature [19,21–23].
In terms of analysis, two different approaches are currently employed to control the presence
of mycotoxins in food and feed. For screening and semi-quantitative analysis, enzyme-linked
immune-sorbent assay (ELISA) and thin-layer chromatography (TLC) are the most frequently used. To
provide accurate quantitative information and therefore reduce the number of possible false-positive
results, chromatographic techniques such as gas chromatography (GC) and high-performance liquid
chromatography (HPLC) coupled to ultraviolet (UV), fluorescence (FL), and mass spectrometry (MS)
detectors are used [24,25].
HPLC coupled to tandem mass spectrometry (MS/MS) is considered the most reliable technique in
order to achieve high specificity and sensitivity for the simultaneous determination of a large number
of mycotoxins, reaching low limits of detection (LOD) and quantification (LOQ). Several studies
using this technique for the analysis of multi-mycotoxins in food and feed commodities have been
published [9,10,12,26,27].
More recently, high-resolution mass spectrometry (HRMS) has been implemented either in Data
Dependent Acquisition mode or in Data Independent Acquisition mode. Besides providing high
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specificity and resolution due to the use of the accurate mass, HRMS allows for performing non-target
screening. Quadrupole time-of-flight (QTOF) instruments offer the advantages of TOF detectors in
terms of resolution and the possibility of acquiring product ion spectra working in MS/MS mode
using accurate mass. This feature provides additional confirmatory parameters besides retention
time and ion fragment ratio, i.e., exact mass, isotope pattern and spectral comparison against spectra
libraries with smart confirmation criteria. Among the applications published employing quadrupole
time-of-flight and Orbitrap® detectors [1,19,28,29] for the mycotoxin analysis in food and feed, the
main part of them use Orbitrap technique.
Hence, the aim of this work was to develop a methodology that allowed the simultaneous analysis
of multi-class mycotoxins in mixed rations. A QuEChERS extraction method was implemented, with
the addition of a clean-up step based on solid phase extraction and dispersive solid phase extraction,
in order to minimize the effect of the matrix. The analytical methodology was carried out using HPLC
followed by triple quadrupole-time-of-flight detection based on a data independent workflow.
The method was optimized and validated for 26 mycotoxins produced by different genera.
Several analytical parameters, such as linearity, repeatability, accuracy, matrix effect, measurement
uncertainties, limits of detection, and recovery, were evaluated.
A monitoring of these mycotoxins was carried out using the proposed methodology analyzing 97
mixed ration samples collected in 20 dairy farms from Galicia (NW Spain) over one year. These rations
may constitute the basis of the diet for dairy cows during 6 to 8 months of the year.
2. Results and Discussion
2.1. Chromatographic Analysis
The aim of this work was to develop an analytical methodology based on high performance liquid
chromatography coupled to triple quadrupole-time of flight mass spectrometry for the simultaneous
analysis of the 26 mycotoxins. Hence, the chromatographic conditions were optimized to achieve an
efficient separation of the target compounds (see conditions in the Experimental section). The initial
step was to consider the ionization of the target mycotoxins by injection of a standard containing all
analytes, both in positive and negative mode. This allows for the selection of the most sensitive mode
for each compound.
Two runs were needed for each analysis, since the methodology does not allow switching from
one ionization mode to the other in such short time.
Different mobile phase configurations were evaluated. Being the solvents used always water as
aqueous phase and methanol as organic phase, two different buffers were tested (ammonium formate
and ammonium acetate, 3 mM), as well as the addition of an acidic component (formic acid and
acetic acid, 0.1% v/v). The regression equations for matrix-matched calibration using each mobile
phase configurations are specified in Tables S1 and S2. As shown, although the slopes obtained using
ammonium acetate and ammonium formate did not present great differences, some frequently found
compounds gave better responses using ammonium acetate rather than ammonium formate. Such
is the case of deoxynivalenol acetylated derivatives (3+15-ADON), FB2, cyclopiazonic acid (CPA) or
alternariol (AOH) (examples in Figure 1). Besides, the addition of an acidic component (formic or acetic
acid) caused a substantial signal suppression in almost all cases in comparison with the mobile phase
without acid. Exceptionally, few compounds such as andrastin A (AND A), and toxins T-2 and HT-2
gave better responses with the addition of 0.1% of acid. Therefore, the mobile phase configuration
selected was a combination of water (A) and methanol (B), both containing 3 mM ammonium acetate.
The method performance will be then assessed with this mobile phase composition.
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(c) 
Figure 1. Response comparisons between the four mobile phase compositions: ammonium acetate
3mM, ammonium formate 3 mM and the addition of acetic or formic acid 0.1%, respectively for (a) 3+15
acetyldeoxynivalenol; (b) cyclopiazonic acid; and (c) alternariol.
The proposed chromatographic method offers a complete separation of all 26 mycotoxins and a
good peak shape for quantification.
The only two exceptions were the isomers 3-DON and 15-DON for which the sum of the two
metabolites was reported, as commonly done in previous published studies [29].
2.2. Method Performance Evaluation
Mixed ration is a difficult matrix to work with because of the complexity of its composition. Thus,
to achieve a reliable detection and quantification of mycotoxins, and exhaustive analytical methodology
is needed, beginning with a matrix effect evaluation. Most publications working with this kind of matrix
emphasized the need of a matrix-matched calibration in order to properly evaluate the concentration
of the analytes [1,21]. For this purpose, a comparison was made between a matrix-matched standard
calibration and an external calibration prepared in MeOH. The concentration range values covered
depended on the mycotoxin, but in all cases, the range was of two orders of magnitude (see individual
ranges of concentration in Table 1) with eight concentration levels. Matrix-matched calibration was
performed using the sample with the lowest analyte content found (blank sample), spiked in the same
range of concentrations as for the external calibration. For most compounds, the signal showed a
suppressive effect when working with matrix (Figure 2), showing a median value of −35%, with some
compounds (e.g., HT-2 toxin and AOH) exhibiting over 70% of signal suppression. However, there
were a few examples of signal enhancement, such as the case of FB1 and FB2. Because of this variance,
further studies and quantification were carried out using the matrix-matched approach.
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Table 1 shows the determination coefficient (R2) for all analytes using matrix-matched calibration.
R2 values were in all cases higher than 0.9991, showing an almost perfect linearity in the relation
between the signals obtained and the concentration in the corresponding ranges. Both intra-day (n = 3)
and inter-day (n = 3) precisions were calculated and expressed in terms of relative standard deviation
(RSD) obtaining satisfactory values, ranging from 0.2% to 10.4%. The limits of quantification (LOQs)
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(b) 
Figure 2. Matrix-matched calibration curves and external calibration. (a) Signal suppression: DON,
ZEA; (b) signal enhancement: FB1.
To evaluate the accuracy of the methodology proposed, a multitoxin reference material containing
ZEA, DON and fumonisins was extracted. Mixed ration is a complex and heterogeneous matrix and
there is no related reference material available; therefore, a maize based one was used. The extraction
recoveries achieved were 78.6% in the case of DON and 98.6% for ZEA, endorsing the trueness of the
proposed methodology.
To evaluate the whole sample preparation and chromatographic methodology for the determination
of all 26 mycotoxins, recovery studies were carried out using the same matrix as in the matrix-matched
calibration. The results, expressed in percentages, are shown in Table 1, as well as the relative standard
deviation in each case. Most compounds gave recovery values between 70% and 120%, especially the most
frequently found in this kind of matrix, DON, ZEA, and FB1 and FB2. Only two mycotoxins achieved
recoveries below 60%, at the two spiking levels (Enniatin B1 (ENN B1) and Penitrem A (PEN A)), but
these analytes are not as recurrent and their contents in food/feed are not yet either regulated. The relative
standard deviations were satisfactory since they were always lower than 9%.
ISO 21748:2017 provides recommendations [30] to assess the expanded measurement uncertainty (U).
Thanks to the performance parameters given in Table 1, especially the intra-day and inter-day
precisions, the relative expanded measurement uncertainty (% U) could be calculated. As shown in
Table 2 for those 17 mycotoxins that were detected in the mixed ration samples, % U were lower than
15% in all cases, except for α-ZOL.
2.3. Application to Real Samples
Using the proposed methodology, 97 mixed ration samples collected in one year at 20 different
dairy farms from Galicia (NW Spain) were analyzed. The criteria used for the correct identification of
the analytes, in addition to the retention time, were the parameters given by the high-resolution mass
spectrometry such as the exact mass accuracy, accepting only a 5 ppm error. The isotopic profile of the
peak found as well as the formula proposed by the software for the mass obtained provided valuable
additional information for the identification. Finally, contrasting the high resolution MS/MS spectra
experimentally obtained with the available library spectra enabled a definitive confirmation.
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Table 2. Concentration ranges, average, maximum and minimum concentrations (with relative
expanded uncertainty, U (%)) and occurrence frequency of the 17 mycotoxins found in the 97 mixed
ration samples.
Compounds Concentration (ng g−1) N◦ Positive Occurrence
Frequency (%)
Average Max Min U (%)
3+15-ADON 426.9 770.0 214.1 13.2 33 33.7
DON 52.8 81.3 36.5 14.1 15 16.3
ENN B 322.0 1305.5 53.1 13.4 49 50.0
FB1 578.8 1453.9 14.0 11.6 95 96.9
FB2 160.6 481.1 13.3 1.1 64 65.3
MAC A 124.3 209.9 46.1 13.6 4 4.1
OTA 5.1 5.1 5.1 11.0 1 1.0
ROQ-C 36.9 59.3 19.6 6.3 4 4.1
STER 8.7 15.3 2.6 10.9 20 20.4
CPA 96.5 257.0 2.6 8.7 22 22.4
AND A 33.3 91.0 8.8 2.8 6 6.1
AOH 126.3 295.4 12.7 12.4 24 24.5
MPA 262.2 3151.4 8.2 7.4 19 19.4
PEN A 159.7 234.5 63.7 9.1 9 9.2
α-ZOL 32.5 50.3 25.3 21.1 28 28.6
β-ZOL 35.3 78.9 8.1 11.0 67 68.4
ZEA 10.2 23.2 3.5 10.2 90 91.8
Figure 3 summarizes the total of positives of each compound found in all samples. Fumonisins
B1 and B2, zearalenone and its metabolite β-zearalenol, cyclopiazonic acid and enniatin B were the
mycotoxins most frequently found. FB1 was detected in 95 samples; ZEA in 90 samples; ENN B in
49 samples and DON in 15 samples. This results are in consonance with other studies published on
mycotoxin occurrence in feed [8,20,31]. All samples exhibited co-occurrence of two or more mycotoxins,
repeatedly zearalenone and fumonisin B1, ZEA-FB1-ENN B and ZEA-FB1-DON. These co-occurrences
are often found in feedstuff, as recent studies show [29,32]. However, the concentrations found in
the mixed ration samples of the present study are much lower than those reported in these previous
studies on maize based feed and silages [26,29,32].
Table 2 collects the concentration ranges and the average values in which the analyzed mycotoxins
were present in the samples. ZEA, DON, FB1, and FB2 concentrations were always lower than the
recommended values in feed intended for dairy cows; 0.5, 5, and 50 mg kg−1, respectively. It should be
noted that 3+15-ADON concentrations were one magnitude order higher than DON ones, with an
occurrence frequency of 34%. As stated by EFSA in 2013 [33], it is important to collect more data on the
incidence of these derivatives to better characterize their potential contribution to the total exposure
to DON.
ENN B showed an average concentration of 0.32 mg kg−1 and reached a maximum content of
1.3 mg kg−1. A particular attention should be paid to this cyclic depsipeptide since a recent EFSA
scientific report, combining an in vivo toxicity and genotoxicity approach, concludes that ENN B poses
a genotoxic hazard [34].
Finally, the screening of non-targeted mycotoxins conducted by implementing a retrospective
approach with the same acquired data files and by contrasting HR MS/MS spectra with those of
the mycotoxin library enabled to identify monocerin, aurofusarin, beauvericin, chlamydosporol,
sambucinol, mevastatin, and two forms of enniantin, enniantins B4 and J1. Two anthraquinone
derivatives, emodin and chrysophanol, were also identified.
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Figure 3. Total number of positives for each mycotoxin in the 97 samples analyzed.
3. Conclusions
The proposed analytical methodology based on QuEChERS with (d)SPE clean-up and HPLC-HRMS
analysis allowed the screening and quantitation of 26 mycotoxins in mixed rations. The full method was
successfully optimized, and its accuracy was confirmed using a reference material, as well. Recovery
values were acceptable for most analytes, giving good results considering the complexity of the matrix for
a multi-analyte methodology. Matrix-matched calibration was utilized to compensate for matrix effects,
mostly suppressive, except from fumonisins.
The analytical method has been applied to the analysis of 97 samples. Fumonisins B1 (97%)
and B2 (65%), zearalenone (92%), its metabolite β-zearalenol (68%) and enniatin B (50%) were the most
frequently found mycotoxins. All samples presented co-occurrence of two or more mycotoxins, recurrently
zearalenone and fumonisin B1, amongst others. The use of SWATHTM acquisition mode proved to be a
very attractive approach for the unambiguous identification as well as for the accurate quantification of
the target mycotoxins in complex feed samples. Additional screening based on a retrospective approach
enabled the identification of non-targeted mycotoxins, most of them originated from Fusarium fungi.
4. Materials and Methods
4.1. Reagents and Standards
The studied compounds, their molecular formula, exact mass, CAS numbers and structure are
summarized in Table 3. Standards of 3+15-ADON, DON, HT-2, OTA, ROQ-C, T-2, ZEA, AFB1, AFG1,
AFB2, AFG2 were obtained from Biopure (Romer Labs, Tulln, Austria); ENN B, ENN B1, STER, α-ZOL
and β-ZOL from Sigma-Aldrich (Saint Louis, MO, USA); fumonisins FB1 and FB2 from Acros Organics
(New Jersey, USA); MARC A and AND A from Santa Cruz Biotechnology (Dallas, TX, USA); CPA and
MPA from Alpha Aesar (Ward Hill, MA, USA); AOH and PEN A from Cayman Chemical (Ann Harbor,
MI, USA). Acetonitrile, water and methanol (both > 99.95% purity) were provided by Carlo Erba
(Milan, Italy). Formic acid (99%), acetic acid glacial, ammonium formate and ammonium acetate were
all LC-MS grade and were provided by Biosolve (Dieuze, France and Valkenswaard, The Netherlands).
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A multitoxin maize reference material (QCM7C1, Biopure, Romer Labs, Tulln, Austria) was used
for checking the extraction method accuracy.
Individual stock solutions for each mycotoxin were prepared in acetonitrile. Further dilutions
and mixtures were prepared in methanol. All solutions were stored at −20 ◦C.
4.2. Sampling and Sample Treatment
Mixed rations for dairy cows in Galicia usually rely on own forages and concentrates, and in
recent years, the ensiled maize proportion is being increasing. Concentrates are mostly a complement
of protein and energy to balance dairy cow rations. In Galicia, these concentrates are made with soya
cake (30%) and rapeseed cake (20%) to increase protein, and with cereals, mainly maize (25%) and
barley (15%), to achieve the cattle energy requirement.
97 mixed ration samples collected in 20 dairy farms between October 2017 and October 2018 in
Galicia (NW Spain). Five hundred grams of the sample was dried for 48 h at 40 ◦C and then put in
vacuum bags and stored at 4 ◦C until their analysis.
4.3. QuEChERS Extraction
Two grams of unifeed samples were weighed and placed in 50 mL falcon tubes with the addition
of 10 mL of water and 10 mL of acetonitrile/formic acid (90:10% v/v). The tubes were placed in an
automated shaker for 1 h at room temperature. Then, a mixture of 0.5 NaSesquihydrate/1g NaCitrate/1g
NaCl/4g MgSO4 (DisQuETM Pouch for CEN, Waters, Milford, USA) was added and the tube was
shaken vigorously by hand for 1 min. After centrifugation (3398× g for 5 min), a portion of the
supernatant was saved for subsequent clean-up.
4.4. Clean-Up Procedure
An Oasis PRiME HLB cartridge (3cc, 150 mg), Waters, Milford, MA, USA) was placed on a vacuum
manifold. Without previous conditioning, after discarding 0.4 mL of supernatant, a 1 mL aliquot
was passed-trough the cartridge and, the collected extract was then transferred to a 2 mL dSPE tube
containing a mixture of sorbents (150 mg MgSO4, 50 mg PSA, 30 mg C18, 30 mg Al-N) (Waters, Milford,
USA). After centrifugation (2 min at 2360× g), a 500 μL aliquot was taken, evaporated under a gentle
nitrogen stream, and reconstituted in 350 μL of methanol.
4.5. HPLC-QTOF Analysis
For LC-HRMS analysis, a HPLC system (Shimadzu Nexera X2) consisting of two high-pressure
pumps (LC-30AD) and a SIL-30AC autosampler was used. HRMS detection was performed by a SCIEX
(Ontario, Canada) TripleTOF® 5600+ equipped with a DuoSprayTM ion source and an Electrospray
Ionization (ESI) probe. The chromatographic separation was achieved with a Kinetex bioZenTM
Peptide XB-C18 (50 × 2.1 mm, 2.6 μm) column from Phenomenex (Torrance, CA, USA), kept at 40 ◦C
with a CTO-30A column oven.
The mobile phase consisted of water (A) and methanol (B), both buffered with 3mM ammonium
formate or ammonium acetate. Formic acid and acetic acid addition (0.1%) was also tested in
combination with its respective buffer.
An 8-min gradient elution profile (10% B to 100% B) was employed reaching a total runtime of 15 min.
The mobile phase flow-rate was kept to 0.25 mL mL−1 and the injection volume was set at 10 μL.
Regarding the HRMS conditions, the source temperature was set at 550 ◦C, the ion source gas at
50 (au, arbitrary units), the curtain gas at 30 (au), and the ion spray voltage floating at 5500 V (−4500 V
in the negative mode).
The HRMS workflow consisted of a Full Scan, using 250 ms as accumulation time and 80 V (−80 V in
negative mode) as the declustering potential in the ESI. Simultaneously, a data independent approach
based on SWATH (Sequential Windowed Acquisition of All Theoretical Fragment Ion Mass Spectra) was
performed. A wide mass range (80–850 Da) was divided in 30 mass windows with an accumulation time
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of 35 ms for each one. The cycle time was slightly higher than 1 s, enabling a perfect reconstruction of
any chromatographic peak. The declustering potential was set to 80 V (−80 V in negative mode) and the
collision energy was 40 V (−40 V in negative mode), with an energy spread of 20 V.
SWATH acquisition is a Data Independent Acquisition (DIA) strategy that delivers the complete
picture of a sample. It provides the best method for performing sample analysis, identifying and
quantifying every detectable analyte in a single chromatographic run.
In contrast to traditional mass spectrometry acquisition techniques that rely on Data Dependent
Acquisition (DDA) strategies, SWATH acquisition is not “dependent” upon some pre-set criteria
determined by the abundance of the compound. With SWATH acquisition, every detectable ion,
irrespective of its concentration, is fragmented, identified and quantified to provide the high-resolution
full MS and MS/MS picture for every peak. The data produced by SWATH then contains all the
information that would be acquired in a multitude of different experimental approaches in a single
all-encompassing dataset. Furthermore, SWATH acquisition cycle time does not increase as the number
of target compounds increases.
In terms of post-acquisition, the complete set of data can serve as a digital archive of each sample,
allowing full access to pull out anything that you may be interested in, without the need to re-inject
your samples. Should new hypotheses arise in the future, this feature allows you to re-interrogate the
sample data without re-analyzing the actual sample.
The system was operated by Analyst® 1.7.1 (SCIEX, Ontario, Canada) control software, PeakView®
2.2 (SCIEX, Ontario, Canada) processing software and MultiQuant® 3.0 (SCIEX, Ontario, Canada)
quantitation software. A mycotoxin HR MS/MS spectral library (1.0), containing 288 compounds was
used for identification and confirmation purposes.
As usual, mass accuracy is expressed in ppm, calculated as the relative difference between the






The limit of quantification (LOQ) of each analyte was evaluated using the parameters of each
matrix-matched calibration curve and the S/N obtained for the lowest concentration level of each analyte.
The matrix effect was calculated by subtracting the ratio of the slope values of the matrix-matched
calibration curve and the external calibration curve to 1, and expressing it as a relative percentage (%)
(See Table 1).
The mixed ration sample selected for recovery experiments was spiked in triplicate at two
concentration levels (individual values indicated in Table 1). Aliquots of 2 g of fortified mixed ration
samples were let interacting for 20 h at ambient temperature and protected from natural and artificial
light exposure. Recovery values were given as the ratio of the signal obtained for these fortified
samples and the response of the corresponding concentration level in the matrix-matched standards.
ISO 21748:2017 provides recommendations [30] to assess the expanded measurement uncertainty
(U) which was calculated (see following equations) by multiplying the combined standard uncertainty
(uc) by a coverage factor (k). At a confidence level of 95%, this k factor was set to two. The standard
uncertainty (uc) formulae combined the variance of the inter-day precision (S2R) and the uncertainty
associated with the bias (ubias2). The latter was calculated using the number of replicates (n), the
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target mycotoxins in negative mode, using different mobile phase compositions.
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Abstract: Ruminants are less susceptible to the effects of mycotoxins than monogastric animals
as their rumen microbiota are claimed to degrade and/or deactivate at least some of these toxic
compounds. However, the mycotoxin degradation is not well-known yet. For this, a sensitive, specific,
and accurate analytical method is needed to determine mycotoxins in the rumen fluid. This study
aims to develop and thoroughly validate an ultra-performance liquid chromatography tandem mass
spectrometry method for the quantitative determination in the rumen fluid of some of the most
relevant mycotoxins found in maize silage in Western Europe: deoxynivalenol (DON), nivalenol
(NIV), zearalenone (ZEN), mycophenolic acid (MPA), roquefortine C (ROQ-C) and enniatin B (ENN B),
as well as their metabolites deepoxy-deoxynivalenol (DOM-1), α-zearalenol (α-ZEL), β-zearalenol
(β-ZEL), zearalanone (ZAN), α-zearalanol (α-ZAL) and β-zearalanol (β-ZAL). As feed is often present
in the rumen fluid samples, the potential interaction of feed particles with the mycotoxin extraction
and analysis was investigated. Extraction recovery and matrix effects were determined in the rumen
fluid with and without maize silage. Differences in those parameters between rumen fluid alone and
rumen fluid with maize silage highlight the importance of using matrix-matched calibration curves
for the quantification of mycotoxins in rumen fluid samples. A cross-validation of the method with
rumen fluid and maize silage demonstrates that this analytical method can be applied in research on
rumen fluid samples to investigate the degradation of the reported mycotoxins by rumen microbiota
if matrix-matched calibration is performed.
Keywords: mycotoxins; UPLC-MS/MS; rumen fluid; maize silage; matrix-matched
Key Contribution: A sensitive and accurate ultra-performance liquid chromatography tandem mass
spectrometry (UPLC-MS/MS) method was developed and validated to determine mycotoxins and
their metabolites in rumen fluid with or without addition of feed particles. This method can be applied
in research to investigate the degradation of mycotoxins by rumen microbiota if matrix-matched
calibration is performed.
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1. Introduction
Mycotoxins are secondary fungal metabolites that are harmful to humans and/or animals.
Monogastric animals, in particular pigs, are more susceptible to toxic effects of mycotoxins
than ruminants as the symbiosis of ruminants with rumen microbiota allows (partial) mycotoxin
degradation [1,2]. Despite this potential degradation, mycotoxin-associated subclinical health problems
have been reported in high-productive dairy cows, reflected by vague and non-specific symptoms
and periodic decrease in milk production [1]. The increased milk yield during the past decades is not
only associated with a higher incidence of metabolic disorders and hence a lower detoxifying capacity
of mycotoxins in the rumen [3], but also with a higher rumen passage rate and a higher proportion
of highly fermentable maize silage in the ration of cows. Unfortunately, this maize silage is more
vulnerable to contamination with multiple mycotoxins than e.g., grassland products [4–6].
In Belgium, which has a temperate climate, some of the most important mycotoxins found in
maize silage are deoxynivalenol (DON), nivalenol (NIV), zearalenone (ZEN), mycophenolic acid
(MPA), roquefortine C (ROQ-C), and enniatins, especially enniatin B (ENN B) [4,7–9] (Tables S1 and S2).
However to determine their rumen degradation, a sensitive, specific, accurate and high-throughput
multi-method allowing analysis of these mycotoxins and their metabolites in rumen fluid is essential.
Nowadays, ultra-performance liquid chromatography (UPLC) combined with tandem mass
spectrometry (MS/MS) offers a powerful tool in the analysis of mycotoxins, as this method offers a
high specificity and sensitivity and can detect low levels of mycotoxins in complex matrices. Hence,
ultra-performance liquid chromatography tandem mass spectrometry (UPLC-MS/MS) has been used
for the detection of several types of mycotoxins in different matrices such as food and feed [10–12],
blood [13] and urine [14,15].
The analysis of mycotoxins in rumen fluid, however, is highly challenging because of the complex
nature of the matrix, including partially degraded feed particles and its microbiota. First, an elaborate
sample preparation before chromatographic analysis is crucial in the development of such a detection
method to eliminate as much as possible the unwanted compounds that can interfere with the
detection of the analytes. In addition, in case of multi-mycotoxin methods, it is difficult to develop
an analytical method for the simultaneous determination of several mycotoxins, since they have
different physicochemical properties. Hence, compromises have to be made in optimizing the sample
preparation and MS parameters. Second, it has been described that bacteria and yeast cell walls,
also present in rumen fluid, are able to bind mycotoxins such as DON, ZEN, aflatoxins and fumonisins
leading to an inferior detection of free mycotoxins in the rumen fluid [16–24].
To the authors’ knowledge, very few methods have been described to determine simultaneously
several mycotoxins in rumen fluid and none of them included all mycotoxins that are often found in
maize silage (DON, NIV, ZEN, MPA, ROQ-C, and ENN B). Kiessling et al. (1984) analyzed six different
mycotoxins (aflatoxin B1, ochratoxin A, ZEN, T-2 toxin, diacetoxyscirpenol, and DON) in the rumen
fluid [25]. However, to determine those mycotoxins from different classes, four different extraction
procedures and detection methods were performed, which are time consuming and expensive. Gallo
et al. (2015) determined simultaneously three Penicillium roqueforti mycotoxins (MPA, ROQ-C and
Penicillium roqueforti toxin (PR toxin)) in the rumen fluid by means of HPLC-MS/MS [26]. Again, the
extraction procedure was very time consuming as the purpose of the study was to distinguish between
mycotoxins present in the supernatant of the rumen fluid and those present in the pellet of the rumen
fluid, so two separate extractions were performed.
Therefore, the goal of this study is first to develop a high-throughput method for rumen fluid to
extract the most prevalent and toxicological important mycotoxins found in maize silage (DON, NIV,
ZEN, MPA, ROQ-C, and ENN B) and their metabolites (deepoxy-deoxynivalenol (DOM-1), α-zearalenol
(α-ZEL), β-zearalenol (β-ZEL), zearalanone (ZAN), α-zearalanol (α-ZAL), and β-zearalanol (β-ZAL))
as these can be formed in the rumen [25,27–31]. Further, a highly specific and sensitive UPLC-MS/MS
method to quantify these components in the rumen fluid was developed and validated. As rumen
fluid is a complex matrix and mycotoxins can bind to feed or other particles present in rumen fluid,
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the impact of the matrix on extraction recovery and matrix effects was evaluated. As the importance of
using matrix-matched calibration curves was evident, a cross-validation of the method with rumen
fluid and maize silage as a matrix was performed to prove the usability of the method in the research
on rumen fluid samples if matrix-matched calibration is used.
2. Results and Discussion
Several criteria were taken into account when developing the UPLC-MS/MS method. The sample
preparation procedure had to be fast and straightforward to ensure an acceptable daily throughput
(sample no. >140). Along with this, a run-time of ≤10 min per ionization mode (electrospray (ESI)
positive (+) or negative (−)) was aimed for. However, simplicity and speed of analysis should not be
reached at the expense of reliability, specificity, and sensitivity. Finally, a thorough method validation
was performed prior to routine application. Special attention was paid to the potential interaction of
feed particles, in this study on maize silage, with the extraction and analysis of mycotoxins, which is
important to setup an appropriate calibration method.
2.1. Mycotoxin Selection
Mycotoxin concentrations in the rumen can be very low, certainly when kinetic degradation
studies are performed as concentrations might gradually decrease. Hence, the developed UPLC-MS/MS
method needs to be very sensitive to detect and quantify mycotoxins and their metabolites. As the
sensitivity which can be reached by a multi-method also partially depends on the number of mycotoxins
included, a selection of the most important mycotoxins found in maize silage in Western Europe was
made. Sensitivity results are reported in Section 2.4.3. Limit of Quantification (LOQ) and Limit of
Detection (LOD).
2.2. UPLC-MS/MS Method
Mass spectrometric parameters of both the precursor and product ions were tuned in their most
sensitive ESI mode (+/−). For each compound, two specific product ions were selected from the mass
spectrum after fragmentation (Table 1). The product ion with the highest intensity was selected for
quantification, whereas the second most intense product ion was used for qualification.
Table 1. Overview of the multiple reaction monitoring (MRM) transitions and tandem mass spectrometry
(MS/MS) parameters for the target analytes.
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Table 1. Cont.

























































a m/z =mass to charge ratio; b CV = cone voltage; c CE = collision energy; d RT = retention time. DON = deoxynivalenol,
DOM-1 = deepoxy-deoxynivalenol, NIV = nivalenol, ENN B = enniatin B, MPA =mycophenolic acid, ROQ-C =
roquefortine C, ZEN = zearalenone, ZAN = zearalanone, α-ZEL = α-zearalenol, β-ZEL = β-zearalenol, α-ZAL =
α-zearalanol and β-ZAL = β-zearalanol. The underlined product ion is used for quantification.
Different columns, mobile phases, LC gradient programs and flow rates were evaluated in
terms of resolution, peak intensity and shape, and signal-to-noise (S/N) ratio (data not shown).
Four different reversed-phase columns were tested (A/ Acquity UPLC BEH C18, Waters; B/Hypersil
gold, ThermoScientific; C/ Acquity UPLC HSS T3 column, Waters; D/ Zorbax Eclipse Plus, Agilent).
The best results were obtained with the Acquity UPLC® HSS T3 column (100 mm × 2.1 mm I.D.,
1.8 μm particle size). Most mobile phases described in literature consist of a combination of water
and methanol (MeOH) or acetonitrile (ACN) to which some additives can be added to improve
chromatography and detection [32]. A better sensitivity was observed for DON when MeOH was used.
For an optimal chromatographic separation of ZEN and its metabolites, ACN was needed [33]. Several
concentrations of ammonium acetate and/or acetic acid or formic acid were tested. The mobile phases
with their LC gradient program that showed the best results were finally chosen for the method are
shown in Table 2. Because of the diverse physicochemical characteristics of the mycotoxins, it was
not possible to analyze all mycotoxins in the same run. Hence, to detect mycotoxins in ESI− and ESI+
mode, the samples had to be analyzed by two subsequent analytical runs, within a total run-time
of 17 min. Chromatographic separation of ZEN and its metabolites was performed in ESI− mode
within a time frame of 7 min using a gradient elution of H2O and ACN as mobile phases (MP); DON,
DOM-1, NIV, ENN B, MPA, and ROQ-C were analyzed in ESI+ mode within a run-time of 10 min,
using a gradient elution of 0.01% acetic acid (v/v) in H2O and 0.01% acetic acid (v/v) in MeOH as MP.
Figures 1 and 2 show the chromatograms of the mycotoxins present in a rumen fluid–buffer mixture
after extraction, determined in ESI+ and ESI−mode, respectively. In comparison with the run-time of
Gallo et al. (2015) to detect PR toxin, MPA, and ROQ-C in the rumen fluid by means of HPLC-MS/MS,
the run-time for the positive ionization mode is 2 min shorter while 12 mycotoxins with various
physicochemical properties were determined [26].
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Table 2. Overview of the UPLC gradient programs used for the mycotoxin ultra-performance liquid





MP A:B Ratio (v:v)
DON, 13C15-DON, DOM-1, NIV, ENN B, 15N3-ENN B,















MP C:D Ratio (v:v)











Note: ESI+: positive electrospray ionization mode; ESI-: negative ESI; MP: mobile phase. MP A = 0.01% acetic
acid (v/v) in H2O; MP B = 0.01% acetic acid (v/v) in MeOH; MP C =H2O; MP D = ACN. DON = deoxynivalenol,
DOM-1 = deepoxy-deoxynivalenol, NIV = nivalenol, ENN B = enniatin B, MPA =mycophenolic acid, ROQ-C =
roquefortine C, ZEN = zearalenone, ZAN = zearalanone, α-ZEL = α-zearalenol, β-ZEL = β-zearalenol, α-ZAL =
α-zearalanol and β-ZAL = β-zearalanol.
2.3. Sample Preparation and Extraction
The use of a simple and practical sample preparation procedure is desirable in order to reduce the
time and cost of analysis. Theoretically, clean-up of samples can be kept to a minimum when analytical
methods as sensitive and specific as UPLC-MS/MS are applied. However, the “dilute-and-shoot”
principle was not considered in this study because of the complexity of the rumen fluid and the higher
chance of clogging and pollution of the MS instrument. On the other hand, the more sophisticated
extraction procedure with solid phase extraction (SPE) was not recommended as this seemed to be
rather expensive and time-consuming, especially when large numbers of samples have to be analyzed.
A liquid–liquid extraction (LLE) was chosen as an alternative and was a good compromise because of
the simplicity of extraction, high throughput sample preparation procedure, and satisfactory sample
clean-up. In the context of “green analytical chemistry” (GAC), ethyl acetate (EtAc) was chosen as
the extraction solvent as this is a more environmentally friendly and cheaper alternative for ACN,
which is often used in mycotoxin extraction protocols [34]. In addition, the simultaneous extraction of
six mycotoxins and six mycotoxin metabolites minimizes the solvent consumption (250 μL PBS and
1.5 mL EtAc per sample) and chemical waste, and makes the chemical analysis more environmentally
friendly [35]. In order to increase the extraction recovery, the volume of the organic extraction solvent
was three times the volume of the aqueous phase (rumen fluid + buffer) as the distribution coefficient of
the analytes between the organic and aqueous phase is dependent on their molar concentrations in the
different phases. The combination of water and ACN as redissolution solvent at a 85/15 (v/v) ratio was
crucial to obtain a good peak shape for all mycotoxins with their various physicochemical properties.
Prior to UPLC-MS/MS analysis, the sample was passed through a filter to remove the remaining solid
particles. For this step, several filters were tested. The Millex®-GV filter (0.22 μm, hydrophilic PVDF
membrane, 13 mm) retained ROQ-C and ENN B and the Millex®-GN filter (0.20 μm, hydrophilic nylon
membrane, 13 mm) retained MPA, ENN B, and ZEN and its metabolites. Only the Millex®-LG filter
(0.20 μm, hydrophilic PTFE membrane, 4 mm) did not show any adsorption of mycotoxins.
2.4. Method Validation with Rumen Fluid–Buffer Mixture as Matrix
For this full method validation, a rumen fluid–buffer mixture was used as the matrix.
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2.4.1. Linearity
Linear calibration curves were obtained for each component over the concentration ranges tested
(see Table 3).
Table 3. Mycotoxin concentrations (limit of quantification (LOQ), medium and high concentration
level) and concentration range in the rumen fluid of the calibration curve (n = 10) used for the in-house
validation of the UPLC MS/MS method and validation results for linearity (r and GOF) and sensitivity













DON 0.45–180 0.05 0.45 12 120 0.9996 4.83
DOM-1 1.56–180 0.08 1.56 12 120 0.9995 4.67
NIV 36–600 5.43 36 120 600 0.9991 4.44
ENN B 0.39–15 <0.01 0.39 1.4 10 0.9982 6.36
MPA 0.6–90 0.17 0.60 6.0 60 0.9995 8.93
ROQ-C 0.1–30 <0.01 0.10 2.0 20 0.9996 5.29
ZEN 0.3–45 0.02 0.30 3.0 30 0.9993 7.82
ZAN 0.3–45 0.07 0.30 3.0 30 0.9997 5.02
α-ZEL 0.3–45 0.08 0.30 3.0 30 0.9990 6.24
β-ZEL 0.3–45 0.07 0.30 3.0 30 0.9938 7.78
α-ZAL 0.3–45 0.02 0.30 3.0 30 0.9983 4.82
β-ZAL 0.3–45 0.02 0.30 3.0 30 0.9931 11.15
Note: DON = deoxynivalenol, DOM-1 = deepoxy-deoxynivalenol, NIV = nivalenol, ENN B = enniatin B, MPA
=mycophenolic acid, ROQ-C = roquefortine C, ZEN = zearalenone, ZAN = zearalanone, α-ZEL = α-zearalenol,
β-ZEL = β-zearalenol, α-ZAL = α-zearalanol, and β-ZAL = β-zearalanol. Acceptability ranges: r = correlation
coefficient ≥0.99; GOF = goodness-of-fit coefficient ≤20%. LOD: signal-to-noise ratio (S/N) = 3; LOQ value, lowest
point of calibration curve and accuracy and precision within acceptability ranges [36].
The correlation coefficients (r) and goodness-of-fit coefficients (gof) met the acceptance criteria of
≥0.99 and ≤20%, respectively (Table 3).
The method of internal standardization was used to compensate for the analyte losses during
sample preparation and for matrix effects during UPLC-MS/MS analysis. For DON, ENN B, MPA,
ROQ-C, and ZEN, the corresponding isotopically labeled internal standard was used, respectively
13C15-DON, 15N3-ENN B, 13C17-MPA, 13C22-ROQ-C, and 13C18-ZEN. Although the use of an IS for
every single mycotoxin included in a multi-mycotoxin method is preferable, this is not feasible in
practice because of financial limitations or lack of commercial availability. In this case, structurally
related standards were also used, e.g., 13C15–DON was chosen as IS not only for the analysis of DON,
but also DOM-1 and NIV, and 13C18-ZEN was chosen not only for the analysis of ZEN but also for its
metabolites, as they have very similar physicochemical properties [10,33]. This is justified as it has
been demonstrated during the method validation experiments that a reliable determination of these
compounds was not impaired.
2.4.2. Accuracy and Precision
The within-run and between-run accuracy and precision were tested at three different concentration
levels (limit of quantification (LOQ, see Section 2.4.3.), medium and high, see Table 3). The acceptability
ranges for accuracy and within-run precision were met for all compounds at the specified levels
according to VICH GL49 [36]. The between-run precision fell within the maximal allowed relative
standard deviation (RSDmax = 2(1–0.5logConc)) [36]. An overview of the results is given in Table 4.
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2.4.3. Limit of Quantification (LOQ) and Limit of Detection (LOD)
The LOQ was set as the lowest concentration of the calibration curve that could be determined
with an accuracy and precision within the acceptability ranges at the specified level. The LOQ ranged
between 0.1 and 1.56 ng/mL, except for NIV that had an LOQ of 36 ng/mL (Table 3). The higher LOQ
of NIV could be attributed to compromises that had to be made for a combined analysis of all analytes.
Although NIV shows a better chromatographic response when determined in ESI- mode with mobile
phases containing acetic acid [37], NIV is determined in ESI+mode as adding acetic acid to the mobile
phases led to a lower sensitivity for ZEN and its metabolites.
The LODs were theoretical and calculated based on the mean S/N ratios of the LOQ samples.
Concentrations corresponding with a theoretical S/N ratio of 3 were set as the LOD and ranged from
<0.01 to 0.17 ng/mL, except for NIV that had a LOD of 5.43 ng/mL.
In the study of Gallo et al. (2015) 15 mL of sample was used for mycotoxin determination with an
LOD and LOQ of 4 and 10 ng/mL for both ROQ-C and MPA, which is much higher than the LOD of
<0.01 ng/mL for ROQ-C and 0.28 ng/mL for MPA, and the LOQ of 0.1 ng/mL for ROQ-C and 0.6 ng/mL
for MPA for the presented UPLC-MS/MS method that used only 250 μL of sample [26].
2.4.4. Signal Suppression/Enhancement (SSE) and Extraction Recovery (RE)
The signal suppression/enhancement (SSE) was considered tolerable if the value ranged between
0.8 and 1.2 [38], with values outside this range indicating a strong matrix effect. SSE has been evaluated
quantitatively and the results are shown in Table 5 (matrix A). As can be seen, there was a strong
matrix effect for almost all analytes evaluated, which can be attributed to the complex matrix of rumen
fluid. Extraction recoveries (RE) were highest for DON and DOM-1 (>40%), around 20% for ZEN and
its metabolites, around 15% for ENN B and ROQ-C and low for NIV and MPA (<10%) (see Table 5).
These variations in RE can be attributed to the different physicochemical properties of the different
mycotoxins which e.g., results in differences in adsorption to particles present in rumen fluid. Such low
RE is hypothesized to be partially linked to enhanced adsorption/binding to (feed) particles as it
has been described that bacteria and yeast cell walls could be involved in binding aflatoxins, DON,
ZEN, and fumonisins, [16–24]. In order to minimize the variations because of RE and SSE, the use of
matrix-matched calibration curves based on samples, which had been subjected to the whole analytical
procedure and the use of isotope labeled ISs are thus mandatory to quantify the selected mycotoxins
and their metabolites in rumen fluid with an acceptable accuracy and precision. Despite the strong
matrix effects and low RE, very low LOD and LOQ values could be obtained because of the very
sensitive UPLC-MS/MS analytical method.
2.4.5. Specificity
Prior to method validation, blank samples of the rumen fluid were analyzed to evaluate
the presence/absence of mycotoxins. Small peaks could be detected at the elution zone of DON,
DOM-1, ENN B, and ZEN, indicating that the rumen fluid already contained small amounts of these
mycotoxins (DON: 0.45 ng/mL, DOM-1: 1.56 ng/mL, ENN B: 0.35 ng/mL, and ZEN: <LOQ) (Figures 3
and 4). However, these “background” mycotoxin levels could be compensated for by the use of a
matrix-matched calibration approach.
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Table 5. Extraction recovery (RE) and signal suppression/enhancement (SSE) of mycotoxins in the
rumen fluid–buffer mixture (Matrix A: RF) and in the rumen fluid–buffer mixture with 10 mg maize
silage per mL (Matrix B: RF +MS). The results show that SSE and RE differ between different matrices.






SSE (%) RE (%) SSE (%) RE (%)
DON 79 42 55 44
NIV 68 9 60 8
ENN B 241 13 197 16
MPA 45 2 48 3
ROQ-C 69 16 62 16
ZEN 60 19 52 19
DOM-1 71 46 60 48
α-ZEL 60 20 53 21
β-ZEL 67 21 60 25
ZAN 64 19 53 21
α-ZAL 64 22 58 25
β-ZAL 68 23 63 29
Note: DON = deoxynivalenol, DOM-1 = deepoxy-deoxynivalenol, NIV = nivalenol, ENN B = enniatin B, MPA =
mycophenolic acid, ROQ-C = roquefortine C, ZEN = zearalenone, ZAN = zearalanone, α-ZEL = α-zearalenol,
β-ZEL = β-zearalenol, α-ZAL = α-zearalanol, and β-ZAL = β-zearalanol. SSE = slope(spiked extract calibration curve)/
slope(standard calibration curve), RE = slope(spiked calibration curve)/slope(spiked extract calibration curve).
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2.4.6. Carry-Over
No carry-over of analytes from one sample to another was observed, except for ROQ-C (0.3%
carry over). This can be attributed to the flow-through-needle (FTN) design of the Acquity H-Class
system. In case of ROQ-C analysis, carry-over could be overcome by the injection of two solvent
samples after each validation/study sample with a suspected high concentration of ROQ-C [39].
2.5. Evaluation of the Impact of Maize Silage on the Extraction Recovery (RE) and Signal
Suppression/Enhancement (SSE)
As a substrate is always added to the rumen fluid to maintain fermentation during in vitro rumen
incubations, and rumen fluid samples from in vivo studies also contain feed particles, feed particles can
interact with the extraction and analysis of mycotoxins. Hence, the effect of feed particles, i.e., maize
silage in this study, on RE and SSE was investigated. The extraction recovery (RE) in rumen fluid–buffer
mixture including 10 mg maize silage per mL (RF +MS) was compared with the corresponding RE in
rumen fluid–buffer mixture without maize silage (RF). The results are shown in Table 5. SSE is mainly
negatively influenced by the addition of maize silage in the samples, which was indeed expected as
maize silage makes the matrix more complex. Moreover, the RE is influenced by the addition of maize
silage, which can be attributed to a change in solubility of the mycotoxins by addition of maize silage
and/or the differences in adsorption to feed particles. Therefore, it is of utmost importance to prepare
matrix-matched calibration curves.
2.6. Cross-Validation of the Method with Rumen Fluid and Maize Silage as Matrix
To prove that the described UPLC-MS/MS method can also be used with rumen fluid samples
that also include substrate, the method was subjected to a cross-validation whereby 10 mg of maize
silage was added per mL of rumen fluid–buffer mixture. Linearity, within-run accuracy and within-run
precision were determined in the same way as the full method validation with rumen fluid–buffer
mixture alone. The results are shown in Tables 6 and 7.
Table 6. Mycotoxin concentrations (limit of quantification (LOQ), medium and high concentration
level) and concentration range of the calibration curve (n = 10) used for the in-house cross-validation of
the UPLC MS/MS method with rumen fluid–buffer mixture and maize silage (10 mg/mL) and validation
results for linearity (r and GOF) and sensitivity (LOD (limit of detection) and LOQ; n = 6). For all













DON 8–187 0.41 7.99 19.4 120 0.9998 1.65
DOM-1 6–180 0.35 6.00 12.0 120 0.9993 3.22
NIV 36–900 9.28 36 120 600 0.9974 6.64
ENN B 0.44–15.34 0.01 0.44 1.34 10 0.9985 5.81
MPA 1.20–90 0.42 1.20 6.0 60 0.9986 6.55
ROQ-C 0.2–30 0.01 0.20 2.0 20 0.9978 9.29
ZEN 1.06–45 0.04 1.06 3.5 30 0.9995 4.09
ZAN 0.3–45 0.10 0.30 3.0 30 0.9989 5.58
α-ZEL 0.6–45 0.15 0.60 3.0 30 0.9994 5.24
β-ZEL 0.6–45 0.08 0.60 3.0 30 0.9992 6.57
α-ZAL 1.5–45 0.04 1.50 3.0 30 0.9993 4.91
β-ZAL 0.3–45 0.06 0.30 3.0 30 0.9994 5.83
Note: DON = deoxynivalenol, DOM-1 = deepoxy-deoxynivalenol, NIV = nivalenol, ENN B = enniatin B, MPA =
mycophenolic acid, ROQ-C = roquefortine C, ZEN = zearalenone, ZAN = zearalanone, α-ZEL = α-zearalenol,
β-ZEL = β-zearalenol, α-ZAL = α-zearalanol, and β-ZAL = β-zearalanol. Acceptability ranges: r = correlation
coefficient ≥0.99; GOF = goodness-of-fit coefficient ≤20%. LOD: signal-to-noise ratio (S/N) = 3; LOQ value, lowest
point of calibration curve and accuracy and precision within acceptability ranges [36].
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Table 7. Validation results of the in-house cross-validation of the UPLC MS/MS method with rumen
fluid–buffer mixture and maize silage (10 mg/mL) for within-run precision (n = 6) with corresponding
accuracy at low (LOQ), medium, and high concentration level. The different concentration levels for
each mycotoxin are mentioned in Table 6. For all components, the acceptability ranges for accuracy
and precision were met.
Analyte
Within-Run (n = 6)
Accuracy (%) Precision (RSD, %)
LOQ Medium High LOQ Medium High
DON −0.3 B 0.1 C −4.8 C 0.6 B 2.5 C 3.6 D
DOM-1 −7.9 B −6.3 C 1.9 C 9.7 B 3.3 C 4.7 D
NIV 1.1 C 5.5 C −1.0 C 5.6 C 2.8 D 8.0 D
ENN B −2.0 A 4.5 B −8.5 C 4.0 A 2.9 B 5.1 C
MPA −1.1 B −7.3 B 3.6 C 5.0 B 8.9 B 7.4 C
ROQ-C −12.5 A −1.0 B −5.2 C 3.1 A 3.3 B 3.0 C
ZEN −6.0 B 2.5 B 3.1 C 8.8 B 6.2 B 7.3 C
ZAN −2.2 A 0.9 B 8.3 C 6.0 A 4.7 B 0.9 C
α-ZEL 1.9 A −7.6 B −5.2 C 4.7 A 2.9 B 6.5 C
β-ZEL −1.4 A −17.6 B −0.7 C 8.2 A 10.0 B 7.8 C
α-ZAL −10.9 B −17.0 B 7.4 C 7.8 B 9.5 B 6.7 C
β-ZAL −8.3 A −16.8 B −2.9 C 6.4 A 11.1 B 7.5 C
Note: DON = deoxynivalenol, DOM-1 = deepoxy-deoxynivalenol, NIV = nivalenol, ENN B = enniatin B, MPA =
mycophenolic acid, ROQ-C = roquefortine C, ZEN = zearalenone, ZAN = zearalanone, α-ZEL = α-zearalenol, β-ZEL
= β-zearalenol, α-ZAL = α-zearalanol, and β-ZAL = β-zearalanol. Acceptability ranges for accuracy: −50 to +20%
for conc. <1 ng/mL (A in superscript), −30 to +10% for conc. ≥1 to 10 ng/mL (B in superscript), −20% to +10% for
conc. ≥10 ng/mL (C in superscript), and within-run precision: RSDmax = 30% for conc. <1 ng/mL (A in superscript),
RSDmax = 25% for conc. ≥1 to 10 ng/mL (B in superscript), RSDmax = 15% for conc. ≥10 ng/mL to 100 ng/mL
(C in superscript), RSDmax = 10% for conc. ≥100 ng/mL (D in superscript).
Similar to the full method validation with rumen fluid–buffer mixture, the correlation coefficients
(r) and goodness-of-fit coefficients (gof) met the acceptance criteria of ≥0.99 and ≤20%, respectively
(Table 6). In addition, the within-run accuracy and precision at three different concentrations (LOQ,
medium, and high) met the acceptability ranges for all compounds (Table 7). The LOQ ranged from
0.2 to 7.99 ng/mL, except for NIV that had a LOQ of 36 ng/mL. The LOD ranged from 0.01 to 0.42 ng/mL,
except for NIV that had a LOD of 9.28 ng/mL. The LOQ and LOD values are somewhat higher compared
to the LOQ and LOD values of the rumen fluid–buffer mixture alone, which can be explained by the
more complex matrix. In addition, for the cross-validation, following concentrations were found in the
blank sample with maize silage: DON: 7.39 ng/mL, ENN B: 0.34 ng/mL, and ZEN: 0.46 ng/mL, which
could be due to a higher contamination of the rumen fluid used for the cross-validation, but also from
the maize silage that is already contaminated with small amounts of mycotoxins. The relative high
concentration of DON in the blank sample explains also the higher LOQ of DON compared to the full
validation method without maize silage. However, these values are still very low compared to other
methods. The method of Gallo et al. (2015) had an LOD and LOQ of 4 and 10 ng/mL for both ROQ-C
and MPA, which is much higher than the LOD of 0.01 ng/mL for ROQ-C and 0.42 ng/mL for MPA, and
the LOQ of 0.2 ng/mL for ROQ-C and 1.2 ng/mL for MPA for the cross-validation with rumen fluid
and maize silage [26].
These results demonstrate that this method can be used for the quantitative determination of
mycotoxins and their relevant metabolites in the rumen fluid samples if matrix-matched calibration
curves are used. For in vitro rumen simulation studies for example, this implies that a calibration
curve has to be prepared with rumen fluid which contains the same substrate as used in the study.
3. Conclusions
This study describes the development and in-house validation of a sensitive and specific
UPLC-MS/MS method for the quantification of the most relevant mycotoxins and their possible
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metabolites in the rumen fluid. The sample extraction procedure is simple and straightforward and
consists of a liquid–liquid extraction using EtAc. Furthermore, the UPLC-MS/MS analysis of each
sample is split in two analytical runs, i.e., in ESI+ and ESI−mode, with a run-time of 10 and 7 min,
respectively, resulting in a total analysis time of 17 min/sample allowing a high throughput. The method
is successfully validated for all analytes of interest according to international guidelines and literature.
Furthermore, as feed particles are often present in rumen fluid samples, the interaction of maize
silage on SSE and RE was demonstrated which emphasizes the importance of using matrix-matched
calibration curves to allow a correct quantification of analytes. A cross-validation of the method with
rumen fluid and maize silage as matrix demonstrates that this analytical method can be applied in
research to investigate the degradation of the reported mycotoxins by rumen microbiota in rumen
fluid samples if matrix-matched calibration curves are used.
4. Materials and Methods
4.1. Mycotoxin Selection
Mycotoxin selection was based on their prevalence in Belgium and their toxicological impact.
In 2016, maize samples from 91 maize fields across Flanders (Belgium) were analyzed on mycotoxin
contamination before ensiling. The mycotoxins most often found in these samples were NIV, DON,
ZEN, and ENN B and were found in respectively 98.9%, 92.3%, 64.8%, and 42.9% of all samples
(Table S1). Of those samples, 2% and 1% exceeded the European Union reference values for DON and
ZEN, respectively. Hence, NIV, DON, ZEN, ENN B and their metabolites DOM-1, ZAN, α-ZEL, β-ZEL,
α-ZAL, and β-ZAL were selected as pre-harvest mycotoxins. Additionally, mycotoxin contamination
data of 21 maize silages and 100 silage samples were used and mycotoxins that had a minimum
prevalence of 90% in non-moldy and/or moldy parts were also included. In addition to DON
(in all samples), ZEN (in 90% of the maize silage samples), and ENN B (in 91% of silage samples),
ROQ-C (in all moldy hot spots) and MPA (95% in non-moldy parts) were highly prevalent (Table S2).
Although citrinin was also often present in maize silage (95%), this mycotoxin was not included in the
UPLC-MS/MS method as this mycotoxin needs acidified extraction solvents in contrast to the other
mycotoxins [40].
4.2. Rumen Fluid, Maize Silage, Mycotoxins, Chemicals, and Reagents
Rumen fluid was collected from three fistulated dairy cows (Institute for Agricultural, Fisheries
and Food Research, EC2014/241) prior to the morning feeding and immediately transferred to thermos
flasks before making the rumen fluid–buffer mixture (see Section 4.3). Sampling was done for the full
method validation and another sampling was performed for the cross-validation.
Maize silage was obtained from Agrivet (Melle, Belgium) in May 2012 and lyophilized. Mycotoxin
concentrations were determined at the Centre of Excellence in Mycotoxicology and Public Health,
Department of Bioanalysis at Ghent University, Belgium. Only small amounts of NIV (201 μg/kg),
DON (593 μg/kg), ZEN (68 μg/kg), and ROQ-C (12 μg/kg) were detected. The concentration of ENN B
was below the cut-off value of 80 μg/kg.
The analytical standards of DON, NIV, MPA, ROQ-C, and ZEN were purchased from Fermentek
(Jerusalem, Israel). The standards of DOM-1, ENN B, ZAN, α-ZEL, β-ZEL, α-ZAL, and β-ZAL
were purchased from Sigma-Aldrich (Overijse, Belgium). The internal standards (IS) 13C17-MPA,
13C22-ROQ-C, and 13C18-ZEN were purchased from Food Risk Management (Oostvoorne, The
Netherlands). The IS 13C15-DON was purchased from Sigma-Aldrich. The IS 15N3-ENN B was
kindly donated by the Chair of Analytical Food Chemistry at the Technical University of Munich
(Freising, Germany) [41].
Methanol (MeOH), acetonitrile (ACN), ammonium acetate, and water (H2O) were purchased
from Biosolve (Valkenswaard, The Netherlands) and were of UPLC/MS grade. Acetic acid (AA),
hydrochloric acid (HCl) 37%, ethyl acetate (EtAc) were purchased from Merck Millipore (Overijse,
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Belgium) and were of analytical grade. Sodium chloride (NaCl), potassium dihydrogenphosphate
(KH2PO4), and ammonium hydrogen carbonate (NH4HCO3) were purchased from VWR (Leuven,
Belgium). The phosphate-buffered saline (PBS) powder packs were purchased from Thermo Fisher
Scientific (Merelbeke, Belgium). Disodium hydrogen phosphate dodecahydrate (Na2HPO4·12H2O)
and magnesium chloride hexahydrate (MgCl2·6H2O) were from Carl Roth (Vienna, Austria). Sodium
hydrogen carbonate (NaHCO3) was purchased from Sigma-Aldrich. Carbon dioxide (CO2) 100% was
purchased from Air Liquide (Aalter, Belgium).
4.3. Preparation of Standard Solutions and Rumen Fluid–Buffer Mixture
Stock solutions of 1 mg/mL in ACN were prepared for DON, NIV, MPA, ROQ-C, ZEN, and ENN
B and of 100 μg/mL in ACN for ZAN, α-ZEL, β-ZEL, α-ZAL, and β-ZAL. DOM-1 was already in
solution upon purchase (50 μg/mL in ACN). An IS-stock solution of 5 μg/mL in ACN was prepared for
15N3-ENN B. All other IS were already in solution upon purchase (13C15-DON: 25.3 μg/mL in ACN,
13C17-MPA: 25.4 μg/mL in ACN, 13C22-ROQ-C: 25 μg/mL in ACN, 13C18-ZEN: 25.4 μg/mL in ACN).
The standard stock solutions were used to make a combined working solution of all standards in ACN
without IS (3 μg/mL for DON and DOM-1, 15 μg/mL for NIV, 0.25 μg/mL for ENN B, 1.5 μg/mL for
MPA, 0.5 μg/mL for ROQ-C, and 0.75 μg/mL for ZEN, ZAN, α-ZEL, β-ZEL, α-ZAL, and β-ZAL). Serial
dilutions (10×, 100×, and 1000×) of the combined working solutions were prepared. A combined
working solution of all IS was prepared with a final concentration of 100 ng/mL for 13C15-DON,
13C17-MPA, and 13C18-ZEN and 10 ng/mL for 15N3-ENN B and 13C22-ROQ-C. The standard and IS
stock solutions were used for the preparation of matrix-matched calibrator and quality control (QC)
samples. All stock and working solutions were stored at ≤−15 ◦C.
As in vitro rumen simulations are performed in a buffered rumen environment, a rumen
fluid–buffer mixture was also used for the method development. The buffer contained the following
compounds per liter: 3.58 g Na2HPO4·12H2O, 1.55 g KH2PO4, 0.124 g MgCl2·6H2O, 8.74 g NaHCO3,
and 1.00 g NH4HCO3. The buffer was saturated with CO2 overnight and kept at 39 ◦C. The next day,
fresh rumen fluid of three cows was mixed and sieved using a sieve with mesh width of 1 mm and
added to the buffer at a rumen fluid/buffer ratio of 263.2 mL/1000 mL. The rumen fluid–buffer mixture
was stored at ≤−15 ◦C until calibrator, validation and quality control (QC) samples were prepared.
4.4. Preparation of Calibrator, Validation and QC Samples
Matrix-matched calibrator samples were prepared by adding the appropriate combined working
solution to 250 μL rumen fluid–buffer mixture with or without maize silage to obtain a calibration range
of 0.24–180 ng/mL of DON and DOM-1, 1.2–900 ng/mL of NIV, 0.02–15 ng/mL of ENN B, 0.12–90 ng/mL
of MPA, 0.04–30 ng/mL of ROQ-C and 0.06–45 ng/mL of ZEN, ZAN, α-ZEL, β-ZEL, α-ZAL and β-ZAL.
QC samples were prepared at medium and high concentration levels (Table 3). For DON and ZEN,
the high concentration levels were based on the recommended maximum values in maize by-products
formulated by the Commission of the European Communities [42]. As no recommended maximum
values are available for the other mycotoxins, the high concentration levels of those mycotoxins were
based on the worst case contamination levels in maize silage found in Belgium/the Netherlands
described in literature [4,7–9].
4.5. Mycotoxin Extraction
The following procedure was applied to extract DON, DOM-1, NIV, ENN B, MPA, ROQ-C, ZEN,
ZAN, α-ZEL, β-ZEL, α-ZAL, and β-ZAL from the matrix-matched calibrator, validation or QC samples:
a 250-μL aliquot of the rumen fluid–buffer mixture was taken and transferred to a polypropylene
15-mL extraction tube, followed by the addition of 25 μL of the IS-mix working solution, 250 μL PBS
and 1.5 mL of EtAc. The samples were vortex mixed and extracted on an overhead shaker (15 min).
After centrifugation (3724× g, 5 min, 4 ◦C), the upper organic phase was collected and evaporated
to dryness under a gentle nitrogen stream at ~50 ◦C. The dry residue was redissolved in 200 μL of
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H2O/ACN (85/15, v/v), vortex mixed, filtered using a 0.20 μm Millex®-LG PTFE filter (Merck Millipore,
Overijse, Belgium), and collected in an autosampler vial.
4.6. UPLC-MS/MS Analysis
The UPLC system consisted of an Acquity H-Class Quaternary Solvent Manager and
Flow-Through-Needle Sample Manager with temperature-controlled tray and column oven from
Waters (Zellik, Belgium). Chromatographic separation of the analytes was achieved on an Acquity
UPLC® HSS T3 column (100 mm × 2.1 mm I.D., particle size (dp): 1.8 μm) in combination with an
Acquity HSS T3 Vanguard pre-column (5 mm × 2.1 mm I.D., dp: 1.8 μm) both from Waters.
Liquid chromatography parameters (mobile phase (MP) composition and gradient programs)
were optimized for optimal chromatographic separation of all analytes. The MP for analysis of DON,
13C15-DON, DOM-1, NIV, ENN B, 15N3-ENN B, MPA, 13C17-MPA, ROQ-C, and 13C22-ROQ-C consisted
of 0.01% AA in H2O (A) and 0.01% AA in MeOH (B). The MP for the analysis of ZEN, 13C18-ZEN and
the metabolites ZAN, α-ZEL, β-ZEL, α-ZAL, and β-ZAL consisted of H2O (A) and ACN (B). A gradient
elution was performed as shown in Table 2. The flow-rate was set at 0.3 mL/min. The temperatures of
the column oven and autosampler tray were set at 40 ◦C and 8 ◦C, respectively. The injection volume
was 5 μL/sample.
The UPLC system was coupled to a Xevo® TQ-S MS/MS system, equipped with an ESI probe
operating in both the positive and negative ionization mode (all from Waters, Zellik, Belgium). A divert
valve was used and the UPLC effluent was directed to the mass spectrometer from 2.50 to 8.50 min for
the ESI+ analysis and from 2.20 to 5.20 min for the ESI− analysis.
Mass spectrometric parameters were optimized by syringe infusion of working solutions of
1 μg/mL of each analyte (flow-rate: 10 μL/min) in combination with the mobile phase (50% A, 50% B,
flow-rate: 0.3 mL/min). The following parameters were used: capillary voltage: 3.3 kV (ESI+) and
2.7 kV (ESI−), source offset: 40 V (ESI+) and 50 V (ESI−), desolvation temperature: 400 ◦C, desolvation
gas: 600 L/h, cone gas: 150 L/h, source temperature: 150 ◦C, nebulizer pressure: 7.0 bar, LM resolution
1 and 2: 3.0, HM resolution 1 and 2: 15.0, ion energy 1: 0.8 (ESI+) and 0.5 (ESI−), ion energy 2: 1.0
(ESI+) and 0.5 (ESI−), collision gas flow: 0.20 mL/min (ESI+) and 0.25 mL/min (ESI−).
MS/MS acquisition was performed in the multiple reaction monitoring (MRM) mode for both the
ESI+ and ESI−mode. In Table 1, an overview is given of compound specific parameters such as MRM
transitions, cone voltage (CV), collision energy (CE), and retention time (RT). Dwell times were set at
10–50 msec/transition.
MassLynx version 4.1 software was used for data processing (Copyright© 2012, Waters,
Zellik, Belgium).
4.7. In-House Method Validation
The developed UPLC-MS/MS method was validated in-house by a set of parameters that were
in compliance with the recommendations as defined by the European Community [43] and with
reference guidelines defined in other EU and FDA documents [36,44,45]. The following parameters
have been evaluated for the full method validation with rumen fluid as matrix: linearity, within-run,
and between-run accuracy, within-run and between-run precision, limit of quantification (LOQ), limit
of detection (LOD), specificity, carry-over, extraction recovery and signal suppression/enhancement.
For the cross-validation with rumen fluid +maize silage (10 mg maize silage per mL rumen fluid–buffer
mixture) as matrix following parameters have been evaluated: linearity, within-run accuracy, within-run
precision, limit of quantification (LOQ), and limit of detection (LOD).
Linearity. Calibration curve samples for the full validation and cross-validation were prepared
by applying standard working solutions directly onto the homogenized blank samples, followed by
a vortex mixing step. Mycotoxins from the calibration curve samples were extracted and quantified
as mentioned in Sections 4.5 and 4.6. By using the same rumen fluid for the calibration curve as the
samples to be analyzed, the initial concentration of mycotoxins can be determined by the standard
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addition method. By adding different concentrations of the mycotoxins to the rumen fluid samples,
after measuring the final extract solutions, the observed signals are linearly regressed on the spiked
amounts. The original unknown amount is estimated by the opposite of the abscissa intercept of the
fitted linear curve. Linearity was evaluated by the correlation coefficients (r) and goodness- of-fit
coefficients (g) that had to be ≥0.99 and ≤20%, respectively [43]. For a curve where no weighting is
applied, the data at the high end of the calibration curve tend to dominate the calculation of the linear
regression as the absolute variation is larger for higher concentrations. Hence, 1/x weighted calibration
curves were used.
Accuracy and precision. Within-run accuracy and precision (repeatability) were determined by
analysing six blank samples that were spiked at LOQ, medium, and high concentration levels on the
same day. The between-run accuracy and precision were determined by analysing two blank samples
that were spiked at LOQ, medium, and high concentration levels, repeated on three different days.
The acceptance criteria for accuracy (i.e., the difference between spiked and measured concentration)
were −30% to +10% for concentrations between 1 and 10 ng/mL and −20% to +10% for concentrations
≥10 ng/mL. For the precision, the relative standard deviation (RSD) had to be below RSDmax =
2(1−0.5log Conc) × 2/3 for within-run precision and 2(1−0.5log Conc) for between-run precision [43,45].
Limit of quantification. The limit of quantification (LOQ) was the lowest concentration for which
the method was validated with an accuracy and precision that fell within the recommended ranges.
The LOQ was determined by analysing six spiked samples and was also the lowest point of the
calibration curve.
Limit of detection. The limit of detection (LOD) was the lowest concentration that could be
determined with a signal-to-noise ratio (S/N) of ≥3 and was calculated using samples spiked at the
LOQ level.
Specificity. The specificity checks for interferences from endogenous compounds. The S/N ratio of
a possible interfering peak in a blank sample (n = 1) had to be below the LOD of the analyte in the
same elution zone.
Carry-over. The carry-over was evaluated by analyzing a solvent sample just after the highest
calibrator sample. The eventual analyte concentration in the solvent sample had to be below the LOD.
Extraction recovery (RE) and signal suppression/enhancement (SSE). These effects were determined
according to Matuszewski et al. [46] and are visualized in Figure 5. Two types of matrix-matched
calibration curves were prepared for each analyte by spiking the blank calibrator samples before
(= spiked) and after (= spiked extract) extraction. In addition, one calibration curve was prepared
using standard solutions (= standard). The extraction recovery (RE) was determined by dividing
the slopes of the resulting linear, spiked calibration curves by the related slopes of the calibration
curves for spiked extracts. The signal suppression/enhancement (SSE) was evaluated by dividing the
slopes of the calibration curves for spiked extracts by the related slopes of the calibration curves for
standard solutions.
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4.8. Evaluation of the Impact of Maize Silage on the Extraction Recovery (RE) and Signal
Suppression/Enhancement (SSE)
Ten milligram of maize silage was added per mL of rumen fluid–buffer mixture, RE and SSE were
determined as mentioned under Section 4.7 and compared with RE and SSE values when using rumen
fluid–buffer mixture alone.
Supplementary Materials: The following are available online at http://www.mdpi.com/2072-6651/11/9/519/s1,
Table S1: Mycotoxins found in maize samples in Belgium, Table S2: Mycotoxins found in silage samples in Europe.
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Abstract: Routine mycotoxin biomonitoring methods do not include many mycotoxin phase I and
phase II metabolites, which may significantly underestimate mycotoxin exposure especially for heavily
metabolized mycotoxins. Additional research efforts are also needed to measure metabolites in vivo
after exposure and to establish which mycotoxin metabolites should be prioritized for the inclusion
during large-scale biomonitoring efforts. The objective of this study was to perform human in vitro
microsomal incubations of 17 mycotoxins and systematically characterize all resulting metabolites
using liquid chromatography–high-resolution mass spectrometry (LC-HRMS). The results obtained
were then used to build a comprehensive LC-MS library and expand a validated 17-mycotoxin
method for exposure monitoring to screening of additional 188 metabolites, including 100 metabolites
reported for the first time. The final method represents one of the most comprehensive LC-HRMS
methods for mycotoxin biomonitoring or metabolism/fate studies.
Keywords: mycotoxins; metabolism; high-resolution mass spectrometry (HRMS); microsomal
incubation; glucuronidation; human; biomonitoring
Key Contribution: This research provides the most comprehensive LC-MS library of mycotoxin
metabolites fully characterized by HRMS to date to enable monitoring of 17 mycotoxins and 188
metabolites in plasma, urine or other biofluids of interest.
1. Introduction
Mycotoxins are toxic chemically diverse secondary metabolites produced by filamentous
fungi. Their structural diversity can give rise to several adverse effects in humans and animals,
such as carcinogenicity, immunosuppression, teratogenicity, nephrotoxicity, and hepatotoxicity [1].
The contamination of food and feed supply with low levels of mycotoxins is widespread, and includes
commodities such as wine, apple juice, cereals, milk, coffee beans, maize, nuts, dried fruits, and meat
products [2–7]. For example, a worldwide survey of more than 19,000 cereal and oilseed samples found
that 72% were contaminated with one or more mycotoxins: aflatoxins (26%), deoxynivalenol (56%),
ochratoxin A (25%), fumonisins (54%), and zearalenone (37%) [8]. In agreement with these findings,
the most recent surveys of Canadian food supply showed 59% and 75% of the tested samples had
detectable levels of at least one mycotoxin, with the most frequent incidence of deoxynivalenol [2,9].
Many other studies to date have also confirmed co-occurrence of multiple mycotoxins in food and feed
Toxins 2019, 11, 433; doi:10.3390/toxins11080433 www.mdpi.com/journal/toxins211
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samples [8,10,11], which in turn may lead to synergistic or antagonistic effects. Currently, the assessment
of human mycotoxin exposure is primarily modelled from the measured/estimated levels of mycotoxins
in the various foods and the calculated daily average food intake of various food groups to estimate
population exposure and introduce regulations for food monitoring when appropriate. However, an
individual’s food consumption pattern depends on personal preferences. Thus, population-based
food intake models can lead to the inaccurate estimation of human exposure to mycotoxins and,
subsequently, higher health risk in some sub-populations. Vegetarian and non-vegetarian adult
exposure to deoxynivalenol is one such example, whereby a recent U.K. study found ~2 × higher
mean level of deoxynivalenol in vegetarians than in non-vegetarians [12]. Furthermore, the exceeded
recommended tolerable daily intakes (32%) were found only in individuals belonging to the vegetarian
group. Biomonitoring of adult and children urine samples in large-scale exposure studies also
demonstrated that daily tolerable intake was exceeded for some mycotoxins [13–15].
To address the limitations of food-based models, direct human biomonitoring of biological
fluids is proposed as an alternative approach to assess health risk [13–15]. However, this approach
currently has several limitations. It requires high-throughout, multi-mycotoxin methods that have
very low limits-of-detection in complex biological matrices such as blood and urine. Secondly,
metabolic pathways have not been investigated thoroughly for all mycotoxins and key metabolites
have not yet been prioritized for inclusion in routine biomonitoring [16]. Consequently, most of the
existing analytical LC-MS methods used for the assessment of human exposure focus only on the
detection of parent compounds. This can lead to significant underestimation of mycotoxin exposure.
For example, a recent study of deoxynivalenol metabolism in humans confirmed the need for the
inclusion of its metabolites in biomonitoring [17]. They showed that approximately 72.6% of total
urinary deoxynivalenol (DON) was composed of its glucuronides, DON-15-glucuronide (15-Gluc-DON)
and DON-3-glucuronide (3-Gluc-DON) and only 27.4% was present as free DON [17]. Thus, the
measurement of DON only would underestimate DON exposure by ~4 ×. Other studies have also
confirmed the importance of 15-Gluc-DON as a predominant glucuronide [15,18,19]. In general,
biomonitoring methods should combine parent compounds and their predominant metabolite(s) in
order to properly estimate exposure risk [20].
Currently, the majority of mycotoxin biomonitoring is performed using urine since it is non-invasive
and accessible in relatively large volume. These methods can be divided into methods with and
without β-glucuronidase treatment. B-glucuronidase catalyzes hydrolysis of conjugated mycotoxins,
such as sulfate and glucuronide conjugates. Thus, the use of enzymatic hydrolysis can provide
an appropriate alternative to direct metabolite monitoring for at least those mycotoxins which are
predominately metabolized to phase II conjugated forms such as DON [17,21]. To date, such methods
cover 7–11 mycotoxins [14,21–23]. The main disadvantages ofβ-glucuronidase treatment are: increases
the cost per sample, requires longer processing time of about 16–18 h, and the additional step in
sample preparation may give a rise to quantification errors. Multi-mycotoxin methods without
β-glucuronidase treatment have been developed for 8–32 mycotoxins in urine [13,24–28], and for
8–27 mycotoxins in blood, serum or plasma [23,24,29,30]. However, these methods often include no or
limited direct monitoring of mycotoxin metabolites.
Due to their toxicity, in vivo data on mycotoxin metabolism in humans after exposure is rare, with
few exceptions [17]. Animal models have been used more frequently, but the interspecies differences
in mycotoxin metabolism should be taken into consideration [31–33]. In vitro human liver microsomal
incubations have been used extensively in the metabolism studies of mycotoxins, for example to
obtain metabolic profile of T-2 and HT-2 toxins [32,33], or to study in detail the glucuronidation of the
zearalenone group [34–36]. Human liver microsomes contain a variety of enzymes that are involved
in both phase I and phase II toxin metabolism and reaction conditions can be easily controlled to
generate the needed quantity of metabolites. The examples of phase I reactions are oxidation, reduction,
dehalogenation, or hydrolysis and are catalyzed by several enzymes including cytochrome P450. Phase
II reactions are conjugation reactions, for example with glucuronic acid, sulfate, glutathione and/or
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amino acids. High-resolution mass spectrometry (HRMS) provides an excellent analytical platform for
the characterization and investigation of mycotoxin metabolites and putative biomarkers for further
human biomonitoring [20]. The combination of HRMS and metabolic software can greatly speed up and
expand the ability to capture the broad spectrum of mycotoxin metabolites using both accurate-mass of
full-scan MS and/or fragmentation mass spectral data (MS/MS or MSn). For instance, Yang et al. used
HRMS to study T-2 and HT-2 metabolism in different species and identify main metabolic pathways
and novel metabolites [32,33]. However, such single-analyte metabolism studies relied on a variety of
analytical platforms and methods, thus hindering the creation of a comprehensive metabolite LC-MS
library using a single analytical method and its further application in human biomonitoring. As such,
it is of utmost importance to include mycotoxin metabolites in ongoing biomonitoring efforts and
to use this information to prioritize the most commonly observed mycotoxin metabolites that may
contribute to under-estimation of exposure. To achieve this goal, the first step is to fully characterize
and build a comprehensive LC-MS library of mycotoxin metabolites using a single well-characterized
LC-MS method.
In this work we present in vitro metabolism studies of 17 mycotoxins detected in the
Canadian food supply: aflatoxins B1, B2, G1 and G2 (AFB1, AFB2, AFG1, AFG2), zearalenone
(ZEN), 7-α-hydroxy-zearalenol (α-ZOL), 7-β-hydroxy-zearalenol (β-ZOL), zearalanone (ZAN),
7-α-hydroxy-zearalanol (α-ZAL), 7-β-hydroxy-zearalanol (β-ZAL), T-2 toxin (T-2), HT-2 toxin (HT-2),
DON, nivalenol (NIV), 15-acetyldeoxynivalenol (15-AcDON), 3-acetyldeoxynivalenol (3-AcDON) and
fusarenon X (FUS-X) in order to characterize phase I and glucuronide phase II mycotoxin metabolites.
Mycotoxin metabolites were generated in vitro using pooled human liver microsomes to build an
extensive in-house library of these species, for which standard compounds are often not commercially
available. The final in-house LC-MS library was built using a previously published validated method
for sensitive quantitation of 17 mycotoxins in plasma using liquid chromatography–high-resolution
mass spectrometry (LC-HRMS) [29]. The use of this method allowed excellent chromatographic
separation of many isomers and the optimized highly sensitive HRMS detection allowed detailed
characterization of both known and novel metabolites.
2. Results
Human liver microsomes are important and common tool for in vitro investigations of toxin
metabolism because they express a variety of enzymes which are involved in phase I metabolism
such as microsomal cytochrome P450 (P450) and flavin-containing monooxygenases (FMO). These
enzymes are responsible for the most common phase I reactions, such as oxidation. Usually, toxins
are converted to more polar compounds due to phase I reactions. Phase II metabolism provides
an additional mechanism to clear toxins from the body by adding water-soluble groups, such as
glucuronic, methyl, sulfate and acetyl groups [20,37]. In this work, phase II glucuronidation reaction
was chosen as a major human metabolic pathway of toxins in addition to phase I metabolism. In total,
17 mycotoxins, such as trichothecene type A (T-2 and HT-2), trichothecene type B (NIV, FUS-X, DON,
3-AcDON and 15-AcDON), aflatoxins (AFB1, AFB2, AFG1, and AFG2) and group of zearalenone (ZEN,
α-ZOL, β-ZOL, ZAN, α-ZAL, and β-ZAL) were incubated individually in the presence of human
microsomes and 188 different fungal metabolites were characterized and detected. The analysis of all
microsomal incubation samples was performed with high-resolution mass spectrometer (LTQ Orbitrap
Velos) coupled with liquid chromatography in order to detect and identify mycotoxin metabolites.
Structural elucidation of metabolites was performed using data-dependent MS/MS acquisition and
collision-induced dissociation (CID) fragmentation technique. Metabolite characterization and data
analysis was performed using Compound Discoverer software 2.1, which contains extensive libraries
of common metabolic pathways and mass spectral libraries.
To confirm enzymatic origin of metabolites, besides test samples for the phase I and II, several
controls were used as shown in Figure 1 and Supplementary Table S1: standard that contains toxin
dissolved in PBS buffer, control without any co-factors, control without NADPH, but with UDPGA, and
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controls with previously heated microsomes (45 ◦C) for both phase I and II samples. The mycotoxin
standard control and the controls without cofactors were used to highlight and eliminate the metabolites
that are not enzymatically produced from the final LC-MS library. Finally, the controls without toxin
ensured that any endogenous species present in microsomes would not be misidentified as mycotoxin
metabolites. The controls with pre-heated microsomes were included in the experiment to test the
stability of microsomal enzymes. In heat-inactivated samples, the metabolic activity was changed
and the generation of metabolites was reduced during the phase I metabolic reactions indicating
that the responsible enzymes were sensitive to heat (Figure 2a). However, an opposite effect was
observed in the phase II reactions, whereby an increased rate of glucuronidation was observed
in all mycotoxin samples (Figure 2b). The deactivation of phase I metabolism observed in our
study matches the previously published work about enzyme stability [38,39]. In contrast, uridine
5′-diphospho-glucuronosyltransferases (UGTs), key enzymes used in our phase II glucuronidation
reactions, appear to be thermally stable enzymes [40], and the heat-inactivation step was beneficial to
generating additional glucuronide metabolites in sufficient quantities for detailed characterization.
Figure 1. Scheme of microsomal incubation experiment to generate phase I and glucuronide phase
II metabolites.
Figure 2. Comparison of the amount of parent toxin remaining after incubation in phase I and heated
phase I (a) and phase II and heated phase II (b) microsomal incubation samples.
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2.1. Trichothecene Type A and B
2.1.1. Trichothecene Type A
The list of T-2 generated metabolites is shown in the Supplementary Table S2. There were two main
pathways for T-2 metabolites, hydrolysis and oxidation in phase I (Figure 3). The chromatographic
separation of T-2 and its metabolites is shown in Supplementary Figures S1 and S2. The identification of
metabolites was performed by comparing [M+Na]+ product ion mass spectra of T-2 and its metabolites.
The fragmentation pattern of T-2 showed some characteristic fragments, 387.2 m/z, 327.2 m/z and
267.2 m/z due to the loss of isovaleric acid (C5H10O2, 102.1 Da) at position 8, and acetic acid (CH3COOH)
at position 15 or 4, respectively, (Supplementary Figure S3d). The extracted ion chromatogram of
[M+Na]+ ion at 447.1989 m/z revealed two peaks at 7.93 min (447.1988, 0.22 ppm) and 8.22 min (447.1986,
0.67 ppm), indicating the presence of two metabolites that were 42.0 Da less then T-2 (Supplementary
Figures S1 and S4a,b). The peak observed at 8.22 min was identified as HT-2, since it had the same
RT and MS2 as the authentic standard of HT2. The second peak could be putatively identified as
15-deacetyl-T-2 (15-de-Ac-T-2). 15-de-Ac-T-2 had been previously observed as a metabolite of T-2 in
Wistar rats [41]. Based on the structure of T-2, the possible loss of 42.0 Da can be due to the loss of
the second acetyl group at position 15. Also, both metabolites had identical MS2 spectra with the
typical losses of isovaleric side chain (102.1 Da) and acetic acid (60.0 Da) at fragments of 345.2 Da
and 285.2 Da, respectively (Supplementary Table S2 and Figure S4a,b). There was also another ion
at 405.1881 (0.74 ppm) m/z corresponding to a loss of two acetyl groups from T-2, but it was very
low intensity ion, so further identification was not possible (Supplementary Table S2 and Figure S1).
The literature reports two possible compounds with this mass, neosolaniol and T-2 triol [41,42].
Figure 3. Microsomal biotransformation of T-2 toxin in phase I and phase II reactions.
The second pathway observed in phase I reactions was oxidation of both T-2 and HT-2.
The theoretical masses of [M+Na]+ ions of T-2 (505.2044) and HT-2 (463.1939) hydroxyl-metabolites
were 16.0 Da higher than T-2 and HT-2, which confirmed the presence of additional oxygen in those
compounds (Supplementary Table S2). There were three T-2 hydroxy metabolites observed at 6.54 min
(505.2042, 0.40 ppm), 6.60 min 505.2041, 0.59 ppm), and 6.81 min (505.2043, 0.2 ppm), Supplementary
Table S2 and Figure S2. All three hydroxyl metabolites had similar MS2 spectra, Supplementary
Table S2 and Figure S3a–c). The position of hydroxyl group was identified by comparing [M+Na]+
product ion spectra of the hydroxyl-metabolites and T-2. In MS2 spectrum of hydroxyl metabolites
there was a fragment with 387.2 m/z that could be generated as the loss of isovaleric acid side chain plus
oxygen atom (C5H10O3, 118.1 Da). This fragment showed a 16.0 Da shift that indicated the position
of hydroxyl group on the isovaleric side chain. Therefore, all three hydroxyl metabolites have OH
group on isovaleric side at position 3′, 4′ or 2′, (Supplementary Table S2 and Figure S3a–c). Hydroxy
metabolites of HT-T-2 also had a 16.0 Da shift. The numbering of HT-2 metabolites was chosen to
match numbering of the peaks described for HT-2 where incubation and detailed characterization
was performed with HT-2 toxin. T-2 microsomal incubation samples had 5 out of 6 metabolites of
these hydroxyl metabolites, but their intensity was ~4 × less than in HT-2 incubations, Supplementary
Table S2 and Figure S2. Overall, only 26% of T-2 metabolized in phase I reactions, with HT-2 as the
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predominant metabolite. The metabolism of T-2 has already been investigated by Yang et al. in farm
animals and humans [33]. Our data are in agreement with their results, HT-2 is predominant metabolite
of T-2. However, our study also generated two additional new hydroxyl metabolites of T-2. LC
chromatographic separation of isomers using our pentafluorophenyl stationary phase and/or excellent
limits of detection of the method may have facilitated the detection of these additional metabolites
versus previous work. Furthermore, these newly detected metabolites are consistent with the available
sites on T-2 for hydroxyl modifications.
In phase II reaction samples of T-2, there were two glucuronide forms, glucuronide of T-2 and
HT-2 (Figure 3, Supplementary Table S2, and Figure S5). The different metabolic activity was observed
in the phase II sample and heated control, about 79% and 18% of T-2 did not metabolize, respectively
(Figure 2b). The most predominant glucuronide form was glucuronide of HT-2 (51%) and only
8% composed T-2 glucuronide in the heated control. Their product ion mass spectra of [M+Na]+,
665.2413 m/z (−0.43 ppm) and 623.2304 m/z (−0.96 ppm) showed the indicative loss for glucuronides,
176.0 Da and typical fragments, 489.2 m/z and 447.5 m/z of T-2 and HT-2 respectively, confirming the
T-2 and HT-2 origin of glucuronides, Supplementary Table S2 and Figure S6a,b. Further comparison
of product ion spectra of [M+NH4]+ (Supplementary Figure S6c) to literature spectra confirmed this
glucuronide as 3-glucuronide-HT-2 by the presence of fragment ions of 425.2 and 499.0 and their
relative intensities to each other [33,43]. Ion with 499.0 m/z should be less intense than 425.2 m/z
according to published data. According to the structure of T-2 and literature data there was only one
possible glucuronide of T-2 [43].
The generated metabolites of HT-2 are presented in Supplementary Table S3. HT-2 is a main
metabolite of T-2, and has hydroxyl group at position 4 instead of acetyl group. Two pathways were
observed in phase I reactions, hydrolysis and oxidation. The chromatographic separation of HT-2 and
its metabolites is shown in Supplementary Figures S7 and S8. Two hydrolysis products were observed
as shown in Supplementary Table S3 and Figure S7. The extracted ion of [M+Na]+ at m/z 363.1413
(0.28 ppm) shows the 84.1 Da mass difference from HT-2 [M+Na]+ ion, which can be attributed to
the loss of isovaleric group at position 8 and the addition of OH group. The first peak at 3.56 min
can be putatively identified as 4-deacetyl-neosolaniol (4-de-Ac-NEO) which has OH group instead of
isovaleric group. The product ion spectrum of the first peak has fragments with mass of 345.1 Da and
303.1 Da that confirm the water loss and further loss of acetic acid which were also found in the product
ion spectra of HT-2, Supplementary Table S3. The [M+Na]+ ion at m/z 463.1939 was 16.0 Da higher
than HT-2 [M+Na]+ ion, m/z 447.1989, and confirmed the hydroxylation pathway, Supplementary
Table S3. The extracted ion chromatogram displayed 6 peaks with the same m/z 463.1936 (0.65 ppm)
at 5.67 min, 5.77 min, 5.95 min, 6.11 min, 6.21 min and 8.23 min, Supplementary Figure S8. The first
two peaks at RTs of 5.67 min and 5.77 min have similar product ion spectra, containing an indicative
fragment ion at m/z 345.5 and 345.2, respectively, Supplementary Table S3 and Figure S9a,b. These
ions were generated as the loss of isovaleric side chain (C5H10O2) plus oxygen atom resulting in the
neutral loss of 118.1 Da. The presence of these fragments confirmed the position of hydroxyl group at
isovaleric side chain either at position 3′ or 4′. 3′ and 4′-hydroxy-HT-2 metabolites were observed
in human and animals, respectively, by Yang et al. [33]. The third peak at 5.95 min was very low
intensity, and its product ion spectra were similar to the previous peaks (Supplementary Figure S9c),
assuming that OH is present at isovaleric group at position 2′. For the next three peaks, the loss of
102.1 Da results in an ion fragment with m/z 361.2 Da, so it indicates that the isovaleric side chain is
not changed, Supplementary Table S3 and Figure S9d–f. Therefore, the position of OH group can be
found at the position 7, 10 or 16 carbon atoms. However, the product mass spectra are similar, so
further identification is not possible. Overall, six hydroxyl metabolites were also detected by Yang et
al., but only four of their metabolites were observed in human liver microsomes [32]. Additionally,
two peaks at RT of 5.44 min and 6.55 min were observed with the mass of 405.1880 (0.99 ppm) which
corresponds to 42.0 Da difference from the parent compound (HT-2) which could indicate the loss of
acyl group at position 15, Supplementary Table S3. However, their product ion mass spectra showed
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similar losses to HT-2. Based on the fragments at 303.2 m/z and 345.2 m/z which were generated as
the loss of isovaleric acid (102 Da) and acetic acid (60 Da) respectively it was concluded that the main
structure is not changed, and from the known metabolites it was not possible to propose putative
structures. Overall, our data are similar to the previous metabolism studies done by Yang et al. [32],
confirming hydroxylation as the major pathway of HT-2.
In phase II reaction samples of HT-2, the 3-glucuronide of HT-2 was generated as described when
discussing the observed T-2 metabolites.
2.1.2. Trichothecene Type B
The common phase I pathways of type B trichothecenes are de-acetylation for 3/15-AcDON and
FUS-X and de-epoxidation for DON (Figure 4) and NIV. Microsomal biotransformation of DON is
summarized in Figure 4 as an example representative for this family. Chromatographic separation and
MS2 spectra of 3/15-AcDON, FUS-X, DON, NIV and their metabolites are shown in Supplementary
Tables S4–S8 and Figures S10–S21. In phase I, all metabolites were generated non-enzymatically—all of
these metabolites were observed not only in the phase I sample, but also in controls without NADPH
and in heat-inactivated controls. The examples of non-enzymatic reactions included the removal of
acetyl group in 3-AcDON converting into DON and de-epoxy-deoxynivalenol DOM-1, 15-AcDON
into DON, FUS-X into NIV, DON into DOM-1, and NIV converted into de-epoxy-nivalenol (DNIV),
Supplementary Tables S4–S8. 1% of 15-AcDON and 50% of 3-AcDON was converted into DON,
whereas 54% of FUS-X was converted into NIV. Only 5% of NIV was converted into DNIV and less
than 1% of DON to DNIV. Higher deacetylation rate of 3-AcDON than 15-AcDON had already been
demonstrated in literature [44]. In our studies, these metabolites were clearly of non-enzymatic origin;
however, other studies have also shown that 3-AcDON can be metabolized to DON (78%) during
incubation with human feces [45].
Figure 4. Microsomal biotransformation of DON in phase I and II reactions.
During phase II incubations, type B trichothecenes generated 3- and 15-Gluc-DON (1%), shown in
Figure 4, Gluc-3-AcDON (11%), and Gluc-15-AcDON (1%) (Supplementary Table S4–S8 and Figures
S10–S15, S17–S21), whereas heated samples generated 3- and 15-Gluc-DON (2%), 41% of Gluc-3-AcDON
and 2% of Gluc-15-AcDON. However, to observe the glucuronidation of NIV (<1%) and FUS-X (<1%),
it was necessary to increase the mycotoxin concentration x10 and incubation time (20 h), and they
were only observed in heated samples (Supplementary Figures S18 and S20). The identifications of
glucuronides were based on the product ion spectra of [M-H]− for Gluc-FUS-X (529.1561, 0.32 ppm),
Gluc-NIV (487.1457, 0.23 ppm), 3- and 15-Gluc-DON (471.1508, 0 ppm), and Gluc-3-AcDON (513.1614,
0.19 ppm) and [M+Na]+ for Gluc-15-AcDON (537.1575, 0.74 ppm), Supplementary Tables S4–S8. It is
interesting to note that all glucuronides in ESI(-) generated only [M-H]− and not [M+HAc-H]− as their
parent mycotoxins. Some mycotoxins, like DON (2 forms), FUS-X (2 forms), and NIV (3 forms), could
have more than one glucuronic form based on their structures. In our experiment, we possibly observed
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two glucuronides of DON based on two distinctive product mass spectra, 3 and 15-Gluc-DON. However,
the peaks were not fully resolved and MS2 spectra could be a mixture of the two, Supplementary
Figures S14 and S17. According to the literature, the first peak can be assigned as 3-Gluc-DON and
the second as 15-Gluc-DON [19]. MS2 spectrum of the first peak has intense fragment of 441.1 m/z
that can happen due to the loss of CH2O at position 15 when it is not glucuronidated, Supplementary
Figure S17. The partial chromatographic separation of 3-Gluc-DON and 15-Gluc-DON shows that
the predominant form is 15-Gluc-DON. FUS-X glucuronide showed only one chromatographic peak
as shown in Supplementary Figure S18. Previously, FUS-X glucuronides were not reported either in
animal nor human samples (Supplementary Figure S19). NIV glucuronides showed two not fully
resolved peaks, assuming that there are at least two glucuronic forms present, Supplementary Figure
S20. Only one MS2 spectrum was obtained for the second peak, Supplementary Figure S21b. However,
previous studies of nivalenol metabolism in rats exhibited only one 3-glucuronide-NIV and DNIV [46].
De-epoxidation of DON also was observed in both human and animals [17,47,48]. In contrast to rat
metabolism studies, NIV incubation with human feces showed no de-epoxydated metabolites [45].
To the best of our knowledge, NIV glucuronides have not been previously observed in human samples,
possibly due to the low extent of glucuronidation and/or poor limits of detection for the polar nivalenol
and its metabolites using most LC-MS methods. The human exposure studies to DON revealed that
the predominant species were 15-Gluc-DON (49%), then free DON (27%), and 3-Gluc-DON (14%) in
urine and proposed to use them as biomarkers of DON exposure [17]. Despite trichothecene type
B mycotoxins, including DON, being extensively studied, we found new metabolites, showing the
importance of these detailed incubation studies and the need to build more systematic libraries of
mycotoxin metabolites.
2.2. Aflatoxins
AFB1 microsomal biotransformations included the following three types of reactions: oxidative
(hydroxylation, epoxidation), reductive (keto-reduction), and hydrolytic (hydrolysis) in phase I, as
summarized in Figure 5 and Supplementary Table S9. AFB1 generated various metabolites, including
aflatoxin M1 (AFM1, 3%), AFB1 8,9 endo/exo-epoxide (AFBO, <1%), aflatoxin B1 di-hydrodiol
(AFB1-diol, <1%), and minor metabolites, AFP1 (<1%), ((H2)+(O))-AFB1 (<1%), and AFL (<1%).
The chromatographic separation of AFB1 and its metabolites is shown in Supplementary Figure S22.
All metabolites were identified based on their MS1 and comparison of their MS2 spectra to the
literature data as described in the Supplementary Table S9. Two hydroxy-metabolites at m/z 329.0651
(1.8 ppm) showed shift of 16.0 Da versus [M+H]+ ion of AFB1 at 313.0707 (0 ppm), thus confirming
the presence of additional oxygen in those compounds, Supplementary Table S9 and Figure S23a,b.
The first peak at RT of 5.03 min was identified as AFBO based on the fact of in-source AFB1-diol
formation, Supplementary Figures S22 and S23e. AFBO was previously described as a non-stable
compound that reacts with water to form AFB1-diol [49,50]. The second peak at RT 6.32 min was
identified as hydroxy-metabolite, AFM1. The identification of this hydroxy metabolite was performed
by comparing its product ion mass spectra (Supplementary Figure S23b) to the published one [51].
The main distinctive fragment ion of AFM1 is 273.0757 m/z, which can be present only in AFM1 and not
in its isomer aflatoxin Q1 (AFQ1) based on the previously published work by Walton et al. [52]. Also,
fragment ions of 273.1 Da and 259.0 Da observed in our product ion spectra were chosen as quantifier
and qualifier ion for AFM1 in other published papers [51,53,54]. Finally, MS2 of AFM1 is similar to
product mass spectra obtained by Everley et al. [51]. [M+H]+ ion at m/z 347.0760 (0.23 ppm) was
34.0 mass units greater than AFB1, Supplementary Table S9 and Figure S23c,d. This difference indicated
the presence of two hydroxyl groups, whereas the presence of two chromatographic peaks indicates
the presence of two isomers as shown in Supplementary Figure S22. Their MS2 spectra exhibited the
intense water loss fragment, 329.0650 (3.3 ppm) and 329.0653 (2.1 ppm) for the first and the second
peaks, which confirms the presence of hydroxyl groups, Supplementary Figure S23c,d. Additionally,
both peaks showed the loss of two water molecules that yielded fragments, 311.0545 (3.5 ppm) and
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311.0549 (2.3 ppm), Supplementary Figure S23c,d. The first peak can be identified as AFB1-diol with
hydroxyl groups at positions 8 and 9. Its product mass spectra fragments, 283.0597 (38%) and 329.0650
(100%), have similar intensity as shown by Walton et al., namely, 329.1 (100%) and 283.0 (32%) [52].
The identification of O-demethylated products with theoretical mass of [M+H]+ ion at 299.0550 m/z
resulted in two chromatographic peaks at 7.05 min (299.0549, 0.33 ppm) and 7.31 min (299.0549,
0.33 ppm), Supplementary Table S9 and Figure S22. Both peaks had similar product ion mass spectra,
Supplementary Figure S24. Based on the comparison of fragment ions 271.0602 Da and 299.0554 Da
(Supplementary Figure S24) observed in their product ion mass spectra to the literature data, it was
possible to determine these peaks as aflatoxin P1 (AFP1) and its isomer [52]. Two metabolites of
keto-reduction pathway with measured m/z 337.0682 (0 ppm) of [M+Na]+ ion at 7.66 min and 8.60 min
were putatively identified as an isomer of aflatoxicol and aflatoxicol (AFL), respectively, since they
were found at trace level, Supplementary Table S9 and Figure S22. The conversion of AFB1 to AFL was
previously confirmed using in vitro studies of placental human microsomal proteins [55]. One more
type of reduction reaction with the further oxidation resulted in metabolites (+(H2)+(O)-AFB1) with
m/z 331.0812 (0 ppm) of [M+H]+ ion at and RT at 5.45 min, Supplementary Table S9 and Figures S22
and S23f. This metabolite definitely has AFB1 origin, since its product mass spectrum has the same
fragments, 285.0757 m/z and 313.0705 m/z as AFB1 (Supplementary Figure S23). Also, the loss of H2O
(18.0106, 0 ppm) in product ion mass spectra confirmed the OH group in this molecule. Dohnal et al.
reviewed aflatoxin metabolism and concluded that besides the interspecies differences there were also
regional, inter-individual differences [56]. The main urinary metabolite of AFB1 was AFM1, which was
observed in Brazilian volunteers [57]. Also, AFM1 was found in Italian adult urine samples [58] and
Italian children urine and serum samples [24]. However, AFQ1 was found as the most predominant
form of aflatoxins in Chinese urinary and fecal samples [59]. Also, previously it was shown that
different enzymes are responsible for the conversion of AFB1 to AFQ1 and AFM1 [60,61].
Figure 5. Microsomal biotransformations of aflatoxin B1 in phase I reactions.
The remaining aflatoxins, AFG1, AFB2, AFG2 were unstable during experiment and produced
non-enzymatic hydroxyl metabolites. AFG1, AFB2, AFG2 and their metabolites are summarized
in Supplementary Tables S10–S12. The stability of aflatoxins in plasma at room temperature was
evaluated and it was shown that AFG1 and AFG2 were not stable in plasma for more than 3 h [29].
Another stability study demonstrated the dependence of aflatoxin stability on the temperature and
the composition of the solvent [62]. One hydroxy metabolite with enzymatic origin was observed
corresponding to hydroxy-metabolite of AFG1, [M+H]+ ion at m/z 345.0604 (0.3 ppm), Supplementary
Table S11. MS2 spectra of AFG1 and its hydroxyl metabolite are shown in Supplementary Figure
S25a,b. This AFG1 hydroxy metabolite can be putatively identified as aflatoxin GM1 (AFGM1)
metabolite [63]; however, this metabolite, to our knowledge, had not been previously found in human
samples. Studies of the prevalence of different aflatoxins in Egyptian infant blood and urine samples
performed by Hatem et al. did not confirm its presence [64]. To our knowledge, there were no in vitro
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metabolism studies performed for AFG1 or AFG2. In our experiment, four non-enzymatic hydroxy
metabolites of AFG2 (Supplementary Table S12) were observed with 347.0761 m/z, at least two of
them could be aflatoxin GM2 (AFGM2) and aflatoxin G2A (AFG2A) as mentioned in the previous
review paper [61]. Product mass spectrum of AFG2 is shown in Supplementary Figure S26. AFB2
was converted non-enzymatically to three hydroxy metabolites with 331.0813 m/z (Supplementary
Table S10). Product mass spectra of AFB2 and its hydroxyl metabolites are shown in Supplementary
Figure S27a–c. Putatively, they can be identified as previously mentioned aflatoxin M2 (AFM2),
aflatoxin Q2 (AFQ2), and aflatoxin B2A (AFB2A) [61,65]. Roebuck et al. performed in vitro metabolism
studies of AFB2 which showed the presence of trace levels of AFQ2, aflatoxin P2 (AFP2) and either
AFM1 or AFM2 in human samples [66]. In phase II, no glucuronides for any aflatoxins were generated.
2.3. Group of Zearalenone
Microsomal biotransformation of ZEN is summarized in Figure 6 as an example representative
for this family. The group of zearalenone, ZEN, α-ZOL, β-ZOL, ZAN, α-ZAL, and β-ZAL, was
metabolized most extensively out of all chosen mycotoxin groups, resulting in total of 133 metabolites
(Figure 7, Supplementary Tables S13–S18). The most predominant phase I metabolic pathway for this
class of mycotoxins is oxidation. There were seven types of oxidation reactions, desaturation with
oxidation (-(H4) +(O)), desaturation with oxidation (-(H2) +(O)), oxidation (+(O)), reduction with
oxidation (+(H2)+ (O)), oxidation (+(O2)), and desaturation with oxidation (-(H2) +(O2) and (-(H4)
+(O2)). Among these oxidation (+(O)) reactions resulted in the formation of the highest number of
metabolites for ZEN, 9 metabolites, α-ZAL (4), β-ZAL (8), α-ZOL (8), β-ZOL (7), except ZAN for which
the reduction with oxidation (+(H2)+ (O)) resulted in the highest number of metabolites (8), as shown
in Table 1. Also, the total pattern number of oxidized metabolites of ZEN and its two metabolites,
α-ZOL and β-ZOL differed from ZAN and its two metabolites, α-ZAL and β-ZAL. ZAN metabolized
the most extensively and resulted in 22 metabolites, but ZEN had only 12 metabolites. α-ZOL (15) had
more oxidized metabolites than β-ZOL (8), but α-ZAL (10) had less than β-ZAL (15). According to the
percentage of metabolized parent toxin in phase I reactions, ZEN (27%), ZAN (66%), α-ZAL (29%),
β-ZAL (23%), α-ZOL (70%), and β-ZOL (7%), this metabolic pathway is not predominant, except for
ZEN and α-ZOL. The metabolism of ZEN has already been investigated by Yang et al. [31], and they
reported a variety of ZEN oxidized metabolites. Also, ZEN, α-ZAL and ZAN oxidized metabolites
were reported in other studies [67,68], but there were no metabolism studies performed for α-ZOL,
β-ZOL and β-ZAL.
Figure 6. Microsomal biotransformation of ZEN in phase I and II reactions.
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Figure 7. Summary of phase I and phase II metabolism of zearalenone group.
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Table 1. Summary of Phase I oxidation metabolites observed for zearalenone group
Mycotoxin




















ZEN 0 1 9(75%) 2 0 0 0 12
α-ZOL 1 6 8(53%) 0 0 0 0 15
β-ZOL 1 1 7(88%) 0 0 0 0 8
ZAN 0 1 5(23%) 8(36%) 6(27%) 2 0 22
α-ZAL 1 3 4(40%) 0 0 1 1 10
β-ZAL 1 4 8(53%) 0 0 1 1 15
Based on the present results, the glucuronidation pathway is the predominant metabolic pathway
for almost all the group of zearalenones. 93% of ZAN, 99% of ZEN, 64% of β-ZAL, 51% of β-ZOL, and
88% of α-ZOL were converted into glucoronides, except α-ZAL where conversion was 36% (Figure 7).
The identifications of both phase I and II reaction products were based on the comparison MS2 spectra
to literature data and/or analysis of MS2 spectra. Phase II reactions resulted in various glucuronide
forms of parent toxin, its metabolites of phase I reactions, and double glucuronide forms (denoted
as 2 × Gluc). The numbers of observed glucuronide forms for each mycotoxin from zearalenone
group are summarized in Table 2. Common glucuronide forms of parent toxins were glucuronides at
position C-14 or C-16 for ZEN and ZAN and at additional position C-7 for α-ZOL, β-ZOL, α-ZAL and
β-ZAL. These glucuronides were previously generated by Stevenson et al. [35], and their studies are in
accordance with ours. Among the most predominant glucuronides were glucuronides of parent toxins
at position C-14, ZEN (86%), ZAN (73%), α-ZOL (72%), β-ZOL (27%), α-ZAL (23%) and β-ZAL (45%).
The sum of parent glucuronides of group of zearalenone composed 91% for ZEN, 74% for ZAN, 86%
for α-ZOL, 49% for β-ZOL, 33% for α-ZAL and 62% β-ZAL as shown in Figure 7. The glucuronides
of oxidized metabolites and double glucuronides were only minor products, 19% for ZAN, 3% for
α-ZAL, 2% for β-ZAL, 8% for ZEN, 2% for α-ZOL, 2% for β-ZOL. Yang et al. have already reported
ZEN glucuronides of oxidized metabolites and di-glucuronide forms [69]. Overall, ZAN was the
most metabolized toxin in phase II and resulted in 24 glucuronides. β-ZOL and β-ZAL were least
metabolized toxins and each generated only 7 glucoronic forms. Comparing phase II reaction samples
to heated controls, it was noticed that the glucururonidation process was more efficient in heated
samples (45 ◦C) vs. phase II reaction samples, except ZAN.
Table 2. Number of glucuronides observed in zearalenone group.








In conclusion, the newly generated LC-MS library containing 188 metabolites represents the
most comprehensive resource of mycotoxin metabolites that can be analyzed using a single LC-MS
method. The in vitro microsomal incubation workflow used in this work was able to successfully
generate metabolites from hydrolysis, oxidation, de-epoxidation, epoxidation, demethylation,
reduction and glucuronidation pathways as summarized in Table 3. The excellent limits-of-detection
and isomer separation capability of our LC-MS method allowed us to characterize for the first
time 100 metabolites that had not been previously reported in the literature, to the best of our
knowledge. Among the known phase I and phase II metabolites of 17 mycotoxins that were the
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focus of this study, only four metabolites—aflatoxin Q1 (AFQ1), aflatoxin P2 (AFP2), Gluc-4-HT-2,
Gluc-3-4-de-acetyl-neosolaniol—could not be generated using our microsomal incubation workflow.
The remaining 88 known metabolites were successfully generated, thus showing the power of our
workflow and high-confidence identification capability. Table 4 summarizes the main subclasses
of the newly characterized metabolites in this study. To ensure the high confidence of our library
identifications we used three key strategies: (i) incubation with one mycotoxin at a time to properly
assign the origin of metabolites to a given parent mycotoxin, (ii) extensive controls to eliminate
endogenous biomolecules present in microsomes, impurities in standards and metabolites that could
be generated non-enzymatically, and (iii) MS/MS comparison to the published literature spectra when
available and to the parent compounds since the generated metabolites share many of the same
structural features as the parent compounds. In the absence of authentic standards for all of these
metabolites, our identifications are putative. In future, this new LC-MS library will be used during
biomonitoring studies to characterize which of these metabolites may be observed in various biological
samples in vivo and to provide semi-quantitative information on their concentrations using parent
calibration curves. This relevant subset of metabolites then can be synthesized for further confirmation
of identity and full quantification. Additionally, the clarification of some metabolite structures that
remain ambiguous in our library (e.g., exact position of hydroxyl groups in several ZEN metabolites)
can be improved in future work by the application of isotopically labeled standards, as was previously
demonstrated in the literature [68,70], or through synthesis of authentic standards.
Table 3. Summary of metabolic pathways of 17 mycotoxins.
Mycotoxins Hydrolysis Oxidation De-Epoxidation Epoxidation Demethylation Reduction Glucuronidation
T-2   
















Table 4. Comparison of literature expected metabolites and generated LC-MS library metabolites.
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4. Materials and Methods
4.1. Chemicals
Water ((H2O, LC-MS grade), methanol ((MeOH), LC-MS grade), acetonitrile ((MeCN), LC-MS
grade), and acetic acid ((AA, LC-MS grade) were purchased from Fisher Scientific (Ottawa, Ontario,
Canada). Sodium chloride ((NaCl), meets specifications of American Chemical Society grade (ACS),
≥99.0%), sodium phosphate dibasic ((Na2HPO4), ACS, ≥99.0%), potassium phosphate monobasic
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((KH2PO4), ACS, ≥99.0%), and magnesium chloride ((MgCl2),anhydrous, ≥98%), β-nicotinamide
adenine dinucleotide 2′-phosphate reduced tetrasodium salt hydrate ((NADPH), ≥97%), uridine
5′-diphosphoglucuronic acid trisodium salt ((UDPGA), 98–100%), alamethicin from Trichoderma viride
(≥98%, HPLC grade), and human microsomes from liver (pooled, CMV-negative, 20 mg/mL) were
purchased from Sigma-Aldrich Canada (Oakville, Ontario, Canada). Potassium chloride ((KCl), reagent
grade, 99.0%) was purchased from BioShop Canada (Burlington, Ontario, Canada).
4.2. Mycotoxin Standards
All mycotoxins were purchased from Sigma-Aldrich Canada, unless otherwise indicated. AFG1,
T-2, HT-2, α-ZAL,β-ZAL were purchased from Toronto Research Chemicals Inc. (Toronto, ON, Canada).
Zearalenone (ZEN) was purchased from Cayman Chemicals (Ann Arbor, MI, USA). Individual standard
stock solutions of all mycotoxins at 1 mg/ml concentration were prepared in methanol and kept at
−80 ◦C.
4.3. Experimental Design and Microsomal Incubations
The purpose of this work was to generate phase I and phase II (glucuronidation) metabolites
of 17 mycotoxins using standard in vitro microsomal incubation protocol. Each toxin was incubated
individually with microsomes in the presence of NADPH for phase I reactions. For phase II
glucuronidation reactions, UDPGA, alamethicin and MgCl2 were also added. In all cases, the following
controls were used in order to confirm product formation during enzymatic reaction: (i) microsomal
incubation without toxin added, (ii) microsomal incubation without co-factors added (iii), microsomal
incubation without NADPH, but containing UDPGA, alamethicin and MgCl2, (iv) incubation with
heated microsomes, and (v) standard solution of each toxin dissolved in PBS buffer. This experimental
design is summarized in Figure 1.
100 mM PBS buffer (pH 7.4), 20 mM NADPH dissolved in 100 mM phosphate buffer, 100 mM
UDPGA in water, 5 mg/mL alamethicin in methanol, 100 mM MgCl2 in water and 200 μg/mL standard
solution of each mycotoxin in acetonitrile were prepared before the start of microsomal incubations.
Microsomes were thawed on ice. In an Eppendorf tube, 182 μL of PBS buffer, 2 μL of NADPH and
5 μL of microsomes were transferred for phase I reactions. For phase II reactions, all of the reagents for
phase I reactions plus alamethicin, 10 μl of UDPGA and MgCl2 were transferred. Microsomes were
then pre-incubated for 5 min, followed by the addition of mycotoxin (final concentration of 1 μg/mL)
and then the remaining amount of NADPH (10 μL). All samples were incubated for 1 h at 37 ◦C,
reactions were stopped by adding 200 μL of acetonitrile. Detailed description of test samples and
controls is shown in Supplementary Table S1.
4.4. LC-HRMS Analysis
All LC-MS measurements were performed according to the validated multi-mycotoxin method
for 17 parent mycotoxins [29]. Briefly, the method combined HPLC 1100 (Agilent Technologies, Santa
Clara, CA, USA) and reversed-phase chromatographic separation on pentafluorophenyl stationary
phase and gradient elution using water and methanol containing 0.1% AA (v/v) for ESI(+), and 0.02%
for ESI(-) [29]. The flow rate of 0.3 mL/min, the column temperature of 30◦C, and 10 μL injection volume
were used for all analyses. MS analysis was performed on LTQ Orbitrap Velos at 60,000 resolving
power using the mass range of 200–700 m/z. In addition, MSn analysis with data-dependent acquisition
(DDA) mode was used for the identification and elucidation of metabolite structures. In DDA mode,
the three most intense ions from the full MS scan were selected for MS2 fragmentation. MS2 analysis
used collision-induced dissociation (CID) and signal threshold: 5,000; normalized collision energy:
35; isolation width: 2 Da; activation time: 30 ms. MS3 used targeted parent and product mass lists to
trigger MS3 for the selected ions of interest. MS3 was performed with CID as activation type; minimal
signal threshold: 5000; isolation width: 2 Da; activation time: 30 ms; normalized collision energy: 45.
For AFB1 and its metabolites, MS2 analysis used higher energy collisional dissociation (HCD) with
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signal threshold: 5000; normalized collision energy: 35; isolation width: 2 Da; activation time: 0.1 ms,
lock mass was used for ESI(−) and ESI(+).
Data was processed using Compound Discoverer 2.1 (ThermoFisher Scientific). Raw data files
were uploaded to Compound Discoverer and analyzed using generic metabolism workflow. General
settings in the workflow were mass tolerance, 5 ppm; signal threshold, 3; minimum peak intensity
10000. Parameters used to generate expected compounds were parent toxin structure, metabolic
transformations for phase I and II reactions, and preferred ions.
Supplementary Materials: The following are available online at http://www.mdpi.com/2072-6651/11/8/433/s1,
Table S1: Microsomal incubation protocol for phase I and II reactions, Table S2: T-2 and its metabolites, detected in
ESI(+), as CID product ion spectra of [M+Na]+, Table S3: HT-2 and its metabolites, detected in ESI(+), as [M+Na]+
ions, Table S4: Metabolites of 3-AcDON generated in phase I and phase II, detected in ESI(−), as [M+CH3COO-H]−
ions, except Gluc-3AcDON which was detected as [M-H]− ion, Table S5: Metabolites of 15-AcDON generated
in phase I and phase II, detected in ESI(+), as [M+Na]+ ions of 15-AcDON and Gluc-15-AcDON, except DON
which was detected as [M+H]+ ion, Table S6: Metabolites of DON generated in phase I and phase II, detected in
ESI(−), as [M+CH3COO-H]− ions, except Gluc-DON which was detected as [M-H]− ion, Table S7: Metabolites
of FUS-X generated in phase I and phase II, detected in ESI(−), as [M+CH3COO-H]− ions, except Gluc-FUS-X
which was detected as [M-H]− ion, Table S8: Metabolites of NIV generated in phase I and phase II, detected
in ESI(−), as [M+CH3COO-H]− ions, except Gluc-NIV which was detected as [M-H]− ion, Table S9: AFB1 and
its metabolites of phase I reactions, detected in ESI(+), as [M+H]+ ions and * [M+Na]+ ions for AFL, Table
S10: AFB2 and its metabolites of phase I reactions, detected in ESI(+), as [M+H]+ ions, Table S11: AFG1 and
its metabolite, OH-AFG1, detected in ESI(+), as [M+H]+ ions, Table S12: AFG2 and its metabolites of phase I
reactions, detected in ESI(+), as [M+H]+ ions, Table S13: Metabolites of ZEN generated in phase I and phase II,
detected in ESI(−), as [M-H]− ions, Table S14: Metabolites of α-ZOL generated in phase I and phase II, detected in
ESI(−), as [M-H]− ions, Table S15: Metabolites of β-ZOL generated in phase I and phase II, detected in ESI(−), as
[M-H]− ions, Table S16: Metabolites of ZAN generated in phase I and phase II, detected in ESI(−), as [M-H]− ions,
Table S17: Metabolites of α-ZAL generated in phase I and phase II, detected in ESI(−), as [M-H]− ions, Table S18:
Metabolites of β-ZAL generated in phase I and phase II, detected in ESI(−), as [M-H]− ions, Figure S1: Extracted
ion chromatograms of T-2 and its metabolites (505.2044 m/z, peak 1-505 to peak 3-505, 463.1939 m/z, peak 1-463 to
peak 5-463, 405.1884 m/z, peak 1-405, 447.1989 m/z, peak 1-447 and peak 2-448) in ESI(+), detected as [M+Na]+
ions, Figure S2: Zooming into extracted ion chromatograms of T-2 (505.2044 m/z) and HT-2 (463.1938 m/z) hydroxy
metabolites in ESI(+), detected [M+Na]+ ions. Panel (a) shows T-2 hydroxyl metabolites, panel (b) shows HT-2
hydroxyl metabolites, Figure S3: Product ion spectra of T-2 hydroxy metabolites at 505.2044 m/z, peak 1-505 (a),
peak 2-505 (b), peak 3-505 (c) and at 489.2095, T-2, detected in ESI(+), as [M+Na]+ ions, Figure S4: Product ion
mass spectra of the peak 1-447 (a) which was tentatively identified as 15-deacetyl-T-2 and the peak 2-447 (b) which
was identified as HT-2, detected in ESI(+), as [M+Na]+ ions, Figure S5: Extracted ion chromatograms of T-2 and
HT-2 glucuronides (665.2416 m/z, Gluc-T-2, and 623.2310 m/z, Gluc-HT-2) in ESI(+), detected as [M+Na]+ ions,
Figure S6: Product ion spectra of HT-2 glucuronide (a) at 623.2310 m/z; T-2 glucuronide (b) at 665.2416 m/z and
HT-2 glucuronide (c) at 618.2756 m/z, detected in ESI(+), as [M+Na]+ ions for (a) and (b) and [M+NH4]+ions
for (c), Figure S7: Extracted ion chromatograms of HT-2 and its metabolites (463.1939 m/z, peak 1-463 to peak
5-463, 405.1884 m/z, peak 1-405 and peak 2-405, 363.1414 m/z, peak 1-363 and peak 2-363) in ESI(+), detected as
[M+Na]+ ions, Figure S8: Zooming into extracted ion chromatogram of HT-2 hydroxyl-metabolites (463.1939 m/z,
peak 1-463 to 5-463), Figure S9: Product ion mass spectra of HT-2 hydroxy metabolites at 463. 1939 m/z: peak
1-463(a), peak 2-463 (b), peak 3-463 (c), peak 4-463 (d), peak 5-463 (e), peak 6-463 (f), detected in ESI(+), as [M+Na]+
ions, Figure S10: Extracted ion chromatograms of 3-AcDON (397.1505 m/z) and its metabolites (355.1399 m/z,
DON, 339.1448 m/z, DOM-1, and 513.1613 m/z, Gluc-3-AcDON) in ESI(-), detected as [M+CH3COO-H]− ions for
all except Gluc-3AcDON ([M-H]−), Figure S11: Product ion mass spectra of 3-AcDON at 397.1505 m/z and its
glucuronide at 513.1613 m/z, detected in ESI(-), as [M+CH3COO-H]− and Gluc-3AcDON ([M-H]− ions, respectively,
Figure S12: Extracted ion chromatogram of 15-AcDON (361.1258 m/z) and its metabolites (297.1333 m/z, DON,
and 537.1579 m/z, Gluc-15-AcDON) in ESI(+), detected as [M+Na]+ ions, Figure S13: Product mass spectra
of 15-AcDON (361.1258 m/z) and its glucuronide (537.1579 m/z), detected in ESI(+) as [M+Na]+ ions, Figure
S14: Extracted ion chromatograms of DON and its metabolites (371.1348 m/z, NIV, 339.1449 m/z, peak 1-339 to
peak 4-339, and 471.1508 m/z, Gluc-DON) in ESI(-), detected as [M+CH3COO-H]− ions for all except Gluc-DON
([M-H]−), Figure S15: Product mass spectra of DON (355.1399 m/z) and NIV (371.1348 m/z) detected in ESI(-),
as [M+CH3COO-H]− ions, Figure S16: Product ion mass spectra of de-epoxy-deoxynivalenol at 339.1348 m/z,
detected in ESI(-), as [M+CH3COO-H]− ions. Peak 1-339 (a) was observed as phase I metabolite of DON and
3-AcDON, peak 2-339 (b) and peak 3-339 (c) were observed as phase I metabolite of DON only, Figure S17: Product
mass spectra of DON glucuronides, 471.1508 m/z, detected in ESI(-), as [M-H]− ions, Figure S18: Extracted ion
chromatogram of FUS-X (413.1454 m/z) and its metabolites (371.1348 m/z, NIV, and 529.1563 m/z, Gluc-FUS-X)
in ESI(-), detected as [M+CH3COO-H]− ions for all except Gluc-FUS-X ([M-H]−), Figure S19: Product ion mass
spectra of FUS-X at 413.1454 m/z and its glucuronide at 529.1563 m/z, detected in ESI(-), as [M+CH3COO-H]− and
Gluc-3AcDON ([M-H]− ions, respectively. Figure S20: Extracted ion chromatograms of NIV, de-epoxy-metabolite
and its isomers (355.1398 m/z, peak 1-355, peak 2-355, peak 3-355) and its glucuronides (487.1457 m/z) in ESI(-),
NIV and de-epoxy-metabolite were detected as [M+CH3COO-H]− ions and glucuronides as [M-H]− ion, Figure
S21: Product ion mass spectra of NIV metabolites: de-epoxy-nivalenol, peak 1-355 (a) at 355.1398 m/z and NIV
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glucuronide (b) at 487.1458 m/z, detected in ESI(-), as [M-H]− and [M+CH3COO-H]− ions, respectively., Figure S22:
Chromatographic separation of AFB1 metabolites generated in phase I reactions. Extracted ion chromatograms
of AFB1 (313.0707 m/z), 337.0682 m/z (peak 1-337 and peak 2-337), 299.0550 m/z (peak 1-299 and peak 2-299),
331.0812 m/z (peak 1-331), 329.0661 m/z (peak 1-329, AFBO, and peak 2-329, AFM1), 347.0761 m/z (peak 1-347 and
peak 2-347) detected in ESI(+), Figure S23: Product mass spectra of AFB1 (a); AFM1, peak 2-329 (b); AFB-diol, peak
1 (c); AFB-diol, peak 2 (d); AFB-8,9-endo/exo-epoxide (AFBO), peak 1-329 (e); peak 1-331 (f), detected in ESI(+),
as [M+H]+ ions, Figure S24: Product ion mass spectra of the peak 1-447 (a) which was tentatively identified as
15-deacetyl-T-2 and the peak 2-447 which was identified as HT-2, detected in ESI(+), as [M+Na]+ ions, Figure S25:
Product mass spectra of AFG1 (a) at 329.0656 m/z and its hydroxyl metabolite peak 1-345 (b), detected in ESI(+),
as [M+H]+ ions, Figure S26: Product mass spectra of AFG2 at 331.0813 m/z, detected in ESI(+), as [M+H]+ ion:.
Figure S27 Product mass spectra of AFB2 (a) at 315.0863 m/z and its hydroxyl metabolites at 331.0813, peak 2-331
(b) and peak 1-331 (c), detected in ESI(+), as [M+H]+ ions,
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Abstract: A reliable and practical multi-method was developed for the quantification of mycotoxins
in plasma, urine, and feces of pigs, and plasma and excreta of broiler chickens using liquid
chromatography–tandem mass spectrometry. The targeted mycotoxins belong to the regulated
groups, i.e., aflatoxins, ochratoxin A and Fusarium mycotoxins, and to two groups of emerging
mycotoxins, i.e., Alternaria mycotoxins and enniatins. In addition, the developed method was
transferred to a LC-high resolution mass spectrometry instrument to qualitatively determine phase I
and II metabolites, for which analytical standards are not always commercially available. Sample
preparation of plasma was simple and generic and was accomplished by precipitation of proteins
alone (pig) or in combination with removal of phospholipids (chicken). A more intensive sample
clean-up of the other matrices was needed and consisted of a pH-dependent liquid–liquid extraction
(LLE) using ethyl acetate (pig urine), methanol/ethyl acetate/formic acid (75/24/1, v/v/v) (pig feces)
or acetonitrile (chicken excreta). For the extraction of pig feces, additionally a combination of LLE
using acetone and filtration of the supernatant on a HybridSPE-phospholipid cartridge was applied.
The LC-MS/MS method was in-house validated according to guidelines defined by the European
and international community. Finally, the multi-methods were successfully applied in a specific
toxicokinetic study and a screening study to monitor the exposure of individual animals.
Keywords: Biomarkers; exposure; LC-MS/MS; LC-HRMS; pig; broiler chicken; multi-mycotoxin
Key Contribution: An LC-MS/MS multi-method was developed, validated and transferred to the
LC-HRMS to determine mycotoxins and their metabolites in plasma, urine and feces of pigs and
plasma and urine of broiler chickens. This method enables the determination of biomarkers for
exposure to mycotoxins in biological samples.
1. Introduction
The worldwide contamination of feed with mycotoxins is of major agro-economic importance.
In addition to crop and feed loss and damage, these mycotoxins can have a large impact on animal
health. Surveys show that mycotoxins occur in more than 70% of the tested feed samples and 38% of
Toxins 2019, 11, 171; doi:10.3390/toxins11030171 www.mdpi.com/journal/toxins233
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these samples contain multiple mycotoxins. Co-contamination of several mycotoxins can result in
additive or synergistic effects. Consequently, multi-methods are an asset in mycotoxin analysis [1].
This study focused on the mycotoxins regulated by the European Union [2,3], as well as the
mycotoxins for which legislation is currently lacking but which reveal evident toxicity and high
prevalence in feed [4]. More specifically, aflatoxin B1 (AFB1), ochratoxin A (OTA), fumonisin B1 (FB1),
T2-toxin (T2), zearalenone (ZEN) and deoxynivalenol (DON), as well as enniatins (ENN), beauvericin
(BEA), alternariol (AOH) and tenuazonic acid (TeA) were included.
Traditionally, mycotoxins are determined and regulated at the level of the feed. However, feed
analysis has some major disadvantages. First, the possible presence of mycotoxin hotspots, i.e., local
areas in the feed with a higher concentration, can cause an unequal distribution of mycotoxins
in the feed and make it difficult to obtain a representative sample [5]. Second, analyzing feed
gives no information about the individual exposure. Fluctuations can arise from differences in
food consumption or in absorption, distribution, biotransformation and excretion (ADME) processes
between the animals. Third, the risk associated with exposure can be underestimated because feed
analysis does not include alternative routes of exposure such as dermal and respiratory exposure [6,7].
Fourth, modified or conjugated forms, previously called masked mycotoxins, can convert back to
their free forms and hence contribute to the adverse effects related to mycotoxin exposure. This has
been demonstrated for 3- and 15-acetyldeoxynivalenol (3ADON and 15ADON, respectively) and
DON-3-glucoside (DON3G) in pigs and broiler chickens [8,9]. Therefore, both ADONs and DON3G
can be considered as toxic as DON itself. Detection of these modified forms in feed can be difficult and
is not always possible with conventional methods where the non-modified mycotoxin is determined.
This creates a possible mismatch between the feed contamination level and the exposure of the
animals [10]. Finally, clinical signs of mycotoxin exposure can appear when the contaminated feed
has already been consumed, thus complicating or preventing diagnosis of herd problems associated
with mycotoxins [11].
These issues can be resolved by biomonitoring of the animals and determining the exposure to
mycotoxins in biological matrices with the use of so-called biomarkers of exposure. Biomarkers are
molecules related to the exposure and are often the mycotoxin itself, the in vivo formed metabolites or
interaction products with macromolecules such as nucleic acids or proteins [12,13].
The selected mycotoxins and their phase I and II metabolites or interaction products
(e.g., aflatoxin-guanine) can be measured in several biological matrices. In this study, plasma, urine
and feces of pigs and plasma and excreta of broiler chickens were chosen as biological matrix since
combining these enables studying all the in vivo toxicokinetic parameters and the complete metabolic
profile. Moreover, these matrices can be used to determine the efficacy of mycotoxin detoxifiers
according to the guidelines of the European Food Safety Authority (EFSA) [14]. In addition, they can
be easily applied for the detection of mycotoxins in these animals under field conditions. Especially,
the non-invasive character of urine and feces collection can be of added value when sampling on farm.
Nowadays, state-of-the-art equipment such as liquid chromatography (LC) coupled to a tandem
mass spectrometer (MS/MS) or a high-resolution mass spectrometer (HRMS) have become the
standard in determining mycotoxins in biological matrices. Indeed, several LC-MS/MS multi-methods
(≥2 mycotoxins) have already been developed for the determination of mycotoxins in biological
matrices of pigs and broiler chickens. However, most of these multi-methods are limited to one
group of mycotoxins. Such methods are available for (the metabolites of) DON [9,15–18], ZEN [19,20],
ENNs [21,22], T2 [23–25], AFB1 [26] and TeA [27]. Only few multi-methods combine mycotoxins from
different families. To the best of our knowledge, this is the case for urine [28–33] and plasma [33–35] of
pigs, and plasma [35] of broiler chickens. These multiclass methods are also available for other animal
species such as for fish plasma [36], human plasma and urine [5,37–40], and rat plasma and urine [39].
The methods for urine clean-up often apply immunoaffinity columns or solid phase columns [30–33].
This approach increases the sensitivity but also the cost of analyzing a large number of samples and it
limits the number of analytes that can be detected. To avoid these limitations, the dilute and shoot
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approach without further pre-treatment is frequently used [5,37,39,40]. However, this method demands
careful optimization of the dilution factor, and often matrix effects and interfering matrix peaks are
observed, which might decrease the sensitivity. Therefore, liquid–liquid extractions (LLE) are preferred
as urine sample preparation because they are easy to perform in large quantity and enough sensitivity
can be obtained. The developed plasma methods by Brezina et al. [41] and De Baere et al. [35] use
OASIS HLB columns that require conditioning before use, limiting the number of samples that can be
processed in a period of time. To increase the possible number of samples processed, LLE and protein
precipitation are preferred. This study therefore aimed to develop a practical, fast and cost-efficient
multi-method for analysis of plasma and urine of pigs and plasma of chickens, using LLE and protein
precipitation, avoiding the use of affinity/solid phase columns.
Multi-methods are to the best of our knowledge currently not available for pig feces and excreta of
broiler chickens. This might be due to high matrix complexity and the diversity of the physicochemical
characteristics of the mycotoxins. Hence, the aim of this study was also to address these difficulties
and to develop a multi-method in these highly complex matrices.
LC-HRMS is especially interesting to elucidate and determine phase I and II metabolites and
interaction products for which analytical standards are not easily available. Especially, since phase
II metabolites might be the most appropriate biomarkers for some mycotoxins due to the extensive
biotransformation by these pathways. The glucuronidated and sulfated metabolites of DON and ZEN,
as well as the metabolites formed after hepatic biotransformation of ENNB and B1 have already been
determined using LC-HRMS [9,20,22,42]. However, to our knowledge, these metabolites of several
toxins belonging to multiple classes have never been determined in a single chromatographic run
using LC-HRMS.
Thus, the combination of LC-MS/MS and LC-HRMS enables not only determining mycotoxins
with an appropriate sensitivity in the lower ng/mL or ng/g range but also detecting a broad range of
mycotoxins, i.e., the mycotoxins and metabolites for which standards are readily available as well as
other phase I and II metabolites and interaction products. This is especially interesting when assessing
the most appropriate biomarker for exposure.
Therefore, the aim of this study was to develop and validate multi-methods using LC-MS/MS
to determine relevant mycotoxins in biological matrices of pigs and broiler chickens. In addition,
the LC-MS/MS method was transferred to LC-HRMS to determine mycotoxins for which analytical
standards are not always commercially available. It is important to consider the main challenges
including the high complexity of the matrix, the large range of different physicochemical characteristics
of the mycotoxins and the need for a method with an appropriate sensitivity (in the lower ng/mL or
ng/g range), so that they can be used not only for specific toxicokinetic studies but also for screening
studies to monitor the exposure of individual animals.
2. Results and Discussion
2.1. Method Development
2.1.1. Sample Preparation and Extraction
Three requirements were prioritized in the development of adequate sample pre-treatments for
the different matrices. First, the sample preparation should be simple and practical, thereby enabling
analysis of a large quantity of samples in a time and cost efficient way. Second, the sample preparation
should be as generic as possible, to allow the extraction of the 24 mycotoxins including some relevant
metabolites, which was a real challenge taking into account the various physicochemical properties of
the different classes of mycotoxins. Third, the method should be sensitive and, therefore, an LOQ of
1 ng/mL of ng/g was aimed for all analytes in all matrices.
Initially, all methods started from the most generic and simple sample preparation:
deproteinization with an organic solvent. However, due to high matrix complexity and the large
variety in physicochemical characteristics of the different mycotoxins more complex methods were
235
Toxins 2019, 11, 171
needed for urine, feces and excreta. A summary of the final protocols can be found in the flowchart
below (Figure 1).
Pig and Chicken Plasma
Method development was started with the optimization of the extraction of the analytes
of interest from pig and chicken plasma. Proteins and phospholipids are often removed from
plasma samples before analysis on LC-MS/MS equipment to prevent clotting and contamination
of the equipment. Deproteinization can be accomplished using organic solvents, such as MeOH
and ACN. The elimination of phospholipids could be obtained using an Oasis Ostro®-plate or
HybridSPE®-phospholipid 30 mg/1 mL solid-phase extraction (SPE) tubes. The use of the Ostro®-plate
required the addition of 0.1% formic acid. Therefore, 0.1% formic acid was added to ACN and MeOH.
For pig plasma, deproteinization with 0.1% formic acid in MeOH and 0.1% formic acid in ACN
were tested in triplicate on spiked pig plasma samples (analyte concentration: 10 ng/mL). In this
study, ACN was preferred as deproteinization solvent for pig plasma, compared to MeOH, since it
gave a clearer supernatant after centrifugation. This is in accordance with previous studies where
deproteinization with ACN was successfully applied to detect mycotoxins in pig plasma [20,34].
Plasma of broiler chickens contains more phospholipids compared to pigs [43]. Therefore,
an additional removal of the phospholipids was necessary to obtain clear samples and to prevent
clogging of tubings of the LC-MS/MS and LC-HRMS instruments during routine sample analysis.
Spiked broiler chicken plasma samples (analyte concentration: 10 ng/mL) were extracted using the
Oasis Ostro®-plate or the hybrideSPE® phospholipid SPE tubes (n = 3 per protocol). As can be seen in
Figure 2, the use of SPE tubes resulted in a lower peak area, especially for ENNs, BEA, TEA, AME
and AOH. Consequently, for broiler chicken plasma, deproteinization with ACN and 0.1% formic acid
was combined with the Oasis Ostro®-plate to obtain the best results. This combination was already
successfully applied to detect mycotoxins in chicken plasma by our group [44].
Pig Urine
Since methanol and ACN are mixable with urine, it was not possible to use the same method
for urine as for plasma. The use of immunoaffinity columns is avoided due to the high cost. Dilute
and shoot methods were eliminated to avoid matrix effects. Therefore, LLE was used to extract the
mycotoxins from urine. The main parameters affecting the extraction of all components were optimized:
type of extraction solvent, pH, solvent volume and extraction time. During initial experiments, ethyl
acetate was evaluated as extraction solvent at neutral pH as in literature extraction of mycotoxins from
human urine with this solvent can be found [5,28]. Next, the pH of extraction was optimized using
urine spiked at analyte concentrations of 10 ng/mL (n = 2 per protocol): acidic (pH 2), neutral (pH 8)
and basic (pH 10) extraction conditions were evaluated. Most components showed good extraction at
neutral pH (see Figure 3); only for TeA, HT2 and OTA neutral pH showed insufficient results. For these
components, significantly higher peak areas were observed at pH 2. This can be explained by the
pKa-values of these components. The pKa of TeA (4.5 ± 1) and OTA (3.2 ± 0.1) [45,46] indicate that
these components are weak acids and at pH 2 all these components will be neutral and can thus easily
be extracted. The pKa values and chemical formulas of the other toxins can be found in Supplementary
Table S12. As a result, it was decided to perform two extraction protocols for pig urine, i.e., one in
acidic medium (pH 2, tube 1) and another in neutral medium (pH 7, tube 2). Since the same internal
standard was used for TeA as for AME and AOH and these components were also detected in acidic
medium, they were also added to the acidic protocol. Finally, the volume of ethyl acetate and the
extraction time were also optimized. Different volumes (1.5, 3, 5, and 7.5 mL) and different extraction
times (15, 30, 45, and 60 min) were tested. It was found that extraction was optimal using a solvent
volume of 3 mL and an extraction time of 15 min (results not shown). The combination of both extracts
into one vial was not possible since DOM1 and ADON were no longer recovered.
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Figure 2. Comparison of the chromatographic peak areas of the different mycotoxins (mean + SD) after
extraction from broiler chicken plasma (spiked at 10 ng/mL) using Oasis Ostro® plate or hybrideSPE®
phospholipid SPE tubes (n = 3 per protocol).
 
Figure 3. Comparison of the chromatographic peak areas of the different mycotoxins after extraction
with ethyl acetate (spiked at 10 ng/mL) from pig urine at three different pH levels: acid (pH 2), neutral
(pH 8), and basic (pH 10) (n = 2 per protocol).
Chicken Excreta
For the excreta of broiler chickens, the same solvents as used for extraction of urine and
deproteinization of plasma were evaluated: ACN, MeOH and ethyl acetate. The excreta samples
were spiked at an analyte concentration of 10 ng/g (n = 3 per protocol). MeOH extraction of broiler
chicken excreta did not contain all the metabolites of ZEN. In addition, the peak areas of the measured
metabolites of ZEN and DON and AOH/AME were much lower. Next, the chromatograms after
extraction with ethyl acetate and ACN were compared. The ethyl acetate extract showed a lower S/N
ratio for ZEN and its metabolites. Moreover, the peak areas for the ENNs, AFB1 and DON family were
much higher after extraction with ACN compared to ethyl acetate (Figure 4). Therefore, ACN was
chosen as optimal extraction solvent. However, to improve the recovery, the influence of the addition
of salts (MgSO4 and Na2SO4), acid (HCl), base (NaOH) and water on the extraction recovery was also
evaluated. The extraction recovery of TeA and OTA increased by a factor 100 by adding HCl, whereas
for all the other components extraction with ACN alone showed the highest recovery. Therefore, it was
238
Toxins 2019, 11, 171
decided to perform the extraction of chicken excreta twice: with and without HCl (only for TeA and
OTA). The final protocol for broiler chicken excreta used 1.5 mL of ACN as an extraction solvent.
 
Figure 4. Comparison of the chromatographic peak areas of the different mycotoxins after extraction from
broiler chicken excreta (spiked at 10 ng/g) with ethyl acetate, acetonitrile and methanol (n = 3 per protocol).
Pig Feces
The extraction of mycotoxins from pig feces was initially evaluated using the same solvents as
for the optimization of chicken excreta: MeOH, ACN, and ethyl acetate. However, these solvents did
not give satisfactory results in recovery and the extracts were not sufficiently clean to inject into the
instrument. Therefore, other extraction solvents (acetone, diethyl ether) were also evaluated, but the
recovery of the mycotoxins was still insufficient. This could be explained by the complexity of the
matrix. This challenge was solved by testing different combination of solvents and the combination
of the different solvents with SPE columns. This led to a double extraction procedure. The first
extraction was a liquid extraction using MeOH/ethyl acetate/formic acid (75/24/1; v/v) to extract
OTA, TeA, AME and AOH. The second protocol to extract the other mycotoxins was a combination of
a liquid extraction with acetone and a solid phase extraction with a HybridSPE-phospholipid column.
All extraction procedures were tested in triplicate at analyte concentrations of 10 ng/g.
Both feces and excreta extraction required the use of a filtration step using the Millex®-LG filter
unit (0.2 μm) to obtain samples that were sufficiently clean to inject on the equipment.
For all matrices, the dried extract was reconstituted in 250 μL (or 150 μL for chicken plasma)
of MeOH/water (85/15; v/v). The combination of water and MeOH was crucial to redissolve all
mycotoxins with their various physicochemical characteristics.
2.1.2. Optimization of LC-MS/MS and HRMS Parameters
Four different reversed phase columns (Hypersil Gold 50 mm × 2.1 mm, dp: 1.9, Thermo Scientific,
Breda, The Netherlands; Zorbax Eclipse C18 50 mm × 2.1 mm, dp: 1.8, Agilent, Sint-Katelijne-Waver,
Belgium; Acquity BEH-C18 50 mm × 2.1 mm, dp: 1.7, Waters, Milford, MA, USA; and Acquity HSS-T3
100 mm × 2.1 mm, dp: 1.8, Waters, Milford, MA, USA) were tested to achieve chromatographic
separation of the selected mycotoxins. The best separation of all components was obtained on the
HSS-T3 column.
The multi-methods were developed with two subsequent analytical runs, i.e., ESI+ and ESI−
mode respectively. This was necessary to be able to detect all the mycotoxins with sufficient sensitivity
without increasing the run time. Therefore, the mobile phases for each ionization mode were optimized
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separately. In the literature, the most common mobile phases for mycotoxin detection consist of water
and an organic solvent (such as ACN or MeOH). These solvents are often combined with mobile phase
modifiers such as volatile acids (formic acid and acetic acid) and ammonium formate or ammonium
acetate [34,35]. Different combinations of these solvents and modifiers were evaluated to identify the
optimal combination for each ionization mode.
In ESI− mode, ZEN, AZEL, BZEL, AZAL, BZAL, ZAN, TeA, AOH and AME were determined.
Baseline separation among ZAN, AZEL, and BZEL as well as between AZAL and BZAL was achieved
using water (MP A) and ACN (MP B) as mobile phases [20]. The use of mobile phase with a pH close to
neutral led to an impaired peak shape for TeA [47]. The peak shape was optimal when using 1% acetic
acid. Therefore, 1% acetic acid in water and 1% acetic acid in ACN were chosen as final mobile phases,
since this combination gave satisfactory results for all analytes. Figure 5a shows the chromatographic
separation of the mycotoxins in ESI− mode with the optimized parameters as described here.
DON, DOM-1, 3-ADON, 15-ADON, T2, HT2, T2G, OTA, AFB1, AFM1, FB1, ENNA, ENNA1,
ENNB, ENNB1 and BEA were determined in ESI+ mode. Taking into account all analytes,
the combination of water (MP A) and MeOH (MP B) was most suitable [34]. These mobile phases
were further optimized using ammonium formate and formic acid to evaluate the formation of
ammonium adducts (M + [NH4+]). These adducts are generally easier to fragment than sodium
adducts, thus enhancing the sensitivity of the method. The final combination of mobile phases was
10 mM ammonium formate and 0.3% formic acid in water (MP A) and in methanol (MP B). Figure 5b,c











Figure 5. (a) LC-MS/MS chromatogram showing the separation of tenuazonic acid (TeA,
6.16 min), alternariol (AOH, 6.45 min), α-zearalanol (AZAL, 7.34 min), α-zearalenol (AZEL,
7.47 min), β-zearalanol (BZAL, 6.73 min), β-zearalenol (BZEL, 6.84 min), zearalanone (ZAN,
8.38 min), zearalenone (ZEN, 8.47 min) and alternariol-monomethyl ether (AME, 8.52 min) at a
concentration of 10 ng/mL in broiler chicken plasma; (b) LC-MS/MS chromatogram showing the
separation of deoxynivalenol (DON, 4.37 min), de-epoxy-deoxynivalenol (DOM1, 4.71 min), 3/15-
acetyl-deoxynivalenol (3/15-ADON, 5.02 min), aflatoxin M1 (AFM1, 5.20 min), aflatoxin B1 (AFB1,
5.73), HT2-toxin (HT2, 7.01 min), T2-glucoside (T2G, 7.08 min), T2 toxin (T2, 8.27 min), ochratoxin
A(OTA , 9.28 min), beauvericin (BEA) and the enniatins (ENNA, A1, B and B1) in broiler chicken plasma
at a concentration of 10 ng/mL; and (c) enlargement of (b): LC-MS/MS chromatogram showing the
separation of BEA and the enniatins (ENNA, A1, B and B1) in broiler chicken plasma at a concentration
of 10 ng/mL.
Since an isotopically labeled IS for each single mycotoxin is too expensive and not
commercially available, an IS labeled with [13C] or [15N] was used for each group of mycotoxins.
[13C15]-deoxynivalenol was used as IS for DON, DOM-1 and 3/15ADON; [13C17]-Aflatoxin B1 for
AFB1 and AFM1; [13C20]-Ochratoxin A for OTA; [13C34]-Fumonisin B1 for FB1; [13C615N]-Tenuazonic
acid for TeA, AME and AOH; [13C18]-Zearalenone for ZEN, AZAL, BZAL, AZEL, BZEL and ZAN;
241
Toxins 2019, 11, 171
and [15N3]-Enniatin B for ENNA, ENNA1, ENNB, ENNB1 and BEA. Hence, an optimal correction
for matrix effects and losses during sample preparation was obtained, which was confirmed during
method validation (see Table 2, Tables S6–S9, and Results Section for accuracy and precision).
Data acquisition on the high-resolution mass spectrometer (HRMS) was done in the positive or
negative ESI resolution mode, using the MSE continuum scan function. The results were processed
using the Unify version 1.8 software (Milford, MA, USA) to determine the phase I and II metabolite,
for which no commercial analytical standards were available.
Metabolites known in the literature were added to the accurate mass—MSe screening method
and additionally a pathway profiling MSE processing method (the chemical formulas and theoretical
accurate masses were added) with additional adducts and transformations was made. Peaks were
identified based on the found accurate mass in the low energy spectrum and the product ions generated
in the high energy spectrum. An additional confirmation criterion was the observed profile of peak
areas versus time, seen in the samples obtained during the toxicokinetic study. An example of an
extracted ion chromatogram of a glucuronidated metabolite of ZEN and the corresponding low energy
and high energy spectra, which was detected in a plasma sample of a pig administered an intra-gastric
bolus of ZEN (3 mg/kg bw), is shown in Figure 6.
The Unify version 1.8. software (Waters, Milford, MA, USA) detected two peaks with the
exact mass of ZEN-glucuronide [m/z 494.1788]. However, only the MS/MS spectrum of the second
peak (4.68 min) showed the product ions [m/z 317 and 175] of ZEN-glucuronide as defined in the
literature [19]. The first fragment ion (m/z = 317), corresponds with the loss of glucuronic acid
(176 amu) and the second at m/z = 175 results from the loss of the aglycone from the quasimolecular
ion [48]. The data of the first peak can be found in Figure S1.
 
(A) Extracted Ion Chromatogram 
 
(B) Low Energy spectrum 
Figure 6. Cont.
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(C) High Energy spectrum 
Figure 6. (A) LC high-resolution extracted mass chromatogram of a plasma sample that was taken
from a pig that received an intra-gastric bolus of zearalenone (ZEN) (3 mg/kg bw); the following
mass-to-charge (m/z) values, corresponding to the theoretical exact mass of the deprotonated
molecular ions [M − H]−, were extracted from the total ion chromatogram using Unify 1.8 software:
ZEN-glucuronide: [m/z 493.1788]. (B) In the low energy MS/MS spectrum, this mass was confirmed
as m/z-value 493.17121 (target mass error = 10 ppm). (C) In the high energy MS/MS spectrum,
the corresponding product ions at m/z 317.13877 and 175.04015 (target mass error = 10 ppm) are shown.
2.2. Method Validation
The most optimal extraction protocol for plasma, urine and feces of pigs and plasma of broiler
chickens was not validated for fumonisins due to low recovery. Therefore, it was decided to only
validate fumonisin B2 in broiler chicken excreta, hence in this matrix 25 mycotoxins were validated.
The correlation coefficient (r) and the goodness-of-fit (g) are shown in Table 1 as an average ±
standard deviation of three curves made across three different analysis days. The linearity results for
the other matrices can be found in Tables S2–S5. They ranged for pig plasma from 0.993 to 0.998 (r) and
9.0% to 17.5% (g); for pig urine from 0.995 to 0.999 (r) and 3.5% to 17.0% (g); for pig feces from 0.993 to
0.999 (r) and 7.1% to 18.7% (g); for chicken plasma from 0.994 to 0.999 (r) and 5.9% to 17.7% (g); and for
chicken excreta from 0.995 to 0.999 (r) and 5.1% to 16.80% (g). Most of the calibration curves matched a
linear calibration model with a 1/x weighing factor, except for the ENNs and BEA. These components
show a quadratic 1/x model. Linearity results of each component separately for pig plasma are shown
in Table 1.
Table 1. Validation results for linearity (linear range, correlation coefficient (r) and goodness-of-fit
coefficient (g)) and limit of quantification (LOQ) of 24 mycotoxins in pig plasma.
Analyte
Linearity (n = 3 Different Days)
LOQ (ng/mL)Linear Range
(ng/mL)
r ± SD g (%) ± SD
ZEN 1–200 0.996 ± 0.003 12.9 ± 3.8 1.0
AZEL 1–200 0.995 ± 0.002 15.0 ± 1.2 1.0
AZAL 1–200 0.995± 0.003 15.2 ± 3.6 1.0
BZAL 1–200 0.996 ± 0.001 10.7 ± 2.0 1.0
BZEL 1–200 0.996 ± 0.002 14.9 ± 3.7 1.0
ZAN 1–200 0.997 ± 0.001 16.3 ± 3.1 1.0
TEA 1–200 0.998 ± 0.001 12.0 ± 4.9 1.0
AOH 1–200 0.997 ± 0.002 12.9 ± 5.2 1.0
AME 1–200 0.996± 0.004 13.1± 5.1 1.0
DON 1–200 0.998 ± 0.002 13.9 ± 4.4 1.0
DOM-1 1–200 0.997 ± 0.003 16.9 ± 2.5 1.0
3/15 ADON 1–200 0.998 ± 0.001 9.3 ± 3.1 1.0
T2 1–200 0.998 ± 0.001 9.9 ± 1.6 1.0
HT2 1–100 0.993 ± 0.002 17.5 ± 2.8 1.0
T2G 2–200 0.995 ± 0.003 14.4 ± 1.2 2.0
AFB1 1–200 0.996 ± 0.002 12.7 ± 2.8 1.0
AFM1 1–200 0.997 ± 0.002 13.8 ± 5.6 1.0
OTA 1–200 0.993 ±0.004 9.3 ± 2.9 1.0
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Table 1. Cont.
Analyte
Linearity (n = 3 Different Days)
LOQ (ng/mL)Linear Range
(ng/mL)
r ± SD g (%) ± SD
ENNA1 1–200 0.998 ± 0.001 9.0 ± 0.9 1.0
ENNA 1–50 0.995 ± 0.003 13.9 ± 3.2 1.0
ENNB 1–100 0.993 ± 0.002 9.3 ± 1.2 1.0
ENNB1 1–100 0.998 ± 0.001 15.9 ± 2.3 1.0
BEA 1–100 0.998 ± 0.000 16.6 ± 4.5 1.0
Note: SD, standard deviation; acceptance criteria: r ≥ 0.990 and g ≤ 20.
The LOQ that was aimed for during method development was 1 ng/mL or ng/g. This could be
obtained for the majority of the components in the different matrices, with the following exceptions:
DOM1 (4 ng/mL) and T2G (2 ng/mL) in pig urine; T2G (2 and 5 ng/mL) in pig and broiler chicken
plasma; and T2G (2 ng/g), HT2 (4 ng/g) and FB2 (10 ng/g) in broiler chicken excreta. In pig feces,
the LOQ for ZEN, AZAL, AOH, DON, DOM-1, HT2 and T2G was established at 5 ng/g.
No peaks were detected at the retention time zone of the analytes of interest in the solvent sample
that was injected after the highest calibrator sample, thus demonstrating the absence of carry over.
Moreover, for none of the components a signal was observed at the elution zone of the analytes of
interest in a blank matrix sample. This indicates a good specificity of the method.
The results of the within-day and between-day precision and accuracy met the specifications for
all mycotoxins and matrices. The results can be found in Table 2 for pig plasma and Tables S6–S9 for
the other matrices.
The results for matrix effects (signal enhancement and suppression) and extraction recovery are
shown in the Tables S10 and S11. Most components gave acceptable results (range 60–140%). However,
for some components, matrix effects were more pronounced and recovery was rather low. However,
for all mycotoxins, an adequate internal standard and matrix-matched calibration curves were used,
resulting in validation results for accuracy and precision matching the acceptance criteria.
The validation results for the other matrices can be found in Tables S6–S9.
This resulted in a fully validated quantitative targeted LC-MS/MS method and additionally
a qualitative untargeted LC-HRMS method. Both methods together enable not only determining
mycotoxins with good sensitivity but also targeting a broad range of mycotoxins and their metabolites,
not limited by the commercial availability of standards. This approach makes is possible to determine
24 mycotoxins and their relevant metabolites in easily obtainable biological matrices (plasma, urine
and feces) of pigs and broiler chickens. This is the first time that a paper covers such a broad range
of matrices and mycotoxins with a simple and practical sample preparation. This leads to a general
applicable method that can be applied in, among others, in vivo toxicokinetic studies and screening
studies to investigate the exposure of individual animals to mycotoxins, as shown in Section 2.3.
2.3. Biological Samples: Toxicokinetic Study
2.3.1. Pigs
In the pig plasma samples, low concentrations (1–15 ng/mL) of DON and ZEN were found
using LC-MS/MS analysis. The plasma concentration–time curves for these components are shown in
Figure S2. However, analysis of the samples using the LC-HRMS instrument showed that DON-GlcA
and ZEN-GlcA are better biomarkers for exposure as their observed peak areas are much higher
than those of the respective parent components DON and ZEN [9,20]. Since no DON-GlcA and
ZEN-GlcA standards were available at our laboratory, these components were tentatively identified
using the LC-HRMS multi-method. DON-GlcA and ZEN-GlcA plasma response–time curves are
shown in Figure 7. The highest response for ZEN-GlcA was achieved at 30 min and for DON-GlcA at
4 h post-administration.
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Figure 7. (A) HRMS response–time curve of deoxynivalenol-glucuronide (DON-GlcA) in plasma after
intra-gastric administration of deoxynivalenol (DON, 36 μg/kg bw) to pigs (n = 8). The mean ratio of
the HRMS peak areas of DON-GlcA/13C15-DON + SD is shown. (B) HRMS response–time curve of
zearalenone-glucuronide (ZEN-GlcA) in plasma after intra-gastric administration of zearalenone (ZEN,
3 mg/kg bw) to pigs (n = 8). The mean ratio of the HRMS peak areas of ZEN-GlcA/13C18-ZEN + SD
is shown.
In pig feces, no traces of DON were observed. This can be explained by the complete absorption
and fast elimination of DON in urine, while only 1–3% of the administered dose is reported to be
excreted via feces [16]. The concentration–time profiles of ZEN and its phase I metabolites in feces
showed maximum levels from the first 12 h after exposure onwards (Figure 8). The highest amounts
were excreted during 12–24 h. This is in line with the observations of Binder et al., who found the
highest amounts of ZEN and metabolites were excreted during 24–48 h [19].
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Figure 8. (A) Concentration–time curve of zearalenone (ZEN) in feces after intra-gastric administration
of ZEN (3 mg/kg bw) to pigs (n = 8). The mean + SD is shown. (B) Concentration–time curves
of α-zearalenol (AZEL) in feces after intra-gastric administration of ZEN (3 mg/kg bw) to pigs
(n = 8). The mean + SD is shown. (C) Concentration–time curve of β-zearalenol (BZEL) in feces
after intra-gastric administration of ZEN (3 mg/kg bw) to pigs (n = 8). The mean + SD is shown.
(D) Concentration–time curve zearalanone (ZAN) in feces after intra-gastric administration of ZEN
(3 mg/kg bw) to pigs (n = 8). The mean + SD is shown.
In pig urine, DON, ZEN and ZEN-GlcA were detected. The maximum concentrations were
achieved after 4–8 h for ZEN, ZEN-GlcA and DON. Nagl et al. also demonstrated a fast elimination of
DON in urine with a maximum concentration in the first 4 h. DON showed to be the most important
urinary metabolite [16]. Binder et al. also detected ZEN and ZEN-GlcA in pig urine after oral
administration of ZEN, with ZEN-GlcA as the major metabolite. In this study, the response ratio of
ZEN-GlcA/IS was also much higher than the area ratio of ZEN/IS, indicating ZEN-GlcA as a major
metabolite [19]. The concentration (or HRMS response)–time curves of these molecules are depicted in
Figure 9.
In all feces and urine samples, low concentrations (or HRMS response areas) were observed at
the time of administration due to the presence of low levels DON and ZEN in the feed. In urine,
this concentration was negligible, especially when compared to the concentration after administration.
In feces, the effect of the administration was only seen after 10 h. Twelve hours fasting before
administration was not enough to eliminate the concentration of mycotoxins in feces after long-term
exposure in this study. However, blank samples were obtained in previous studies, as shown in
Figure S3.
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Figure 9. (A) Concentration–time curves of deoxynivalenol (DON) in urine after intra-gastric
administration of DON (36 μg/kg bw) to pigs (n = 8). The mean + SD is shown (B) Concentration–time
curves of zearalenone (ZEN) in urine after intra-gastric administration of ZEN (3 mg/kg bw) to pigs
(n = 8). The mean + SD is shown. (C) The HRMS response–time curves of zearalenone-glucuronide
(ZEN-GlcA) in urine after intra-gastric administration of ZEN (3 mg/kg bw) to pigs (n = 8). The mean
ratio of the HRMS peak areas of ZEN-GlcA/13C18-ZEN + SD is shown.
2.3.2. Broiler Chickens
AFB1 and OTA were detected in plasma, as well as in excreta samples. No other relevant
metabolites were found by LC-HRMS. The concentration (response)–time curves are shown in Figure 10.
OTA and AFB1 showed a second peak in the plasma concentration–time curve around 4 h p.a. This can
be attributed to enterohepatic recirculation, which has previously been described for OTA [49,50].
The maximum concentration measured for AFB1 was 8.4 ng/mL and for OTA was 50 ng/mL, for both
toxins observed after 15 min. After administration of DON, only DON-sulfate was found in plasma
and excreta due to the high conversion rate of DON to DON-sulfate in broiler chickens, confirming
previous literature reports [9,16]. The maximum response was achieved after 30 min.
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(A) Broiler chicken plasma 
 
(B) Broiler chicken excreta 
Figure 10. (A) Concentration–time curves of aflatoxin B1 (AFB1) and ochratoxin A (OTA), and HRMS
response–time curves of deoxynivalenol-sulfate (DON-S) in plasma after PO administration of
deoxynivalenol (DON, 0.5 mg/kg bw), AFB1 (2 mg/kg bw) and OTA (0.25 mg/kg bw) to broiler
chickens (n = 16). The mean + SD is shown for AFB1 and OTA and the mean ratio of the HRMS
peak areas of DON-S/13C15-DON + SD is shown. (B) Concentration–time curves of AFB1 and
OTA and HRMS response–time curves of DON-sulfate (DON-S) in excreta after PO administration
of DON (0.5 mg/kg bw), AFB1 (2 mg/kg bw) and OTA (0.25 mg/kg bw) to broiler chickens
(n = 16). The mean + SD is shown for AFB1 and OTA and the mean ratio of the HRMS peak areas of
DON-S/13C15-DON + SD is shown.
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2.4. Screening Study
Plasma samples from pigs and broiler chickens were obtained from the field and analyzed with the
presented method for the presence of mycotoxins in plasma. Two interesting samples are highlighted.
The first sample is a pig plasma sample from Belgium. This sample contained ZEN, TeA and DON
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(C) 
Figure 11. The extracted ion chromatograms showing the presence of: deoxynivalenol (DON) (A);
tenuazonic acid (TeA) (B); and zearalenone (ZEN) (C) in pig plasma samples obtained from a farm
in Belgium.
The second sample is a broiler chicken plasma sample from Lithuania. This sample contained TeA






Figure 12. The extraction ion chromatograms showing the presence of: deoxynivalenol (DON) (A);
and tenuazonic acid (TeA) (B) in broiler chicken plasma samples obtained from a farm in Lithuania.
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3. Conclusions
This paper describes a fully validated quantitative targeted LC/MS-MS method, and a qualitative
untargeted LC-HRMS approach to determine mycotoxins and their relevant metabolites in easily
obtainable biological matrices of pigs and broiler chickens. The methods were applied to plasma, urine,
feces and/or excreta samples that were obtained during in vivo toxicokinetic studies with DON and
ZEN in pigs, and with DON, AFB1 and OTA in broiler chickens and during a pilot field screening study
to monitor exposure to mycotoxins. These results show the successful applicability of the multi-method
to pig and broiler chicken samples, providing a proof-of-concept of the developed methods.
4. Materials and Methods
4.1. Chemicals, Products and Reagents
The analytical standards of ZEN, T2, HT2 toxin (HT2), OTA, AFB1, aflatoxin M1 (AFM1), FB2,
AOH, alternariol monomethyl ether (AME), TeA, DON, 3ADON, 15ADON, enniatin A (ENNA),
enniatin A1 (ENNA1), enniatin B1 (ENNB1), enniatin B (ENNB) and BEA were obtained from
Fermentek (Jerusalem, Israel). Zearalanone (ZAN), α-zearalenol (AZEL), β-zearalenol (BZEL),
α-zearalanol (AZAL) and β-zearalanol (BZAL) were purchased from Sigma-Aldrich (Bornem, Belgium).
De-epoxy-deoxynivalenol (DOM-1) was obtained from Biopure (Tulln, Austria). T-2 toxin-3α-glucoside
(T2G) was synthesized by the U.S. Department of Agriculture (USDA) as described [51,52]. Internal
standards (IS) of 13C15-DON, 13C24-T2, 13C18-ZEN, 13C20-OTA, 13C34-FB1 and 13C17-AFB1 were
purchased from Biopure. The internal standard 13C615N-TeA was synthesized according to the
method of Asam et al. [53], and 15N3-ENN B was synthesized according to the method of Hu and
Rychlik [54]. All standards were stored according to the recommendations of the supplier. Water,
methanol (MeOH), acetonitrile (ACN), ammonium formate, glacial acetic acid and formic acid for the
preparation of mobile phases were of LC-MS grade and were obtained from Biosolve (Valkenswaard,
The Netherlands). Acetone, ammonium formate, formic acid and ethyl acetate were of analytical
grade and were purchased from VWR (Leuven, Belgium). Millex®-LG filter units (0.2 μm), sodium
hydroxide (NaOH) pellets and hydrochloric acid (HCl) 37% fuming solution were obtained from
Merck (Overijse, Belgium). Ostro®-96 well plates were obtained from Waters (Milford, MA, USA).
HybridSPE®-phospholipid 30 mg/1 mL SPE tubes were purchased from Sigma-Aldrich. Merck Alcalit
pH indicator paper pH 0–14 was obtained from Novolab (Geraardsbergen, Belgium).
4.2. Preparation of Standard Solutions
Standard stock solutions (SS) for ZEN, AZAL, BZAL, AZEL, BZEL, ZAN, DON, T2, T2-G, HT2,
AFB1, AFM1, AOH, AME, ENNs, BEA and FB1 were prepared in ACN at 100 μg/mL. Standard
SS for OTA was prepared in ACN at 10 μg/mL. The standard SS of TeA was prepared in methanol
at 100 μg/mL. Following standards were purchased as solutions: 3ADON (100 μg/mL in ACN),
15ADON (100 μg/mL in ACN) and DOM-1 (50 μg/mL in ACN). A standard SS of 10 μg/mL in ACN
was prepared for DOM-1. All internal standards (IS) were obtained as solutions: 13C15-DON (25 μg/mL
in ACN), 13C24-T2 (25 μg/mL in ACN), 13C18-ZEN (25 μg/mL in ACN), 13C20-OTA (10 μg/mL in
ACN), 13C34-FB1 (25 μg/mL in ACN/water) and 13C17-AFB1 (0.5 μg/mL in ACN). Standard SS of
the synthesized internal standards were prepared at a concentration of 100 μg/mL in MeOH for
13C615N-TeA and 10 μg/mL in ACN for 15N3-ENN B. The SS were stored at ≤−15 ◦C.
A combined working solution of all analytical standards (WSmix, without IS) at a concentration of
1 μg/mL was prepared by transferring 10 μL of the stock solutions with a concentration of 100 μg/mL
and 100 μL of a 10 μg/mL solution of DOM-1 and OTA, followed by further dilution with ACN up
to a total volume of 1 mL. Serial dilutions of the WSmix were prepared, yielding concentrations of
100 ng/mL and 10 ng/mL. Individual working solutions of 1 μg/mL were made for all IS, except
for 13C17-AFB1 (100 ng/mL) and 15N3-ENN B (100 ng/mL). Next, a combined working solution of
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all IS (WSmix_IS) was prepared with a final concentration of 100 ng/mL for all components, except
13C17-AFB1 (10 ng/mL) and 15N3-ENN B (10 ng/mL). All working solutions were stored at ≤−15 ◦C.
4.3. Biological Samples
A toxicokinetic study was performed to demonstrate the applicability of the developed method.
Incurred plasma samples were obtained from 8 hybrid pigs (6 weeks of age, 9.94 ± 1.24 kg, ♂/♀4/4),
dosed with a single oral (intragastric) bolus of DON (36 μg/kg bodyweight (bw)) and ZEN (3 mg/kg
bw) after a fasting period of 12 h, and from 16 12 h-fasted broiler chickens (Ross 308, 3 weeks of
age, 1.05 ± 0.11 kg, ♂/♀5/11) administered AFB1 (2 mg/kg bw), DON (0.5 mg/kg bw) and OTA
(0.25 mg/kg bw). All mycotoxin doses were administered as a single oral bolus (acute exposure,
by gavage), and corresponded with doses previously used in toxicokinetic studies and studies to test
the efficacy of mycotoxin detoxifiers. For DON, this dose was in agreement with the EU legislation in
feed. The maximum guidance level in pig feed is set at 0.9 mg/kg DON [3]. Pigs of this age category
consume on average 40 g feed/kg bw/day. This resulted in the administration of 36 μg DON/kg
bw as described in [8]. For broiler chickens, the EU regulations set the maximum guidance level at
5 mg/kg feed [3]. Broilers (±1 kg bw) consume on average 100 g feed/kg bw/day. This resulted in the
administration of 0.5 mg DON/kg bw as described in [8].
For ZEN in pigs and AFB1 and OTA in broiler chickens, the administered doses were higher
than set by the EU legislation. These doses corresponded to the doses previously administered in
toxicokinetic studies and studies to determine the efficacy of mycotoxin detoxifiers [50]. These higher
doses were necessary to obtain sufficiently high plasma concentrations to evaluate the toxicokinetic
parameters of the toxins, as well as to demonstrate the efficacy of mycotoxin detoxifiers. Although
the doses were higher than the guidance levels, they did not evoke clinical toxicity after this single
administration. This was the case in the previously mentioned studies [50], as well as in the present
study. The most important read-out of this single oral bolus dosing in animals is the area under the
plasma concentration–time curve (AUC), which has to be high enough to be able to demonstrate a
statistical significant reduction in AUC when combined with the detoxifier. As the goal here was to
evaluate the use of the analytical methods in this type of studies, the same doses were used.
Blood was sampled before administration (0 min) and at 5, 10, 20, 30, 45, 60, 90, and 120 min, and 3,
4, 6, 8, 10, 12 and 24 h after administration of mycotoxins. Blood was collected via the vena jugularis
in EDTA tubes using a Venoject® system and centrifuged (2851× g, 10 min, 4 ◦C) to obtain plasma,
which was stored at ≤−15 ◦C until analysis. Urine was collected from male pigs using pediatric urine
collection bags as described by Gasthuys et al.[55]. Sampling was done at 4 intervals: 0–4 h, 4–8 h,
8–12 h and 12–24 h. Feces were collected every 2 h by rectal stimulation of the pigs. Excreta were
collected every 2 h by placing the broiler chickens in separate boxes for sampling. The animal trial was
approved by the ethical committee of the Faculty of Veterinary Medicine and the Faculty of Bioscience
Engineering of Ghent University (EC2017/05) on 30 March 2017.
A multi-mycotoxin LC-MS/MS analysis of the pig and chicken feed (Primoris, Zwijnaarde,
Belgium) showed only low amounts of DON (respectively, 139 and 140 μg/kg) and ZEN (respectively,
12 and 20 μg/kg). The feed was conform the EU legislation since these amounts are below the guidance
values of the European commission [3]. Blank plasma, urine and feces samples were obtained from pigs
and broiler chickens on the mycotoxin control diet. The blank samples were used for the preparation
of matrix-matched calibration curves and quality control samples.
Besides the toxicokinetic studies, a preliminary screening study (n = 1 farm per animal species)
was performed to monitor the exposure of pigs and broiler chickens to mycotoxins and to demonstrate
the applicability of the developed method in the field. Therefore, farms with problems that might be
related to mycotoxins (e.g., postpartum problems, tail necrosis and refused feed intake) and where
mycotoxins were found in feed were selected. Blood of 10 pigs (5 sows and 5 piglets) and 10 broiler
chickens (2 weeks of age) was collected around 30 min after feeding. The blood was collected in EDTA
tubes and centrifuged (2851× g, 10 min, 4 ◦C) to obtain plasma. The animal trial was also approved by
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the ethical committee of the Faculty of Veterinary Medicine and the Faculty of Bioscience Engineering
of Ghent University (EC2017/115) on 30 March 2017.
4.4. Sample Pre-Treatment
4.4.1. Pig Plasma
To 250 μL of plasma, 20 μL of a 100 ng/mL WSmix_IS were added, vortex mixed and set for
equilibration at room temperature for 5 min. Next, 750 μL of ACN with 0.1% formic acid of analytical
grade were added, followed by vortex mixing (10 s) and centrifugation (8,517× g, 10 min, 4 ◦C).
The total supernatant was collected and dried under a nitrogen (N2) stream at 40 ± 5 ◦C. The dried
supernatant was reconstituted in 250 μL of methanol/water (85/15; v/v), followed by vortex mixing.
The reconstituted sample was transferred into an autosampler vial and an aliquot (5 μL) was injected
onto the LC-MS/MS and LC-HRMS instrument.
4.4.2. Pig Urine
To two tubes (tube 1 and 2), each containing 500 μL of urine, were added 20 μL of a 100 ng/mL
WSmix_IS, followed by vortex mixing and equilibration at room temperature for 5 min. The pH was
determined by means of pH test strips and was adjusted to pH 8 in tube 1 and to pH 2 in tube 2, using
a 0.1 M NaOH solution and a 1 M HCl solution, respectively. This pH adjustment was necessary to
allow extraction of the different mycotoxins. At pH 8 most mycotoxins were extracted except for TeA,
AOH, AME and OTA that extracted best at pH 2.
Thereafter, 3 mL of ethyl acetate were added to each tube, followed by vortex mixing for 10 s
and rotating during 15 min on a horizontal roller shaker (Staffordshire, UK). Finally, the tubes were
centrifuged for 10 min at 3724× g and 4 ◦C. The organic phase of each tube was transferred to separate
polypropylene tube and evaporated to dryness using a gentle N2-stream at 40 ± 5 ◦C. The dried
extracts of tube 1 and 2 were reconstituted in 250 μL of MeOH/water (85/15; v/v) and vortex mixed.
The redissolved extracts of tube 1 and 2 were transferred to a separate autosampler vial and an aliquot
(5 μL) was injected onto the analytical instruments.
4.4.3. Pig Feces
Feces samples were first freeze dried for 48 h to eliminate variation due to different moisture
contents. Then, 20 μL of a 100 ng/mL WSmix_IS were added to two tubes (tube 1 and 2), each containing
250 mg of freeze-dried feces. The samples were vortex mixed during 10 s and equilibrated at room
temperature for 5 min. The extraction of TeA, OTA, AME and AOH was performed using tube 2,
with 5 mL of methanol/ethyl acetate/formic acid of analytical grade (75/24/1; v/v), whereas the
other mycotoxins were extracted using tube 1 with 5 mL of acetone. Both tubes were shaken for
40 min on an in-house made vertical rotator (75 rpm), followed by centrifugation (3724× g, 10 min,
4 ◦C). The supernatant of tube 1 was transferred onto a HybridSPE-phospholipid cartridge. The eluate
of tube 1 and the supernatant of tube 2 were evaporated until dryness using a gentle N2-stream at
40 ± 5 ◦C. The dried extracts were reconstituted in 250 μL of MeOH/water (85/15; v/v) and filtered
through a Millex®-LG 0.2 μm filter. The redissoved extracts of tube 1 and 2 were transferred to a
separate vial and an aliquot (5 μL) was injected onto the LC-MS/MS and the LC-HRMS instrument.
4.4.4. Broiler Chicken Plasma
First, 150 μL of chicken plasma was brought in a well of an Ostro® 96-well plate. Next, 15 μL
of a 100 ng/mL WSmix_IS were added, followed by a gentle up and down pipetting for mixing and
equilibration for 5 min at room temperature. Next, 450 μL of ACN containing 0.1% formic acid of
analytical were added. After gentle mixing, the Ostro® 96-well plate was placed under vacuum
(67.7 kPa) to allow the sample to pass through the plate. The eluate of each sample was transferred
254
Toxins 2019, 11, 171
to a polypropylene tube, dried under a gentle N2-stream at 40 ± 5 ◦C and reconstituted in 150 μL of
MeOH/water (85/15; v/v). An aliquot of 5 μL was injected onto the analytical instruments.
4.4.5. Broiler Chicken Excreta
Excreta samples were first freeze dried for 48 h to eliminate variation due to different moisture
contents. The extraction of TEA, AME, OTA and AOH was performed in acidic medium (tube 1),
whereas the other mycotoxins were extracted without adjustment of the pH (tube 2). Hence, 250 mg
of freeze-dried chicken excreta were added to tube 1 and 2, followed by the addition of 20 μL of a
100 ng/mL WSmix_IS and equilibration for 5 min at room temperature. Next 1.5 mL of ACN was added
to both tubes, followed by adding 250 μL of a 1 M HCl solution to tube 1. The pH of the excreta
in tube 2 was not adjusted. The two tubes were vortex mixed and shaken for 15 min on a vertical
rotator, followed by centrifugation (3724× g, 10 min, 4 ◦C). The supernatants were transferred to
separate polypropylene tubes and dried under a N2-stream at 40 ± 5 ◦C. The dried extracts were
reconstituted in 250 μL of MeoH/water (85/15; v/v) and filtered through a Millex®-LG 0.2 μm filter.
Each sample was transferred to a separate vial. An aliquot of 5 μL was injected onto the LC-MS/MS
and LC-HRMS instruments.
4.5. Chromatography
The chromatographic systems consisted of an Acquity H-Class ultra-performance liquid
chromatograph (UPLC) coupled to a Xevo® TQ-S mass spectrometer and an Acquity I-Class
UPLC coupled to a Synapt® G2-Si high definition mass spectrometer (HDMS), all from Waters.
Chromatographic separation was achieved on an Acquity HSS T3 column (100 mm × 2.1 mm i.d.,
dp: 1.8 μm) and a VanGuard pre-column of the same type (5 mm × 2.1 mm i.d., dp: 1.8 μm),
both from Waters. The temperatures of the column oven and autosampler tray were set at 45 ◦C and
8 ◦C, respectively.
The chromatographic conditions were optimized for the different ionization modes, i.e., positive
and negative electro-spray ionization (ESI). The optimal chromatographic conditions for the ESI
positive mode were obtained with the mobile phases (MP) containing 10 mM ammonium formate,
0.3% formic acid in water (MP A), and 10 mM ammonium formate, 0.3% formic acid in methanol
(MP B), all of LC-MS grade. In ESI negative mode, the most suitable mobile phases consisted of 1%
acetic acid in water (MP C) and 1% acetic acid in acetonitrile (MP D), all of LC-MS grade. A gradient
elution program was run for each ionization mode separately. For ESI positive: 0–1.5 min, 95% A,
5% B; 1.5–3 min, linear gradient to 40% A; 3–5 min, 40% A, 60% B; 5.0–10 min, linear gradient to 20% A;
10–10.50 min, linear gradient to 1% A; 10.50–13.0 min, 1% A, 99% B; 13–14 min, linear gradient 95% A;
14.0–16.0 min, 95% A, 5% B. For ESI negative: 0–1.5 min, 95% C, 5% D; 1.5–3 min, linear gradient to
60% C; 3.0–4.0 min, 60% C, 40% D; 4.0–7.0 min, linear gradient to 40% C; 7.0–9.0 min, 40% C, 60% D;
9.0–9.5 min, linear gradient 95% C; 9.5–12.0 min, 95% C, 5% D. The flow rate was set at 300 μL/min.
The chromatographic parameters were the same for both the LC-MS/MS and LC-HRMS instruments.
4.6. Mass Spectrometry
Instrument parameters were optimized by syringe infusion of working solutions of 10 μg/mL of
each compound (flow rate 10 μL/min).
4.6.1. LC-MS/MS
The settings on the Xevo® TQ-S mass spectrometer were as follows: desolvation gas flow
rate: 800 L/h; desolvation temperature: 600 ◦C; cone gas flow rate: 150 L/h; source temperature:
150 ◦C. The capillary voltage was optimized at 3.2 kV for ESI positive and 3.0 kV for ESI negative
mode, respectively. Dwell times of 25 and 10 ms/transition were selected for each component
separately. The Xevo® TQ-S mass spectrometer was operated in the selected reaction monitoring (SRM)
mode. For every compound, the two most intense product ions were selected for quantification and
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qualification, respectively. In Table 3; Table 4, an overview is given of the compound specific MS/MS
parameters at the selected ionization mode (ESI negative and ESI positive, respectively).
4.6.2. LC-HRMS
Following instrument parameters were selected: desolvation gas flow: 800 L/h; desolvation
temperature: 600 ◦C; cone gas flow: 50 L/h; source temperature: 150 ◦C. The capillary voltage was
3.2 kV for ESI positive and and 3.0 kV for ESI negative. The HRMS acquisition was performed in
resolution mode using the MSE continuum scan function. The MSE data acquisition was optimal
for use in the Unify 1.8. software (Waters, Milford, MA, USA). The settings were as follows: low
mass, 50 dalton (Da); high mass, 1200 Da; scan time, 0.1 s; data format, continuum. The lock mass
solution consisted of leucine encephalin (200 pg/μL). The lock spray capillary voltage was 2.8 kV
for positive and 2.15 kV for the negative ionisation mode. The additional lock spray settings were
as follows: scan time, 0.1 s; interval, 30 s; scans to average, 3; mass window, 0.5 Da. The lock spray
was acquired during HRMS acquisition, but not corrected. The lock spray correction (m/z 556.276575;
m/z 554.26202) and data processing was performed using Unify 1.8 software (Waters, Milford, MA,
USA). Identification of analytes for which analytical standards were available was based on retention
time (target TR tolerance: 0.1 min) and mass (target mass tolerance: 10 ppm). Identification of phase I
and II metabolites for which no analytical standards existed was based on the found exact mass (target
mass tolerance: 10 ppm).
For every mycotoxin and some of their phase I and II metabolites, the accurate masses were
defined in the Unify 1.8 processing method, as shown in Table S1. The search for phase I and II
metabolites was performed using a pathway profiling approach. Additional adducts (e.g., Na+, NH4+,
CH3COO−, HCOO−) and the following transformations were added to the method: glucuronidation,
sulfation, oxidation, glutathione conjugations, glucosylations. After detection of a peak based on
the accurate mass by Unify 1.8, the given MS/MS spectrum was inspected to confirm the proposed
structure based on the present product ions.
4.7. Method Validation
The LC-MS/MS method was validated according to a protocol previously described by De Baere
et al. [35], using spiked blank plasma, urine and feces samples obtained from healthy, untreated
animals. The validation requirements are in compliance with the recommendations and guidelines
defined by the European and international Community [56–58]. Following parameters were evaluated:
linearity, within-day and between-day precision and accuracy, limit of quantification (LOQ), carry
over, specificity, extraction recovery and matrix effects.
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4.7.1. Linearity
Linearity was assessed by preparing three matrix-matched calibration curves over a concentration
range of 1–200 ng/mL or 1–200 ng/g. Ten concentrations were included: 0, 1, 2, 4, 5, 10, 30, 50,
100 and 200 ng/mL or ng/g. The correlation coefficients (r) and the goodness-of-fit coefficients (g)
were calculated and acceptance criteria were set, respectively, at ≥0.99 and ≤20% [59].
4.7.2. Precision and Accuracy
Within-day precision and accuracy were evaluated by analyzing six blank samples spiked at low
(LOQ), medium (10 ng/mL or ng/g) and high (100 ng/mL or ng/g) concentration levels. Between-day
precision and accuracy were determined by analyzing in threefold three quality control samples
spiked at low (LOQ), medium (10 ng/mL or ng/g) and high (100 ng/mL or ng/g) concentration level
on three different days. The acceptance criteria for within-day and between-day accuracy were as
follows: −50% to +20%, −30% to +10% and −20 to +10% for concentrations of ≤1 ng/mL or ng/g,
1–10 ng/mL or ng/g and ≥10 ng/mL or ng/g, respectively. For the within-day precision, the relative
standard deviation (RSD%) had to be lower than the maximum relative standard deviation (RSDmax),
which was <25%, and <15% for concentrations ≥1 to <10 ng/mL or ng/g and ≥10 to <100 ng/mL or
ng/g, respectively [58]. For the between-day precision, the RSD% had to be lower than the RSDmax,
which was defined by the Horwitz equation: RSDmax = 2(1–0.5 log Concentration(g/mL)). The RSDmax was
22.6%, 32% and 45% for the respective concentrations of 100 ng/mL, 10 ng/mL and 1 ng/mL [56,57].
4.7.3. Limit of Quantification (LOQ)
The LOQ was the lowest concentration of the analyte for which the method was validated with
an acceptable accuracy and precision according to the guidelines described above. The LOQ was also
the lowest concentration of the calibration curves. The LOQ was determined by analyzing different
concentrations spiked in six-fold on the same day.
4.7.4. Carry Over
Carry over was assessed by analyzing a mixture of MeOH/water (85/15; v/v) directly after the
highest calibrator (200 ng/mL or ng/g). The concentration of mycotoxins in this mixture had to be
below a signal-to-noise ratio of 3/1.
4.7.5. Specificity
The specificity of the method was evaluated with respect to interference of endogenous
components. Hence, a blank sample was analyzed. The signal of the eventual interference at the
elution zone of the analytes of interest should be below the signal-to-noise ratio of 3/1.
4.7.6. Extraction Recovery and Matrix Effects
The extraction recovery and matrix effects of the method were calculated according to the method
of Matuszewski et al. [60] Therefore, three types of samples were prepared. The first samples were
matrix-matched and prepared by spiking blank samples before extraction (=Spiked). The second
samples consisted of matrix-matched blank samples that were spiked after extraction (=SpikedExtract).
The third samples were prepared using standard solutions (=Standard). All samples were spiked at
10 ng/mL or 10 ng/g and were made in triplicate. The peak areas of these samples were compared to
calculate the recovery of the extraction step (RE) and the signal suppression/enhancement (SSE) due
to matrix effects.
SSE = 100 × (Area SpikedExtract/Area Standard)
RE = 100 × (Area Spiked/Area SpikedExtract)
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Supplementary Materials: The following are available online at http://www.mdpi.com/2072-6651/11/3/171/s1,
Table S1: Overview of the theoretical accurate mass of the 24 mycotoxins and possible phase I and/or phase II
metabolites, Figure S1: Extracted ion chromatogram of the first peak (4.09 min) in the trace of ZEN-glucuconide
[m/z 493.1788] with HRMS spectrum, Table S2: Validation results for linearity (linear range, correlation coefficient
(r) and goodness-of-fit coefficient (g)) and limit of quantification (LOQ) of 24 mycotoxins in pig feces, Table S3:
Validation results for linearity (linear range, correlation coefficient (r) and goodness-of-fit coefficient (g)) and
limit of quantification (LOQ) of 24 mycotoxins in pig urine, Table S4: Validation results for linearity (linear range,
correlation coefficient (r) and goodness-of-fit coefficient (g)) and limit of quantification (LOQ) of 24 mycotoxins
in broiler chicken plasma, Table S5: Validation results for linearity (linear range, correlation coefficient (r) and
goodness-of-fit coefficient (g)) and limit of quantification (LOQ) of 25 mycotoxins in broiler chicken excreta,
Table S6: Results of the within-day and between-day precision and accuracy experiments for 24 mycotoxins in pig
feces, Table S7: Results of the within-day and between-day precision and accuracy experiments for 24 mycotoxins
in pig urine, Table S8: Results of the within-day and between-day precision and accuracy experiments for
24 mycotoxins in broiler chicken plasma, Table S9: Results of the within-day and between-day precision and
accuracy experiments for 25 mycotoxins in broiler chicken excreta, Figure S2: Concentration–time curves of
zearalenone (ZEN) and deoxynivalenol (DON) in plasma after intra-gastric administration of DON (36 μg/kg
bw) and ZEN (3 mg/kg bw) to pigs (n = 8). The mean + SD is shown, Figure S3: ZEN metabolites extracted ion
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Abstract: Dispersive magnetic solid-phase extraction (DMSPE) has received growing attention for
sample treatment preconcentration prior to the separation of analytes due to its many advantages.
In the present work, the potential of DMSPE for the determination of emergent mycotoxins (enniatins
A, A1, B and B1, and beauvericin) is investigated for the first time. Different magnetic nanoparticles
were tested and a magnetic multiwalled carbon nanotube (Fe3O4@MWCNT) composite was selected
for the extraction and preconcentration of the five target mycotoxins in human urine samples before
their analysis by ultrahigh performance liquid chromatography coupled to high resolution mass
spectrometry (UHPLC-HRMS). The nanocomposite was characterized by energy dispersive X-ray
spectrometry, scanning electron microscopy, Fourier transform infrared spectrophotometry, and X-ray
diffraction. Several parameters affecting the adsorption and desorption of DMSPE steps were
optimized and the method was fully validated. Due to a matrix effect, matrix-matched calibration
curves were necessary to carry out quantification. In this way, limits of quantification of between 0.04
and 0.1 μg/L, relative standard deviation values lower than 12% and recoveries between 89.3% and
98.9% were obtained. Finally, a study of the reuse of the Fe3O4@MWCNT composite was carried out,
confirming that it can be reused at least four times.
Keywords: emergent mycotoxins; urine; dispersive solid-phase extraction; magnetic carbon
nanotube composite
Key Contribution: The first application of dispersive magnetic solid-phase extraction using a
magnetic multiwalled carbon nanotube nanocomposite is described for the determination of the
emergent mycotoxins enniatins and beauvericin in urine.
1. Introduction
Mycotoxins are low molecular weight noxious secondary metabolites produced by toxicogenic
strains of some mould species that mainly belong to the genera Aspergillus, Fusarium, Penicillium,
Alternaria, and Claviceps. To date, approximately 400 different mycotoxins have been described,
although the most common are aflatoxins (B1, B2, G1, and G2), ochratoxin A, fumonisins, trichothecenes,
zearalenone, and patulin. Mycotoxins can contaminate animal feed, food, or the raw materials used
for their production, originating diseases and disorders, both in humans and animals. Mycotoxins
can bioaccumulate in fluids, tissues and organs, especially the liver and kidney, as well as affect the
nervous, endocrine, and immune systems. Due to their toxicity, the European Union has established or
recommended maximum permissible contents for some of these contaminants in various foods [1–3].
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Among mycotoxins, enniatins and beauvericins have aroused great interest in recent years. These
compounds, also known as emerging mycotoxins, due to their recent discovery, are produced by
Fusarium species and, although no specific legislation has dealt with them yet, their toxicity-including
genotoxicity, cytotoxicity, and effects on the reproductive system, has been demonstrated in in vitro
studies [4]. The European Food Safety Authority (EFSA) suggests that chronic exposure to these
mycotoxins might be a concern and should be confirmed with more acute toxicological data [5].
Enniatins and beauvericins are cyclic hexadepsipeptide compounds. Enniatins are made of
six residues that vary between N-methyl amino acids and hydroxylated carboxylic acids, whereas
beauvericins have a core structure made up of three N-methyl-L-phenylalanine blocks connected
alternately with three 2-hydroxy-D-isovaleric acid units [6]. About 44 enniatins and beauvericins have
been isolated and determined, the most commonly found in food and animal feed being enniatins A
(ENNA), A1 (ENNA1), B (ENNB), B1 (ENNB1), and beauvericin (BEA) (Figure 1), all of which have
been described on a worldwide scale [5,7–12]. Some studies have demonstrated the presence of these
toxins in 100% of the samples analyzed [11,12]. However, it is difficult to measure real exposure to
mycotoxins based on their occurrence described in animal feed and food—an effective alternative might
be monitoring them in biological liquids such as urine or blood (serum and plasma). The mycotoxins
present in biological fluids could be considered as biomarkers for the consumption of contaminated
foodstuff. Among biological fluids, urine is the most often used for measuring toxin exposure [13]
since big amounts can be collected simply and non-invasively.
Figure 1. Chemical structures of enniatins and beauvericin.
The determination of mycotoxins in biological samples requires sensitive, effective, and accurate
methods, as these compounds appear at very low concentration levels. According to EFSA
recommendations, the application of liquid chromatography with tandem mass spectrometry
(LC-MS/MS) is recommended rather than LC with UV detection, since matrix effects can be better
handled, and concentrations below 1 μg/kg can be quantified [5].
The determination of ENNA, ENNA1, ENNB, ENNB1, and BEA has been carried out
in urine [14–19], and serum [14–16,18,20–24], from both humans and animals, but also in feces
samples [15,16,18] and in different organs and tissues from animals [25–28]. The vast majority
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of these analytical methods are based on LC-MS/MS, although LC coupled to high resolution mass
spectrometry (HRMS) has also been proposed [17–19].
Regarding sample treatment, solid-phase extraction (SPE) [14,26,27] and liquid–liquid extraction
(LLE) using ethyl acetate or acetonitrile [15,16,18,21–23,25–28] are the most commonly used.
Miniaturized techniques like dispersive liquid–liquid microextraction (DLLME) have also been
proposed [24] and, recently, Rodríguez-Carrasco et al. [19] compared and evaluated three different
sample preparation approaches (dilute and shoot, DLLME, and salting-out liquid–liquid extraction
(SALLE)) for the determination of ENNB and its phase I metabolites in human urine samples, concluding
that SALLE showed satisfactory validation results. Moreover, Escrivá et al. [17] also compared three
extraction methods, SALLE, DLLME, and miniQuEChERS (quick, easy, cheap, effective, rugged,
and safe) for the determination of ENNA, ENNA1, ENNB, ENNB1, and BEA together with another six
mycotoxins in human urine and, in this case, DLLME was selected as the most suitable methodology.
In recent years, the use of magnetic nanoparticles (MNPs) has increased for sample treatment.
More specifically, MNPs can be used as magnetic sorbents in SPE (MSPE) for the separation and
preconcentration of different analytes [29]. The magnetic sorbent can also be dispersed in the sample
directly (dispersive magnetic solid-phase extraction, DMSPE), instead of using a solid-phase packed
cartridge, enhancing the mass transfer and improving the extraction efficiency [30], while reducing
the volume of organic solvent needed in the desorption step. In DMSPE, MNPs can be separated
simply and rapidly by applying an external magnetic field, avoiding filtration or centrifugation steps.
However, despite its multiple advantages, to the best of our knowledge, DMSPE has not been applied
for the determination of emerging mycotoxins.
In this study, the potential of DMSPE has been investigated for the determination of ENNA, ENNA1,
ENNB, ENNB1, and BEA in human urine samples, and a magnetic multiwalled carbon nanotube
(Fe3O4@MWCNT) composite is applied for the first time as sorbent material for the preconcentration
of these mycotoxins before determination by UHPLC-HRMS.
2. Results and Discussion
2.1. Optimization of Sample Treatment
In order to get the best extraction conditions, different materials were evaluated for the preparation
of the magnetic nanoparticles: β-cyclodextrin (β-CD) [31], polydopamine (PDA) [32], chitosan [33],
oleic acid [34], polystyrene (PS) [35], Fe3O4@MWCNTs [36], MWCNTS/Fe3O4/polypyrrole (PPy) [36],
PPy-nanotubes (NTs) [37] and magnetic cellulose particles [38], and desorption solvents, methanol
(MeOH), and acetonitrile (MeCN). For this study, a mass of 20 mg of each nanoparticle type was
added to 5 mL of sample spiked at 100 ng/mL before submitting the mixture to orbital shaking for
20 min. Then, 3 mL of extraction solvent (MeOH or MeCN) was used to desorb the mycotoxins from
the nanomaterial. A total of 18 experiments were carried out and the best results were obtained with
the combination of Fe3O4@MWCNTs and MeCN. The results are shown in Supplementary Materials
(Figure S1).
Once the type of nanoparticle and the composition of the desorption solvent had been selected,
the other factors influencing the extraction efficiency in DMSPE were optimized: sample volume,
nanoparticle mass, absorption and desorption times, volume of desorption solvent, and percentage
of NaCl in the sample. Initially, sample volume was investigated between 5 and 40 mL. The best
preconcentration factor was obtained using 30 mL, which was therefore selected as the optimum
volume. Then, the mass of nanoparticles, and absorption and desorption times were optimized by
means of a multivariate method, to consider potential interactions between the variables. A central
composite design (23 + star, face centered), with three spaced central points, including 17 runs, was used
to create the response surface, using the peak area as analytical response. The different factors were
evaluated in the following ranges: mass of nanoparticles (5–35 mg), absorption time (5–40 min),
and desorption time (1–10 min).
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The nanoparticle mass and its quadratic term had a significant effect on the recovery of the target
mycotoxins. Subsequently, multiple response optimization was carried out using the desirability
function; the response surface plot is shown in Figure 2. The determination coefficient (R2) obtained
for the target analytes ranged between 83.7% and 92.1%, confirming the suitability of the design.
The optimum conditions were as follows: nanoparticles mass, 30 mg; absorption time, 35 min;
and desorption time, 5 min.
Figure 2. Estimated response surface for the study of significant variables in the dispersive magnetic
solid-phase extraction (DMSPE) step obtained by multiple response optimization.
After the multivariate study, the desorption solvent volume between (0.5 and 5 mL) and percentage
of NaCl in the sample between (0 and 10% wt.) were optimized using a univariate method. No significant
differences were found for the different salt percentages, and so NaCl was not added to the sample
for the DMSPE procedure. In the case of desorption solvent, the best preconcentration and recovery
results were obtained using 1.5 mL of MeCN.
Under these optimum conditions, the obtained preconcentration factors were 95, 35, 44, 19,
and 34 for ENNB, ENNB1, ENNA1, ENNA, and BEA, respectively. The preconcentration factors
were calculated as the ratio of the slope of the calibration curves applying the DMSPE method and
the slope of the calibration curves obtained by direct injection of the standards in urine into the
UHPLC-HRMS system.
2.2. Characterization of Nanocomposite
The characterization of the multiwalled carbon nanotube (MWCNT) and magnetic multiwalled
carbon nanotube (Fe3O4@MWCNT) nanocomposite was carried out by scanning electron microscopy
(SEM), energy dispersive X-ray spectrometry (EDS), X-ray diffraction (XRD), and Fourier transform
infrared spectrophotometry (FT-IR).
The pictures obtained by SEM show the morphology of the MWCNT (Figure 3a) and the
synthetized Fe3O4@MWCNT (Figure 3b) material, where it can be appreciated how the iron oxide
nanoparticles were fixed on the surface of the MWCNTs to produce Fe3O4@MWCNTs.
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Figure 3. Scanning electron microscopy (SEM) images of multiwalled carbon nanotube (MWCNT) (a)
and Fe3O4@MWCNT (b) nanocomposite. Energy dispersive X-ray spectrometry (EDS) spectrum of
Fe3O4@MWCNT (c).
Peaks related to Fe, C, and O atoms were observed in the EDS spectrum of the Fe3O4@MWCNT
adsorbent material (Figure 3c). The quantitative analysis gave weight ratios of 14.95%, 68.06%,
and 15.49% for Fe, C, and O, respectively. Aluminum was used as support for the measurements.
Analysis of the XRD data using XPOWDER software [39] showed the presence of two types of
magnetic iron oxide; magnetite (Fe3O4, around 10% wt.) and maghemite (gamma-Fe3O4, around 61%
wt.). The standard X-ray diffraction peaks (2θ = 30.014◦, 35.578◦, 43.180◦, 53.652◦, 56.788◦, and 62.757◦)
which can be assigned to maghemite or magnetite match with those observed in the spectrum depicted
in Figure 4. The other signals are related to the oxidized and non-magnetized carbon nanotubes
(Carbon and Graphite).
Figure 4. X-ray diffraction (XRD) spectrum of Fe3O4@MWCNT nanocomposite.
The Fe3O4@MWCNT material was also analyzed by FTIR to determine the functional groups
present on the surface of the nanocomposite particles. Figure 5 shows several bands related to the
carboxylic acid groups formed during the oxidation step of the nanoparticle synthesis process. Note the
COO− asymmetric stretching band at 1633 cm−1, the 3435 cm−1 signal due to the stretching band for
O-H, and the 578 cm−1 signal for characteristic Fe-O band.
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Figure 5. Fourier transform infrared spectrophotometry (FTIR) spectrum of MWCNT nanocomposite.
2.3. Method Validation
In order to evaluate the suitability of the proposed method for the determination of emergent
mycotoxins in urine, an in-depth validation was carried out by evaluating the linear dynamic ranges,
limits of detection (LOD) and quantification (LOQ), matrix effect (ME), trueness, and precision.
The ME (Table 1) was calculated as 100 × [(signal of analyte in sample extract−signal of analyte
in neat solvent)/signal of analyte in neat solvent] and was evaluated at three concentration levels for
each emergent mycotoxin (0.1, 5, and 25 μg/L). A significant signal suppression effect was found,
and matrix-matched calibration curves were therefore necessary for quantification purposes.




Linearity R2 LOD (μg/L)
LOQ
(μg/L)
ENNA y = 629312 x + 871432 0.04–50 0.996 0.01 0.04
ENNA1 y = 1755799 x + 1381024 0.10–50 0.995 0.03 0.10
ENNB y = 833213 x + 669371 0.04–50 0.995 0.01 0.04
ENNB1 y = 1883668 x + 3420346 0.04–50 0.992 0.01 0.04
BEA y = 1468318 x – 1256332 0.04–50 0.993 0.01 0.04
Matrix Effect (%) Trueness (%)
0.1 μg/L 5 μg/L 25 μg/L 0.1 μg/L 5 μg/L 25 μg/L
ENNA –12.5 –18.6 –17.0 97.0 92.2 89.3
ENNA1 –33.6 –34.3 –22.3 96.9 92.4 93.9
ENNB –33.7 –37.8 –37.2 97.6 95.7 98.9
ENNB1 –5.1 –8.7 –12.1 98.6 98.3 98.0
BEA –35.5 –20.3 –35.1 96.7 90.5 94.4
Repeatability, %RSD (n = 9) Intermediate Precision, %RSD (n = 12)
0.1 μg/L 5 μg/L 25 μg/L 0.1 μg/L 5 μg/L 25 μg/L
ENNA 6.0 6.7 6.9 10.1 8.2 7.4
ENNA1 6.8 8.0 8.6 7.5 8.5 10.2
ENNB 8.9 9.4 8.7 10.2 9.3 9.9
ENNB1 8.5 6.9 5.9 8.6 9.1 11.7
BEA 8.7 8.8 9.0 8.9 9.0 9.1
Matrix-matched calibration curves were set up using urine samples spiked at six concentrations
levels between 0.1 and 50 μg/L of emergent mycotoxins. Each concentration level was processed in
triplicate and also injected in triplicate, considering peak area as the analytical signal. Determination
coefficients above 0.99 (Table 1) were obtained in all cases, confirming satisfactory linearity over the
whole studied range.
The LODs and LOQs were calculated using the criteria of 3 and 10 times the signal-to-noise ratio
(S/N), respectively. Low LOQs were obtained for all the target mycotoxins, which were similar to [14,17]
or lower than [15,16,18] those obtained with other analytical methods described in the literature.
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The precision of the method was studied in terms of repeatability (intraday precision) and
intermediate precision (interday precision). Repeatability was evaluated by applying the complete
procedure to three samples (experimental replicates) spiked at three different concentration levels
of each emergent mycotoxin (0.1, 5, and 25 μg/L). All the samples were measured on the same day,
and each extract was injected in triplicate (instrumental replicates). Intermediate precision was
assessed with a similar procedure, spiking and analyzing four different samples on four different days.
The results of the precision study, expressed as the relative standard deviation (RSD, %) of analyte peak
area are shown in Table 1 and, in all cases, RSD values lower than 12% were obtained, conforming
with the legislation concerning other mycotoxins [40].
In order to evaluate the trueness of the proposed method, recovery experiments were performed
with urine samples previously analyzed to establish the lack of detectable mycotoxins. None of them
provided a positive result above the LODs of the method. These samples were spiked at three different
concentration levels (0.1, 5, and 25 μg/L), treated as described previously and injected in triplicate into
the UPLC-HRMS equipment. Recoveries ranged between 89.3% and 98.9%, fulfilling the requirements
of current legislation for other mycotoxins [40].
2.4. Application to Urine Samples
The suitability of the method was finally evaluated by analyzing ten samples of human urine
according to the optimized method. ENNA, ENNA1, ENNB, ENNB1, and BEA were not detected in
any of the samples.
2.5. Nanomaterial Reuse
One of the disadvantages of DMSPE is that it requires a stage of magnetic material synthesis,
which must be carried out very carefully to obtain reproducible results, thereby slowing down the
analytical procedure. One way to avoid this disadvantage would be the possibility of reusing the
nanomaterial. For this reason, a study of the reuse of the Fe3O4@MWCNT composite synthetized
for the determination of emergent mycotoxins in urine was carried out. For the assay, 30 mg of
Fe3O4@MWCNTs was used to extract the five mycotoxins at 10 μg/L from 30 mL of urine and, after a
desorption step, the nanocomposite was used to consecutively extract another three urine samples
fortified at the same concentration level. Although a small loss of nanoparticle mass was assumed
during the sample treatment, the results, shown in Figure 6, confirmed that it can be reused at least
4 times. The only significant difference in concentration was observed for ENNA1, where a decrease in
the signal of approximately 6% was observed.
Figure 6. Fe3O4@MWCNTs reuse study.
3. Conclusions
In this work, the applicability of MNPs in sample treatment for the determination of
emergent mycotoxins (ENNA, ENNA1, ENNB, ENNB1, and BEA) before their determination
by UHPLC-HRMS has been demonstrated for the first time. The proposed method based on
DMSPE has multiple advantages over other sample treatments, such as the enhancement of the
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mass transfer, the improvement of the extraction efficiency, and the reduction of organic volume
solvent in the desorption step, avoiding filtration or centrifugation steps. A wide variety of the
most used nanoparticles for other types of contaminants were explored (β-CD, PDA, chitosan,
oleic acid, PS, Fe3O4@MWCNTs, MWCNTS/Fe3O4/PPy, PPy-NTs, and magnetic cellulose particles) and
Fe3O4@MWCNTs showed the best result in term of recovery. The proposed methodology was applied
for the determination of the target mycotoxins in urine samples since the determination of mycotoxins
in biological samples requires sensitive, effective, and accurate methods, as these compounds appear
at very low concentration levels. The DMSPE-UHPLC-HRMS method allowed to achieve low LOD
and LOQ, enabling the detection of target mycotoxins at levels normally found in urine. In addition,
the precision was lower than 12% and recoveries ranged between 89.3% and 98.9%, demonstrating that
the Fe3O4@MWCNT composite can be reused at least four times.
4. Materials and Methods
4.1. Chemicals, Reagents, and Standards
Individual standards of ENNA, ENNA1, ENNB, ENNB1, and BEA were obtained from Sigma
Aldrich (St. Louis, MO, USA). Mycotoxin stock solutions were prepared at 1 mg/L in acetonitrile
(MeCN) and stored at −20 ◦C. Ethanol and MeCN were provided by ChemLab (Zedelgem, Belgium).
Nitric acid (65%) was purchased from Panreac (Barcelona, Spain). Iron chloride (III) (>99%) (FeCl3),
ammonium iron (II) sulfate hexahydrate ((NH4)2Fe(SO4)2·6H2O), ammonia solution, and sodium
chloride were also purchased from Sigma-Aldrich. MeOH and formic acid (HCOOH) used as mobile
phase were LC-MS grade and were also obtained from Sigma-Aldrich.
MWCNTs (average diameters between 40 and 60 nm, average length of >5 μm, specific surface
area of 40–70 m2/g) were provided by Shenzhen Nanotech Port Co., Ltd. (Shenzhen, China). For the
filtration of samples before the chromatographic analysis, nylon syringe filters, 0.22 μm × 25 mm
(Agela Technologies, New York, NY, USA) were used.
4.2. Instrumentation and Software
The UHPLC system consisted of an Agilent 1290 Infinity II Series HPLC (Agilent Technologies,
Santa Clara, CA, USA) provided with an automated multisampler unit and a high speed binary pump,
coupled to an Agilent 6550 Q-TOF mass spectrometer (Agilent Technologies, Santa Clara, CA, USA)
equipped with an ESI source (Agilent Jet Stream Dual electrospray, AJS-Dual ESI, Santa Clara, CA,
USA). For data processing, MassHunter Workstation Data Acquisition software (Agilent Technologies,
Rev. B.08.00, Santa Clara, CA, USA) was used. The statistic software Statgraphics Centurion XV.II was
used for data treatment.
A Unicen-21 centrifuge (TQTech, Shenzhen, China), an IKA-KS-130-Basic orbital agitator (IKA
Werke GmbH & Co KG, Staufen, Germany), a vortex stirrer LLG-uniTEXER (Serviquimia, Constantí,
Tarragona), a rotavapor (BUCHI, Labortechnink:AG: Flawil, Switzerland), and an Xcelvap air-drying
system (Horizon Technology Inc., Salem, NH, USA) were also used for sample treatment.
Permanent magnets were purchased from Supermagnete (Gottmadingen, Germany). The magnets
were blocks composed of Nd-Fe-B (50 × 15 × 15 mm and 86 g weight) with a strength of 33 kg.
4.3. Synthesis of Fe3O4@MWCNTs Composite
The magnetic Fe3O4@MWCNT composite material was synthetized following the methodology
described by Asgharinezhad and Ebrahimzadeh [36]. In a first step, MWCNTs were purified with 1 M
nitric acid solution for 6 h at room temperature and then washed many times with distilled water and
dried in an oven at 100 ◦C. Then, about 0.5 g of the purified nanotubes were added into 250 mL of a
solution containing 0.85 g (NH4)2Fe(SO4)2·6H2O and 0.4222 g FeCl3 at 50 ◦C. After that, the suspension
was sonicated for 20 min and 20 mL of 8 M ammonia solution was added dropwise to precipitate the
magnetized particles while the solution was still under sonication. The pH was controlled to ensure
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that it remained in the 10–11 range by adding ammonia solution 25% (w/w). In order to enhance the
whole growth of the nanoparticle crystals, the reaction was allowed to proceed at 50 ◦C for 30 min.
The dispersion was cooled to room temperature, the Fe3O4@MWCNT were collected by a strong
permanent magnet and washed three times with deionized water followed by ethanol. The magnetic
composite substance was dried at 60 ◦C overnight and lastly ground in a mortar and kept at room
temperature in an amber glass vial.
4.4. Sample Preparation
Urine samples were obtained from healthy volunteers and were collected in sterile plastic
containers and refrigerated until analysis. For sample treatment, 30 mg of Fe3O4@MWCNTs and
30 mL of urine were placed in a test tube, which was orbitally shaken for 35 min at room temperature.
The nanocomposite was then attracted with the external neodymium magnet and the supernatant
solution was discarded.
In order to desorb the emergent mycotoxins, 1.5 mL of MeCN was added and the mixture was
shaken using the orbital shaker for 5 min at room temperature. After that, the nanomaterial was again
attracted with the magnet and in this case, the supernatant solution was recovered. A 250 μL volume
of the recovered organic phase was mixed with 250 μL of water and filtered through a 0.2 mm filter
before injection in the UHPLC-Q-TOF system.
4.5. UHPLC-HRMS Analysis
The separation and determination of emergent mycotoxins was performed in a ZORBAX RRHD
Eclipse Plus C18 (1.8 μm, 2.1 × 100 mm) column equipped with a 0.3 μm inline filter from Agilent
Technologies and using a mobile phase consisting of H2O:MeOH (95:5, v/v) containing 0.1% HCOOH
(solvent A) and MeOH:H2O (95:5, v/v) containing 0.1% HCOOH (solvent B) at a flow rate of 0.4 mL/min.
The elution program was applied as follows: 0–1 min: 70% B; 1–3 min: 70–100% B; 3–5 min: 100% B;
5–5.2 min: 100–70% B; 5.2–9 min: 70% B. The column temperature was set at 35 ◦C and the autosampler
temperature was 5 ◦C. A volume of 20 μL of the sample was injected.
The mass spectrometer worked in the positive mode. The nebulizer gas pressure was established
to 30 psi, while the drying gas flow was set to 16 L/min at a temperature of 130 ◦C, and the sheath
gas flow was set to 11 L/min at a temperature of 300 ◦C. The capillary spray, nozzle, fragmentor,
and 1 RF Vpp octopole voltages were 4000, 500, 360, and 750 V, respectively. Data acquisition was
carried out using “All-ion mode” and three collision energies (0, 10, and 40 V) were measured. Profile
data in the 50–1500 m/z range were acquired for MS scans in 2 GHz extended dynamic range mode
with 3 spectra/s, 333.3 ms/spectrum, and 2675 transients/spectrum. Reference masses of 121.0509 and
922.0098 m/z were used for mass correction during the analysis. For quantification purposes, extracted
ion chromatograms (EIC) from the full-scan MS data were obtained for the protonated molecule of each
analyte with a 5 ppm window. The monitored ions of the target analytes are shown in Table 2, as well as
their retention times, the theoretical and experimental m/z values, and the corresponding instrumental
error, which was calculated (in terms of percentage) as the difference between the experimental and
theoretical m/z values divided by the theoretical m/z value multiplied by 106.











Q1, m/z Q2, m/z
ENNB 4.00 C33H58N3O9+ 640.4168 640.4173 0.8 196.1341 214.1441
ENNB1 4.21 C34H60N3O9+ 654.4324 654.4326 0.3 196.1333 210.1489
BEA 4.21 C45H58N3O9+ 784.4168 784.4163 −0.6 244.1334 262.1438
ENNA1 4.43 C35H62N3O9+ 668.4481 668.4485 0.6 210.1491 228.1592
ENNA 4.67 C36H64N3O9+ 682.4637 682.4636 −0.1 210.1491 228.1593
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Figure 7 shows a chromatogram obtained with the method proposed for the determination of
emergent mycotoxins in urine.
Figure 7. UHPLC–HRMS extracted ion chromatograms of a spiked urine sample at 0.1 μg/L analyzed
with the proposed method.
Supplementary Materials: The following are available online at http://www.mdpi.com/2072-6651/12/1/51/s1,
Figure S1: Study of different materials for the preparation of the magnetic nanoparticles and desorption solvents
(MeCN (a) and MeOH (b)) for the extraction of emergent mycotoxins (n = 3).
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Abstract: An intercollaborative study was organized to evaluate the performance characteristics of a
liquid chromatography tandem mass spectrometry procedure for the simultaneous determination of
12 mycotoxins in food, which were ochratoxin A, aflatoxins B1, B2, G1, G2, and M1, deoxynivalenol,
zearalenone, fumonisins B1 and B2, and T-2 and HT-2 toxins. The method combined the simplicity
of the QuEChERS (Quick, Easy, Cheap, Efficient, Rugged and Safe) approach with the efficiency of
immunoaffinity column cleanup (the step used to enhance sensitivity and sample cleanup for some
matrices only). Twenty-three entities were enrolled and were European reference laboratories for
mycotoxin analysis, U.S. and European service laboratories, and Nestlé laboratories. Each participant
analyzed 28 incurred and/or spiked blind samples composed of spices, nuts, milk powder, dried fruits,
cereals, and baby food using the protocol given. Method performances were assessed according to
ISO 5725-2. Relative standard deviations of repeatability and reproducibility and trueness values
for each of the 115 mycotoxin/sample combinations ranged from 5% to 23%, 7% to 26%, and 85% to
129%, respectively, in line with requirements defined in EC 401/2006. The overall set of data gathered
demonstrated that the method offered a unique platform to ensure compliance with EC 1881/2006
and EC 165/2013 regulations setting maximum limits for mycotoxins in food samples, even at low
regulated levels for foods intended for infants and young children. The method was applicable
regardless of the food, the regulated mycotoxin, and the concentration level, and thus is an excellent
candidate for future standardization.
Keywords: LC-MS/MS; mycotoxins; collaborative study; isotopic dilution; compliance; infant food
Key Contribution: Validation data gathered through this international collaborative study
demonstrated that the analytical method proposed was suitable to ensure full compliance with regards
to EC 1881/2006 and EC 165/2013 regulations, even at low regulated levels for foods intended for infants
and young children. The method was applicable regardless of the food commodity, the regulated
mycotoxin, and the concentration level, and thus is an excellent candidate for future standardization.
1. Introduction
Mycotoxins are a group of toxic chemical substances produced by filamentous fungi (molds) that
commonly grow on a number of food commodities such as cereals, nuts, spices, fruits, oil seeds, or coffee.
These toxins can be produced before harvest in the crop and even after harvest if climate conditions
are favorable for further fungal growth. Mycotoxins are undoubtedly one of the most severe food
safety hazards amplified by global climate change. Indeed, the ability of fungi to produce mycotoxins
is largely influenced by temperature, precipitation, relative humidity, and stress conditions in the
plants. For instance, aflatoxin-producing fungi (mainly Aspergillus flavus and Aspergillus parasiticus),
Toxins 2019, 11, 658; doi:10.3390/toxins11110658 www.mdpi.com/journal/toxins275
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usually more prevalent in tropical and sub-tropical regions, are expected to be found in areas such
as southern and eastern Europe or the USA, where temperatures >30 ◦C (close to the optimum for
aflatoxin production) may become usual [1,2].
Among several hundreds of mycotoxins identified so far, a few are of concern from a food safety
perspective. To protect consumer health, maximum levels (MLs) for mycotoxins in foodstuffs have
been established worldwide. In particular, the European Union legislation (often considered as the
most stringent one) has established MLs for aflatoxins (AFLAs), ochratoxin A (OTA), zearalenone
(ZEN), fumonisins (FBs), and deoxynivalenol (DON) (EC 1881:2006 [3]) and recently indicative levels
for T-2 and HT-2 toxins (EC 165/2013 [4]) in a broad range of food commodities. Lower MLs have been
also established for food intended for infants and young children.
International organizations such as ISO (International Organization for Standardization), CEN
(European Committee for Standardization), or AOAC International have continued gathering experts
over the years to develop internationally recognized analytical standards. The goal is to avoid
discrepancies in results that may arise from the use of different analytical approaches, with the risk to
distorted global food trade. Today, there are 72 official methods available from these organizations
for the monitoring of mycotoxins in food (Table 1). These methodologies are often limited to a single
compound or to certain family of mycotoxins only and generally validated for a single food category.
Indeed, current regulations were established on toxicological data from studies taking into account
only one mycotoxin exposure at a time and did not consider the combined effects of mycotoxins [5].
Noteworthy, the co-occurrence of mycotoxins has been extensively described over the last decade. In
2016, data from 107 publications were compiled to summarize the findings on mycotoxins and their
co-occurrence in various foods and feeds from all over the world [5]. AFLAs + FBs, DON + ZEN,
AFLAs + OTA, and FBs + ZEN were the most observed combinations. Another study on barley and
wheat (n = 72 and n = 83, respectively) evidenced that among the mycotoxin-positive samples, 70%
of barley samples and 54% of wheat samples were co-contaminated with at least two mycotoxins [6].
The need to develop methods able to screen several mycotoxins at once was justified in a large-scale
global survey in feed where mycotoxin co-contamination was common [7]. Concentrations of aflatoxin
B1 (AFB1), ZEN, FBs, OTA, DON, and T-2 toxin were analyzed in 74,821 samples of feed and feed
raw materials (e.g., maize, wheat, soybean) collected from 100 countries from 2008 to 2017. In total,
a large fraction of samples (64%) was co-contaminated with more than two mycotoxins, whilst 88%
of the samples were contaminated with at least one mycotoxin. In that regard, moving from single
residue analysis toward “multi-analyte and multi-matrix” ones is of interest to speed up efficiently and
rationalize mycotoxin analysis in high-throughput routine environments.
Table 1. Official methods (n = 72) for the determination of mycotoxins in food (AOAC, CEN, ISO).
ELISA, enzyme-linked immunosorbent assay; HPLC-FLD, high performance liquid chromatography
with fluorescence detection; IAC, immunoaffinity column; TLC, thin layer chromatography; HPLC-UV,
high performance liquid chromatography with ultra violet detection; GC, gas chromatography.
Mycotoxin(s) Document Scope Technique
AFB1 AOAC 990.32 Corn, roasted peanuts ELISA
AFB1 AOAC 2000.16 Infant formula HPLC-FLD (IAC)
AFB1 EN 15851:2010 Cereals, cereal based foods 1 HPLC-FLD (IAC)
AFB1 AOAC 978.15 Egg TLC
AFB1, AFB2, AFG1, AFG2 AOAC 990.34 Corn, cotton seed, peanuts, peanut butter ELISA
AFB1, AFB2, AFG1, AFG2 AOAC 991.31 Corn, raw peanuts, peanut butter HPLC-FLD (IAC)
AFB1, AFB2, AFG1, AFG2 AOAC 2005.08 Corn, raw peanuts, peanut butter HPLC-FLD (IAC)
AFB1, AFB2, AFG1, AFG2 AOAC 994.08 Corn, almonds, nuts, peanuts, pistachio nuts HPLC-FLD
AFB1, AFB2, AFG1, AFG2 AOAC 968.22 Peanuts and peanut products TLC
AFB1, AFB2, AFG1, AFG2 AOAC 970.45 Peanuts and peanut products TLC
AFB1, AFB2, AFG1, AFG2 AOAC 972.27 Soybeans TLC
AFB1, AFB2, AFG1, AFG2 AOAC 971.23 Cocoa beans TLC
AFB1, AFB2, AFG1, AFG2 AOAC 971.24 Coconut, copra TLC
AFB1, AFB2, AFG1, AFG2 AOAC 972.26 Corn TLC
AFB1, AFB2, AFG1, AFG2 AOAC 993.17 Corn, peanuts TLC
AFB1, AFB2, AFG1, AFG2 AOAC 970.46 Green coffee TLC
AFB1, AFB2, AFG1, AFG2 AOAC 974.16 Pistachio nuts TLC
AFB1, AFB2, AFG1, AFG2 AOAC 998.03 Shelled peanuts TLC
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Table 1. Cont.
Mycotoxin(s) Document Scope Technique
AFB1, Total AFLAs AOAC 990.33 Corn, peanut butter HPLC-FLD
AFB1, Total AFLAs ISO 16050:2003 Cereals, nuts, oilseed products, dried fruits HPLC-FLD
AFB1, Total AFLAs AOAC 999.07 Peanut butter, pistachio paste, fig paste, paprika HPLC-FLD (IAC)
AFB1, Total AFLAs EN 14123:2007 Hazelnuts, peanuts, pistachios, figs, paprika HPLC-FLD (IAC)
Total AFLAs AOAC 991.45 Peanut butter ELISA
Total AFLAs AOAC 993.16 Corn ELISA
Total AFLAs AOAC 2013.05 Olive oil, peanut oil, sesame oil HPLC-FLD (IAC)
Total AFLAs AOAC 975.36 Corn, peanut, peanut butter, pistachio nuts UV Lamp
Total AFLAs AOAC 979.18 Corn, raw and shelled peanuts Visual fluorescence
AFM1 ISO 14675:2003 Milk products ELISA
AFM1 ISO 14501:2007 Milk products HPLC-FLD
AFM1 AOAC 2000.08 Liquid milk HPLC-FLD (IAC)
AFM1 ISO 14674:2005 Milk products TLC
AFM1 AOAC 974.17 Dairy products TLC
AFM1 AOAC 980.21 Milk, cheese TLC
AFM1 AOAC 982.26 Liver TLC
AFM1, AFB1 AOAC 982.24 Liver TLC
AFM1, AFB1 AOAC 982.25 Liver TLC
AFM1, AFM2 2 AOAC 986.16 Liquid milk HPLC-FLD
CIT 3 EN 17203:2018 Cereals, red yeast rice LC-MS/MS
DON AOAC 986.18 Wheat GC
DON EN 15891:2010 Cereals, cereal based foods 1 HPLC-UV
DON AOAC 986.17 Wheat TLC
FB1, FB2 AOAC 2001.04 Corn, corn flakes HPLC-FLD (IAC)
FB1, FB2 EN 16187:2015 Maize based food 1 HPLC-FLD (IAC)
FB1, FB2 EN 14352:2004 Maize based food HPLC-FLD (IAC)
FB1, FB2, FB3 4 AOAC 995.15 Corn HPLC-FLD
Total FBs AOAC 2001.06 Corn ELISA
OTA AOAC 991.44 Barley, wheat, rye, corn HPLC-FLD
OTA ISO 15141:2018 Cereals HPLC-FLD
OTA AOAC 2000.03 Barley HPLC-FLD (IAC)
OTA AOAC 2000.09 Roasted coffee HPLC-FLD (IAC)
OTA AOAC 2001.01 Wines, beer HPLC-FLD (IAC)
OTA AOAC 2004.10 Green coffee HPLC-FLD (IAC)
OTA EN 15835:2010 Cereal based food HPLC-FLD (IAC)
OTA EN 15829:2010 Dried fruits (currants, raisins, sultanas, figs) HPLC-FLD (IAC)
OTA EN 14133:2009 Wine, beer HPLC-FLD (IAC)
OTA EN 14132:2009 Barley, roasted coffee HPLC-FLD (IAC)
OTA ISO 15141:2018 Cereals, cereal based products HPLC-FLD (IAC)
OTA AOAC 975.38 Green coffee TLC
OTA, OTB 5 AOAC 973.37 Barley TLC
Patulin ISO 8128-2:1993 Apple juice and apple juice based products HPLC-UV
Patulin EN 15890:2010 Fruit juice and fruit based purée 1 HPLC-UV
Patulin EN 14177:2003 Clear and cloudy apple juice and puree HPLC-UV
Patulin AOAC 995.10 Apple juice HPLC-UV
Patulin AOAC 2000.02 Apple juice, apple puree HPLC-UV
Patulin ISO 8128-1:1993 Apple juice and apple juice based products TLC
Patulin AOAC 974.18 Apple juice TLC
T-2, HT-2 EN 16923:2017 Cereals, cereal based foods 1 LC-MS/MS
ZEN AOAC 994.01 Corn, wheat, feed ELISA
ZEN EN 15850:2010 Cereals, cereal based foods 1 HPLC-FLD (IAC)
ZEN EN 16924:2017 Edible vegetable oils
HPLC-FLD or
LC-MS/MS
ZEN AOAC 976.22 Corn TLC
ZEN, α-ZEL 6 AOAC 985.18 Corn HPLC-FLD
1 Including foods intended for infants and young children; 2 aflatoxin M2; 3 citrinin; 4 fumonisin B3; 5 ochratoxin B;
6 α-zearalenol.
Most of the current reference methods still make use of non-confirmatory approaches for
quantitative analysis of mycotoxins, e.g., TLC, HPLC-UV, and HPLC-FLD. Use of IAC cleanup often
compensates for the lack of specificity of these detection techniques, as authorized in EC 2002/657 [8].
However, LC-MS/MS is currently considered as the state-of-the-art technique to analyze hundreds of
contaminants (pesticides, veterinary drugs, etc.) in various food commodities, including mycotoxins, as
emphasized in a recent review [9]. The first official LC-MS based methodologies for the determination
of mycotoxins in foods were published in 2017 by the CEN and are limited to ZEN [10], and T-2/HT-2
toxins’ [11] determination. Indeed, the need for standardized LC-MS methods for mycotoxins’
determination was highlighted only recently by regulatory authorities and scientific advisory bodies,
triggering the CEN organization to establish European standards within the M/520 standardization
mandate [12]. Among the several LC-MS methods still under development or at the final approval
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stage at CEN, only two are multi-mycotoxin methods for food analysis [13]. The first one is devoted to
the screening of OTA, AFB1, DON, ZEN, FB1, FB2, T-2, and HT-2 toxins and excludes foods for infants
and young children from the scope. The second one does not include regulated aflatoxins, zearalenone,
and fumonisins and is limited to cereals and cereal based products. Such limited analyte and/or matrix
scopes are constraints for food business operators willing to use efficient standard protocols to ensure
the safety and compliance of a broad range of food commodities.
To fill this gap on our side, an analytical method was developed and internally validated in
2013 [14] before its deployment in 10 Nestlé Quality Assurance Centers (NQACs, control laboratories)
in Brazil, Chile, the USA, France, Italy, Poland, Russia, China, Singapore, and India. The procedure
enables the quantitative LC-MS/MS determination of regulated mycotoxins (OTA, AFB1, AFB2, AFG1,
AFG2, AFM1, DON, ZEN, FB1, FB2, and T-2 and HT-2 toxins) in a broad range of food items including
cereals and cereal based baby foods (infant cereals, biscuits), spices, nuts, coffee, tea, cocoa, vegetable
oils, dried fruits, infant formula, dairy products, feed/pet food, etc. This routine method has the
advantage of offering a unique platform to ensure full compliance with the EC 1881/2006 regulation [3],
even at low regulated levels for foods intended for infants and young children. Its sample preparation
combines the simplicity of the QuEChERS approach (widely used for pesticide residues analysis;
European Norm EN 15662:2018 [15]) with the efficiency of IAC cleanup (this step being used for
some matrices only). Quantification is performed by the isotopic dilution approach using 13C-labeled
mycotoxins as internal standards (ISTD). The collection of thousands of validation data over time [16],
the high number of analyses conducted each year (15,000 samples analyzed in 2017 [17]), and the
regular enrollment of NQACs to internal (under ISO 17043:2010 accreditation [18]) and external
proficiency tests have demonstrated the high robustness of this method.
In this context, we set up an international collaborative study to support its standardization.
Twenty-three (23) laboratories from authorities and private sectors were involved in this study,
representing entities from 14 countries. This collaborative study was organized according to the
AOAC International guideline [19], and statistical evaluation was performed following ISO 5725-2
document [20]. The present paper summarizes the overall set of data gathered and demonstrates the
method’s applicability over a broad range of concentrations across different food categories, including
foods for infants and young children.
2. Results and Discussion
2.1. Samples and Homogeneity Testing
Providing blank matrices to be further spiked by each participant as done in previous studies [21]
was not considered to avoid potential analytical bias introduced by operators. Alternatively, the
preference was to use blind duplicates of former proficiency test samples still available as quality
control (QC) materials (paprika, black pepper, almonds, hazelnuts, dried raisins, dried figs, wheat,
maize (2), milk powder (2), maize (2), rice, and wheat based infant cereals samples). The homogeneity
of such materials was extensively tested by their providers. However, since the study samples were
repacked from 200-g aluminum bags to 25-g units before shipping, a small-scale testing was performed
(six replicates from six different units for each sample) to ensure sample homogeneity. The resulting
coefficients of relative standard deviation of repeatability RSDr ranged from 0.5% to 12%, in line with
internal validation data, evidencing the satisfactory homogeneity of the set of samples. The exception
was a maize sample with unacceptable RSDr for ZEN and HT-2, at 40% and 21%, respectively.
The particle size distribution of this material was heterogeneous (evidence by visual inspection), which
led us to re-open and merge all individual units. The resulting bulk material (ca. 2 kg) was ground
in our laboratory by means of a cryogenic grinder (SPEX 6875D Freezer/Mill, Stanmore, U.K.) and
further dispatched again into 25-g units. Subsequent homogeneity testing (duplicate analysis of six
different units) successfully validated this new preparation with a global decrease of RSDr for the
twelve mycotoxins (ZEN and HT-2 at 6.7 and 10.6%, respectively).
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2.2. Participants Instrumental Method Setup
Knowing the diversity of laboratory equipment available worldwide, participants were free to
select their instrumental setup, meaning choice of LC columns, mobile phases, MS parameters, etc.
Typical LC-MS/MS conditions were provided by the study director for information purposes only.
The use of HR-MS instruments was accepted, but none of the twenty-three participants reported its
usage. As shown in Figure 1, 13 different LC columns and 11 models of MS instruments were engaged.
Mobile phases and LC gradient provided in the guidance document were chosen by 16 and 18 out
the 23 participants, respectively (sometimes with a reduction of the final equilibration time). Various
column temperatures (from 30 ◦C to 50 ◦C) and injection volumes (from 4 μL to 20 μL) were considered.
All instruments operated in MS/MS mode using polarity switching, except three labs for which ESI
was only used in positive mode. In this last case, ZEN was analyzed as its [M + H]+ adduct as already
reported [22,23]. The diversity of the instrumentation (i.e., different generations, varying degrees of
performance) used by participants was an additional proof of the applicability of the method.
Figure 1. Instrumental setup used by the participating laboratories (n = 23).
To facilitate lab work, calibrant solutions (nine levels) were provided as ready-to-use to each
participant. The extent of mycotoxin contaminations is known to be unpredictable and variable; thus,
the calibration range of each analyte was set broad enough to avoid reinjection or re-analysis of highly
contaminated samples. Participants were asked to consider the two highest levels (calibration point 7
(CAL 7) and CAL 8) only when facing such highly contaminated samples with concentrations out of
the classical calibration range (CAL 0 to CAL 6). Use of a weighing factor (1/x or 1/x2) for drawing
calibration curves was strongly recommended, or alternatively to force regression lines through the
origin (i.e., intercept = 0), as done elsewhere [14], this to maintain good precision of data at low
contamination levels. Typically, such an approach enabled the direct quantification of either AFB1
from 0.025 μg/kg to 32 μg/kg or OTA from 0.125 μg/kg to 32 μg/kg in cereals within one single analysis,
avoiding a tedious re-extraction of the sample using a reduced test portion.
2.3. Laboratory Qualification
Participants were first asked to analyze one single sample (practice sample) to get familiar with
the protocol and to communicate generated results to the study director. This was to ensure that the
method was correctly set up before engaging laboratories in the second part of the study, consisting of
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the analysis of 28 samples. This practice sample being a maize based infant cereal, an IAC cleanup
was required to get extra sensitivity for AFLAs and OTA. Other mycotoxins were extracted using the
“QuEChERS” procedure (Figure 2). The 11 assigned values derived from the proficiency test were
0.26 μg/kg AFB1, 0.28 μg/kg AFB2, 0.15 μg/kg AFG1, 0.15 μg/kg AFG2, 0.81 μg/kg AFTOT, 0.71 μg/kg
OTA, 138 μg/kg DON, 31 μg/kg ZEN, 31 μg/kg T-2, 27 μg/kg HT-2, 56 μg/kg T-2 + HT-2, 61 μg/kg FB1,
79 μg/kg FB2, and 140 μg/kg FBTOT, thus very close to the low regulated levels for foods intended
for infants and young children [3]. Twenty (20) out of 23 participants successfully reported data with
z-scores (Z) and recoveries (Rec) within −2 < Z < +2 and 70% < Rec < 130% for these 11 mycotoxins
and were thus qualified for the second part of the study. At this stage, assistance provided by the
study director was limited to a few participants facing issues in using the correct ISTD concentrations
or eliminating FBs’ carry-over on their MS instrument. One laboratory did not see any peak for
ZEN, OTA, FBs, HT-2, T-2, and DON, which are compounds to be detected by the QuEChERS stream.
Investigations to identify the root cause failed. As the method could not be properly implemented in
this lab, all data further generated were not considered for method performance evaluation. Another
laboratory missed reporting practice sample data before starting the full study. Unfortunately, the
z-scores for ZEN and AFG2 and recoveries for AFB1, AFB2 and AFG1 were unsatisfactory, which
highlighted a lack of control of the procedure together with a possible instrumental issue. A third
laboratory reported both technical and organizational problems and did not provide data for the
practice sample. For consistency with other participants, the decision was made to remove these three
laboratories for the final statistical evaluation. Consequently, 20 laboratories were eventually approved
in the full collaborative study.
Figure 2. Overview of the sample preparation.
2.4. Full Collaborative Study
Among the 3700 individual data tentatively collected, only a few of them were missing or excluded
(n = 84, i.e., 2.3% of the data) before statistical evaluation for the following reasons: (a) one lab did not
report DON and HT-2 toxin concentration data in the wheat based baby food due to ion ratios out of
tolerance; (b) OTA level in the black pepper sample was discarded for one laboratory facing a low
signal-to-noise-ratio (<3) along with a very bad peak shape; (c) one lab did not report data for ZEN in
maize and wheat samples due to important baseline interference for ZEN ISTD; (d) all data for black
pepper were removed for one lab because the sample preparation was not followed; (e) data for T-2
280
Toxins 2019, 11, 658
and HT-2 toxins were not considered for another laboratory reporting major instrumental issues for
these two toxins; (f) an error during the ISTD spiking step (DON, ZEN, T-2, HT-2) of the wheat based
infant cereal was mentioned by one laboratory.
The precision of the method was characterized by the repeatability RSDr and the reproducibility
RSDR, after removal of outliers as recommended in ISO 5725-2 [20]. As shown in Tables 2–4 and
Figure 3, RSDr ranged from 3% to 22% (average 7%) and RSDR from 5% to 28% (average 12%), most
values being largely below 20%. All these data fulfilled Commission Regulation (EC) No. 401/2006 [24],
which has established method performance criteria for the official control of the levels of mycotoxins
in foodstuffs. As expected, reproducibility values were higher than the repeatability ones for all
combinations except three.
Table 2. Method performance evaluation for AFB1, AFB2, AFG1, AFG2, Total AFLAs and OTA in
twelve samples.
S1 S2 S3 S4 S5 S6 S7 S8 S9 S10 S11 S12
AFB1
Assigned Value (μg/kg) 5.4 11.4 11.3 6.54 8.2 2.48 4.86 2 4.58 0.26 0.51 0.0857
No. of Laboratories 20 20 20 19 20 20 20 20 20 20 20 19
No. of Outliers 1 2 2 0 2 1 2 0 0 0 2 0
No. of Accepted Results 19 18 18 19 18 19 18 20 20 20 18 19
Mean (μg/kg) 6.46 12.7 12.7 8.42 8.44 2.89 4.86 2.33 4.97 0.237 0.491 0.0848
SDr (μg/kg) 0.32 0.53 0.47 0.71 0.3 0.14 0.29 0.45 0.39 0.013 0.028 0.0101
RSDr (%) 5 4 4 8 4 5 6 19 8 5 6 12
SDR (μg/kg) 0.67 1.15 1.31 1.22 0.6 0.3 0.69 0.54 0.57 0.031 0.036 0.0155
RSDR (%) 10 9 10 15 7 10 14 23 12 13 7 18
Rec (%) 120 111 113 129 103 116 100 116 109 91 96 99
HorRat Values 0.5 0.4 0.5 0.7 0.3 0.5 0.6 1.1 0.5 0.6 0.3 0.8
AFB2
Assigned Value (μg/kg) 3.3 12.5 0.9 5.59 4.4 0.96 n.d. 1.9 2.01 0.25 0.5 0.0792
No. of Laboratories 20 20 20 19 20 20 - 18 20 20 20 19
No. of Outliers 2 2 0 2 1 1 - 1 0 0 1 2
No. of Accepted Results 18 18 20 17 19 19 - 17 20 20 19 17
Mean (μg/kg) 4.06 13.7 0.991 6.52 4.22 1.09 - 2.07 2.1 0.269 0.483 0.0778
SDr (μg/kg) 0.12 0.71 0.062 0.46 0.17 0.05 - 0.15 0.26 0.022 0.022 0.0077
RSDr (%) 3 5 6 7 4 4 - 7 12 8 5 10
SDR (μg/kg) 0.22 0.91 0.115 0.84 0.36 0.09 - 0.25 0.24 0.027 0.031 0.0121
RSDR (%) 5 7 12 13 9 8 - 12 11 10 6 16
Rec (%) 123 109 110 117 96 113 - 109 105 108 97 98
HorRat Values 0.2 0.3 0.5 0.6 0.4 0.4 - 0.5 0.5 0.5 0.3 0.7
AFG1
Assigned Value (μg/kg) 2.1 20.9 9.5 3.03 1.8 2.65 n.d. 1.7 7.77 0.2 0.5 0.0628
No. of Laboratories 20 20 20 19 20 20 - 18 20 20 20 19
No. of Outliers 1 1 1 2 0 0 - 1 0 1 0 3
No. of Accepted Results 19 19 19 17 20 20 - 17 20 19 20 16
Mean (μg/kg) 2.06 21.6 10.2 3.58 1.79 3.02 - 1.71 8.42 0.199 0.504 0.0613
SDr (μg/kg) 0.094 0.75 0.49 0.26 0.093 0.24 - 0.17 0.65 0.027 0.018 0.0049
RSDr (%) 5 3 5 7 5 8 - 10 8 13 4 8
SDR (μg/kg) 0.15 1.55 0.79 0.35 0.15 0.27 - 0.24 1.1 0.023 0.034 0.0083
RSDR (%) 7 7 8 10 8 9 - 14 13 11 7 14
Rec (%) 98 103 107 118 99 114 - 101 108 100 101 98
HorRat Values 0.3 0.3 0.4 0.4 0.4 0.4 - 0.6 0.6 0.5 0.3 0.6
AFG2
Assigned Value (μg/kg) 2.2 15 11.9 2.84 0.9 0.83 n.d. 3.7 5.79 0.31 0.52 0.052
No. of Laboratories 20 20 20 19 19 19 - 19 20 20 20 15
No. of Outliers 2 1 0 2 1 3 - 0 0 1 2 1
No. of Accepted Results 18 19 20 17 18 16 - 19 20 19 18 14
Mean (μg/kg) 2.32 16.4 11.3 3.46 0.814 0.885 - 3.13 6.14 0.304 0.488 0.052
SDr (μg/kg) 0.1 1.01 0.65 0.33 0.059 0.055 - 0.48 0.56 0.041 0.045 0.0077
RSDr (%) 4 6 6 9 7 6 - 15 9 14 9 15
SDR (μg/kg) 0.19 1.85 0.97 0.37 0.133 0.072 - 0.66 1.05 0.048 0.043 0.0077
RSDR (%) 8 11 9 11 16 8 - 21 17 16 9 15
Rec (%) 105 109 95 122 90 107 - 84 106 98 94 100
HorRat Values 0.4 0.5 0.4 0.5 0.7 0.4 - 1 0.8 0.7 0.4 0.7
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Table 2. Cont.
S1 S2 S3 S4 S5 S6 S7 S8 S9 S10 S11 S12
Total
AFLAs
Assigned Value (μg/kg) 12.5 58.4 33.8 19.2 15.2 6.81 4.86 9.2 20.2 1.05 2.07 0.28
No. of Laboratories 20 20 20 19 20 19 20 20 20 20 20 19
No. of Outliers 0 0 0 0 0 1 2 0 0 1 1 1
No. of Accepted Results 20 20 20 19 20 18 18 20 20 19 19 18
Mean (μg/kg) 15 65.4 35.6 21.7 15.3 7.83 4.86 8.9 21.6 1 1.95 0.268
SDr (μg/kg) 0.67 3.04 2.09 1.3 0.76 0.35 0.29 0.65 1.36 0.051 0.058 0.0305
RSDr (%) 4 5 6 6 5 4 6 7 6 5 3 11
SDR (μg/kg) 1.22 5.22 3.16 2.36 1.15 0.56 0.69 1.36 2.16 0.073 0.097 0.0351
RSDR (%) 8 8 9 11 8 7 14 15 10 7 5 13
Rec (%) 120 112 105 113 101 115 100 97 107 95 94 96
HorRat Values 0.4 0.4 0.4 0.5 0.3 0.3 0.6 0.7 0.5 0.3 0.2 0.6
OTA
Assigned Value (μg/kg) 16.9 7 12 17.2 1 9.05 3.46 4.1 2.2 0.52 0.51 0.448
No. of Laboratories 20 20 20 18 20 20 20 20 20 20 20 20
No. of Outliers 1 0 0 1 0 1 2 0 2 1 0 0
No. of Accepted Results 19 20 20 17 20 19 18 20 18 19 20 20
Mean (μg/kg) 17.7 8.3 14.5 20.9 1.05 9.81 3.37 4.51 2.72 0.6 0.535 0.444
SDr (μg/kg) 0.64 0.21 0.77 1.26 0.06 0.31 0.37 0.54 0.22 0.03 0.0345 0.0341
RSDr (%) 4 3 5 6 5 3 11 12 8 5 6 8
SDR (μg/kg) 2.73 1.27 1.91 4.16 0.16 1.33 0.43 1.27 0.44 0.069 0.06 0.056
RSDR (%) 15 15 13 20 15 14 13 28 16 11 11 13
Rec (%) 105 119 121 122 105 108 97 110 123 116 105 99
HorRat Values 0.7 0.7 0.6 0.9 0.7 0.6 0.6 1.3 0.7 0.5 0.5 0.6
S1: paprika; S2: hazelnuts, S3: dried raisins; S4: black pepper; S5: almond powder; S6: Figs; S7: maize; S8:
maize; S9: wheat; S10: wheat based infant cereal; S11: maize based infant cereal; S12: rice based infant cereal; SDr:
standard deviations of repeatability; RSDr: relative standard deviations of repeatability; SDR: standard deviations
of reproducibility; RSDR: relative standard deviations of reproducibility; Rec: recovery; n.d.: not detected.
Table 3. Method performance evaluation for ZEN, DON, T-2, HT-2, T-2+HT-2, FB1, FB2, Total FBs in
six samples.
S7 S8 S9 S10 S11 S12
ZEN
Assigned Value (μg/kg) 5.4 11.4 11.3 6.54 8.2 2.48
No. of Laboratories 20 20 20 19 20 20
No. of Outliers 1 2 2 0 2 1
No. of Accepted Results 19 18 18 19 18 19
Mean (μg/kg) 6.46 12.7 12.7 8.42 8.44 2.89
SDr (μg/kg) 0.32 0.53 0.47 0.71 0.3 0.14
RSDr (%) 5 4 4 8 4 5
SDR (μg/kg) 0.67 1.15 1.31 1.22 0.6 0.3
RSDR (%) 10 9 10 15 7 10
Rec (%) 120 111 113 129 103 116
HorRat Values 0.5 0.4 0.5 0.7 0.3 0.5
DON
Assigned Value (μg/kg) 743 506 176 220 295 45.2
No. of Laboratories 20 20 20 18 20 20
No. of Outliers 1 0 1 1 0 0
No. of Accepted Results 19 20 19 17 20 20
Mean (μg/kg) 739 527 195 220 269 43.7
SDr (μg/kg) 22 41.5 12.3 10.4 18.9 3.3
RSDr (%) 3 8 6 5 7 8
SDR (μg/kg) 48.5 52.5 13.6 15.5 25.3 3.86
RSDR (%) 7 10 7 7 9 9
Rec (%) 99 104 111 100 91 97
HorRat Values 0.4 0.6 0.3 0.3 0.5 0.4
T-2
Assigned Value (μg/kg) 57.9 43 10.3 15 23.3 11.3
No. of Laboratories 19 19 19 18 19 19
No. of Outliers 1 0 0 0 0 2
No. of Accepted Results 18 19 19 18 19 17
Mean (μg/kg) 56.9 44.4 9.66 16.1 22.2 10.6
SDr (μg/kg) 3.5 3.29 0.78 0.89 1.52 0.7
RSDr (%) 6 7 8 6 7 7
SDR (μg/kg) 3.78 5.98 2.15 1.54 2.2 0.87
RSDR (%) 7 13 22 10 10 8
Rec (%) 98 103 94 107 95 94
HorRat Values 0.3 0.6 1 0.4 0.5 0.4
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Table 3. Cont.
S7 S8 S9 S10 S11 S12
HT-2
Assigned Value (μg/kg) 81.8 27 28.6 19 14.5 9.5
No. of Laboratories 19 19 19 17 19 19
No. of Outliers 0 0 0 1 0 0
No. of Accepted Results 19 19 19 16 19 19
Mean (μg/kg) 81.1 30.3 32.3 15.9 16.1 8.1
SDr (μg/kg) 5.19 2.34 2.65 1.24 1.79 0.82
RSDr (%) 6 8 8 8 11 10
SDR (μg/kg) 10.2 4.67 4.65 1.8 2.88 1.03
RSDR (%) 13 15 14 11 18 13
Rec (%) 99 112 113 83 111 85
HorRat Values 0.6 0.7 0.7 0.5 0.8 0.6
T-2 + HT-2
Assigned Value (μg/kg) 132 68 38.9 36 38.2 20.8
No. of Laboratories 19 19 19 17 19 19
No. of Outliers 0 0 0 1 0 0
No. of Accepted Results 19 19 19 16 19 19
Mean (μg/kg) 137 74.7 42 31.8 38.4 18.7
SDr (μg/kg) 6.49 4.43 2.89 1.98 2.83 1.17
RSDr (%) 5 6 7 6 7 6
SDR (μg/kg) 12.6 6.72 5.45 2.49 3.97 1.92
RSDR (%) 9 9 13 8 10 10
Rec (%) 104 110 108 88 100 90
HorRat Values 132 68 38.9 36 38.2 20.8
FB1
Assigned Value (μg/kg) 275 4262 n.d 72 121 31.1
No. of Laboratories 20 18 - 20 20 20
No. of Outliers 0 0 - 1 0 0
No. of Accepted Results 20 18 - 19 20 20
Mean (μg/kg) 291 4735 - 76.5 125 33.1
SDr (μg/kg) 14.9 258 - 4.32 8.15 3.14
RSDr (%) 5 5 - 6 7 9
SDR (μg/kg) 35.2 541 - 11.9 18.6 5.53
RSDR (%) 12 11 - 16 15 17
Rec (%) 106 111 - 106 103 106
HorRat Values 0.6 0.9 - 0.7 0.7 0.8
FB2
Assigned Value (μg/kg) 223 1299 n.d 72 130 44.2
No. of Laboratories 20 19 - 20 20 20
No. of Outlier 0 0 - 2 2 2
No. of Accepted Results 20 19 - 18 18 18
Mean (μg/kg) 245 1500 - 74.8 134 41.1
SDr (μg/kg) 10 72.2 - 5.46 7.45 4.17
RSDr (%) 4 5 - 7 6 10
SDR (μg/kg) 25 180 - 7.25 10 4.63
RSDR (%) 10 12 - 10 7 11
Rec (%) 110 115 - 104 103 93
HorRat Values 0.5 0.8 - 0.4 0.3 0.5
Total FBs
Assigned Value (μg/kg) 485 5528 n.d. 150 245 75.3
No. of Laboratories 20 18 - 20 20 20
No. of Outliers 0 0 - 2 1 0
No. of Accepted Results 20 18 - 18 19 20
Mean (μg/kg) 536 6233 - 152 263 76
SDr (μg/kg) 18.6 291 - 8.9 12.3 5.6
RSDr (%) 3 5 - 6 5 7
SDR (μg/kg) 51.5 588 - 16.1 26.7 11.3
RSDR (%) 10 9 - 11 10 15
Rec (%) 110 113 - 101 107 101
HorRat Values 0.5 0.8 - 0.5 0.5 0.7
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Table 4. Method performance evaluation for AFM1 in two milk powder samples (S13 and S14).
S13 S14
AFM1
Assigned Value (μg/kg) 0.1121 0.0342
No. of Laboratories 20 16
No. of Outliers 2 2
No. of Accepted Results 18 14
Mean (μg/kg) 0.127 0.0333
SDr (μg/kg) 0.013 0.0073
RSDr (%) 10 22
SDR (μg/kg) 0.017 0.0087
RSDR (%) 13 26
Rec (%) 113 97
HorRat Values 0.6 1.2
Figure 3. Method performances on 115 mycotoxin/sample combinations: (a) repeatability;
(b) reproducibility; (c) Horwitz ratio (HorRat) values; (d) trueness. Rec, recovery.
The Horwitz ratio (HorRat) is a useful index of method performance with respect to precision and
is calculated as the ratio between the RSDR as obtained during the collaborative study and the RSDR as
predicted by the modified Horwitz equation [25,26]. Method reproducibility is considered as normal
when the HorRat value is between 0.5 and 1.5 [19]. In this study, HorRat values ranged from 0.2 to
1.3 for the 115 mycotoxin/sample combinations (Tables 2–4, Figure 3). Approximately 50% of HorRat
values were even lower than 0.5. This might be explained by: (a) the high robustness of the method
(already known since it has been heavily used for >5 years in routine environments at Nestlé), (b) by
the use of isotopically labelled internal standards for quantification purpose, and (c) by the analytical
skills of participating laboratories.
The trueness of the method was then assessed by calculating the recovery (Rec, %) for each of the
115 mycotoxin/matrix combinations. Rec figures ranged from 84% to 129% with eleven data slightly
above the requirements defined in EC 401/2006 [24]. We mention that three of them concerned FB1,
FB2, and FBs in the maize sample for which levels were out of the calibration range (data reported for
information purposes only). The overall set of data unambiguously demonstrated the high confidence
level of the method regardless of the sample/concentration/mycotoxin combinations.
Focusing on individual participant data, all mycotoxins were correctly detected of the sample
except in two cases. While all laboratories detected AFG2 at 0.31 μg/kg in the wheat based infant cereal,
five of them could not detect AFG2 at a lower level in the rice based infant cereal (0.052 μg/kg), which
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could jeopardize the conclusion with respect to method sensitivity. However, neither AFG2 nor AFTOT
(sum of the four AFLAs) are regulated for infant cereals. AFM1 in each of the two milk powders
was detected by 16 and 20 out of the 20 laboratories, respectively. According to the related supplier
recommendation, respective concentration levels in reconstituted milk correspond to 0.0034 μg/kg and
0.0117 μg/kg. Consequently, the highest AFM1 validated level that was detected by all participants
was still half of the ML set for AFM1 in milk-based products (0.025 μg/kg [3]).
As shown in Table 5, the lowest level of the sum of T-2 and HT-2 validated in this study was
18.6 μg/kg (i.e., 10.6 μg/kg and 8.0 μg/kg for T-2 and HT-2 as individual toxin, respectively). This is
slightly higher than the 15 μg/kg level set for cereal based foods for infants and young children as an
indicative level for which subsequent investigations should be performed according to EC 165/2013 [4].
However, internal validation data at 10 μg/kg for the sum of T-2 and HT-2 (i.e., 5 μg/kg for each T-2 and
HT-2 toxins) [14,16] demonstrated the good performance of this method and its compliance with EC
165/2013 [4]. For all other mycotoxins considered, the lowest validated level in this study was lower
than the lowest EU MLs [3], evidencing the method as fit for purpose to ensure compliance of food
materials with regards to this regulation.
Table 5. Fitness-for-purpose of the method with regards to EU regulations for foods intended for
infants and young children.
Mycotoxins ML (μg/kg) a Lowest Validated Level (μg/kg) RSDr (%) RSDR (%) Rec%
AFB1 0.1 0.084 12 18 99
OTA 0.5 0.44 8 13 99
DON 200 43.6 8 9 97
ZEN 20 8.8 8 13 92
T-2 + HT-2 15 b 18.6 6 10 90
FBTOT 200 76.2 7 15 101
AFM1 0.025 c 0.0117 10 13 113
a Commission Regulation (EC) No. 1881/2006; b Commission Regulation (EC) No. 165/2013; c refers to the products
ready to use (marketed as such or after reconstitution as instructed by the manufacturer).
2.5. Output: Future Perspective
Whilst LC-MS/MS based methods are recognized as state-of-the-art approaches for chemical
contaminants’ analysis in food, current standards for mycotoxin monitoring are still mainly based
on TLC or HPLC-UV/FLD and/or often limited to a single compound, or family at best [13]. This
study proved that the proposed methodology is an excellent candidate for future standardization since
it offers a highly trustful and efficient approach for multi-residue analysis of regulated mycotoxins.
Its applicability whatever food type, mycotoxin, and concentration level is well adapted for food
control environments, today facing shorter and shorter turn-around times.
The cost effectiveness of any routine method is not to be neglected, and the price of 13C-labeled
compounds used as ISTD might impede their usage. However, our own estimation showed that the
sample throughput by using this isotopic dilution approach was increased by a factor of three, which
was balanced with the additional cost of the ISs. The matrix matched calibration curve (which is
restricted to one or two sample types analyzed per batch with the additional requirement to have
blank matrices available for spiking purposes) or standard addition (requiring several extractions for
one single analysis) quantifications are indeed time consuming, not user friendly, and not adapted
for laboratories dealing with a broad range of food matrices on a daily basis. The use of labelled
ISTD also improves method precision and accuracy, as recently highlighted in a study evaluating
different approaches (extraction, clean-up, quantification) for mycotoxins determination in cereals [27].
The best performances were achieved by a method making use of 13C-labeled internal standards
for quantification.
Finally, the proposed extraction procedure (QuEChERS) is generic and already known to be
efficient for a wide range of compounds with different polarity. Our trials already demonstrated
that such an extraction approach is valid as well for deoxynivalenol acetylated or modified forms
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(e.g., 3-acetyl-DON, 15-acetyl-DON, DON-3-glucoside). These compounds are not regulated yet, but
the European Commission initiated discussions to review the existing maximum levels for DON,
taking into account DON acetylated and modified forms [28]. Related isotopically labelled compounds
are now commercially available, making these compounds good candidates for future scope extension.
3. Conclusions
Standardized and internationally accepted methods for food compliance testing are of utmost
importance to avoid discrepancies in results, as this may generate unsubstantiated disputes and
ultimately distort global food trade. The current standardized methodologies devoted to the analysis
of mycotoxins in food are not adapted anymore to high-throughput routine environments, facing
today a broader range of items to monitor, an increasing pressure to shorten turn-around time, and
cost constraints. This paper proposes an efficient analytical approach for multi-residue analysis of
regulated mycotoxins, even at low regulated levels for foods intended for infants and young children.
The overall set of data derived from this study proved that the proposed methodology is an excellent
candidate for future standardization.
4. Materials and Methods
4.1. Study Organization
4.1.1. Study Materials
Each participant was supplied with AFLAOCHRA PREP® IACs (R-Biopharm, Darmstadt,
Germany, n = 26), ready-to-use QuEChERS salt mixtures (Agilent, Geneva, Switzerland, n = 35), and
ready-to-use PBS tablets (Oxoid, Basingstoke, U.K., n = 10).
4.1.2. Study Samples
Each participant was given 30 bottles containing ca. 25.0 g of foods. Samples were composed of
28 blind duplicate samples randomly coded from A to β and of one “practice sample” in duplicate.
Samples A to L (n = 12) belonged to the group “nuts, spices, and dried fruits” and were paprika,
black pepper, almonds, hazelnuts, dried raisins, and dried figs. Samples M to R were “raw cereals”
composed of wheat or maize (n = 6). Samples S to X were either rice, wheat, or maize based “infant
cereals” (n = 6). Samples Y to β were “milk powder” (n = 4). The “practice sample” was a maize based
infant cereal. All samples were in powdered form except hazelnuts and dried raisins, which were
provided as slurry paste.
These samples were prepared by Fapas (York, U.K.) or BIPEA (Paris, France). All items but one
were former proficiency test materials from the last 2 years, still commercially available as QC materials.
They were initially packaged in 200-g aluminum bags, but further re-dispatched in smaller 25-g units
after extensive mixing. Mycotoxins were either naturally present in the material and/or spiked by
the supplier to reach the level of interest. Only the rice based infant cereal sample was specifically
prepared by BIPEA using a mycotoxin-free product available from a supermarket in France. The item
was further spiked at levels close to the first calibration point (i.e., at the limit of quantification).
4.1.3. Study Analytical Standards Solutions for Spiking Purposes
Five ready-to-use 13C-labelled mycotoxin mixtures to be used as internal standards were prepared
by Romer Labs (Tulln, Austria): (a) the 13C-AFLA mixture was composed of (13C17)-AFB1, (13C17)-AFB2,
(13C17)-AFG1, and (13C17)-AFG2, each at 0.5 μg/mL in acetonitrile; (b) the 13C-AFM1 solution was
composed of (13C17)-AFM1 at 0.1 μg/mL in acetonitrile; (c) the 13C-[DON, T-2, HT-2, ZEN] mixture
was composed of (13C15)-DON, (13C24)-T-2 toxin, (13C22)-HT-2 toxin, and (13C18)-ZEN, at 5, 2.5, 2.5,
and 2 μg/mL in acetonitrile, respectively; (d) the 13C-FBs solution was composed of (13C34)-FB1 and
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(13C34)-FB2, each at 10 μg/mL in acetonitrile/water (50 + 50); (e) 13C-OTA was composed of (13C20)-OTA
at 10 μg/mL in acetonitrile.
These prepared solutions were dispatched as such to all participants with the exception of 13C-OTA,
which was subsequently diluted at 0.1 μg/mL in methanol-water (85 + 15) by the study organizer.
4.1.4. Study Analytical Standard Solutions for External Calibration Curves
Unlabeled mycotoxin working standard solutions were provided by Romer Labs and were:
(a) the AFLA mixture composed of AFB1, AFB2, AFG1, and AFG2, each at 1 μg/mL in acetonitrile;
(b) AFM1 at 0.1 μg/mL in acetonitrile; (c) the DON, T-2, HT-2, and ZEN mixture at 5, 2.5, 2.5, and
2 μg/mL in acetonitrile, respectively; (d) the FB mixture composed of FB1 and FB2, each at 5 μg/mL in
acetonitrile-water (50 + 50); (e) OTA at 10 μg/mL in acetonitrile. The AFLA mixture was then diluted
at 0.1 μg/mL and 0.01 μg/mL in acetonitrile and OTA at 0.1 μg/mL in methanol-water (15 + 85).
To ease lab work, a set of nine individual “ready-to-be injected” calibration points (named CAL 0
to CAL 8) was also provided. Related concentrations are given in the Supplementary Data. The same
batch of each labelled mycotoxin mixture was intended to be used for both making calibration solutions
and spiking test portions. These ready-to-use calibration solutions were all prepared at Nestlé Research
Lausanne (Lausanne, Switzerland). A total of 30 mL of each of individual calibration solution was
prepared and aliquoted in crimp vials before being stored at −20 ◦C. A previous internal stability study
evidenced that such calibration solutions are stable for at least 4 months when stored at −20 ◦C.
Before use, all calibration solutions were brought to room temperature, extensively vortexed
(minimum 1 min), and sonicated (approximately 10 min) to ensure efficient (re)solubilization of
all analytes.
4.1.5. Shipping Study Materials
Initially, 26 laboratories enrolled in this study, but two labs could not receive materials due to
customs issues (Romania, Russia). One lab withdrew its participation due to a lack of available time.
Thus, 23 packages were finally dispatched to laboratories in Austria, France, Germany (2), Hungary,
India, Ireland (2), Italia (5), Poland, Serbia, Singapore, Switzerland, The Netherlands (2), The United
Kingdom (2), and the USA (2) in June 2019.
Samples and mycotoxin standards’ solutions were all sent in a frozen state (dry ice), whereas
other materials were sent at room temperature.
4.2. Sample Preparation
Participants were asked to follow strictly the provided protocol. Samples were extracted as
previously reported [14] with minor modifications.
Test portions (5 g for cereals and cereal based products and 2 g for milk powders, nuts, spices,
and dried fruits) were weighed in 50 mL polypropylene tubes and each subsequently spiked with
50 μL of 13C-labelled working standard solutions of interest. Water (10 mL) was added, and the tube
was vigorously shaken by hand until complete dissolution. Acetonitrile containing 1% acetic acid
(10 mL) was added, and the tube was then mechanically shaken for 10 min at approximately 300 rpm.
Ready-to-use QuEChERS salt mixture containing 4.0 ± 0.1 g of MgSO4 and 1.0 ± 0.1 g of NaCl was
supplemented to initiate phase separation. The tube was immediately hand shaken to prevent any
lump formation and then placed onto a mechanical shaker for 10 min. After centrifugation (4000× g,
10 min, room temperature (RT)), 5 mL of the supernatant acetonitrile phase were mixed with 5 mL of
n-hexane and shaken for approximately 10 min on a mechanical shaker. After centrifugation (4000× g,
1 min, RT), the upper n-hexane phase was discarded.
The sample extract was then divided into two portions and submitted to two different clean-up
protocols, named “QuEChERS” and “IAC”, depending on the mycotoxin/matrix combination and the
sensitivity required for AFLAs and OTA. A general scheme is presented in Figure 1:
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• “QuEChERS”: Generic cleanup for all mycotoxins potentially present in cereals when an improved
sensitivity for AFLAs and OTA is not required. An aliquot of the defatted acetonitrile layer (1 mL)
was evaporated to dryness under a stream of nitrogen at about 40 ◦C and reconstituted in 75 μL
methanol and 425 μL water. The resulting extract was mixed for about 5 s using a vortex mixer
and ultracentrifuged at 8500× g at room temperature for 10 min.
• “IAC”: Specific cleanup for AFLAs and OTA for sensitivity purposes when dealing with infant
foods (e.g., infant cereals) and “difficult” matrices (e.g., spices, nuts, dried fruits). An aliquot of the
acetonitrile layer (2 mL) was diluted in a PBS solution (25 mL), and the whole extract was applied
onto IAC containing antibodies specific to AFLAs and OTA. The IAC was then washed with
20 mL water and the toxins finally eluted with methanol (3 × 800 μL). The eluate was evaporated
to dryness under a stream of nitrogen at about 40 ◦C and reconstituted in 30 μL of methanol
and 170 μL of water. The resulting extract was mixed for about 5 s using a vortex mixer and
ultracentrifuged at 8500× g at room temperature for 10 min.
4.3. LC-MS/MS Analysis
Instrumental conditions described hereafter were given to the participants, who were free to
adapt them for their own instrument.
LC analysis was performed with an Agilent 1290 binary pump system (Agilent, Geneva,
Switzerland). Optimal LC conditions were obtained using a Waters Acquity BEH C18 column
(2.1 × 100 mm, 1.7 μm) equipped with a BEH C18 VanGuard precolumn (2.1 × 5 mm, 1.7 μm), both
thermostated at 50 ◦C. The mobile phases were constituted of formic acid (0.15%) in water containing
10 mM of ammonium formate (Solvent A) and formic acid (0.05%) in methanol (Solvent B). A gradient
program was set up as follows: 0–0.3 min with 85% A; 0.3–4.0 min linear gradient down to 0% A; hold
at 0% A for 3 min; return to 85% A in 0.05 min and hold at 85% A for 3.95 min (total run time 10 min).
The flow rate was 0.4 mL/min, and the injection volume was 10 μL. The LC flow was directed into the
MS detector between 1.0 and 6.0 min.
MS detection was performed using a Sciex TRIPLE QUAD 6500+ instrument (Foster City, USA)
equipped with a Turbo V™ ion source. MS parameters were first obtained by syringe-infusing (each
individual standard solution in electrospray ionization (ESI) mode at concentrations of ca. 0.1 μg/mL
to 1.0 μg/mL along with the LC flow (0.4 mL/min, constituted of 50% Aqueous Mobile Phase A and
50% Organic Mobile Phase B) using a T connector. Analyses were conducted using tandem MS in
scheduled selected reaction monitoring (scheduled MRMTM) mode alternating two transition reactions
for each compound with an acquisition window of 40 s and a target scan time of 250 ms. The block
source temperature was maintained at 550 ◦C, and gas values were set as follows: curtain gas 35 psi,
GS1 40 psi, GS2 40 psi, and collision activated dissociation (CAD) gas at 10 psi. Other parameters were
ion spray voltage (5.0 kV or −4.0 kV), entrance potential (±10 eV), and collision exit potential (±15 eV).
MS/MS operated in positive/negative ionization switching mode. Individual MS parameters for the 24
compounds are provided in the Supplementary Data. Data acquisition was carried out using Analyst
software 1.7 and subsequent data processing done using Multiquant software 3.0 (both from Sciex).
4.4. Identification of Mycotoxins
Mycotoxins were considered as positively identified in the sample when all confirmation criteria
defined in the SANTE/12089/2016 document [29] were fulfilled: (a) a signal visible at least at two
diagnostic transition reactions selected for each mycotoxin and each corresponding IS; (b) the retention
time of the analyte in the sample extract corresponds to that of the average of the calibration standards
measured in the same sequence with a tolerance of ±0.2 min; (c) the retention time of the analyte
corresponds to that of its labelled internal standard with a tolerance of ±0.05 min; (d) the peak area
ratio from the different transition reactions recorded for each analyte is ±30%.
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4.5. Quantification
Quantification was performed by the isotopic dilution approach using 13C-labeled mycotoxins
as internal standard. For each mycotoxin, the calibration curve was built by plotting the peak area
ratio of each mycotoxin and its ISTD using the transition reaction for quantitation (= y axis) against the
concentration ratio of each mycotoxin and its ISTD (= x axis) using calibration solutions from CAL 0 to
CAL 6. CAL 7 and CAL 8 were only considered in the case of a highly contaminated sample when
mycotoxin levels were out of the classical calibration range.
To improve the precision of the results at the low calibration points, participants were encouraged
to use a 1/x or 1/x2 weighing factor for drawing calibration curves. Alternatively, the regression line was
forced through the origin (i.e., intercept = 0) as initially validated [14]. Deviations of back calculated
concentrations of calibrant standards from the true concentration were checked to be below ±20% [30].












where Aa is the peak area of a given analyte; Ais is the peak area of the corresponding ISTD; I is the
intercept of the regression line; S is the slope of the regression line; ma is the mass of the test portion, in
g (either 2.0 g or 5.0 g); mis is the mass of ISTD added to the test portion, in ng.
4.6. Statistical Evaluation
Each participating laboratory was first asked to analyze a “practice sample” by strictly following
the protocol given and to report results to the study director. Such a preliminary trial was intended
to familiarize the participant with the procedure and to ensure that the method was correctly set up
before starting the full study. The practice sample was an old proficiency test sample. Therefore, for
each laboratory, z-scores and recoveries were calculated based on the p-test assigned values (BIPEA,
Babyfood, round 12-3931, December 2018). When z-scores (Z) and recoveries (Rec) were within
−2 < Z < +2 and 70% < Rec < 130% ranges, the laboratory was qualified for the second part of the
study. When a laboratory did not return satisfactory results, technical support was provided to
fix issues.
Method performances were then assessed based on ISO 5725-2 [20] and AOAC International [19]
procedures using the data from the 28 blind duplicate samples that were analyzed over a maximum of
four different days by the qualified labs. After data collection, outliers and stragglers were detected
using Cochran and Grubbs tests (with critical values set at 1% and 5%, respectively). Outliers were
removed prior to calculations, but stragglers were retained. Statistics for AFTOT, FBTOT, and T2 +HT-2
toxins were derived from the sum of individual mycotoxin concentrations. Averaged concentrations,
standard deviations of repeatability (SDr), and relative standard deviations of repeatability (RSDr)
were estimated from blind duplicates for each sample and each mycotoxin. Standard deviations
of reproducibility (SDR), relative standard deviations of reproducibility (RSDR), and HorRat values
were also calculated. Trueness was evaluated based on the assigned values given by proficiency test
manufacturers for each individual material, except for Sample S12 (Tables 2 and 3) for which reference
values were obtained using our internal method (six replicates).
Supplementary Materials: The following are available online at http://www.mdpi.com/2072-6651/11/11/658/s1:
Document 1: Determination of mycotoxins by liquid chromatography-tandem mass spectrometry (LC-MS/MS),
standard operation procedure for the method validation study, 3 July 2019.
Author Contributions: Conceptualization, T.B.; Methodology, A.D., T.B. and C.M.; Validation, C.M. and T.B.;
Formal analysis, T.B.; Investigation, T.B. and C.M.; Supervision, P.M.; Writing—original draft, T.B.; Writing—review
& editing, T.B., C.M., P.M. and A.D.; Project administration, T.B.
Funding: This research received no external funding.
289
Toxins 2019, 11, 658
Acknowledgments: The authors would like to thank R-Biopharm AG (Germany), who kindly provided the
immunoaffinity columns for this study, Romer Labs Division Holding GmbH (Austria) for their help in preparing
ready-to-use analytical standard mixtures, and FAPAS (United Kingdom) and BIPEA (France) for their support to
prepare the set of samples. The authors wish to warmly thank the following people for their strong involvement
in this collaborative study: Sonia Colicchia, Helmut Rost, Ervin Tanyi, and Daniel Piller (Romer Labs Diagnostic
GmbH, Austria); Nina Tomcic, Dragana Marinkovic, and Biljana Marosanovic (SP LABORATORIJA, Serbia);
Daniel Tan and Quentin Baslé (Nestlé Quality Assurance Center, Singapore); Marta Ferro and Silvia Anselmo
(Arpal Dipartimento Laboratorio Regionale, Italy); Jozsef Kereszturi and Gabor Kiraly (WESSLING, Hungary);
Aengus O’Briain, Audrey Nugent, and Julie Tierney (The State Laboratory, Ireland); Ernest Capraro and Kimberly
Bowman (Nestlé Quality Assurance Center Dublin, USA); Phillip D Anderson, Dan Hengst, and John Zulkoski
(Eurofins Food Integrity and Innovation, USA); Wim Broer and Manuska Ganpat (NOFALAB, The Netherlands);
Joanna Oleniacz, Justyna Kłeczek-Panek, and Magdalena Migut (Nestlé Quality Assurance Center Rzeszow,
Poland); Elisabetta Caprai, Giuseppe Luca Polonini, and Simonetta Menotta (Istituto Zooprofilattico Sperimentale
della Lombardia e dell’Emilia Romagna, Italy); Manfred Schneider and Marco Feyer (CVUA Rheinland, Germany);
Amrit Kaur, Gurpreet Raj, and Mohit Mogla (Nestlé Quality Assurance Center Moga, India); Ed Boers, and Ruud
van Dam (Wageningen Food Safety Research, The Netherlands); Marc Zollinger, Daniela Matera, and Thomas
Gude (SQTS, Swiss Quality Testing Services, Switzerland); Alessandro Scantamburlo (Nestlé Quality Assurance
Center Padova, Italy); Cristina Poligani, Gaia Alice Romeo and Marco Meschiari (Neotron S.p.A, Italy); Elaine
Marley, Carol Donnelly and Dave Leeman (R-Biopharm Rhone LTD, United Kingdom); Nicolas O’Sullivan, Alison
Brazil, and Patrick English (Public Analyst’s Laboratory, Ireland); Florence Bouveret, Martine Briand, Fiona
Gasparini, Marie-Thérèse Renon, and Vincent Dufailly (Nestlé Quality Assurance Center Cergy, France); Barbara
De Santis, Carlo Brera, and Gabriele Moracci (Italian National Institute of Health, Italy); Simone Staiger, Christina
Pille, and Niels Eick (Eurofins WEJ Contaminants GmbH, Germany); Susan MacDonald and Joanna Stratton (Fera
Science Ltd., U.K.).
Conflicts of Interest: The authors declare no conflict of interest.
References
1. Paterson, R.R.M.; Lima, N. Toxicology of mycotoxins. In Molecular, Clinical and Environmental Toxicology:
Volume 2: Clinical Toxicology; Luch, A., Ed.; Birkhäuser Basel: Basel, Switerland, 2010; pp. 31–63. [CrossRef]
2. Battilani, P.; Toscano, P.; Van der Fels-Klerx, H.J.; Moretti, A.; Camardo Leggieri, M.; Brera, C.; Rortais, A.;
Goumperis, T.; Robinson, T. Aflatoxin B1 contamination in maize in Europe increases due to climate change.
Sci. Rep. 2016, 6, 24328. [CrossRef] [PubMed]
3. European Union. COMMISSION REGULATION (EC) No 1881/2006 of 19 December 2006 setting maximum
levels for certain contaminants in foodstuffs. Off. J. Eur. Union 2006, L 364, 5–24.
4. European Union. 2013/165/EU Commission Recommendation of 27 March 2013 on the presence of T-2 and
HT-2 toxin in cereals and cereal products Text with EEA relevance. Off. J. Eur. Union 2013, L 91, 12–15.
5. Smith, M.-C.; Madec, S.; Coton, E.; Hymery, N. Natural Co-Occurrence of Mycotoxins in Foods and Feeds
and Their in vitro Combined Toxicological Effects. Toxins 2016, 8, 94. [CrossRef] [PubMed]
6. Shi, H.; Schwab, W.; Yu, P. Natural Occurrence and Co-Contamination of Twelve Mycotoxins in
Industry-Submitted Cool-Season Cereal Grains Grown under a Low Heat Unit Climate Condition. Toxins
2019, 11, 160. [CrossRef] [PubMed]
7. Gruber-Dorninger, C.; Jenkins, T.; Schatzmayr, G. Global Mycotoxin Occurrence in Feed: A Ten-Year Survey.
Toxins 2019, 11, 375. [CrossRef] [PubMed]
8. European Union. Commission Decision (EC) No 657/2002 of 12 August 2002 implementing Council Directive
96/23/EC concerning the performance of analytical methods and the interpretation of results. Off. J. Eur. Union
2002, L 221, 8–36.
9. Tittlemier, S.A.; Cramer, B.; Dall’Asta, C.; Iha, M.H.; Lattanzio, V.M.T.; Malone, R.J.; Maragos, C.; Solfrizzo, M.;
Stranska-Zachariasova, M.; Stroka, J. Developments in mycotoxin analysis: an update for 2017–2018. World
Mycotoxin J. 2019, 12, 3–29. [CrossRef]
10. EN 16924:2017. Foodstuffs—Determination of Zearalenone in Edible Vegetable Oils by LC-FLD or LC-MS/MS;
European Committee for Standardization: Brussels, Belgium, 2017.
11. EN 16923:2017. Foodstuffs—Determination of T-2 Toxin and HT-2 Toxin in Cereals and Cereal Products for Infants
and Young Children by LC-MS/MS after SPE Cleanup; European Committee for Standardization: Brussels,
Belgium, 2017.
12. European Union. MANDATE FOR STANDARDISATION ADDRESSED TO CEN FOR METHODS OF
ANALYSIS FOR MYCOTOXINS IN FOOD. Available online: https://law.resource.org/pub/eu/mandates/m52
0.pdf (accessed on 19 September 2019).
290
Toxins 2019, 11, 658
13. Pascale, M.; De Girolamo, A.; Lippolis, V.; Stroka, J.; Mol, H.G.J.; Lattanzio, V.M.T. Performance Evaluation
of LC-MS Methods for Multimycotoxin Determination. J. AOAC Int. 2019. [CrossRef] [PubMed]
14. Desmarchelier, A.; Tessiot, S.; Bessaire, T.; Racault, L.; Fiorese, E.; Urbani, A.; Chan, W.C.; Cheng, P.;
Mottier, P. Combining the quick, easy, cheap, effective, rugged and safe approach and clean-up by
immunoaffinity column for the analysis of 15 mycotoxins by isotope dilution liquid chromatography
tandem mass spectrometry. J. Chromatogr. A 2014, 1337, 75–84. [CrossRef] [PubMed]
15. EN 15662:2018. Foods of Plant Origin. Multimethod for the Determination of Pesticide Residues Using GC-
and LC-Based Analysis Following Acetonitrile Extraction/Partitioning and Clean-up by Dispersive SPE. Modular
QuEChERS-Method; European Committee for Standardization: Brussels, Belgium, 2018.
16. Chan, W.-C.; Cheng, P.; Desmarchelier, A.; Fiorese, E.; Stephan, M. Mycotoxins in Foodstuffs by Isotope
Dilution LC-MS/MS. In Proceedings of the World Mycotoxin Forum 8th Conference, Vienna, Austria,
10–12 November 2014.
17. Bessaire, T. Prevention & Control of Mycotoxins at Nestlé—The Pivotal Role of Analytics. In Proceedings
of the 12th International Fresenius Conference—Contaminants and Residues in Food, Cologne, Germany,
10 April 2019.
18. ISO 17043:2010. Conformity Assessment—General Requirements for Proficiency Testing; International Organization
for Standardization: Geneva, Switzerland, 2010.
19. AOAC International. Appendix D: Guidelines for Collaborative Study Procedures To Validate Characteristics
of a Method of Analysis. J. AOAC Int. 1995, 78, 143A–160A.
20. ISO 5725-2. Accuracy (Trueness and Precision) of Measurement Methods and Results—Part 2: Basic Method for the
Determination of Repeatability and Reproducibility of a Standard Measurement Method; International Organization
for Standardization: Geneva, Switzerland, 1994.
21. Zhang, K.; Schaab, M.R.; Southwood, G.; Tor, E.R.; Aston, L.S.; Song, W.; Eitzer, B.; Majumdar, S.; Lapainis, T.;
Mai, H.; et al. A Collaborative Study: Determination of Mycotoxins in Corn, Peanut Butter, and Wheat
Flour Using Stable Isotope Dilution Assay (SIDA) and Liquid Chromatography–Tandem Mass Spectrometry
(LC-MS/MS). J. Agric. Food Chem. 2017, 65, 7138–7152. [CrossRef] [PubMed]
22. De Boevre, M.; Di Mavungu, J.D.; Maene, P.; Audenaert, K.; Deforce, D.; Haesaert, G.; Eeckhout, M.;
Callebaut, A.; Berthiller, F.; Van Peteghem, C.; et al. Development and validation of an LC-MS/MS method
for the simultaneous determination of deoxynivalenol, zearalenone, T-2-toxin and some masked metabolites
in different cereals and cereal-derived food. Food Additi. Contam. Part A Chem. Anal. Control. Expo. Risk
Assess. 2012, 29, 819–835. [CrossRef] [PubMed]
23. De Santis, B.; Debegnach, F.; Gregori, E.; Russo, S.; Marchegiani, F.; Moracci, G.; Brera, C. Development of a
LC-MS/MS Method for the Multi-Mycotoxin Determination in Composite Cereal-Based Samples. Toxins
2017, 9, 169. [CrossRef] [PubMed]
24. European Union. Commission Regulation (EC) No 401/2006 of 23 February 2006 laying down the methods
of sampling and analysis for the official control of the levels of mycotoxins in foodstuffs. Off. J. Eur. Union
2006, L 70, 12–34.
25. Horwitz, W.; Kamps, L.R.; Boyer, K.W. Quality assurance in the analysis of foods and trace constituents.
J. Assoc. Off. Anal. Chem. 1980, 63, 1344–1354. [PubMed]
26. Thompson, M. Recent trends in inter-laboratory precision at ppb and sub-ppb concentrations in relation to
fitness for purpose criteria in proficiency testing. Analyst 2000, 125, 385–386. [CrossRef]
27. Solfrizzo, M.; Gambacorta, L.; Bibi, R.; Ciriaci, M.; Paoloni, A.; Pecorelli, I. Multimycotoxin Analysis by
LC-MS/MS in Cereal Food and Feed: Comparison of Different Approaches for Extraction, Purification, and
Calibration. J. AOAC Int. 2018, 101, 647–657. [CrossRef] [PubMed]
28. European Union. Summary Report of the Standing Committee on Plants, Animals, Food and Feed Held in
Brussels on 17 September 2018. Available online: https://ec.europa.eu/food/sites/food/files/safety/docs/reg-com
_toxic_20180917_sum.pdf?_cldee=bXZhbndlZWRlQGZubGkubmw%3d&recipientid=contact-2800eeaa6e2b
e8118127e0071b65ce91-45527089537b4f53a6f83c9233e6de1d&esid=3b6db41a-2660-e911-a96d-000d3ab490f3
(accessed on 30 September 2019).
291
Toxins 2019, 11, 658
29. SANTE/12089/2016. Guidance Document on Identification of Mycotoxins in Food and Feed; European Commission
Directorate General for Health and Food Safety: Brussels, Belgium, 2016.
30. SANTE/11813/2017. Guidance Document on Analytical Quality Control and Method Validation Procedures for
Pesticide Residues and Analysis in Food and Feed; European Commission Directorate General for Health and
Food Safety: Brussels, Belgium, 2017.
© 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution






Tel. +41 61 683 77 34






St. Alban-Anlage 66 
4052 Basel 
Switzerland
Tel: +41 61 683 77 34 
Fax: +41 61 302 89 18
www.mdpi.com ISBN 978-3-03936-207-3 
